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Abstract
Head and neck cancer (HNC) is the seventh highest cause of cancer mortality worldwide. Upwards
of 50% of those affected experience malnutrition and this is associated with reduced survival.
Evidence-based guidelines (EBGs) provide recommendations to help prevent and manage
malnutrition. However, it is unclear how well these are implemented in practice. Therefore, the aim
of this thesis was to explore the implementation of nutritional EBGs for individuals with HNC.

In Chapter 1 introduce this thesis and outline the translational research framework that guided this
work. In Chapter 2 I discuss the methodology and provide the rationale for a sequential mixedmethods research design.

In Chapter 3 I carried out a narrative literature review of quantitative and qualitative studies (n=21).
From this I identified that implementing nutritional EBGs results in positive outcomes for
individuals with HNC. However, several factors can influence implementation in practice.

In Chapter 4 I measured adherence to several EBG recommendations, by retrospectively reviewing
patient medical records (n=81). Recommendations relating to completing initial nutritional
assessments and using prophylactic feeding tubes were well adhered to. However, the
recommendation for weekly nutritional assessments with a dietitian during radiotherapy was only
met 62% of the time, and patients had difficulty meeting energy intake targets.

In Chapter 5 I conducted a longitudinal qualitative study by interviewing individuals with HNC
throughout their treatment journey (n=10). Their ability and willingness to implement nutritional
recommendations was affected by physical and psychosocial barriers. However, a collaborative
multidisciplinary approach to care, and having clinic structures that promote continuity with the
dietitian may minimise these barriers.

In Chapter 6 I conducted a systematic literature review of qualitative studies (n=9) on the experience
individuals with HNC who were receiving nutrition support through a feeding tube (n=159). Most
believed that having a feeding tube placed when it was recommended was beneficial. However, an
individualised approach and support from a multidisciplinary team inclusive of dietitians was
important to promote a positive experience.

In Chapters 7, 8 and 9 I conducted three international multi-site studies with healthcare professionals
(n=46) from four HNC teams to explore: feeding tube practices, the role of the dietitian, and
facilitators of collaborative nutritional care, respectively. In Chapter 7 I highlight how a patient’s
ability and willingness to action advice, access to a speech pathologist, dietitian and nutritional
equipment, and multidisciplinary collaboration, could influence how well feeding-tube practices
aligned with EBGs. In Chapter 8 I found that dietitians were viewed as the experts in nutritional
i

care. However, the delineation of nutritional care within the HNC team was influenced by
professional experience, nutrition-care gatekeeping, clinic structure, culture, and the presence of
national EBGs. In Chapter 9 I found that collaborative nutritional care for HNC patients was
connected to: access to dietitians, communication, and role-clarity; and was influenced by funding
for dietitian positions, the strength of evidence, team meetings, communication systems,
multidisciplinary clinics, non-clinical activities, and respect.

In the final chapter I synthesised the findings from this thesis. This highlighted several factors that
can influence the implementation of EBGs, including: the presence and strength of nutritional EBGs,
interprofessional education, dietetic training and experience, workplace culture, clinic structure,
team meetings, interprofessional respect, and patient characteristics. In conclusion, engagement
with governing organisations, professional associations, service managers, healthcare professionals,
patients, and carers is central to enhancing the implementation of nutritional EBGs for individuals
with HNC for improved outcomes.
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CHAPTER 1: Introduction
1.1 Overview
1.1.1 Position of the researcher and research setting
Prior to reading this thesis, it is important to understand the position of the researcher. I carried out this
research as part of a combined PhD and clinician research program offered by the Illawarra Shoalhaven
Local Health District (ISLHD). This program supports clinicians employed by the ISLHD to undertake
research. The ISLHD is in New South Wales, Australia, and comprises a 250 km-long coastal district that
includes rural, regional and metropolitan areas. It provides health services to approximately 400,000
residents of the Illawarra Shoalhaven region (2).

Figure 1. Map of the local health district regions in NSW and the hospitals that comprise the
Illawarra Shoalhaven Local Health District. Images from NSW Health (2)

Within the ISLHD head and neck cancer (HNC) is the ninth most common cancer and accounts for nearly
three percent of all cancers

(3).

The ISLHD has two cancer-treatment centres located at the northern and

southern aspects of the district. Patients treated for HNC at either of the two ISLHD cancer-treatment
centres are routinely scheduled to attend a clinic that combines the services of a specialist oncology nurse,
dietitian, and speech pathologist throughout their cancer journey. The opportunity to conduct research that
was focused on the nutritional care of patients with HNC was supported by the ISLHD Cancer Care Centre’s
radiation oncologist staff-specialist trust fund in conjunction with the Australian Government Research
Training Program Scholarship with the University of Wollongong.

I was led to this thesis that focuses on nutritional care for patients with HNC through professional
experiences of training and working as a dietitian within the ISLHD, and through having a personal
1

appreciation of the impact of cancer on the lives of family and friends. I embarked on this PhD as an earlycareer dietitian in 2016. Through working in the hospital environment, I quickly learnt that a unique and
complex interplay of psychosocial and physiological characteristics influence each patient’s willingness
and ability to act on evidence-based nutritional advice. I noticed that such barriers were particularly
profound among people with HNC as the physical effects of the disease and treatment meant that eating
was a remarkably difficult task.

I was inspired by stories from patients who described feeling defeated by and a loss for the innately
pleasurable and culturally connected experience of eating. This was in addition to coming to terms with a
cancer diagnosis and the stark awareness of one’s own mortality. I was motivated to learn more from those
affected by HNC so that I could ensure that the evidence-based nutritional recommendations that I needed
to provide as a dietitian could be delivered in a way that was considerate and patient-centred.

I gained an appreciation for and basic skills in both qualitative and quantitative research after completing
my honours thesis on patient-centred care for older malnourished patients in the hospital setting

(4).

Thus,

when I learnt of the opportunity to undertake formal research that focused on the nutritional care for patients
with HNC within the ISLHD I saw this an important way to gain and share knowledge about how evidencebased nutritional care could be better delivered to patients. This was considered integral to improving
nutritional outcomes for these vulnerable individuals locally, and in similar health services across the globe.

Within the hospital setting dietitians work within the context of multidisciplinary teams. Dietetic goals must
align with the goals of physicians, nurses, and other allied health professionals and collectively those goals
must be patient centred. Multidisciplinary healthcare teams are shaped by the priorities of that medical
specialty, the staffing available and the physical setting. Thus, healthcare teams in different settings may
vary in structure and composition. I was curious to understand more about how the characteristics of the
practice setting could influence how dietitians, in collaboration with other members of the multidisciplinary
team, deliver nutritional care in line with nutritional evidence-based guidelines (EBGs). Particularly, to
nutritionally vulnerable people, such as those with HNC. Therefore, the experiences of healthcare
professionals who provide nutritional care to patients with HNC was recognised as a way to complement
and expand on the patient experiences and provide a more holistic understanding of how the implementation
of evidence-based nutritional care could be enhanced.

Equipped with the motivation to undertake mixed-method research with both patients and healthcare
professionals, much of the reading in my first semester of PhD candidature concerned different qualitative
methodologies. With the minimal experience using a qualitative methodology I was eager to learn more
about the different philosophies, principles, and techniques. I was fortunate that four of my supervisors had
expertise in qualitative research from different kinds of inquiry, such as conversation analysis,
phenomenology and grounded theory. I also undertook a training program to enhance my skills in
qualitative research through the Australian Consortium of Social and Political Research Incorporated during
the first session of my PhD enrolment in 2016. This encouraged me to reflect on my own ontological (i.e.
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the understanding of the nature of the world) (5) and epistemological (i.e. the philosophical understandings
of how knowledge is produced) (5) position. It was through this that I learnt of the need to be reflexive and
consider how my own background as a well-educated, middle class, English speaking Caucasian, cis-female
dietitian creates a lens that may influence how I interpret the experiences of patients and colleagues from
different cultural, social and professional backgrounds.

I came to recognise my constructivist position, as constructivism is a philosophical paradigm that is
underpinned by a relativist ontology that assumes that an individual’s perception of reality is an
interpretation that is constructed through social interactions and experiences. Therefore multiple realities
exist within a group of individuals, although elements are often shared

(6, 7). The constructivist philosophical

paradigm has a transactional or subjectivist epistemology that assumes that the researcher and phenomena
under study are inherently linked, as we cannot separate ourselves from what we know. In other words,
how the researcher understands the world will influence how they interpret the perceptions and experiences
of others (6, 8, 9).

On several occasions throughout the research process my background lens was revealed to me. For
example, I recall initially feeling somewhat affronted by some comments made by patients or healthcare
professionals regarding dietitians in Study 2 (Chapter 5) and Study 4 (Chapters 7-9). Through discussion
with my co-researchers, we were able to identify the lens that I was imposing on the data. By using the
constant comparison analysis technique and line-by-line coding methods as outlined by Charmaz (10) I was
better able to listen to what the participants were saying by asking the data ‘what is the issue here’, ‘how
does this process develop’, ‘when, why and how does the process change’ and ‘what are the consequences’
(10).

Once this understanding developed, I was able to engage more closely and work reflexively with the

data, the participants and my fellow researchers. More detail regarding the methodology used in this thesis
is provided in Chapter 2.

1.1.2 Structure of the thesis
Being a relatively novice researcher, I made a commitment to have my work examined over the course of
this thesis. For this reason, this thesis is prepared according to the University of Wollongong guidelines for
a Thesis by Compilation (11).
In Chapters 1 and 2 I introduce this thesis by providing the background and details of the methodology,
respectively. The next seven chapters (Chapter 3-9) comprise the empirical components of the research: a
narrative literature review that summarises quantitative and qualitative studies with patients with HNC and
their healthcare professionals on the implementation of nutritional EBGs, a retrospective chart review of
patient medical records to assess adherence to nutritional EBGs, a longitudinal qualitative study with
patients on the experience of nutritional care, a qualitative systematic literature review on the patient
experience of having a feeding tube, and an international multi-site qualitative study with healthcare
professionals that was divided into three sub-studies focusing on perceptions of: feeding tubes, the role of
the dietitian and collaborative nutritional care for patients with HNC, respectively. In the concluding
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chapter (Chapter 10) I summarise the quantitative and qualitative findings to highlight the factors that may
influence the implementation of nutritional EBGs for patients with HNC. In this chapter I also discuss
implications for clinical practice, recommendations for changes in clinical care and suggestions for future
research to promote the implementation of nutritional EBGs for patients with HNC.
The empirical studies included in Chapters 3 to 9 are prepared in journal-article format. A chapter overview
is included at the start of these chapters to link them with other chapters and the overarching thesis aim and
objectives. Five of these seven chapters (Chapters 5, 6, 7, 8 and 9) have been submitted for or published
with external peer review. Four conference papers related to this thesis have been peer-reviewed, published,
and presented at national and international dietetic and nutrition conferences. The peer-review process for
publication was considered important to gain feedback and confirm the relevance of this work to a wider
audience. Permission to reproduce the published chapters has been obtained from each journal. While all
published chapters were originally formatted according to the guidelines for each journal, the format has
been adjusted for consistency within the thesis. This included changing the referencing of all studies to
Vancouver style.

4

1.2 Background
1.2.1 Head and neck cancer
Head and neck cancer (HNC) is the seventh highest cause of cancer mortality worldwide

(12).

HNC is the

umbrella term for cancers of the upper aero-digestive tract, including the mouth, lip and tongue (oral cavity),
nasopharynx, oropharynx (inclusive of the base of the tongue and the tonsils), hypopharynx and larynx, in
addition to the paranasal sinuses and the salivary glands

(12, 13).

The disease is staged using the TNM

classification system, whereby T stage relates to the size of the primary tumour, N stage relates to the
presence and degree of nodal spread and M stage related to metastatic spread to distant sites (14).

Figure 2. Anatomical head and neck cancer regions. Image from Centers for Disease Control and
Prevention (15).
HNC is most common amongst men who are 40 years and older
account for 80% of HNC cases globally

(16, 17).

(16).

Extensive tobacco and alcohol use

Additionally, poor nutritional status and in particular,

inadequate intake of fresh fruit and vegetables, has been associated with more than double the risk of
developing HNC

(16, 18).

While rates of smoking and alcohol-related HNC are declining in North America

and Europe, the prevalence of the disease is expected to rise in developing countries in anticipation of the
effects of the tobacco epidemic

(12).

Additionally, there has been a rapid rise in human papillomavirus-

related HNC in developed countries, which has seen younger and less socially disadvantaged individuals
affected by the disease (19, 20). Therefore, HNC remains a highly prevalent, burdensome and complex disease
for individuals, and for the health economy on a global scale (16).
The treatment for HNC is intense and often involves multi-modality treatment with surgery, radiotherapy
and chemotherapy depending on the disease site and stage

(21).

Hence, interprofessional collaboration

among surgeons, radiation oncologists and medical oncologists is required to determine the optimal
treatment strategy for individual patients, in consideration of expected functional outcomes, treatmenttolerance and comorbidities (22).
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Standard curative-intent treatment for HNC, involves high-dose radiotherapy five days per week for six to
seven weeks. Prior to radiotherapy many patients with HNC also undergo surgery to remove or de-bulk the
tumour

(19).

This surgery can lead to swelling, pain or functional changes including dysphagia (difficulty

swallowing) (19). These side-effects are then often compounded, as radiotherapy treatment uses high-energy
radiation beams to destroy cancer cells, or to hinder their growth and spread to other areas of the body (16).
The radiation cannot differentiate between cancerous and non-cancerous cells and so nearby healthy tissue
within the head and neck region is also affected. This can alter a person’s taste and saliva production causing
dysgeusia (altered taste) and xerostomia (dry mouth) respectively, which can persist for several years
following treatment (23).
Advancements in radiotherapy technology, such as the development of intensity-modulated radiotherapy
(IMRT), has been able to minimize radiation exposure to nearby non-cancerous tissue. However, side
effects such as oral mucositis (the ulceration of mucous membranes) remains prevalent with nearly 80% of
patients with HNC affected (24-27).
Chemotherapy is often used in combination with radiotherapy to help treat more-advanced HNCs.
Chemotherapy is the delivery of cytotoxic chemicals into the blood stream that target rapidly dividing
cancer cells and interrupt cell division to prevent tumour growth and spread

(16).

Like radiotherapy,

chemotherapy cannot differentiate between cancerous and non-cancerous cells; hence this further
compounds the treatment toxicity that healthy rapidly dividing cells, such as oral mucosal cells, are exposed
to (16). Nausea and renal toxicity are other issues associated with chemotherapy (28).
In consideration of the severe treatment burden, it comes as no surprise that many people with HNC modify
or reduce their oral intake of food and fluids from as early as week two of radiotherapy

(29),

and many

become malnourished (25, 30).

1.2.2 Malnutrition and head and neck cancer
The Global Leadership Initiative on Malnutrition characterises malnutrition by the presence of at least one
phenotypic criterion (non-volitional weight loss, low body mass index or reduced muscle mass) and one
etiologic criterion (reduced food intake or assimilation, and inflammation or disease burden) as outlined in
Table 2

(31).

Phenotypic criteria can be used to define the severity of malnutrition and it is recommended

that etiologic criteria guide intervention and anticipated outcomes (31, 32).
Over 30% of patients with HNC experience malnutrition, with some studies demonstrating rates upwards
of 50% (25, 30). Studies have also demonstrated that more than 50% of patients can be malnourished prior to
commencing radiotherapy

(33).

This has been related to a high representation of smokers and extensive

alcohol users within this population

(34),

and the presence of the tumour, which may affect appetite and

physical swallow function while increasing metabolic demand (35).
The consequences of malnutrition are serious for patients with HNC. This includes decreased immune
function, poor wound repair, treatment interruptions, hospitalisations, increased length of stay, reduced
quality of life, poorer disease control and reduced survival (29, 36-43).
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Table 2. Phenotypic and etiologic criteria for the diagnosis of malnutrition taken from the Global
Leadership Initiative on Malnutrition criteria for the diagnosis of malnutrition, a consensus report
from the global clinical nutrition community (44)

Phenotypic criteria g

Weight loss (%)

>5% within past 6
months, or >≥10%
beyond 6 months

Etiologic criteria g

Low body mass
index (kg/m2)

Reduced muscle
mass a

Reduced food
intake of
assimilation b, c

Inflammation d-f

<20 if <70 years, or
<22 if >70 years
Asia:
<18.5 if <70 years,
or
<20 if >70 years

Reduced according
to validated body
composition
measuring
techniques a

≤50% of ER >1
week, or any
reduction for >2
weeks, or any
chronic GI
condition that
adversely affects
food assimilation or
absorption b, c

Acute disease/
injury d,f
Or chronic diseaserelated e,f

GI = gastro-intestinal, ER = energy requirements.
a
For example fat-free mass index (FFMI, kg/m2)) by dual-energy absorptiometry (DXA) or corresponding standards using other
body-composition methods like bioelectrical impedance analysis, CT or MRI. When not available by regional preference, physical
examination or standard anthropometric measure like mid-arm of mid-calf circumference may be used. Thresholds for reduced
muscle mass need to be adapted to race (Asia). Functional assessment like hand-grip strength may be considered as a supportive
measure.
b
Gastrointestinal symptoms can be considered as supportive indicators that can impair food intake or absorption e.g. dysphagia,
nausea, vomiting, diarrhoea, constipation or abdominal pain. Clinical judgment should be used to discern severity based upon the
degree to which intake or absorption are impaired. Symptom intensity, frequency, and duration should be noted.
c
Reduced assimilation of food/nutrients is associated with malabsorptive disorders like short bowel syndrome, pancreatic
insufficiency and after bariatric surgery. It is also associated with disorders like oesophageal strictures, gastroparesis, and intestinal
pseudo-obstruction. Malabsorption is a clinical diagnosis manifest as chronic diarrhoea or steatorrhea. Malabsorption in those with
ostomies is evidenced by elevated volumes of output. Clinical judgment or additional evaluation should be used to discern severity
based upon frequency, duration, and quantitation of faecal fat and/or volume of losses.
d
Acute disease/injury related. Severe inflammation is likely to be associated with major infection, burns, trauma or closed head
injury. Other acute disease/injury-related conditions are likely to be associated with mild to moderate inflammation.
e
Chronic disease related. Severe inflammation is not generally associated with chronic disease conditions. Chronic or recurrent mild
to moderate inflammation is likely to be associated with malignant disease, chronic obstructive pulmonary disease, congestive heart
failure, chronic renal disease or any disease with chronic or recurrent inflammation. It should be noted that transient inflammation of
a mild degree does not meet the threshold for this etiologic criterion.
f
C-reactive protein may be used as a supportive laboratory measure.
g
Requires at least one phenotypic criterion and one etiologic criterion for diagnosis of malnutrition.
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1.2.3 Nutritional care for patients with head and neck cancer
There is increasing demand on HNC services and a push for multidisciplinary teams so that patient care
can be distributed safely and efficiently among healthcare professionals based on patient needs and
professional expertise (16, 45). Considering the complexity of HNC, it is recommended that patients not only
have access to specialist oncological surgeons and physicians but also specialist nurses and allied health
professionals, including dietitians (21).
Dietitians are skilled in undertaking comprehensive nutritional assessments and providing tailored
nutritional interventions that can help to prevent and manage malnutrition and thus improve outcomes for
patients with HNC

(46, 47).

For example, dietetic counselling and the targeted use of oral nutrition

supplements for patients both during and after radiotherapy can improve nutritional intake, minimise weight
loss and malnutrition and promote quality of life

(38, 48-52).

Additionally, dietitian-led clinics for patients

treated with chemo-radiotherapy can reduce nutrition-related hospitalisations and unplanned nasogastric
tube insertions during treatment and can improve the transition to oral intake post-treatment (47).
Clinics that are led by dietitians in cooperation with specialist oncology nurses and other members of the
multidisciplinary team are well received by patients
interruptions and hospitalisations

(53, 54).

(46, 47)

and can minimise weight loss, treatment

However, there appears to be shortages in dietetic staffing within

the HNC setting both in Australia and internationally

(13).

Therefore, it is unclear how well the current

evidence supporting the role of the dietitian and collaborative multidisciplinary nutritional care for patients
with HNC is being translated into practice. Greater exploration into this is necessary to identify potential
barriers and promote quality care for patients with HNC.
Enteral nutrition should be recommended for patients with HNC who are unable to maintain adequate oral
intake throughout treatment (55). There is strong evidence to support the benefit of enteral nutrition over oral
intake alone in increasing energy and protein intake and minimising weight loss

(38, 52).

However, the

feeding-tube type and timing of placement remains a debated topic. In 2014 the Canadian Agency for Drugs
and Technologies in Health published a review of systematic reviews and EBGs to determine the
effectiveness of nasogastric tubes compared to percutaneous endoscopic gastrostomy tubes

(56).

They

concluded that due to a lack of randomised controlled trials (RCTs) there is limited evidence to support one
feeding-tube type over another (56). Therefore, they recommend that tube selection should be individualised
to suit the expected duration of enteral feeding, the patient’s psychosocial characteristics and personal
preferences and medical conditions that may restrict patients to the use of one approach (56).
The debate about the timing of feeding-tube placement centres on the use of a prophylactic gastrostomy
tube approach (i.e. a gastrostomy tube placed prior to radiotherapy and the onset of the symptoms of severe
nutrition impact) or a reactive feeding-tube approach (i.e. placing a gastrostomy or nasogastric tube at the
time that a patient requires nutritional supplementation from enteral nutrition). Langius et al 2009 found
prophylactic gastrostomy tube approach may offer better shorter-term outcomes. Yet there was minimal
difference in the longer term

(38).

Salas et al. 2009 compared a prophylactic gastrostomy to a reactive

gastrostomy and found no difference in body mass index (BMI) at either the end of treatment or six months
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post-treatment

(57),

although, there were positive effects on quality of life at both points in patients who

received a prophylactic gastrostomy tube

(57).

Silander et al. 2012 and 2013 reported a trend that fewer

patients who received a prophylactic gastrostomy tube were malnourished two months after treatment
commencement

(58, 59).

Additionally, there were non-significantly higher energy and protein intakes and

improved quality of life among patients with a prophylactic gastrostomy tube after treatment at two, three,
and six months, and at one and two years, (58, 59). There have also been several lower-level evidence studies
undertaken by researchers who have found less weight-loss and fewer hospitalisations and treatment
interruptions among patients who have a prophylactic gastrostomy tube (60-68). One salient argument against
the prophylactic gastrostomy tube approach is the risk of prolonged feeding-tube use or tube-dependence
and subsequent increased swallow impairment long term. However, feeding-tube dependence is currently
poorly defined and Shaw et al. suggests that the impact of a gastrostomy on swallowing outcomes after
treatment remains unclear (69).
The inconclusive evidence surrounding the type of feeding tube and timing of placement for patients with
HNC has been attributed to differences in feeding-tube practices in different HNC teams. Currently a
physician’s personal preferences and institutional traditions appear to direct feeding-tube practices for
patients with HNC (70). This presents a challenge to being able to determine outcomes associated with the
different approaches, and about the consistency and quality of care. More research is required to explore
current practices and the perspectives and experiences of patients and healthcare professionals to
understand how the current evidence on this nutritional intervention is translated to practice.

1.2.4 Evidence-based guidelines for the nutritional care of patients with
head and neck cancer
EBGs are used in healthcare to help translate evidence to practice by assisting healthcare professionals and
patients to make informed evidence-based decisions about care in specific clinical situations (71). The latest
evidence on nutritional care for patients with HNC has been summarised in several EBGs to provide
recommendations on the nutritional management of patients with HNC, as outlined in Table 3. For example,
the National Institute for Clinical Excellence recommends that “dietitians should be involved in pretreatment assessment…to correct patients’ pre-existing nutritional deficiencies…and to maintain their
nutritional status during treatment” (p.45) (13). The National Comprehensive Cancer Network provides more
detail by outlining that patients should be evaluated for nutritional risk during treatment and receive
nutritional counselling by a dietitian along with nutrition intervention such as feeding tubes before, during
and after treatment

(21).

They also recommend that prophylactic feeding-tube placement should be

considered for patients based on several factors related to weight loss, nutritionally significant side effects,
co-morbidities, aspiration and dysphagia

(21).

These two sets of EBGs provide a framework of

multidisciplinary care for patients with HNC by highlighting the importance of dietitians and nutritional
care.
National guidelines from the United Kingdom (UK) and Australia provide guidance for dietetic practice
and collaborative multidisciplinary nutritional care at each stage of the nutrition care process. This includes
specific recommendations regarding nutritional screening and assessment, the development of evidence9

based goals, interventions and dietary prescription and nutritional monitoring and follow-up (25, 72, 73). The
Australian guidelines have also been endorsed in the UK and New Zealand (25).
Despite the existence of EBGs, several barriers to implementing evidence-based practice exist within
healthcare

(74).

Surveys with physicians and nurses indicate that barriers can include a lack of time,

resources, experience, training and management support, a lack of evidence and conflicting evidence (75). It
is possible that dietitians and other healthcare professionals may experience similar barriers to
implementing nutritional EBGs for patients with HNC. However, more research that explores the
implementation of EBGs is required to provide insight into potential barriers to, and ways to enhance the
provision of evidence-based nutritional care within this context.
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Table 3. Overview of evidence-based guidelines for the nutritional management of patients with head and neck cancer

a

Guideline

Last
reviewed

Dietitians as
core member
of the team

National Institute for
Clinical Excellence (13)
National Comprehensive
Cancer Network (21)
United Kingdom (76)
Clinical Oncology
Society of Australia (25)

2015



2016



2016
2018




Nutritional
screening

Pretreatment
nutritional
assessment


Nutritionalassessment
parameters

Nutritional
implementati
on

Nutritional
monitoring
and follow-up

Palliative
dietetic
support






Nutritional
prescription/
intervention

a







Limited to feeding-tube placement recommendations
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1.2.5 Exploring the implementation of nutritional evidence-based guidelines
for patients with head and neck cancer
According to Rubio and Schoenbaum et al, “translational research fosters the multidirectional integration
of basic research, patient-oriented research, and population-based research, with the long-term aim of
improving the health of the public” (p. 4) (77). A model by the National Institutes of Health (NIH) outlined
the steps of translational research. This involves translating basic science with animals to an understanding
of human biochemistry and physiology; translating basic human biochemical and physiology research into
improved treatments for use in clinical practice; and delivering these treatments to the right patient at the
right time (78). The theoretical model “Practice-Based Research -‘Blue Highways on the NIH Roadmap’ by
Westfall et al

(1)

(Figure 3) is an extension of the National Institutes of Health Roadmap for Medical

Research (78) with the inclusion of an additional practice-based research dimension. This added dimension
is important to connect the research that occurs in scientific laboratories to day-to-day clinical care (1). The
extension of the model recognises the importance of implementation research as a way to explore the use
of EBGs in practice (79).
The World Health Organization explains “The basic intent of implementation research is to understand not
only what is and isn’t working, but how and why implementation is going right or wrong…” (p. 27) (80). An
important objective for implementation research in healthcare is to explore the phenomenon to make
hypotheses or generalisations from specific examples via practice-based research (80). This is important for
gaining an understanding of the possible factors and agents responsible for enhanced implementation (1, 80).
These principles could be applied to exploring how nutritional EBGs for patients with HNC are
implemented in practice.
The model for translational research by Westfall et al

(1)

has been adopted by several researchers and

research organisations. In the cancer-care context, this has involved study of the process of care through
diagnosis, treatment and long-term management to identify issues or barriers to implementing evidencebased practice and to develop strategies for overcoming them (81). To understand how nutritional EBGs for
patients with HNC are implemented in practice and what barriers may exist, more implementation research
within the T2 and T3 “translation to practice” sections of the theoretical model by Westfall, Mold
required.
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(1)

is

BENCH

BEDSIDE

Basic Science Research

T1

Preclinical Studies
Animal Research

Case Series
Phases 1 and 2
Clinical Trials

PRACTICE

Human Clinical Research
Controlled Observational
Studies
Phase 3 Clinical Trials

T2

Clinical Practice
Delivery of Recommended
Care to the Right Patient at the
Right Time
Identification of New Clinical
Questions and Gaps in Care

T2a

Practice-Based Research a

T3a

TRANSLATION TO
HUMANS

Guideline Development
Meta-analyses
Systematic Reviews

Phases 3 and 4 Clinical Trials
Observational Studies
Survey Research

TRANSLATION TO
PATIENTS

Figure 3. Theoretical model: Practice-Based Research - ‘Blue Highways’ on the NIH Roadmap” adapted from Westfall and Mold (1)
a

Indicates the dimension added by Westfall, Mold (1)
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Dissemination Research
Implementation Research

TRANSLATION TO
PRACTICE

1.3 Thesis aims and objectives
The overarching aim of this thesis was to explore the implementation of nutritional EBGs for patients with
HNC. The central question directing this thesis was, how are nutritional EBGs for patients with HNC
implemented in practice and what factors may influence implementation?
The specific objectives of this thesis were to:
1.

Synthesise current knowledge related to the implementation of evidence-based nutritional care for
patients with HNC by:
a.

Describing quantitative studies that have measured the implementation of nutritional EBGs
for patients with HNC

b.

Describing qualitative studies with patients with HNC and healthcare professionals related to
their perceptions of and experiences with dietitians and nutritional interventions.

The study findings related to this objective are presented in Chapter 3.
2.

Measure adherence to nutritional EBGs for individuals with HNC in one regional cancer care network
by measuring:
a.

The number of patients that are reviewed weekly by a dietitian during radiotherapy in line
with EBGs

b.

The number of patients that are assessed for malnutrition using a validated malnutrition
assessment tool in line with EBGs

c.

The number of patients that receive a prophylactic feeding tube and patient characteristics
associated with this compared with EBGs

d.

The adequacy of patient energy consumption compared with EBG recommendations of
30kcal/kg/day (125kJ/kg/day)

e.

The prevalence of and factors associated with adverse nutrition-related outcomes including
significant weight loss, hospitalisations, unplanned feeding-tube placements, radiotherapy
interruptions, reactive intravenous fluids and prolonged feeding-tube use.

The study findings related to this objective are presented in Chapter 4.
3.

Identify and explore factors that influence the implementation of nutritional EBGs for patients with
HNC based on their own perspectives and experiences by:
a.

Conducting a series of interviews with individuals at key points during their HNC treatment
journey in one regional cancer care network

b.

Formally summarising patient-experience research related to having and using a feeding tube
during treatment for HNC.

The study findings related to this objective are presented in Chapters 5 and 6, respectively.
4.

Identify and explore factors that influence the implementation of nutritional EBGs for patients with
HNC from the perspectives and experiences of healthcare professionals by:
a.

Conducting interviews with healthcare professionals in diverse HNC teams in Australia and
the United States.

The study findings related to this objective are presented in Chapters 7, 8 and 9.
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1.4 Thesis outline
In Table 4 I have provided an outline of the structure of this thesis, including the chapters in which the
thesis objectives are addressed. In Chapter 2 I give an overview of the methodology used in this thesis. This
provides the rationale for the thesis structure and an overview of the different study designs. More detail
regarding the rationale for and designs of each study are also included within the Methods section of
Chapters 3 through 9.
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Table 4. Overview of thesis structure

Chapter
(Study
number)
Title

Thesis
objective
addressed

Introduction
and
background

Methodology

Narrative
review

Quantitative
phase

1

2

3

4 (Study 1)

5 (Study 2)

6 (Study 3)

7 (Study 4a)

8 (Study 4b)

9 (Study 4c)

10

Introduction

Methodology

Exploring the
implementation
of nutritional
evidence-based
guidelines for
patients with
head and neck
cancer: A
narrative review

The
experience of
nutritional
care among
patients
treated for
head and neck
cancer in a
regional
Australian
cancer care
network: A
longitudinal
qualitative
study

The patient
experience of
having a
feeding tube
during
treatment for
head and neck
cancer: A
systematic
literature
review

Healthcare
professionals’
perceptions of
feeding tube
practices for
patients with
head and neck
cancer: A
qualitative
multi-site study

Healthcare
professionals’
perspectives on
the role of
dietitians within
multidisciplinar
y head and neck
cancer teams: A
qualitative
multi-site study

Healthcare
professionals’
perspectives
on what
facilitates
collaborative
nutritional
care within
head and neck
cancer teams:
A multi-site
qualitative
study

Overarching
discussion and
conclusion

n/a

n/a

1
Synthesise
current
knowledge
related to the
implementation
of evidencebased
nutritional care
for patients with
HNC

Measuring
adherence to
nutritional
evidence-based
guidelines and
outcomes
among patients
treated for head
and neck cancer
in a regional
Australian
cancer care
setting: a
retrospective
review of
patient medical
records
2
Measure the
implementation
of nutritional
EBGs for
patients with
HNC in one
regional cancer
care network

EBGs= Evidence-based guidelines, HNC = head and neck cancer
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Qualitative phase

3
Identify and explore factors that
influence the implementation of
EBGs for patients with HNC
from the perspectives and
experiences of patients

Synthesis of
quantitative
and
qualitative
findings

4
Identify and explore factors that influence the
implementation of EBGs for patients with HNC from
the perspectives and experiences of healthcare
professionals

n/a

1.5 Significance of the research
Through this thesis I have contributed to the literature on how nutritional evidence is translated into practice
for patients with HNC. Specifically, this thesis focuses on exploring the implementation of nutritional EBGs
for patients with HNC. The intent was to provide information to inform clinical practice and direct future
research to improve patient care.

There is increasing demand on HNC services and a push for multidisciplinary healthcare so that patient
care can be distributed safely and efficiently among a team of healthcare professionals based on patient
needs, and professional expertise. Patients undergoing treatment for HNC experience severe nutritional
consequences, and dietitians are skilled at undertaking comprehensive nutritional assessments and
providing tailored interventions that can improve patient outcomes. Therefore, dietitians are positioned to
lead aspects of nutritional care for patients with HNC as part of a multidisciplinary approach to care.

The development of nutritional EBGs for patients with HNC is an important step in ensuring that the
delivery of quality nutritional care reaches patients at the practice level, by providing specific
recommendations with regards to dietitian involvement, collaborative interprofessional nutritional care and
nutritional interventions (such as enteral feeding). There is a gap in knowledge related to the
implementation of nutritional EBGs for patients with HNC. Therefore, more research is required that
explores this by measuring adherence to nutritional EBGs, and by exploring what influences the
implementation of EBGs from the perspectives and experiences of stakeholders including patients and
healthcare professionals. I have summarised findings from studies that address objectives related to this in
the final chapter. In the final chapter, I have also provided recommendations for the implementation of
EBGs and for future research.

The research I have undertaken within this thesis may promote enhanced clinical care and improved
outcomes for patients with HNC. Specifically, an understanding of potential external factors may encourage
governing organisations to develop policies for HNC teams that relate to the provision of nutritional care.
Similarly, the identification of organisational barriers and enablers to patients receiving quality evidencebased nutritional care may allow service managers and developers to address this through the exploration
and implementation of suggested strategies. Dietitians and other healthcare professionals who provide care
to patients with HNC may gain knowledge about the collaborative provision of nutritional care and how
patients experience this care so that evidence-based interventions can be more patient-centred. Patients may
also benefit in the longer term from the provision of evidence-based nutritional care that is patient-centred.
Throughout this thesis I highlight future directions for research that relate to enhancing the implementation
of evidence-based nutritional care to patients with HNC. Therefore, an improved understanding of how
nutritional EBGs for individuals affected by HNC are implemented in practice, may lead to enhanced
clinical care and improved outcomes for this vulnerable group.
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CHAPTER 2: Methodology
2.1 Chapter overview
In Chapter 1 I provided readers with an overview of the nutritional burden associated with head and neck
cancer (HNC). In Chapter 1 I also provided a summary of the current evidence on nutritional interventions
and identified and outlined outcomes for patients with HNC and evidence-based guidelines (EBGs)
designed to help translate this evidence to practice

(13, 21, 25, 73).

The theoretical framework “Practice-Based

Research- ‘Blue Highways’ on the NIH Roadmap” by Westfall et al (1) was introduced. This allowed me to
explain the need for research that explores how nutritional EBGs for patients with HNC are implemented
in practice to facilitate the translation of evidence to practice and improve their outcomes.
In the current chapter I provide the rationale for a sequential explanatory mixed-methods research design
as the methodological approach most suited for this thesis which aims to explore the implementation of
nutritional EBGs for patients with HNC. I also discuss the philosophical principles of both quantitative and
qualitative research, and provide an overview of the methods selected for each study.
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2.2 Methodological approach
This thesis used a sequential explanatory mixed-methods approach

(82).

This approach involves the

collection and analysis of quantitative data, followed by qualitative data (82). This design was advantageous
for this thesis as a quantitative retrospective chart review provided local information about the research
problem by measuring the implementation of nutritional EBGs in practice and the resulting patient
nutritional outcomes

(80).

Sequential qualitative data expanded on the statistical results by exploring

participants’ views in more depth (6, 83).
An important advantage of sequential mixed-methods thesis design is that it can maximise the strengths of
both quantitative and qualitative methods, while minimising their limitations (84). For example, quantitative
research includes statistical procedures to minimise confounders and has the potential to provide
generalisable findings from large samples. However, the deductive approach is not suited to understanding
why things are happening (82). In comparison, qualitative research is typically inductive, which allows for
hypotheses and theories to be generated about a certain phenomenon. While qualitative methods allow
researchers to delve deeper into their research questions, this is often with a smaller representative sample
(82, 83). Therefore, providing information

about characteristics and trends within a larger sample of the patient

population using quantitative methods can help to contextualise the sequential qualitative findings (83).
Peters and Tran et al in a report for the World Health Organisation (WHO) recognised the benefit of mixedmethods research as a way to study implementation in healthcare

(80).

In the report they note that using

mixed-methods designs is a practical way for researchers to “understand multiple perspectives, different
types of causal pathways, and multiple types of outcomes” (p.51). Specifically, mixed methods can allow
researchers to gain participant enrichment (i.e. to gain the most information from a sample of participants)
and meaning enhancement (i.e. to maximise the interpretation of statistical analysis by using qualitative
measures). Quantitative research methods are recommended for implementation research to provide
baseline data about the phenomenon under investigation

(80).

This method could provide data on current

practice related to adherence to nutritional EBGs. Peters and Tran et al also emphasised the importance of
qualitative research methods, such as key informant interviews and focus groups, to expand on quantitative
findings to understand why implementation is or isn’t occurring

(80).

Therefore, a sequential explanatory

mixed-methods research design that incorporates quantitative data and key informant interviews was a
defensible way for me to explore the implementation of nutritional EBGs for patients with HNC in this
thesis.
Within sequential mixed-methods research designs, researchers typically place more emphasis on either the
quantitative or the qualitative phase depending on the research question

(82, 85).

To address the research

question related to exploring the implementation of nutritional EBGs in this thesis, I place greater emphasis
on qualitative research to provide rich insight into the barriers and enablers of implementation (80). Hence,
I report one on a quantitative study in one of the chapters (Chapter 4) and this is followed by five chapters
where I report on qualitative studies (Chapter 5-9) (Table 4).
An essential component of sequential-mixed-methods research is that findings from the quantitative and
the qualitative findings are mixed
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(85, 86).

I used quantitative data from the study in Chapter 4 to help to

characterise and contextualise the patient population and trends in local practices that relate to the
implementation of nutritional EBGs for patients with HNC. This allowed for key areas to be identified that
could be expanded upon through qualitative exploration with stakeholders (i.e. patients and healthcare
professionals). Specifically, this guided me to develop the aims and methods for the sequential qualitative
studies. In the final chapter (Chapter 10) I summarise findings from both the quantitative and qualitative
studies and synthesise the key factors that influence the implementation of nutritional EBGs for patients
with HNC that were identified throughout this thesis. The synthesis of these key findings guided the
development of recommendations for practice and for future research.
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2.3 Philosophical paradigm
Epistemology is the theory of what we know and how we know what we know, and ontology concerns the
assumptions and beliefs that we hold about the nature of reality

(6, 8).

Core differences between

epistemologies and ontologies characterise different philosophical paradigms and influence the type of
research questions asked and how researchers interpret data (87).
Mixed-methods research is traditionally considered to be a methodology underpinned by positivist or postpositivist assumptions (88). However, modern researchers note that with the growing need to address morecomplex questions in healthcare, such as how to deliver patient-centred care, mixed-methods research
provides a versatile and practical methodology for researchers from all paradigms (88).
In the first chapter (Section 1.1.1), I positioned myself as a constructivist researcher. Constructivism,
(otherwise known as interpretivism) is underpinned by a relativist ontology, which assumes that an
individual’s perception of reality is an interpretation that is constructed through their social interaction and
experiences. This philosophical approach stems from the assumption that reality is subjectively dependent
on one’s background experiences. Therefore multiple realities exist within a group of individuals, although
elements are often shared (6, 7). The constructivist philosophical paradigm has a transactional or subjectivist
epistemology that assumes that the researcher and phenomena under study are inherently linked, as we
cannot separate ourselves from what we know. In other words, the way that the researcher understands the
world will influence how they interpret the perceptions and experiences of others (6, 8, 9). Therefore, research
outcomes are considered a co-construction between the participant and the researcher.
Constructivist researchers aim to capture the multiple realities of an experience and conceptualise its
complexity by inductively developing a theory or “pattern of meaning” (p. 46) (6). Constructivist researchers
also recognise that experiences are subject to a context, situation, or time. Therefore, methods. such as
interviews, that allow participants to share their personal perceptions and experiences of the phenomena
under study are useful

(89).

Although constructivism is a philosophical paradigm that operates using

predominantly qualitative methods, Lincoln and Guba (90) recognize that quantitative data can also be used
within constructivist inquiry if it can support or add to the qualitative findings to deepen the description (91).
This further supports the use of a sequential-mixed-methods research design for this thesis. Therefore, in
Chapter 4 I report on a retrospective chart review to provide a snapshot of trends in nutritional care for
patients with HNC at a particular time and local setting, to help contextualise the following qualitative
chapters (Chapters 5-9).
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2.4 Methods used in this thesis
The methods used in this thesis were a narrative review (Chapter 3), a retrospective chart review (Chapter
4), semi-structured interviews guided by a constructivist grounded-theory approach (Chapters 5 and 7-9)
and a systematic literature review of qualitative studies (Chapter 6).

2.4.1 Narrative review
The narrative review method allows researchers to investigate and summarise complex topics that involve
both quantitative and qualitative research. A paper by Green, Johnson

(92)

that described the narrative

review method provided guidance on developing and implementing an appropriate search strategy,
extracting relevant data and synthesising and presenting important findings (92).
A narrative review is useful within theses to provide an overview of the current evidence in the field and to
identify gaps in the evidence base. The narrative review included in this thesis (Chapter 3) aimed to
summarise current evidence from (i) quantitative studies that have measured adherence to nutritional EBGs
and (ii) qualitative studies with patients and their healthcare professionals related to the experience of
receiving and delivering nutritional care within the HNC context. This was important to help develop the
thesis objectives and for study design.

2.4.2 Retrospective chart review
Retrospective chart reviews have been used within the HNC patient context to measure patient
characteristics and outcomes associated with adverse nutrition-related events and the use of feeding tubes
(60, 67, 93-96).

One of few studies that have assessed adherence to nutritional EBGs for patients with HNC also

utilised a retrospective chart review (97). Retrospective chart reviews have helped to inform nutritional EBGs
for patients with HNC. Therefore, this method would be useful in this thesis to provide data on how
nutritional EBGs for patients with HNC are implemented in the local setting.
A retrospective review of the medical records of patients treated for HNC in a cancer-care network in
regional Australia would help to address a gap in research related to how well nutritional EBGs for patients
with HNC are implemented in practice. Measuring adherence to specific recommendations within the
EBGs, such as whether patients saw a dietitian weekly during radiotherapy, whether malnutrition was
assessed with a validated tool, whether patients were able to meet energy targets and how prophylactic
feeding tubes were used, would provide information on nutritional interventions and how the role of the
dietitian is enacted in practice

(25, 98).

Additionally, measuring the association between adherence to EBG

recommendations and patient nutritional outcomes such as critical weight loss, nutrition-related
hospitalisations, interruptions to radiotherapy treatment and prolonged feeding tube use, would help to
highlight the impact of the dietitian and nutritional interventions for patients with HNC in the local setting.
By using a purposive consecutive sampling technique of patients treated for HNC between 2016 and 2018
contextual information would be available that could then be directly expanded on by a qualitative study
that explores the nutritional care experience with a representative sample of those patients treated in the
same setting in 2017 (Chapter 5) (99).
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Although the prospective collection of quantitative data is considered gold standard, the retrospective
medical record review method offers several advantages for the present thesis (99, 100). Firstly, the variables
that were of interest (i.e. patient demographics, nutritional status and nutritional outcomes), are recorded
within the patient’s electronic medical record as mandatory per the local documentation policy.
Furthermore, the presence of an external researcher for prospective data collection could introduce bias if
staff were to alter their practices. Thirdly, prospective data collection with patients during their radiotherapy
for this quantitative phase of the thesis was deemed unethical, as several of the patients who were eligible
were already participating in the qualitative study in Chapter 5. Finally, all patients treated for HNC in the
ISLHD cancer care network are provided with a consent form which allows them to select whether they
wish to have their medical record data used for research purposes or not. Thus, as data on usual nutritional
care practices was readily available from the electronic medical record at no extra burden to the patients,
the retrospective chart review design was deemed ethically and practically beneficial for this PhD thesis.

2.4.3 Semi-structured interviews using a grounded-theory approach
Several different qualitative methodological approaches fall within the constructivist paradigm, such as
grounded theory, ethnography and phenomenology

(101).

Grounded theory is “a general methodology for

developing theory that is grounded in data systematically gathered and analysed” (p. 273) (8) and is useful
within the constructivist philosophical paradigm as it encourages phenomena to be explored from the
interpretations of multiple first-hand experiences (8).
Grounded theory first gained traction following the 1967 publication of the book The Discovery of
Grounded Theory by Barney Glaser and Anselm Strauss (102). In the 1960’s positivist research dominated
the scientific community and qualitative research was criticised for lacking validity and verifiability

(8).

However, Glaser and Strauss recognised that generating new theories via qualitative research was essential
for understanding social phenomena

(10).

Therefore, they set out to develop a systematic approach to

qualitative research which they named grounded theory (102).
The use of the term theory in grounded theory has raised some concern among positivist researchers who
view theory as something that can be scientifically tested. However, Denzin and Lincoln (8) explain that, a
“grounded theory” is “not the formulation of some discovered aspect or pre-existing reality” (p. 279).
Rather it is a “substantive theory” or a conceptual interpretation of a process or experience from given
perspectives within a specific context (e.g. a location, point in time or disease context) (103).
Grounded theory has become more valued within the traditionally positivist health-research landscape as it
has allowed researchers to produce conceptually dense analyses that are person-centred and thus inform
clinical practice, service development and future research (104, 105). Additionally, in a report from the WHO
Peters et al recognise Grounded Theory as a useful methodology for implementation research that aims to
explore a phenomenon within healthcare

(80).

Grounded-theory methods have been successfully used in

research with patients with HNC to understand their experiences with and perspectives of a dietitiandelivered health-behaviour intervention that aimed to promote the implementation of nutritional EBGs (106)
and to explore the views of patients with HNC on the decision to have a gastrostomy tube (107). Therefore,
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grounded theory is a supported methodology help explore the implementation of nutritional EBGs for
patients with HNC.
Since the publication of The Discovery of Grounded Theory, several theoretical branches have emerged.
The first major divergence occurred when Strauss co-authored the Basics of Qualitative Research:
Grounded Theory and Techniques with Juliet Corbin in 1990 (108). Constructivist grounded theory was later
described in Constructing Grounded Theory: a practical guideline through Qualitative Analysis

(10)

by

Charmaz, who was a former student of Glaser and Strauss. Today, “Classical”, “Straussian” and
“constructivist” grounded theory are considered the three major approaches.
Classic grounded theory is underpinned by the belief that researchers should have a “neutral” epistemology
and ontology

(102).

Additionally, some classic grounded theorists suggest that having a specific research

question or knowledge of extant literature prior to data collection is undesirable, as it may encourage the
researcher to be more deductive rather than inductive in their analysis

(102).

This has received criticism as

positioning the research within a philosophical interpretive framework that recognises the researcher’s
epistemological and ontological assumptions, and conducting a literature review prior to data collection are
essential for most modern research pursuits (103, 108). As I am a dietitian working within the hospital setting,
I naturally bring disciplinary knowledge regarding the nutritional care of patients with HNC to this research.
Therefore, the classic grounded-theory methodology would present challenges for this PhD thesis.
Straussian grounded theorists appreciate that people commence qualitative research with an understanding
of their professional and disciplinary literature (108). However, the Straussian approach to grounded theory
has been criticised for introducing more technical procedures for data verifiability which could encourage
researchers to force the qualitative data into pre-conceived categories, thus conflicting with the open and
emergent basic tenets of grounded theory (10, 109, 110).
The constructivist approach to grounded theory, as detailed in Charmaz’s Constructing Grounded Theory:
a practical guideline through Qualitative Analysis, also appreciates the researcher’s inherent knowledge,
while promoting induction (10). Specifically Charmaz (10) did not believe that theory was discoverable from
the data separate from the researcher. Rather, the resulting grounded theory is a natural co-construction
between the participants and researcher as “we are part of the world we study and the data we collect. We
construct our grounded theories through our past and present involvements and interactions with people,
perspectives and research practices” (p. 10) (6). While some have argued that the constructivist approach to
grounded theory makes the researcher’s impact on the data more important than the participant’s experience
(111),

constructivist grounded theorists explain that this approach simply recognises the inherent role that the

researcher has in qualitative research and that their background assumptions and disciplinary perspectives
naturally lead them to particular research questions (10). As a clinical dietitian, I bring a specific lens to the
research field. Thus, it was important that Charmaz

(10)

puts forward several recommendations for data

collection and analysis to prevent my own views from blinding me to emergent ideas. The constructivist
approach also appreciates the practicalities and benefits of undertaking a literature review prior to data
collection, as this allows researchers to become sensitised to emergent ideas within the data, that might
otherwise be overlooked

(10).

Therefore, with consideration of rigour and reflexivity, the constructivist

approach to grounded theory as outlined in Charmaz’s Constructing Grounded Theory: a practical
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guideline through Qualitative Analysis guided the methods for the qualitative studies in this thesis (Chapters
5 and 7-9).
Participant interviews are recognised as a useful data-collection method in constructivist grounded theory
as they allow researchers to capture the multiple realities of an experience

(10).

Constructivist grounded

theory encourages larger participant samples that are purposefully and inductively pursued throughout the
research process, so that a more diverse spread of individuals who have experienced the phenomenon under
different conditions can be included (10). Qualitative longitudinal study designs have been used to explore
symptoms, including pain and how normality is regained after treatment among patients with HNC (112-114).
Additionally, Martin, de van der Schueren

(70)

used a multi-site research design to explore enablers and

barriers to nutritional care for patients with HNC in several cancer centres in Europe. Therefore,
undertaking a longitudinal study that collects data via participant interviews with patients at key points over
the course of their HNC treatment journey, and a multi-site study that collects data via participant interviews
with healthcare professionals from different HNC teams, would provide in-depth qualitative data so that
the implementation of nutritional EBGs for patients with HNC can be explored.
Grounded theory is valued for its explorative, open and inductive nature by allowing the findings to evolve
and become continually more focused over the study

(10).

Furthermore, the constructivist approach to

grounded theory recommends that interview questions remain open and flexible so that participants can
discuss the ideas that are most significant to their personal experience

(10).

This is also important for

sequential mixed-method research as it allows researchers to focus questions in response to findings from
previous quantitative or qualitative data

(82).

In consideration of this, the two interview guides developed

for the qualitative studies in this thesis comprised open questions covering broad topic areas, and over the
data-collection period the prompting questions became more refined. For the interviews with patients with
HNC (Chapter 5), the interview guide included broad questions about their individual HNC journey and
involvement from different healthcare professionals at different times. Prompting questions were developed
during the research period in response to important emergent ideas, such as whether they had seen a dietitian
or speech pathologist and if they had plans to follow up with them. Please see examples below.
Post-operative interview











How are things going at the moment?
Tell me about your hospital stay and the surgery – was it what you had expected?
What is the next step now that you have been discharged from hospital?
Have you had an opportunity to see the surgeon again after your surgery?
Did you see any other health professionals while you were in hospital (e.g. speech pathologist,
dietician, social work, specialist nurses etc)? If so, is there any plan to follow up with these health
professionals?
Have you seen a GP since your discharge from hospital? If so, how many times?
Are you still seeing the same GP who referred you regarding your cancer diagnosis?
Do you talk to your GP about the cancer treatment?
Do you feel you have enough information about your condition and treatment?
Do you feel that there is sufficient communication between the health professionals about your
condition and treatment?

Six weeks post-radiotherapy interview
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How are things going at the moment?










What do you understand is the “next step” /where to from here?
Have you seen a GP since your surgery/since completing the radiotherapy? If so, how many
times?
Are you still seeing the same GP who referred you regarding your cancer diagnosis?
Do you have any ongoing contact with health professionals other than doctors? If so, what is the
plan for follow-up with these health professionals?
Is there anything that has been helpful or unhelpful to your understanding of your current
progress?
When you have questions or concerns about your progress, who do you feel most comfortable
discussing this with? Do you feel that any concerns or questions that you have are being
addressed?
Do you feel you have enough information about your condition and treatment?
Do you feel that there is sufficient communication between the health professionals about your
condition and treatment?

Likewise, the semi-structured interview guide for healthcare professionals (Chapters 7-9) involved broad
questions that related to nutritional issues among patients with HNC and how they were managed by the
HNC team. Prompting questions (in brackets below) became more refined over the data-collection period
so that the interviewer could explore emergent ideas in depth.



Can you tell me a bit about the main nutritional issues that arise with the head and neck patients
in your opinion? (Which patients are most nutritionally at risk? Do you have a system or guideline
for identifying patients at nutritional risk, e.g. screening process?)
Are you able to talk through a scenario where a patient with head and neck cancer had a
nutritional issue and how that was managed by the team? (Do you have or follow any nutritioncare policies or guidelines?)

The full semi-structured interview guides that were used in this thesis with patients with HNC and with
healthcare professionals are included in Appendix 2 and 5, respectively.
For constructivist grounded theory, Charmaz

(10)

recommends the use of several analytical techniques to

promote induction and reflexivity, including: constant-comparison analysis, memo-writing and theoretical
sampling (115). Constant-comparison analysis occurs during coding and this is the essential link between the
data and the developing the grounded theory

(10).

To facilitate this, Charmaz

(10)

recommends that initial

coding occur line by line and that the data is coded as actions using gerunds to keep the analysis as reflective
of the raw data as possible. During initial coding, comparisons are made between codes, and as strong
analytic connections emerge “focused codes” synthesise and explain larger segments of the data. Charmaz
(10)

emphasises that constant-comparison analysis is not linear, rather, as more data is collected new codes

emerge that are compared to existing codes. Thus, codes are continually reshaped and refitted until they
become substantiated by data (110).
Memo-writing is encouraged throughout data collection and analysis as a technique to promote
trustworthiness in the coding process. Memo-writing encourages the researcher to reflect on the data, ask
questions of it, consider the multiple perspectives and record any deliberations and gaps in the data (102, 110).
Through identifying gaps in the focused codes, the researcher can return to previously collected data or
collect more data with greater focus to promote saturation. This process is termed “theoretical sampling”
(103).

Through memo-writing and theoretical sampling, focused codes become substantiated and raised to

categories. Relationships between categories are then explored and recorded as memos to facilitate the
identification of core categories
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(10).

In contrast to the Straussian and classical approaches to grounded

theory, constructivist grounded theory does not require the discovery of one core category (87), as Charmaz
(10)

argued that pre-determining that one core category will emerge from the data is a positivist notion that

limits the inductive approach (87).
Finally, the constructivist approach to grounded theory encourages the participant’s narrative to be
embedded in the grounded theory by “rendering participants’ experiences into readable theoretical
interpretations” Mills, Bonner (87) (p. 32). Specifically, Charmaz recommends the use of an active coding
language and recommends that raw data remain in memos and the write-up as participant quotes, so that
the participants’ voice remains present. This helps readers to identify the connection between the grounded
theory and the data from which it was derived

(87)

and is important, as researchers are ethically obliged to

describe the participant’s experience in the most faithful way possible to promote authenticity (87, 116). Thus,
a constructivist approach to grounded theory, that uses participant interviews for data collection, is a
defensible methodology to guide the qualitative studies included in this thesis (Chapters 5 and 7-9) so that
the experience of individuals who receive and provide care can inform how nutritional EBG’s are
implemented for patients with HNC.

2.4.4 Qualitative systematic review
Qualitative systematic reviews are useful for synthesising findings from multiple qualitative studies to
provide a rich perspective on a topic from the experiences of those to whom it most relates

(117).

Several

studies provide insight into the experience of having a feeding tube through interviews with patients with
HNC

(107, 118-125).

Hence, a systematic review of this qualitative evidence is important to provide a strong

patient perspective on how patients accept and use this nutritional intervention.
The Joanna Briggs Institute provides guidelines for conducting a qualitative systematic review by using a
meta- aggregative approach (126). This approach allows for the development of generalisable statements in
the form of recommendations to guide practitioners and policy-makers (126). A qualitative systematic review
on the patient experience of having a feeding tube would add to this thesis by providing insight into how
patient factors may influence the implementation of nutritional EBGs related to enteral nutrition

(25).

This

may allow strategies to promote patient acceptance and usability of this evidence-based nutritional
intervention to be developed for use in clinical practice.
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CHAPTER 3: Exploring the implementation of nutritional
evidence-based guidelines for patients with head and neck
cancer: A narrative review
3.1 Chapter overview
In Chapter 2 I provided the rationale for a sequential mixed-methods thesis design to explore the
implementation of nutritional EBGs for patients with HNC. In the current chapter I report on a narrative
review that aimed to address Objective 1 of this thesis: Synthesise current knowledge related to the
implementation of evidence-based nutritional care for patients with HNC. The synthesised findings from
quantitative and qualitative research provide insight into the impact that implementing nutritional EBGs
has on patient outcomes and identifies several factors that may influence how well EBGs are implemented
in practice. Several gaps in the knowledge are identified; these are subsequently addressed in later chapters.
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3.2 Abstract
Background: Exploring the implementation of nutritional evidence-based guidelines (EBGs) for patients
with head and neck cancer (HNC) through research is an important step in translating evidence to practice
for best nutritional outcomes. However, to date no comprehensive reviews have synthesised both
quantitative and qualitative research on how nutritional EBGs for patients with HNC are implemented and
what may enhance this. Therefore, the aim of this review was to synthesise findings from quantitative
studies that have measured adherence to nutritional EBGs, and qualitative studies on the experience of
receiving and delivering nutritional care according to HNC patients and their healthcare professionals.

Methods: A narrative review was undertaken. Two search strategies were applied to the databases Web of
Science, Scopus and Science Direct. Both searches included common terms related to: HNC and nutrition.
Search (i) included additional search terms related to EBGs and adherence; search (ii) included additional
terms related to experiences and qualitative methods. Papers that were eligible for inclusion involved adult
patients who had HNC or healthcare professionals that had a role in the clinical care of patients with HNC;
reported on adherence to EBGs within practice or described perspectives on nutritional care for patients
with HNC; reported results in English; and were available in a full-text version.

Results: Three quantitative studies that measured adherence to nutritional EBGs and 19 qualitative studies
that explored nutritional care experiences in the HNC context with patients and healthcare professionals
were included. Adhering to nutritional EBGs for patients with HNC can provide positive outcomes for
patients. However, the implementation of nutritional EBGs appears to be influenced by multiple factors
including executive support, dietetic resources, multidisciplinary clinic structures, perceptions and
experiences regarding the value of dietitians and nutritional care among physicians and nurses, the level of
evidence supporting nutritional recommendations in EBGs, and patient acceptance of the dietitian and
nutritional care.

Conclusion: To explore the implementation of nutritional EBGs for patients with HNC more research is
required that measures adherence to recommendations within nutritional EBGs. This should be
accompanied by qualitative research with patients and healthcare professionals to understand their
perceptions of and experiences with dietitians and nutritional care on HNC teams. This is important to
understand how the implementation of nutritional EBGs may be enhanced in practice to improve outcomes
for patients with HNC.
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3.3 Introduction
EBGs are used in healthcare to help healthcare professionals and patients make informed, evidence-based
decisions about appropriate care in specific clinical situations

(79).

Thus they facilitate the translation of

evidence into practice (79). National EBGs for the nutritional management of patients with HNC have been
developed in the United Kingdom (UK) and in Australia

(25, 73).

These EBGs provide specific

recommendations regarding nutritional screening, assessment, goal setting, interventions, monitoring and
follow-up (25, 73).
Barriers to implementing evidence-based practice within healthcare settings can include a lack of time,
resources, experience, training and management support and having limited or conflicting evidence to
support changes in practice (75). These barriers could hinder the ability of dietitians and other members of
HNC teams to provide evidence-based nutritional care to patients with HNC. However, there has been
limited focused research on this to date. Exploring factors that may be responsible for good implementation
or for enhancing implementation of nutritional EBGs for patients with HNC is important to promote the
translation of evidence to practice (80).
Quantitative and qualitative research are both useful for understanding what influences the implementation
of EBGs, and to what degree (1, 80). The combination of these methods offers rich insight into implementation
from multiple angles

(1, 80).

No comprehensive reviews have summarised either quantitative or qualitative

research that provides insight into how nutritional EBGs for patients with HNC are implemented in practice
to date. Therefore, the aim of this narrative review was to synthesise quantitative studies that have measured
adherence to nutritional EBGs for patients with HNC and qualitative studies with patients of HNC and their
healthcare professionals that have explored perceptions and experiences of nutritional care within the HNC
context.
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3.4 Methods
The narrative-review format offers a method for investigating and summarising complex topics that involve
both quantitative and qualitative research. A paper by Green, Johnson

(92)

that describes the narrative-

review method guided the development and implementation of an appropriate search strategy, extraction
of relevant data and synthesis and presentation of important findings (92).

Literature search
The databases Web of Science, Scopus and Science Direct were searched in August 2016 and again in
August 2019 to capture more-recent studies. Internet searches and snowballing of relevant reference lists
from existing research were also completed. Two search strategies were applied to capture studies that: 1.
measured adherence to nutritional EBGs for patients with HNC; and 2. explored perceptions and
experiences of nutritional care among patients with HNC and their healthcare professionals using
qualitative methods. The key words used to identify papers are outlined in Table 5, along with the MeSH
terms and Boolean operators that were applied. All searches were restricted to literature published in
English.

Table 5. Search terms used in a narrative review to identify studies relevant to exploring the
implementation of nutritional evidence-based guidelines for patients with head and neck cancer.

Search

Search term

MeSH terms and Boolean operators

Common
search terms

Head and neck

Head and neck OR Oral OR oropharyngeal OR *pharynx
OR upper gastro* OR upper *digest*
Cancer OR Oncolog*
Nutrition* OR diet* OR eat*
Evidence OR guideline* OR evidence base* guideline*
Adherence OR Implement* OR translat* OR evaluat* OR
measur* OR assess* OR fidelity OR feasibility
Experience* OR perspective OR view OR belief OR
meaning OR understanding
Qualitative OR interview OR focus group OR survey

Search 1

Search 2

Cancer
Nutrition
Evidence-based guidelines
Adherence
Experience
Qualitative

Inclusion criteria
Papers that were eligible for inclusion comprised (i) studies of adult patients who had HNC or healthcare
professionals who had a role in the clinical care of patients with HNC during anti-cancer treatment; (ii)
studies that reported on adherence to EBGs within practice or described perspectives on nutritional care for
patients with HNC, including changes to eating and dietetic involvement and interventions (iii) studies that
reported results in English and (iv) studies that were available in a full-text version.
Practice guidelines, literature-review articles and editorials, studies that were not focused on HNC,
paediatric studies and studies that were not available in English were excluded. No date restriction was
placed on the searches to enhance the number of studies that could be captured. However, initial searches
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yielded few relevant papers that had been published before the Australian national EBGs for patients with
HNC were first released in 2010 (25, 127).

Critical appraisal of studies
The quantitative studies eligible for inclusion were given an overall rating of positive, neutral of negative
quality using the Academy of Nutrition and Dietetics’ Evidence Analysis Manual: Steps in the Academy
Evidence Analysis Process (100).
The qualitative studies eligible for inclusion were then assessed using the Consolidated Criteria for
Reporting Qualitative Health Research (COREQ)

(128).

The COREQ checklist was created to address the

gap in reporting standards between quantitative and qualitative studies. It is well regarded in healthcare
research, with many journals requiring a completed COREQ checklist for submission. The checklist uses
32 items to assess the study in three domains: research team and reflexivity, study design and analysis and
findings (128). The scores for each study are reported in Appendix 1.

Data extraction and synthesis
The studies were read and reread in full prior to data extraction. Information related to the author, year and
country published, aim, methods and study population were then extracted. Data that measured adherence
with EBGs for patients with HNC were extracted from quantitative studies and themes, sub-themes, main
author conclusions and direct participant quotes related to nutritional care were extracted from the
qualitative studies. Summary tables of included studies are available in Appendix 1.
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3.5 Results
Twenty-two studies were eligible for inclusion in this literature review. These are summarised in Appendix
1.

Overview of included studies
Three studies were identified that measured adherence to national nutritional EBGs for patients with HNC.
These were all conducted in Australia and compared practices to the internationally endorsed Australian
nutritional EBGs for patients with HNC that were developed by the Clinical Oncology Society of Australia
(25)

(Appendix 1, Table 1). These comprised: a pre-post-test cohort study, a retrospective cohort study and

a step-wedged randomised controlled trial (47, 129, 130).
The first quantitative study included in this narrative review was a pre-post-test design cohort study by
Kiss, Krishnasamy (47) in 2012. This study included patients treated with concurrent chemo-radiation in one
metropolitan radiotherapy department (n=98 in the pre-intervention group and 100 in the post-intervention
group). The intervention involved the implementation of a dietitian-led clinic and a nutritional-care pathway
based on several recommendations from the Australian nutritional EBGs (47).
The second quantitative study identified was a retrospective study by Hofto, Abbott (97). This also assessed
adherence to several recommendations from the Australian nutritional EBGs in addition to locally produced
guidelines for feeding-tube placement (97). This was carried out in one metropolitan radiotherapy department
with data from the medical records of patients who were treated between 2014 and 2016 (n=209) (97).
The third quantitative study included in this review reported on findings from a step-wedge randomised
trial that was conducted in 2016. This study assessed the feasibility of a motivational interviewing and
cognitive behavioural therapy program “Eating as treatment” (EAT) that was delivered by dietitians in four
radiotherapy departments in metropolitan hospitals (131). The study involved patients and dietitians (n=151
and n=11 in the pre-intervention group and n=156 and n=18 in the post-intervention group, respectively).
Several papers have reported on findings related to this study (106, 131, 132). One of these papers by McCarter,
Baker

(106)

reported on changes in adherence to the Australian nutritional EBG following the EAT

intervention (133).
Eighteen qualitative studies were identified that described the experiences of patients with HNC regarding
nutritional care (106, 107, 118-121, 124, 125, 134-143). These studies were conducted in the UK (n=6), Sweden (n=4),
Canada (n=3), Australia (n=1), Denmark (n=1) Norway (n=1), the Netherlands (n=1) and the United States
(n=1). Collectively these provided the perspectives of 250 patients with HNC. The findings from the
qualitative studies with patients with HNC related to three key topics: the nutritional burden of HNC, the
role of the dietitian, and the experience of having a feeding tube (Appendix 1, Table 2 and Table 3).
Only one study was identified that reported the experiences of different healthcare professionals related to
providing nutritional care for patients with HNC (70). This study by Martin, de van der Schueren (70) focused
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on enablers and barriers to nutritional care for patients with either HNC or oesophageal cancer. Participants
were recruited from five different cancer networks in France, Italy, Sweden, Scotland and the Netherlands.
The sample comprised a total of 29 healthcare professionals (physicians (n=16), dietitians and nutritionist
physicians (n=6), nurses (n=5) and speech pathologists (n=1))

(70).

The international, multi-site and

multidisciplinary design of this study provided rich insight into how nutritional care was implemented in
different settings. Five key themes comprising several barriers and enablers were identified that related to
the implementation of nutritional care

(70) :

the evidence base on the benefit of nutrition interventions;

implementation processes for nutrition care (e.g. assessment, intervention, and follow-up protocols; and
communication and coordination barriers); provider characteristics (e.g. awareness, knowledge and
training, professionals roles, motivation and expected outcomes); site factors (e.g. resources and hospital
structure); and patient characteristics (e.g. preferences and motivation) (70)
From the qualitative studies of both patients and healthcare professionals included within this review, 508
direct participant quotes were extracted that related to perceptions and experiences of nutritional care for
patients with HNC. Relevant quotes are included throughout this review to support and explain key findings
related to what may influence the implementation of nutritional EBGs for patients with HNC in practice.
Only one study included in this narrative review was published prior to 2011. Therefore, the following
narrative review summarises and discusses practices and experiences of patients and healthcare
professionals involved with HNC services within the most recent decade. The majority were also
undertaken following the first publication of the Australian and UK national nutritional EBGs for patients
with HNC, published in 2010 and 2016, respectively

(25, 73).

Therefore, findings relate to practices and

experiences of nutritional care following the existence of national nutritional EBGs focused on HNC.

Quality appraisal of included studies
The three quantitative studies received a positive quality rating according to the Academy of Nutrition and
Dietetics Quality Criteria Checklist for primary research (100). The qualitative studies all had an acceptable
COREQ score (128) (Appendix 1).
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3.6 Discussion
Adherence to nutritional evidence-based guidelines and improved outcomes
for patients with head and neck cancer
Australian EBGs for patients with HNC outline that all patients receiving radiotherapy for HNC should be
seen by a dietitian weekly and be assessed for malnutrition using a validated tool during radiotherapy (25).
It is also recommend that patients are reviewed by a dietitian fortnightly for monitoring of weight, intake
and nutritional status, for at least six weeks following radiotherapy

(25).

Two studies included within the

present review demonstrate that greater adherence to these recommendations results in positive patient
outcomes (47, 133). For example, in accordance with the EAT intervention, more patients were assessed using
a validated malnutrition assessment tool (PG-SGA©) during the first week of radiotherapy (69.1% vs
89.7%), saw a dietitian weekly during radiotherapy (63.5% vs 71.5%), had their weight, intake and
nutritional status monitored during or after radiotherapy (adherence criteria: the use of PG-SGA© at least
once during or after radiotherapy in addition to Week 1 of radiotherapy) (56.7% vs 88.8%)

(133).

This was

associated with positive outcomes, as patients were more likely to remain well-nourished during treatment
(34% vs 21%), lose less weight (8.64% vs 9.88%) and have fewer treatment interruptions (8% vs 14%),
and reported a higher quality of life (p<0.05) (131).
Additionally, in the pre-post-test design cohort study by Kiss, Krishnasamy (47), dietitian adherence to the
care pathway was 92.3-99.7%, which resulted in fewer nutrition-related hospitalisations (4.5% vs 12%
(p=0.003)), fewer unplanned nasogastric tube placements (15 vs 11 (p=0.02)) and more patients who had
transitioned back to an oral diet by eight weeks post-treatment (76.7% vs 68.3% (p=0.10)) (47). These two
studies were both conducted in metropolitan areas within Australia, and while they demonstrate positive
outcomes, more research is required in different settings, including in regional Australia as this context may
introduce unique considerations for care provision.

Factors that may influence implementation of nutritional evidence-based
guidelines in practice
Findings from the studies included in this narrative review highlight multiple factors that may influence
how well nutritional EBGs for patients with HNC are implemented in practice. Examples identified include
executive support and the availability of dietetic resources, multidisciplinary clinic structures, perceptions
of the role of dietitians and the value of nutritional care among other members of the multidisciplinary
team, the level of evidence supporting EBGs and patient acceptance of and capacity to adhere to nutritional
recommendations.

Executive support and dietetic resources
The ability to deliver nutritional care in line with EBGs for patients with HNC appears to be influenced by
support from an executive level (i.e. service managers, directors and developers) and the relationship with
funding for dietetic positions and nutritional equipment. Currently it is recommended that patients with
HNC are seen by a dietitian weekly during treatment

(25).

Adherence to the recommendation for weekly

dietetic review was high in the studies by McCarter, Baker (133), Kiss, Krishnasamy (47) and Hofto, Abbott
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(97).

However, from a multi-site survey in Australia in 2010 with 60 HNC teams researchers have found that

the reported dietetic resources would not have been able to meet this recommendation (144). The adequacy
of dietetic resources also appears to be a barrier to quality nutritional care internationally. For example, the
National Institute for Health and Clinical Excellence

(13)

highlights that there are shortages in specialist

HNC dietitians across England and Wales and recommends addressing this to support the provision of
quality care.
Martin, de van der Schueren

(70)

whom explored healthcare professionals’ experiences, expands on these

quantitative findings by demonstrating how executive support and the relationship with dietetic resources
can influence the implementation of nutritional care in practice (70). For example, having a dietitian within
the multidisciplinary team was important for ensuring that evidence-based nutrition care was prioritised
and implemented

(70).

However, it was noted that the composition of HNC teams and the roles and

responsibilities for nutrition care varied between settings.

One factor related to different national

credentialing and legislation for nutrition-care providers (70). However, even in nations where dietitian was
a recognised profession, lack of funding for dietitian positions and the prioritisation of funds for drugs and
surgical equipment over nutritional-care resources were identified as barriers to nutritional care (70). These
findings draw attention to how an understanding of and respect for nutritional care at an executive level
may influence how well nutritional EBGs can be implemented in practice. The following participant quotes
from the study by Martin, de van der Schueren (70) support this:
Physician nutritionist (Italy): “…sometimes the general manager does not think that having one more
dietitian is better for the general care of the patient than having the newest endoscopic surgery or
whatever. So, they prefer to buy these new drugs maybe but not having one or two more dietitians.”
Dietitian (Scotland): “It’s a funding thing. I think we need more. My job is only partly head and neck
and I’m called all the time to do more and more, and I do outpatients for all the other oncology patients
as well.”
Oncologist (Sweden): “We have fought very hard to get funding for dietitians and speech and language
therapists because they’re often seen as non-essential, but they are essential…. 1. They [the dietitians,
SLPs] give patients a better outcome. 2. They take away a huge load from me, I could not do my job
without them, and why should I be doing that?”

These findings are supported by a study by Cahill, Suurdt

(145)

whom carried out multiple case-studies in

four Canadian intensive-care units using semi-structured interviews with healthcare professionals. The
authors developed a comprehensive framework of barriers and enablers of nutritional EBGs in the criticalcare setting (145). They found that having a dietitian within the team was important to ensure that the EBGs
were advocated for (145). However, the need for adequate staffing and the constraints of department budgets
could be barriers to the implementation of nutritional EBGs

(145).

Furthermore, participating dietitians

identified that a lack of time hindered their ability to act as leaders for implementing the national nutritional
EBGs in practice (145).
The authors who reported on the EAT intervention identified that executive support strategies were
implemented to support adherence to the nutritional EBGs

(25).

However, few details about what the

executive support involved were provided. More qualitative research with healthcare professionals that
focuses on experiences with nutritional-care delivery for patients with HNC would provide further insight
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into how dietetic resources and support from executives may influence the implementation of nutritional
EBGs.

Multidisciplinary clinic structures
In nutritional EBGs for patients with HNC the importance of a multidisciplinary team approach that is
inclusive of oncologists, nurses, dietitians and speech pathologists is highlighted. Specifically to ensure that
patients who may benefit for enteral feeding are identified, to manage treatment side effects and to promote
patient adherence with dietary advice (25). Therefore, the structure of multidisciplinary clinics may influence
how nutritional EBGs for patients with HNC are implemented by enhancing or hindering collaborative
work. This was evident in the study by Kiss, Krishnasamy (47), as the intervention involved establishing a
“dietitian-led clinic” near where the radiation oncologist conducted their reviews

(47).

The authors

hypothesised that the proximity of dietitians and radiation oncologists may have allowed dietitians to better
adhere to the care pathway

(47).

Authors also noted that this clinic structure positioned dietitians to lead

aspects of nutritional care, including identifying patients for enteral feeding (47).
Moreover, from their retrospective study Hofto, Abbott (97) found that there was a high level of adherence
to the EBGs as 86% of patients were screened for malnutrition using a validated tool prior to treatment; all
patients were assessed for malnutrition using a PG-SGA© during radiotherapy; 80% of patients saw a
dietitian weekly during radiotherapy and 62% of patients saw a dietitian fortnightly for six weeks postradiotherapy

(97)

. The authors attributed this to the structure of the multidisciplinary clinic which was

attended by surgical specialists, medical and radiation oncologists, cancer-care nurses, speech pathologists
and dietitians (97). This suggests that multidisciplinary clinic structures that raise the visibility of dietitians
within the HNC team can promote the implementation of nutritional EBGs.
Martin, de van der Schueren

(70)

supports this as they identified that having dietitians in the same clinic

location as physicians and nurses was an enabler of nutritional care for patients with HNC. Specifically,
this was viewed to promote communication in order to expedite nutritional care.
Dietitian (The Netherlands): “We are actually on the same floor in the outpatient clinic so we see
patients together. Sometimes together, really together physically, and sometimes after each other so there
is a lot of interaction between us…it is very easy and when I think that this patient needs a tube to get
additional nutrition, it is easily arranged so I can arrange it the same day or the day after. So there are
not a lot of problems with communication.”(146)

The importance of having a dietitian present within a multidisciplinary clinic has also been highlighted by
Wood (147) in their study that measured adherence to locally produced nutrition-care guidelines. They found
that none of the patients who lost weight in the clinic that had no involvement from a dietitian were referred
to a dietitian, yet 83% of patients who lost weight and were seen in the multidisciplinary clinic that included
a dietitian had a follow up referral to the dietitian (147).
Cahill, Suurdt (145) also support and expand on this by highlighting that multidisciplinary clinic structures
that allow dietitians to be a central member of the team and that facilitate collaboration between different
healthcare professionals can enhance the implementation of nutritional EBGs. Specifically, they found that
having: a clear multidisciplinary team structure, a nutrition leader, mentorship, group learning and
opportunities for collaborative decision-making (such as via team rounding), influenced the implementation
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of nutritional EBGs within the critical-care context (145). More research with healthcare professionals should
explore how different multidisciplinary clinic structures influence the implementation of nutritional EBGs
within the HNC care setting.

Perceptions of the role of dietitians and the value of nutritional care among
other members of the multidisciplinary team
As previously noted, a multidisciplinary team approach is recommended for the implementation of
nutritional EBGs for patients with HNC (25, 73). Therefore, how other healthcare professionals perceive the
role of the dietitian and nutritional care within HNC teams may influence how well nutritional EBGs are
implemented in practice. Hofto, Abbott
Furthermore, Kiss, Krishnasamy

(47)

(97)

found that 86% of patients were screened for malnutrition.

found that there were improvements in the number of patients who

were seen by a dietitian in the first five days of radiotherapy (81% vs 39.8%, p=<0.0001) following
implementation of the care pathway. This suggests that in these two Australian departments there was good
support from other healthcare professionals, including physicians and nurses, to screen and refer patients
to dietitians prior to radiotherapy commencement.
In contrast, using qualitative methods Martin, de van der Schueren (70) highlighted the impact of having less
support for nutritional care from physicians and nurses. In this study, physicians were identified as the
primary decision-makers for nutritional care and so were responsible for the initiation of the nutritionalcare plans and feeding-tube placements; they also had a role in advocating for dietetic services at an
executive level

(70).

Nurses were described as “the lynchpin”, “spider in the web,” or “gatekeeper” due to

their role in the provision, organisation and support of nutrition care

(70).

Comparatively, the dietitians

expected contribution to nutrition care was variable and their primary roles were to assess, plan and provide
nutrition interventions and to follow up patients’ nutrition status while under care

(70).

This apparent

hierarchy in the nutritional-care structure was emphasised as participants explained that provider
characteristics, such as a lack of awareness about the importance of nutrition, limited nutritional knowledge
and training, competing patient priorities, an acceptance that nutrition decline was part of treatment, being
unclear about the benefit of nutrition interventions and perceived complications of enteral nutrition, were
barriers to the implementation of nutritional care

(70).

This was concerning for the participating dietitians,

as they noted that patients were often already nutritionally compromised by the time they saw a dietitian,
or patients were not referred to a dietitian until a feeding tube was being placed (70). The following quotes
supported this finding.
Dietitian (Italy): “…the major problem that they see here at this hospital is the fact that they [the
doctors] send the patient to us when they have already lost weight. This is one of the major problems
because they should actually be referred to us before they become malnourished.”
Physician nutritionist (Italy): “They [the doctors] are not using any actual nutrition risk tools…they
were making the assessment based on weight loss and anorexia but there was not a structured
threshold. So, it was mainly based on the personal experience and therefore this patient looks high risk,
or medium risk….”
Dietitian (Scotland): “I don’t have any input on who is getting a feeding tube…. I don’t meet them
[the patient] until they’re coming in for the tube. So, I don’t know whether they’re already struggling
with their weight and where they’re going to have to be. I trust the team but I do think dietitians should
be involved in figuring out [who gets a tube].”
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Wikström

(148)

supports findings by Martin, de van der Schueren

(70)

in their study with hospital-based

dietitians in Sweden, as physicians and nurses were described as the “gate-keepers” and the “controlling
members” of nutritional care

(148).

critical-care setting, Cahill, Suurdt

Moreover, in their study which focused on nutritional EBGs in the
(145)

could also influence implementation

identified that the perceptions of other healthcare professionals

(145).

Specifically, provider characteristics, professional roles, critical

care experience, educational background, personality, knowledge, familiarity, awareness, attitudes,
outcome expectancy, self-efficacy, motivation and agreement influenced the implementation of nutritional
EBGs (145). More qualitative research with different healthcare professionals within diverse HNC teams is
required to explore how the role of the dietitian is perceived and enacted and how this may influence the
implementation of nutritional EBGs in the HNC care context.

The level of evidence supporting nutritional guidelines
In the Australian nutritional EBGs for patients with HNC, it is recommended that “prophylactic enteral
feeding should be considered…for patients who have: T4 tumours undergoing concurrent chemoradiotherapy; hypo-pharyngeal tumours”. Additionally, “other patient groups should be considered by the
multidisciplinary team on an individual basis dependent on other clinical factors such as tumour site,
staging, effect of multi-modality treatments, radiotherapy treatment fields and dose, type of surgical
procedure, nutritional status and dysphagia”

(25).

However, to date attempts at randomising patients to

receive either a gastrostomy tube prophylactically or a feeding tube (either a nasogastric or gastrostomy
tube) reactively have not been very successful, limiting the ability for conclusions to be drawn from this
evidence and for conclusive recommendations on this topic (56, 149, 150).
Martin, de van der Schueren

(70)

found that the strength of evidence supporting recommendations within

nutritional EBGs influenced nutritional care. Through exploring these findings in more detail the
researchers revealed that the weak and conflicting evidence on the use of different enteral feeding
approaches was considered to be a barrier to HNC teams adopting a prophylactic approach to feeding-tube
placements (70). This was connected to unclear evidence on complications such as the risk of delayed return
to normal swallow function due to prolonged feeding-tube use following the placement of a gastrostomy
tube (70). This was highlighted by the following participant quotes:

Radiologist (France): “The question is to know when they can be put on a nutrition treatment plan.
Should we put the nasogastric tube at the beginning of treatment because the people who have
radiotherapy often have significant complications? Should it be done at the beginning and if at the
beginning, is it the 1st, 2nd, or 3rd cycle of radiotherapy or do we wait for them to lose 5kg, 6kg?”
Dietitian (The Netherlands): “There is still not enough evidence in literature to give all the patients the
PEGs…. So, we still don’t know yet which patients we should give a PEG and which patients we
shouldn’t.”
Surgeon (Sweden): “I think that depends on the hospital and their traditions. A lot of the hospitals that
send patients to us are very fond of PEGs and the patients get PEGs as soon as they can’t swallow. We
like the nasogastric tubes and we believe that when the patients get the PEGs, they kind of stop trying….
I don’t know if that is correct or not but that is our tradition.”
Physician nutritionist (Italy): “Maybe here we are not using PEG tubes so much; it’s just because of
the difficulty in having access to this because we have to find a bed in a hospital…. Probably if we could
have better access to the PEG placement, maybe we would have more patients because they are definitely
much more accepted by the patient.”
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Surgeon (France): “In our team, some of the physicians they decide PEG for every patient…and with
others, no PEG…there is not very good data…. Everyone does what he thinks is good.”

Moor, Paterson

(151)

support this as from their survey with healthcare professionals (n=117 speech

pathologists, head and neck surgeons, clinical nurse specialists, dietitians and oncologists) from different
cancer networks in the UK (n=33) they found there was no national consensus on which patients with HNC
should receive a gastrostomy tube before commencing chemo-radiation (i.e. prophylactically)

(151).

Furthermore, only 57% of respondents stated that their multidisciplinary team had a protocol in place for
the insertion of gastrostomy tubes (13, 151). There were also statistically significant differences in perspectives
between allied health professionals (i.e. dietitians and speech pathologists) and medical professionals (i.e.
physicians and nurses). For example, fewer allied health professionals thought a prophylactic gastrostomy
tube would have an adverse effect (12% versus 33%) and more thought it would have a positive effect (28%
versus 11%) (p=0.009) (151). From the free-text comments from the survey, authors were able to expand on
the quantitative data by demonstrating that while some healthcare professionals associated prophylactic
gastrostomy tubes with better nutrition and pain control ,and perceived that they could take the pressure off
the patient, others had negative perceptions that related to feeding-tube dependency or over-reliance and
delayed return to normal swallow function post-treatment

(151).

Currently the unclear evidence appears to

be affecting the consistency of nutritional care available to patients with HNC.
More well-designed studies are needed to support recommendations within nutritional EBGs for patients
with HNC, particularly regarding prophylactic feeding-tube use. More research should also measure
prolonged feeding-tube use among patients who receive a prophylactic gastrostomy tube. This data should
be complemented by measuring adherence to current nutritional EBGs to contribute to providing further
clarity on current practices. Qualitative research with healthcare professionals could also be completed to
provide further insight into current feeding-tube practices within different HNC teams and how placement
decisions are made. Additionally, patient perceptions of having and using a feeding tube could also be
explored to provide insight into their experiences, which may allow enteral feeding tube recommendations
to be more patient centred.

Patient acceptance of and capacity to adhere to nutritional recommendations
In nutritional EBGs it is highlighted that “patient adherence with dietary advice and nutrition support
recommendations are essential to achieve positive outcomes through nutrition intervention”

(25).

Hofto,

Abbott (97) found that one of the major reasons for dietitians not being able to adhere to the nutritional EBG
recommendation for weekly review during radiotherapy was due to patients not attending scheduled dietetic
appointments (97). Additionally, Kiss, Krishnasamy (47) found that dietetic clinic non-attendance rate was at
27% prior to implementing the evidence-based care pathway. Furthermore, Capuano, Grosso (29) found that
47% of patients with HNC declined nutritional counselling or enteral nutrition and 100% of those patients
continued to lose weight, while 90% of patients who agreed to see a dietitian maintained their weight (29).
Moreover, in a randomised controlled trial with patients with HNC who had a prophylactic feeding tube,
outcomes were compared between those who commenced supplementary tube feeding immediately
following tube placement to those who were advised to commence enteral feeding by a dietitian in line with
standard care

(152).

Only 51% of the entire patient sample managed to consume ≥75% of the prescribed
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enteral feeding

(152).

However, those who did consume ≥75% had less weight loss (-10.3% vs -12.6%,

p=0.038) (152). Therefore, patient acceptance of nutritional care, including the use of interventions such as
enteral feeding, may influence both how well nutritional EBGs are implemented in practice and overall
patient outcomes.
Martin, de van der Schueren

(70)

expands on the quantitative data, as the participating healthcare

professionals identified that social issues and difficulties engaging with the HNC patient population due to
a high representation of food insecurity, smoking, alcoholism and social isolation was a barrier to nutrition
care (70).
Nurse (France): “It is very difficult because often these patients are alone and they often don’t have
family that can help them make decisions. Sometimes patients refuse treatment because they don’t
understand or because they don’t want to. It’s a choice.”
Physician nutritionist (Italy): “Because of the not so good acceptance by the patients of the artificial
nutrition, of course we try to start with the texture modification, oral supplements, all of these to try to
have the patient meeting at least 65-70% of their estimated energy and protein requirements. If this fails,
of course we would propose the artificial nutrition….”

Researchers who have carried out qualitative research with patients with HNC help to clarify why adhering
to nutritional recommendations can be so challenging. For example, physical side effects such as pain,
nausea, increased mucous production, taste and smell alterations, swallowing difficulties, mouth dryness
and numbness and dental issues are common, and can affect the ability to meet energy targets (118, 121, 124, 135,
136, 138, 140-142, 153-155).

Furthermore, the effects may be compounded by psychosocial barriers such as the fear

of choking and pain on swallowing

(118, 136, 154, 155)

and embarrassment due to the stigma associated with

changes to their diet and ability to manipulate food into their mouths (118, 154, 155). Additionally, some patients
may not value or accept certain nutritional recommendations; for example high energy-intake targets and
the threat of enteral feeding if those targets are not met, can be a source of anxiety (118, 135, 155). Some patients
also view weight loss as a positive side-effect of not being able to maintain adequate energy intake (142).
Negative perceptions of enteral nutrition may also affect patient acceptance and motivation to use it as
recommended in line with nutritional EBGs. For example, patients can have concerns about the surgical
placement procedure for a gastrostomy tube (121, 143), or feel socially isolated due to social stigma associated
with having a visible nasogastric tube (142, 156). They may associate using a feeding tube with defeat (118, 124,
141, 153),

can have fears regarding feeding-tube dependence

difficult, and time-consuming and physically limiting

(118)

and can find using the feeding tube to be

(121, 124, 125, 142, 143, 153).

Additionally, the financial

burden of enteral feeding could lead patients to consume less enteral formula than recommended by a
dietitian

(121, 124).

Transitioning off the feeding tube can also be challenging, as although this is often a

desired prospect and a milestone in recovery, patients describe having to relearn physical tasks and social
norms associated with eating

(107, 121, 125, 135, 141-143).

Subsequently patients can experience a sense of

“dependence” due to the discomfort associated with transitioning back to oral intake

(121, 125, 143).

This

research also highlights that support from a dietitian and other healthcare professionals such as speech
pathologists, multidisciplinary rehabilitation programs and their family members and has helped patients
make the transition back to oral intake (121, 124, 135).
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To better understand how patient acceptance of nutritional advice may influence the implementation of
nutritional EBGs, it would be worthwhile measuring the energy intake of patients during radiotherapy and
comparing those to recommendations from nutritional EBGs, particularly for patients with feeding tubes.
This could be complemented by qualitative research with patients to understand how they accept and can
adhere to nutritional recommendations in line with EBGs throughout their entire treatment journey.
Formally summarising the current qualitative evidence on the patient experience of having a feeding tube
using a systematic literature review method may also provide focused insight into patients’ acceptance of
feeding tubes and their capacity to use this evidence-based intervention. This research is important to
identify opportunities for how multidisciplinary HNC teams can best support patients through a difficult
experience to improve nutritional care and patient outcomes.

42

3.7 Conclusion
Implementing nutritional EBGs for patients with HNC can provide positive outcomes for patients with
HNC. However, the implementation of nutritional EBGs appears to be influenced by multiple elements
such as executive support, the availability of dietetic staff, multidisciplinary clinic structures, perceptions
and experiences regarding the value of dietitians and nutritional care among physicians and nurses, the level
of evidence supporting nutritional EBGs, and patient acceptance of the dietitian and of nutritional care.
To explore the implementation of nutritional EBGs in the HNC setting in more detail, further quantitative
and qualitative research with patients and healthcare professionals in diverse HNC teams including in
regional Australia would be worthwhile as part of this PhD thesis. Quantitative research should focus on
measuring practices against recommendations within EBGs related to the frequency of dietetic reviews
during treatment, the use of prophylactic gastrostomy tubes and associated patient characteristics and the
adequacy of energy intakes against EBG targets, particularly for patients with a feeding tube. This research
would be strengthened through qualitative research with patients and healthcare professionals from
different settings to understand their perceptions of, and experiences with, dietitians and nutritional care on
HNC teams. Specifically, qualitative research with patients should explore how patients understand and
value nutritional recommendations in line with EBGs throughout their treatment journey, and their
perceptions of having and using a feeding tube. Qualitative research with healthcare professionals should
also expand on this research through exploring current feeding-tube practices within different HNC teams,
how the role of the dietitian is perceived by multidisciplinary healthcare professionals, and factors that
influence the implementation of collaborative interprofessional nutritional care in line with EBGs. This
would research would provide insight into factors that influence the implementation of nutritional EBGs
which is an important step in translating evidence to practice and improving outcomes for patients with
HNC.
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CHAPTER 4: Measuring adherence to nutritional evidencebased guidelines and outcomes among patients treated for
head and neck cancer in a regional Australian cancer care
setting: a retrospective review of patient medical records
4.1 Chapter overview
In Chapter 4 I reported on a retrospective review of patient medical records that was designed to address
Objective 2 of this thesis: Measure adherence to nutritional evidence-based guidelines (EBGs) for patients
with head and neck cancer (HNC) in one regional cancer-care network. This chapter provides insight into
current nutritional-care practices and patient outcomes in a regional setting and helps to contextualise and
provide background information for the following qualitative chapters that explore the implementation of
nutritional EBGs from the perspectives and experiences of patients with HNC and their healthcare
professionals.
Findings from this study were presented at the ESPEN Congress on Clinical Nutrition and Metabolism in
September 2017.
Citation: Hazzard, E. Walton, K. McMahon, A. Milosavljevic, M. Tapsell, L. (2018) Prophylactic
gastrostomy tube practice for head and neck patients: an international mixed methods study, ESPEN
Congress on Clinical Nutrition and Metabolism, 1-4 September 2017, Madrid Spain.
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4.2 Abstract
Background: Evidence-based guidelines (EBGs) provide recommendations regarding dietetic
involvement and nutritional care for patients with HNC. Despite the existence of EBGs, barriers to
evidence-based practice exist. Measuring the extent to which nutritional EBGs for patients with HNC are
adhered to in practice is necessary to understand what possible factors are responsible for good or enhanced
implementation. This study aimed to report on adherence to nutritional EBGs and nutrition-related adverse
events among patients with HNC.
Methods: The medical records of patients treated with radiotherapy for HNC in one regional cancer-care
network between January 2016 and January 2018 were retrospectively reviewed. Data on demographics,
nutritional status, nutrition-related adverse events and feeding-tube use was analysed using frequencies, Ttests and chi-square tests.
Results: All patients (n=81) were seen by a dietitian and assessed for malnutrition using a validated tool
(PG-SGA©) at least once during radiotherapy. Sixty-two percent saw a dietitian at least once per week and
these patients were less likely to have a nutrition-related hospitalisation (p=0.012). Sixty percent received
a feeding tube prophylactically. All patients with hypo-pharyngeal tumours, 70% of patients with T4
tumours and proportionally more patients who were treated with chemo-radiotherapy received a
prophylactic feeding tube (81.3% vs 21.2%, p = 0.000). Among patients who received a feeding-tube,
average energy intake from oral and enteral sources combined was lowest in week 4 of radiotherapy (64%
of energy requirements based on 30kcal/kg/day) and highest in week 7 (79% of estimated requirements)
when more were using their feeding tube for nutrition (48% vs 90%). Patients treated with chemotherapy
were more likely to have >10% weight-loss; a nutrition-related hospitalisation, radiotherapy re-scanning
due to weight loss and reactive intravenous fluids (p=0.001; 0.025; 0.040; 0.000, respectively). Patients
who experienced >5%, >10% weight-loss or required reactive intravenous fluids were more likely to have
stage III-IV tumours (p= 0.004; 0.017; 0.002, respectively). 7% of patients were still using a feeding tube
12 months post-radiotherapy and this was more common among patients who started treatment with
swallowing issues (p=0.084) and who by 18 months post radiotherapy had recurrent disease (33.3% vs
15.8%, p=0.297) or were deceased (33.3% vs 5.3%, p=0.083).
Conclusion: This study supports the need for routine dietetic involvement for patients with HNC. However,
in a setting where there was a high level of adherence to nutritional EBG recommendations related to
dietetic involvement, assessment and feeding-tube placement, adverse nutrition-related events still
occurred, particularly among patients who received chemotherapy or who had more progressive disease.
Qualitative research that explores the perspective and experiences of nutritional care among patients with
HNC and their healthcare professionals would provide insight into how the implementation of nutritional
EBGs could be enhanced.
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4.3 Introduction
The Clinical Oncology Society of Australia developed evidence-based guidelines for dietetic involvement
for patients with HNC, including that patients should be reviewed weekly during radiotherapy and be
assessed for malnutrition using a validated tool

(25).

Recommendations regarding nutritional interventions

and nutritional prescription are also provided. For example, patients who have T4 or hypo-pharyngeal
tumours and are undergoing concurrent chemo-radiotherapy should be considered for prophylactic enteral
feeding, and patients should aim for energy intakes of at least 30kcal/kg/day (25). Measuring adherence to
these evidence-based nutritional practice recommendations is an important step in ensuring that
nutritionally vulnerable patients with HNC have access to the best care for improved outcomes. However,
only a small number of studies have done so and these have all been conducted in metropolitan cancer
centres within Australia (47, 129, 130).
There is increasing local and international demand for HNC services hence multidisciplinary teams are
recommended so that patient care can be distributed safely and efficiently among different healthcare
professionals (3, 12, 45). This includes having dietitians present to be leaders in nutritional care. Exploring the
implementation of nutritional EBGs for patients with HNC in a regional setting where patients have access
to the care of a dietitian, specialist oncology nurse and speech pathologist in a combined clinic and
measuring patient outcomes may contribute to evidence on effective multidisciplinary team structures for
nutritionally vulnerable patients with HNC.
Gastrostomy tubes placed prophylactically (i.e. prior to radiotherapy and the onset of severe nutritionimpact symptoms) and nasogastric or gastrostomy tubes placed reactively (i.e. at the time that a patient
required nutritional supplementation from enteral nutrition) are two common approaches to feeding-tube
placements for patients with HNC (25, 157). The current evidence suggests that while a prophylactic feeding
tube may minimise weight loss, promote quality of life and reduce hospitalisations, length of stay and
treatment interruptions during radiotherapy, both approaches provide comparable benefits at three months
post-treatment (25). However, few randomised controlled trials have compared the two approaches and those
that have are limited by sample size due to difficulties with recruitment and randomisation

(158, 159).

Furthermore, there is conflicting evidence about swallow outcomes associated with the use of prophylactic
gastrostomy tubes

(69).

The lack of conclusive evidence on the topic of feeding tubes may explain why

different practices exist (151). More research, that explores the use of prophylactic feeding tubes compared
with EBG recommendations and patient outcomes, including prolonged feeding-tube use may help provide
clarity and consistency in nutritional care for patients with HNC (25, 129).
Using data from a regional cancer-care network in Australia where patients had access to such a combined
clinic, this study aimed to help address gaps in evidence by reporting on the extent of adherence to
nutritional EBG recommendations in terms of dietetic involvement and feeding tube practices; and by
describing documented nutrition-related adverse events among patients with HNC.
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4.4 Methods
Study design
A retrospective chart review of the electronic medical records of patients treated for HNC in one regional
cancer-care network in Australia was undertaken. Ethics approval was obtained (2016/996).

Study population
The medical records of patients who were treated with radiotherapy for HNC between January 2016 and
January 2018 were eligible for review. Inclusion criteria were patients who were 18 years or older, with
newly diagnosed, locally advanced head and neck squamous cell carcinomas, planned to receive curative
radiotherapy (with or without prior surgery and chemotherapy). Records for patients receiving palliative
care, those with non-squamous cell carcinomas or recurrent disease and patients who received radiotherapy
treatment outside of the local health district or declined treatment were excluded (Figure 4).
All patients who were eligible for inclusion in this study were treated on 6-MV linear accelerators with
2Gy/day for five days per week, until total doses of 70Gy (definitive) or 60Gy (adjuvant) were delivered.
Radiotherapy techniques included IMRT step and shoot, volumetric arc therapy and three-dimensional
conformal radiotherapy. Patients treated with chemotherapy in addition to radiotherapy received Cisplatin
or Cetuximab.
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Medical records of all patients
diagnosed with head and neck cancer
and planned to receive treatment
between January 2016 and January
2018 in one local cancer-care network
(n=160)

Excluded (n=73)
Surgery only (n=20)
Non-squamous cell carcinoma (n=16)
Skin (n=11)
Palliative (n=12)
Treated else-where (n=9)
Recurrence: (n=2)
Declined treatment (n=3)

Records analysed
(n=87)
Excluded (n=6)
Non-curative treatment (n=2)
Treated as inpatient (n=1)
Recurrence (n=1)
Skin (n=1)
Study sample
(n=81)

Non-squamous cell carcinoma (n=1)

Figure 4. Sample selection for Study 1 (Chapter 4)
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Study context
At the time of this study two cancer-treatment centres existed within the local cancer-care network. Patients
treated with radiotherapy for HNC had access to a weekly clinic that combined the services of a specialist
oncology nurse, dietitian and speech pathologist.
At the time of this study, the recommendation about the placement of a prophylactic feeding tube for
patients who were expected to become nutritionally compromised during treatment was initiated by the
treating radiation oncologist in liaison with the multidisciplinary team. Percutaneous endoscopic
gastrostomy tubes placed by a gastroenterologist were used preferentially, unless medical contraindications
were present and other feeding tubes, such as a jejunostomy, were more appropriate. Nasogastric tubes
were placed reactively during treatment if patients who did not receive a feeding tube prophylactically
became nutritionally compromised.

Data collection
All data was collected retrospectively from electronic medical records. Data was de-identified and stored
in a Microsoft Excel file (version 1911, 2019).

Demographic, clinical and nutritional data
Demographic data included age, gender, smoking status, living situation and marital status. Disease-specific
data included tumour site, stage and classification, treatment modality, radiotherapy dose and technique
and P16 status. Tumour sites and classifications were coded using the International Classification of
Disease–Version 10–Australian Modification (National Centre for Classification in Health, 2010) and the
Union for International Cancer Control Tumour, Node, and Metastasis (TNM) staging system. Diseaserelated outcomes included the presence of recurrent disease and survival at 12 and 18 months postradiotherapy.
Nutritional-status information included whether the patients saw a dietitian or a speech pathologist prior to
or within the first week of radiotherapy, whether malnutrition was assessed using the Patient-Generated
Subjective Global Assessment (PG-SGA©) tool (160, 161) and whether dysphagia was assessed by a speech
pathologist. Nutrition-assessment outcomes recorded included: the PG-SGA© global rating score (A, B or
C), presence of dysphagia, pre-radiotherapy weight loss, body mass index (BMI) (kg/m2) and BMI
category, oral-diet texture and whether they received a prophylactic gastrostomy tube (Table 6).

Data relating to evidence-based guidelines
Data on the frequency of dietitian reviews, malnutrition assessments using a PG-SGA©

(160, 161),

feeding-

tube placements and patient energy intake, including the contribution from enteral nutrition was collected
for each week of radiotherapy. This data enabled comparison against four recommendations from the
Australian EBGs for the nutritional management of patients with HNC (25):
1.

Patients should be reviewed by a dietitian weekly during radiotherapy.

2.

Patients should be assessed for malnutrition using a validated malnutrition assessment tool.
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3.

Patients who have T4 or hypo-pharyngeal tumours and receive concurrent chemo-radiotherapy
should be considered for a prophylactic enteral feeding. Other patients should be individually
considered for early enteral feeding based on their tumour site and stage, treatment, nutrition
status, dysphagia and social support.

4.

Aim for energy intakes of at least 30kcal/kg/day in patients receiving radiotherapy or radiotherapy
+ chemotherapy (25).

Adverse nutrition-related events
Data on malnutrition, weight-loss, nutrition-related hospitalisations, radiotherapy re-scanning due to weight
loss, reactive intravenous fluids, reactive feeding-tube placements and prolonged feeding-tube use was also
collected. Classification and rationale for the nutritional data and nutrition-related adverse events measured
are outlined in Table 6.
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Table 6. Classification and rationale for the nutritional data and nutrition-related adverse events measured in Study 1 (Chapter 4)
Nutritional-outcome measure
Malnutrition

Dysphagia
Pre-radiotherapy weight loss
BMI

Oral-diet texture
Weight loss during radiotherapy
Nutrition-related hospitalisations

Radiotherapy rescanning due to weight-loss
Reactive intravenous fluids
Reactive feeding-tube placements
Prolonged feeding-tube use

Classification and rationale
The PG-SGA© is a malnutrition assessment tool that has been validated for use with oncology patients (161). This tool measures
subjective information about changes in body weight, dietary intake, gastrointestinal symptoms and functional capacity (161). In
addition, it considers loss of subcutaneous fat, muscle wasting, oedema, ad ascites and the metabolic effects of the disease (161). The
use of the PG-SGA© was standard practice in the settings of this study, and has been recommended by national nutritional EBGs (25).
In this study patients were classified as malnourished if they received a PG-SGA© global rating score of B or C (160).
As assessed by a speech pathologist. Classified as Dysphagia OR No Dysphagia
Measured by comparing a patient’s reported usual stable weight within the previous six months to their baseline weight measured on
clinic scales.
BMI category determined using the WHO classification. (For younger adults <65 years: underweight: <18.5 kg/m2; normal weight:
18.5-24.9 kg/m2; overweight: >25-29.9 kg/m2; obese: ≥30 kg/m2. For older adults ≥65 years: underweight: < 23 kg/m2; normal
weight: 23-31kg/m2; overweight: ≥31 kg/m2)
Based on speech pathologist’s or dietitian’s written assessment. Classified as: Nil Oral Intake, Full/Normal Diet, Soft/Minced OR
Puree.
Critical weight loss during radiotherapy classified as weight-loss ≥5% and >10% of their baseline weight compared to their lowest
weight recorded during radiotherapy, as this is common and predictive of worse outcomes for patients with HNC (43, 162).
Classified as overnight hospitalisations and emergency- department visits up to one month post-radiotherapy if the primary cause
could be attributed to inadequate food or fluid intake; be resolved through adequate food or fluid intake (e.g. protein-energy
malnutrition, weight loss, dehydration) or resulted from feeding-tube issues (e.g. aspiration pneumonia, gastrostomy-site infections).
This was used as a proxy measure of radiotherapy interruptions and associated burden on health-service resources and the patient,
related to nutrition that may otherwise be prevented (163).
This was used as a proxy measure of dehydration (95). This excluded occasions where intravenous fluids were provided with
chemotherapy as part of a standardised protocol.
This was used as a proxy indicator of how accurately nutritionally vulnerable patients were being identified for a prophylactic
gastrostomy tube in a setting where this approach was favoured.
Measured at 6 and 12 months post radiotherapy as radiotherapy causes fibrosis of the pharyngeal muscles and soft tissues which can
lead to persistent dysphagia and xerostomia up to 12 months post-treatment (164)
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Statistical analyses
Data was analysed using descriptive statistics (frequencies and percentages for categorical variables and
means and standard deviations for continuous variables).
Independent sample T-tests were used for continuous variables and Pearson’s chi-squared tests were used
for categorical variables to determine factors associated with the nutrition-related adverse events and the
placement of a prophylactic feeding tube. If a category had n≤5 a Fisher’s exact test was used. Overall
significance was set at p<0.05. Data was analysed using IBM SPSS database and statistical package
(version 24, SPSS Inc., Chicago).
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4.5 Results
Sample characteristics
Of the 160 patients diagnosed with HNC, who were discussed at the local cancer-care network
multidisciplinary team meeting and planned to receive treatment between January 2016 and January 2018,
87 were screened as eligible for inclusion. Six were subsequently excluded due to receiving non-curative
treatment (n=2), receiving treatment as an inpatient (n=1), being treated for recurrent disease (n=1) and
being treated for having a skin (n=1) or a non-SCC (n=1) cancer. The remaining sample of 81 patients were
mostly male (84%), the mean age was 63 years, many were previous smokers (47%) and most were married
(61%) and lived with family or friends during treatment (75%).
The majority had stage IV tumours (57%) of the oropharynx (52%). The majority were also treated with
multimodality treatment (89%), including 57% who were treated with radiotherapy and chemotherapy, and
27% who received surgery with adjuvant radiotherapy. Of the 62% of patients who received chemotherapy
(either in addition to radiotherapy or in addition to radiotherapy and surgery), 35% received Cisplatin, 41%
received Cetuximab and 6% were switched from Cisplatin to Cetuximab due to toxicity. The mean dose of
radiation treatment that patients received was 67Gy delivered over 33 doses. Radiotherapy techniques
included IMRT step and shoot (n=64, 79%), volumetric arc therapy (n=15, 19%) and three-dimensional
conformal radiotherapy (n=2, 25%). By 18 months post-treatment 10 patients had passed away and six had
recurrent disease (Table 7).

Nutritional data
Over half of the patients reported that they had lost some weight within the six months prior to commencing
radiotherapy (52%). Pre-treatment weight-loss reached a critical level of ≥5% and >10% for 30% and 16%
percent of the sample, respectively (Table 7).
Most patients saw a dietitian and were assessed for malnutrition with a PG-SGA© tool prior to or within
the first week of radiotherapy (88%). Over half saw a speech pathologist prior to or within the first week
of radiotherapy (52%). Nearly a third of the sample commenced radiotherapy with a PG-SGA© global
rating score of B or C (31%), 14% were underweight, 47% were a healthy weight and 38% were overweight
or obese (age adjusted). Nearly 30% of patients were assessed as having dysphagia, and most patients were
experiencing oral intake limitations and required food modifications prior to or within the first week of
radiotherapy (57%). At baseline, three patients were already relying on enteral nutrition for 100% for their
nutritional intake and three patients were supplementing their oral intake with enteral nutrition (Table 7)
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Table 7. Characteristics of the sample included in Study 1 (Chapter 4) (n=81)
No. (%) or Mean (SD)
General demographics
Gender
Age
Smoking status

Living arrangement

Marital status

Female
Male
Mean (SD)
Median (range)
Never
Previous smoker
Current smoker
Family/friend
Alone
Patient accommodation
Married
Unmarried

13 (16%)
68 (84%)
63 (12.9)
65 (24-87.1)
25 (30.9%)
38 (46.9%)
18 (22.2%)
61 (75.3%)
18 (22.2%)
2 (2.5%)
49 (60.5%)
32 (39.5%)

Disease and treatment
Tumour site

Stage

T stage

N stage

P16 positive

Oropharynx
Oral cavity
Larynx
Nasopharynx
Parotid
Hypopharynx
I
II
III
IV
1
2
3
4
0
1
2
3
Positive
No/undetected
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42 (51.9%)
22 (27.2%)
11 (13.6%)
2 (2.5%)
2 (2.5%)
2 (2.5%)
7 (8.6%)
6 (7.4%)
22 (27.2%)
46 (56.8%)
18 (12.0%)
20 (13.3%)
26 (17.3%)
17 (11.3%)
22 (27.16%)
19 (23.46%)
40 (49.38%)
0
30 (37%)
51 (63%)

Treatment modality

Radiotherapy + chemotherapy
Cisplatin
Cetuximab
Cisplatin  Cetuximab a
Surgery + radiotherapy
Radiotherapy alone
Surgery + radiotherapy and chemotherapy
Cisplatin
Cisplatin  Cetuximab

46 (56.8%)
25 (54.3%)
19 (41.3%)
4 (8.70%)
22 (27.2%)
9 (11.1%)
4 (4.9%)
3 (75.0%)
1 (25.0%)

Radiation dose mean (SD)

Gray
Fractions

66.9 (4.5)
33.2 (3.1)

Alive
Deceased
Alive
Deceased
Alive
Deceased
Yes
No
Yes
No

80 (98.8%)
1 (1.2%)
75 (92.6%)
6 (7.4%)
71 (87.7%)
10 (12.3%)
10 (6.7%)
65 (43.3%)
6 (4.0%)
65 (43.3%)

Disease outcome and survival
Survival at six months post-radiotherapy
Survival at 12 months post-radiotherapy
Survival at 18 months post-radiotherapy
Recurrence at 12 months post-radiotherapy (n=75)
Recurrence at 18 months post-radiotherapy (n=71)

Nutritional status
Weight loss within six months prior to radiotherapy
Percentage of weight loss within six months prior to radiotherapy

Saw a dietitian prior to or within the first week of radiotherapy
Saw a speech pathologist prior to or within the first week of radiotherapy
PG-SGA© score at baseline assessment (n=74)
Baseline dysphagia as assessed by a speech pathologist (n=41)
Baseline oral-diet texture (n=78)

Mean (SD) (%)
0%
<5%
5-<10%
>10%
Yes
Yes
A
B or C
Yes
No
Nil by mouth
Normal
Soft/ minced
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2.73kg (5.4) (3.45%)
39 (46.9%)
17 (21.0%)
12 (14.8%)
13 (16.0%)
74 (91.4%)
42 (51.9%)
49 (60.5%)
25 (30.9%)
27 (33.3%)
14 (17.3%)
3 (3.8%)
33 (42.3%)
39 (50.0%)

Baseline nutritional-intake source

Baseline body mass index classification

Saw a dietitian every week of radiotherapy
Total weight loss by the final week of radiotherapy
Highest recorded weight loss during radiotherapy
Total weight loss by one month post-treatment
Total weight loss by three months post-treatment

Puree
Total oral diet
Oral diet + enteral nutrition
Total enteral nutrition
Underweight
Normal weight
Overweight
Obese
Yes

3 (3.8%)
75 (92.6%)
3 (3.7%)
3 (3.7%)
11 (13.6%)
39 (48.1%)
23 (28.4%)
8 (9.9%)
50 (61.7%)

Mean (SD) (%)
Median (range)
Mean (SD) (%)
Median (range)
Mean (SD) (%)
Median (range)
Mean (SD) (%)
Median (range)

4.67kg (4.05) (5.59%)
4.3kg (-3.1kg – 14.8kg)
5.5kg (4.13) (6.83%)
4.9kg (-1.8kg-15.6kg)
5.81kg (4.43) (7.1%)
5.6kg (-6.1kg-15.1kg)
6.64kg (6.2) (7.93%)
6.2kg (-10.8kg-31.2kg)

SD = standard deviation
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Adherence to evidence-based nutritional-management guidelines
Dietitian involvement and malnutrition assessment
During radiotherapy all patients were seen by a dietitian and assessed for malnutrition using the PG-SGA©
at least once. Sixty-two percent of patients saw a dietitian at least once per week during radiotherapy (Table
7). Patients who saw a dietitian each week of radiotherapy were less likely to have a nutrition-related
hospitalisation (33.3% vs 66.7%, p=0.012) (Table 11).

Factors associated with the prophylactic placement of a feeding tube
Nearly 60% of the sample received a feeding tube prophylactically. One patient had a jejunostomy; all
others had a percutaneous endoscopic gastrostomy tube.
Patients who received a prophylactic feeding tube were more likely to have stage III-IV tumours (95.8% vs
66.7%, p=0.001) of the oropharynx and hypopharynx (64.6% vs 33.3% and 1.2% vs 0%, respectively,
p=0.005). All patients with hypo-pharyngeal tumours and 70% of patients with a T4 tumour received a
feeding tube prophylactically. Patients who were treated with radiotherapy + chemotherapy (81.3% vs
21.2%, p = 0.000) and specifically with Cisplatin (52.1% vs 24.2%, p=0.000) were more likely to receive
a feeding tube prophylactically. Proportionally more patients who were assessed as malnourished and who
were underweight or obese according to their BMI at baseline received a prophylactic feeding tube,
although this was not statistically significant. There were no statistically significant associations between
the placement of a feeding tube prophylactically and age, smoking status, living situation or marital status
(Table 8).
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Table 8. Factors associated with the placement of a prophylactic feeding tube from Study 1 (Chapter 4)

Characteristics

Prophylactic feeding tube

Gender

Female
Male

7 (14.6%)
41 (85.4%)

Yes (n=48)

No (n=33)
6 (18.2%)
27 (81.2%)

0.665

Age

Mean (SD)

63 (10.9)

63 (15.5)

0.941

Tumour site

Oropharynx
Oral cavity
Larynx
Nasopharynx
Parotid
Hypopharynx
0-II
III-IV
1
2
3
4
0
1
2

31 (64.6%)
8 (16.7%)
5 (10.4%)
2 (4.2%)
0
2 (4.2%)
2 (4.2%)
46 (95.8%)
7 (14.6%)
9 (18.8%)
20 (41.7%)
12 (25.0%)
7
10
31

11 (33.3%)
14 (42.4%)
6 (18.2%)
0
2 (6.1%)
0
11 (33.3%)
22 (66.7%)
11 (33.3%)
11 (33.3%)
6 (18.2%)
5 (15.2%)
15
9
9

0.005 a

Radiotherapy + chemotherapy
Surgery + radiotherapy
Radiotherapy alone
Surgery + radiotherapy and
chemotherapy
None
Cisplatin
Cetuximab
Yes
No
Yes
No

39 (81.3%)
3 (6.3%)
3 (6.3%)
3 (6.3%)

7 (21.2%)
6 (18.2%)
1 (3.0%)
19 (57.6%)

0.000 a

5 (10.4%)
25 (52.1%)
18 (37.5%)
15 (31.9%)
32 (68.1%)
19 (41.3%)
27 (58.7%)

24 (72.7%)
8 (24.2%)
1 (30.3%)
10 (30.3%)
23 (69.7%)
6 (21.4%)
22 (78.6%)

0.000 a

Underweight
Normal
Overweight
Obese

8 (16.7%)
21 (43.8%)
13 (27.1%)
6 (12.5%)

3 (9.1%)
18 (54.5%)
10 (30.3%)
2 (6.1%)

0.591 a

Stage
T stage

N stage

Treatment modality delivered

Chemotherapy

Pre-radiotherapy weight loss
>5%
Baseline malnutrition using the
PG-SGA© global rating score
(n=76)
Baseline BMI
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P value

0.001 a
0.030 a

0.002

1.000
0.128

Baseline dysphagia (n=41)
Baseline oral-diet texture

Saw dietitian prior to or within
the first week of radiotherapy
Saw a dietitian every week of
radiotherapy

Yes
No
Nil by mouth
Normal
Soft/minced
Puree
Yes
No
Yes
No

17 (65.4%)
9 (34.6%)
3 (6.4%)
16 (34.0%)
26 (55.3%)
2 (4.3%)
46 (95.8%)
2 (4.2%)
31 (64.6%)
17 (35.4%)

SD = standard deviation
a
Using Fisher’s exact test
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10 (66.7%)
5 (33.3%)
0
17 (54.8%)
13 (41.9%)
1 (3.2%)
25 (75.8%)
8 (24.2%)
19 (57.6%)
14 (42.4%)

1.000 a
0.233 a

0.013 a
0.524

Energy intake from enteral nutrition
Patients who had a feeding tube during treatment at any time during radiotherapy were only meeting 73%
of their estimated energy requirements on average prior to or within the first week of radiotherapy (intakes
compared with EBG recommendation of 30kcal/kg/day (25)). Energy intake was lowest in the fourth week
of radiotherapy, providing on average 64% of their estimated total daily energy needs. However, mean
energy intake steadily increased over the following weeks of radiotherapy as did the number of patients
who were using their feeding-tube for supplemental or full nutrition. By the seventh week of treatment,
feeding-tube use peaked with 45 patients (90%) using their feeding tube for nutrition. At that time total
energy intake from oral and enteral sources combined was the highest it had been since the first week of
radiotherapy and enteral nutrition was contributing 73% of total energy intake on average. Two patients
who received a prophylactic feeding tube did not use the tube for nutritional intake at all during treatment.
However, both lost weight during treatment (this reached a critical level of ≥5% of baseline weight for one
patient) (Table 9).
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Table 9. Energy intake and proportion provided by enteral nutrition among patients with a feeding tube for each week of radiotherapy from Study 1
(Chapter 4) (n=51a)

Variable

One-week preradiotherapy
(n=48)

Week 1

Week 2

Week 3

Week 4

Week 5 (+1
NGT)

Week 6

Week 7 (+2
NGT)

Three months
postradiotherapy
(n=51)

Percentage of
patients using
enteral nutrition
(n)

12.5% (6)

18.8% (9)

27.1% (13)

33.3% (16)

47.9% (23)

81.6% (40)

85.7% (42)

90.0% (45)

31.3% (15)

Average
proportion of
estimated daily
energy
requirements
being met based
on 30kcal/kg/day
(SD)
Average
proportion of
total energy
provided from
enteral nutrition
(SD)

73.2% (25.3)

79.2% (27.7)

72.3% (31.6)

69.0% (32.3)

63.7% (33.9)

78.4% (26.2)

76.4% (29.2)

78.6% (26.6)

84.0% (30.7)

11.6% (30.3)

17.1% (38.1)

19.4% (38.0)

22.5% (38.0)

31.5% (39.7)

55.3% (38.0)

46.6% (36.1)

72.6% (32.0)

25.3% (42.6)

NGT= nasogastric tube; SD = standard deviation
a
(n=48 with prophylactic feeding tube; n=3 with reactive nasogastric tube)
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Adverse nutrition-related events
Malnutrition and weight loss
Sixty-three percent of patients received a PG-SGA© global rating score of B or C over the course of their
treament. Patients lost an average of 5.5kg (6.8%) weight during radiotherapy based on their lowest
recorded weight and 4.7kg (5.6%) by the final week of radiotherapy. Weight loss continued post-treatment:
by one month post-treatment average weight loss reached 5.8kg (7.1%) and by three months post-treatment
this reached 6.6kg (7.9%) (Table 10).
Sixty-one percent experienced critical weight loss of ≥5% when their baseline weight was compared to
their lowest recorded weight during radiotherapy. This was significantly associated with stage III and IV
tumours (94% vs 69%, p=0.004) of the oropharynx (65% vs 31%, p=0.016), radiotherapy + chemotherapy
(71.4% vs 34.4%, p=0.006) and Cisplatin (44% vs 19%, p = 0.005). Proportionally more patients who were
overweight at baseline (38.8% vs 12.5%) and proportionally fewer patients who were within a healthy
weight range (38.8% vs 62.5%) lost ≥5% of body weight (p=0.030) (Table 10).
Twenty-six percent of patients had lost greater than 10% weight when their baseline weight was compared
to their lowest recorded weight during radiotherapy. On average this totalled 10.8kg (13.2%) of weight lost.
Weight-loss of >10% was significantly associated with stage III and IV tumours (100% vs 78.3%, p=0.017),
T3 tumours (48% vs 27%, p=0.0378) and tumours of the oropharynx; and inversely associated with those
of the oral cavity (76%, vs 43% and 5% vs 35%, respectively, p=0.017). Patients were also more likely to
have received radiotherapy + chemotherapy (90.5% vs 45%, p=0.004) and Cisplatin as their chemotherapy
agent (57% vs 27%, p=0.003), and were more likely to have required reactive intravenous fluids during
radiotherapy (76.2% vs 65%, p=0.002). Patients who lost >10% body weight were more likely to be
consuming a normal oral diet at baseline and less likely to be limited to soft and minced textures at baseline
(70% vs 57.6% and 30% vs 56.9%, respectively, p=0.036) (Table 10)
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Table 10. Critical weight loss during radiotherapy and associated factors from Study 1 (Chapter 4)

Patient characteristics

Weight loss >5
% (n=49)

Weight loss <5%
(n=32)

P value

Weight loss >10
% (n=21)

Weight loss
<10% (n=60)

P value

Age (years)
Gender

Mean (SD)
Female
Male

61 (11.5)
10 (20.4)
39 (79.6%)

66 (14.5)
3 (9.4%)
29 (90.6%)

0.1
0.229 a

58 (12.4)
2 (9.5%)
19 (90.5%)

65 (12.8)
11 (18.3%)
49 (81.7%)

0.057
0.497

Tumour site

Oropharynx
Oral cavity
Larynx
Nasopharynx
Parotid
Hypopharynx
0-II
III-IV
1
2
3
4
Radiotherapy +
chemotherapy
Surgery + radiotherapy
Radiotherapy alone
Surgery + radiotherapy and
chemotherapy
None
Cisplatin
Cetuximab

32 (65.3%)
9 (18.4%)
6 (12.2%)
1 (2.0%)
0
1 (2.0%)
3 (6.1%)
46 (93.9%)
10 (20.4%)
12 (60.0%)
19 (38.8%)
8 (16.3%)
35 (71.4%)
3 (6.1%)
2 (4.1%)
9 (18.4%)

10 (31.3%)
13 (40.6%)
5 (12.5%)
1 (3.1%)
2 (6.3%)
1 (3.1%)
10 (31.3%)
22 (68.8%)
8 (25.0%)
8 (25.0%)
7 (21.9%)
9 (28.1%)
11 (34.4%)
6 (18.8%)
2 (6.3%)
13 (40.6%)

0.016 a

16 (76.2%)
1 (4.8%)
2 (9.5%)
1 (4.8%)
0
1 (4.8%)
0
21 (100.0%)
3 (14.3%)
4 (19.0%)
10 (47.6%)
4 (19.0%)
19 (90.5%)
0
0
2 (9.5%)

26 (43.3%)
21 (35.0%)
9 (15.0%)
1 (1.7%)
2 (3.3%)
1 (1.7%)
13 (21.7%)
47 (78.3%)
15 (25.0%)
16 (26.7%)
16 (26.7%)
13 (21.7%)
27 (45.0%)
9 (15%)
4 (6.7%)
20 (33.3%)

0.017

11 (22.4%)
24 (49.0%)
14 (28.6%)

18 (56.3%)
9 (28.1%)
5 (15.6%)

0.010 a

1 (4.8%)
13 (61.9%)
7 (33.3%)

28 (46.7%)
20 (33.3%)
12 (20%)

0.001 a

B or C (malnourished)
A (well-nourished)

12 (27.3%)
32 (72.7%)

13 (43.3%)
17 (56.7%)

0.211

3 (15.8%)
16 (84.2%)

22 (40.0%)
33 (60.0%)

0.090 a

Yes
No

11 (22.9%)
37 (77.1%)

14 (43.8%)
18 (56.3%)

0.084

3 (14.3%)
18 (85.7%)

22 (37.3%)
37 (62.7%)

0.059 a

Stage
T

Treatment
modality delivered

Chemotherapy

Baseline
malnutrition using
the PG-SGA©
global rating score
(available for
n=80)
Critical weight
loss >5% within
the six months
prior to
radiotherapy

0.004
0.370

0.006 a
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0.017 a
0.0378

0.004 a

Baseline BMI
classification

Baseline
dysphagia
Baseline oral-diet
texture

Saw a dietitian
every week of
radiotherapy
Recurrence by 12
months
Survival at 12
months
Recurrence by 18
months
Survival at 18
months
Average weight
loss during
radiotherapy b
Percentage weight
loss during
radiotherapy b
Nutrition-related
hospitalisations
Radiotherapy
rescanning due to
weight loss
Reactive
intravenous fluids
Reactive
nasogastric tube

Underweight
Normal
Overweight
Obese
Yes
No
Nil intake
Normal oral diet
Soft/ minced
Puree
Yes
No

5 (10.2%)
19 (38.8%)
19 (38.8%)
6 (12.2%)
12 (24.5%)
9 (18.4%)
2 (4.1%)
23 (46.9%)
22 (44.9%)
1 (2.0%)
30 (61.2%)
19 (38.8%)

6 (18.8%)
20 (62.5%)
4 (12.5%)
2 (6.3%)
15 (46.9%)
5 (15.6%)
1 (3.1%)
10 (31.3%)
17 (53.1%)
2 (6.3%)
20 (62.5%)
12 (37.5%)

0.030 a

1 (4.8%)
10 (47.6%)
7 (33.3%)
3 (37.5%)
2 (33.3%)
4 (66.7%)
0
14 (70.0%)
6 (30.0%)
0
13 (61.9%)
8 (38.1%)

10 (16.7%)
29 (48.3%)
16 (26.7%)
5 (8.3%)
25 (71.4%)
10 (28.6%)
3 (5.2%)
19 (32.8%)
33 (56.9%)
3 (5.2%)
37 (61.7%)
23 (38.3%)

0.519 a

Yes
No
Alive
Deceased
Yes
No
Alive
Deceased
Mean (SD)

8 (16.3%)
37 (75.5%)
45 (91.8%)
4 (8.2%)
2 (4.1%)
39 (79.6%)
41 (83.7%)
8 (16.3%)
-7.98 kg (3.41)

2 (6.3%)
28 (87.5%)
30 (93.8%)
2 (6.3%)
4 (12.5%)
26 (81.3%)
30 (93.8%)
2 (6.3%)
-1.77kg (1.42)

0.298 a

6 (10.9%)
49 (89.1%)
55 (91.7%)
5 (8.3%)
6 (10.9%)
49 (89.1%)
53 (88.3%)
7 (11.7%)
3.7kg (2.7)

0.442 a

0.000

4 (20.0%)
16 (80.0%)
20 (95.2%)
1 (4.8%)
4 (20.0%)
16 (80.0%)
18 (85.7%)
3 (14.3%)
10.8kg (2.8)

Mean (SD)

9.75% (3.46)

2.37% (1.81)

0.000

13.2% (2.2)

4.6% (2.9)

0.000

Yes
No
Yes
No

12 (24.5%)
37 (75.5%)
13 (26.5%)
36 (73.5%)

3 (9.4%)
29 (90.6%)
3 (9.4%)
29 (90.6%)

0.142

5 (23.8%)
16 (76.2%)
7 (33.3%)
14 (66.7%)

10 (16.7%)
50 (83.3%)
9 (15.0%)
51 (85.0%)

0.520 a

Yes
No
Yes
No

21 (65.3%)
17 (34.7%)
3 (6.1%)
46 (93.9%)

5 (15.6%)
27 (84.4%)
0
32 (100%)

0.000 a

16 (76.2%)
5 (23.8%)
1 (4.8%)
20 (95.2%)

39 (65%)
21 (35%)
2 (3.3%)
58 (96.7%)

0.002 a

0.326
0.483 a

0.908

1.0

a

0.233 a
0.301 a

0.086

0.274

SD = standard deviation
a
Using Fisher’s exact test
b
Using lowest recorded weight
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0.157 a
0.036 a

0.985

1.000
0.442 a
0.714 a
0.000

0.108

1.000

Nutrition-related hospitalisations
Thirty-nine (48%) patients were hospitalised during radiotherapy. Fifteen patients had a nutrition-related
hospitalisation (dehydration, enteral-feeding commencement or failure to thrive (n=9); feeding-tube
complications (n=6)). These patients were more likely to have received surgery prior to radiotherapy +
chemotherapy (20% vs 2%, p=0.048), Cisplatin (73.3% vs 33.3% p=0.025), and required reactive
intravenous fluids (87% vs 36%, p=0.000). They were also less likely to have seen a dietitian every week
of radiotherapy (33.3% vs 66.7%, p=0.012). By three months post-treatment average total weight loss and
percentage weight loss were significantly less among those who had had a nutrition-related hospitalisation
(3.67kg vs 7.4kg p=0.044 and 4.1% vs 8.9%, p=0.026) (Table 11). This could be related to having access
to greater support, including nutritional services during periods of hospitalisation.

Radiotherapy rescanning due to weight-loss
Sixteen patients (19.8%) were rescanned due to weight loss. Rescans occurred in week 3 (n=3), week 4
(n=3), week 5 (n=4) and week 6 (n=6) of radiotherapy. Patients who were rescanned lost significantly more
total weight and percentage weight during treatment (8.1kg vs 4.9kg, p = 0.005 and 9.4% vs 6.2%, p=0.012,
respectively). Proportionally more patients who were rescanned for weight loss received radiotherapy +
chemotherapy (81.3% vs 50.8%, p=0.015) and were overweight at baseline (56.3% vs 21.5%, p=0.008)
(Table 11).

Reactive intravenous fluids
Thirty-seven patients (45.7%) required reactive intravenous fluids. These patients were more likely to have
stage III or IV tumours (97.3% vs 72.7%, p=0.002), and to receive radiotherapy + chemotherapy (70.2%
vs 45.5%, p=0.031) and Cisplatin (62.2% vs 22.7%, p=0.000). These patients lost significantly more total
weight and percentage weight during radiotherapy (7.40kg vs 3.95kg, p=0.000 and 9% vs 5%, p=0.000,
respectively) (Table 11).
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Table 11. Nutrition-related hospitalisations, radiotherapy rescanning due to weight loss and reactive intravenous fluids and associated factors from Study 1
(Chapter 4)

Patient characteristics

Age (years)
Gender
Tumour site

Stage
Treatment
modality
received

Chemothera
py

Mean (SD)
Female
Male
Oropharynx
Oral cavity
Larynx
Nasopharyn
x
Parotid
Hypopharyn
x
0-II
III-IV
Radiotherap
y+
chemotherap
y
Surgery +
radiotherapy
Radiotherap
y alone
Surgery +
radiotherapy
and
chemotherap
y
None
Cisplatin
Cetuximab

Nutrition related
hospitalisati
on (n=15)

No
nutritionrelated
hospitalisati
on (n=66)

P value

58 (15.0)
4 (26.7%)
11 (73.3%)
5 (33.3%)
5 (33.3%)
3 (20.0%)
0
1 (6.7%)
1 (6.7%)

64 (12.2)
9 (13.6%)
57 (86.4%)
37 (56.1%)
17 (25.8%)
8 (12.1%)
2 (3.0%)
1 (1.5%)
1 (1.5%)

0.078
0.247 a

1 (6.7%)
14 (93.3%)
7 (46.7%)
2 (13.3%)
3 (20.0%)
3 (20.0%)

12 (18.2%)
54 (81.8%)
39 (59.1%)
7 (10.6%)
1 (1.5%)
19 (28.8%)

0.444 a

3 (20.0%)
11 (73.3%)
1 (6.7%)

26 (39.4%)
22 (33.3%)
18 (27.3%)

0.025 a

0.241 a

0.048 a

Radiotherap
y rescanning
for weight
loss (n=16)

No rescan
for weight
loss (n=65)

P value

63 (9.9)
2 (12.5%)
14 (87.5%)
12 (75.0%)
2 (12.5%)
1 (6.3%)
0
0
1 (6.25%)

63 (13.6)
11 (16.9%)
54 (83.1%)
30 (46.2%)
20 (30.8%)
10 (15.4%)
2 (3.1%)
2 (3.1%)
1 (1.5%)

0.931
1.000 a

1 (6.3%)
15 (93.8%)
13 (81.3%)
0
2 (1.25%)
1 (6.25%)

12 (18.5%)
53 (81.5%)
33 (50.8%)
9 (13.8%)
2 (3.1%)
21 (32.3%)

0.447 a

2 (12.5%)
7 (43.8%)
7 (43.8%)

27 (41.5%)
2 (40.0%)
12 (18.5%)

0.040 a
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0.264 a

0.015 a

Reactive
intravenous
fluids (n=37)

No reactive
intravenous
fluids (n=44)

P value

59 (12.9)
7
30
25 (67.6%)
8 (21.6%)
2 (5.4%)
1 (2.7%)
1 (2.7%)
0

66 (12.0)
6
38
17 (38.6%)
14 (31.8%)
9 (20.5%)
1 (2.3%)
1 (2.3%)
1 (2.3%)

0.011
0.557

1 (2.7%)
36 (97.3%)
26 (70.2%)
2 (5.4%)
3 (8.1%)
6 (16.2%)

12 (27.3%)
32 (72.7%)
20 (45.5%)
7 (15.9%)
1 (2.3%)
16 (36.4%)

0.002 a

6 (16.2%)
23 (62.2%)
8 (21.6%)

23 (52.3%)
10 (22.7%)
11(25.0%)

0.000 a

0.055 a

0.031 a

Baseline
malnutrition
using the
PG-SGA©
global rating
score (n=80)
Preradiotherapy
weight loss
>5%
Baseline
BMI

Baseline
dysphagia
(n=41)
Baseline
oral-diet
texture
Saw a
dietitian
every week
of
radiotherapy
Average
weight loss
during
radiotherapy

Yes
No

5 (41.7%)
7 (58.3%)

20 (32.3%)
42 (67.7%)

0.525 a

4 (26.7%)
11 (73.3%)

21 (35.6%)
38 (64.4%)

0.761 a

11 (33.3%)
22 (66.7%)

14 (34.1%)
27 (65.9%)

1.000 a

Yes
No

6 (40.0%)
9 (60.0%)

19 (28.8%)
46 (69.7%)

0.538

5 (31.3%)
11 (68.8%)

20 (31.3%)
44 (68.8%)

1.000

10 (27.0%)
27 (73.0%)

15 (34.9%)
28 (65.1%)

0.479

Underweight
Normal
Overweight
Obese
Yes
No

2 (13.3%)
6 (40.0%)
5 (33.3%)
2 (13.3%)
6 (75.0%)
2 (25.0%)

9 (13.6%)
33 (50.0%)
18 (27.3%)
6 (9.1%)
21 (63.6%)
12 (36.4%)

0.872 a

1 (6.3%)
3 (18.8%)
9 (56.3%)
3 (18.8%)
5 (62.5%)
3 (21.4%)

10 (15.4%)
36 (55.4%)
14 (21.5%)
5 (7.7%)
22 (66.7%)
11 (33.3%)

0.008 a

2 (5.4%)
19 (21.4%)
12 (32.4%)
4 (10.8%)
11 (61.1%)
7 (30.4%)

9 (20.5%)
20 (45.5%)
11 (25.0%)
4 (9.1%)
16 (69.6%)
7 (38.9%)

0.272 a

Nil intake
normal
Soft/ minced
Puree
Yes
No

1 (6.7%)
4 (26.7%)
7 (46.7%)
1 (6.7%)
5 (33.3%)
10 (66.7%)

2 (3.0%)
29 (43.9%)
32 (48.5%)
2 (3.0%)
45 (68.2%)
21 (31.8%)

0.327 a

0
3 (20.0%)
12 (80.0%)
0
1 (62.5%)
6 (37.5%)

3 (4.8%)
30 (47.6%)
27 (42.9%)
3 (4.8%)
40 (61.5%)
25 (38.5%)

0.064 a

1 (2.8%)
16 (44.4%)
18 (50.0%)
1 (2.8%)
25 (67.6%)
12 (32.4%)

2 (4.8%)
17 (40.5%)
21 (50.0%)
2 (66.7%)
25 (56.8%)
19 (43.25)

1.000 a

Mean (SD)

6.18kg (4.27)

5.38kg
(4.12kg)

0.505

8.1kg (4.06)

4.9kg (3.93)

0.005

7.40kg (4.29)

3.95kg (3.28)

0.000

Mean (SD)

7.6% (5.0)

6.7% (4.6)

0.490

9.4% (4.82)

6.2% (4.42)

0.012

9.0% (4.91)

5.0% (3.53)

0.000

Mean (SD)

5 (33.3%)
10 (66.7%)

16 (24.2%)
50 (75)

0.520

7 (43.8%)
9 (56.3%)

14 (21.5%)
51 (78.5%)

0.108

16 (43.2%)
21 (56.8%)

5 (11.4%)
39 (88.6%)

0.002

Mean (SD)

3.67kg (5.63)

7.4kg (6.2)

0.044

9.23kg
(5.35kg)

5.91kg
(6.27kg)

0.066

7.40kg
(5.87kg)

5.85kg
(6.522kg)

0.303

0.692 a

0.012

1.000 a

1.000 a

0.742

0.321

b

Percentage
weight loss
during
radiotherapy
b

>10 %
lowest
weight
Average
weight loss
by three
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months postradiotherapy
Average
percentage
weight loss
by three
months
Survival at
12 months
Recurrence
by 18
months
Survival at
18 months
Nutritionrelated
hospitalisati
ons
Radiotherap
y rescanning
due to
weight loss
Reactive IV
fluids
Recurrence
by 12
months

Mean (SD)

4.14% (7.6)

8.9% (6.8)

0.026

10.49% (6.5)

7.22% (7.3)

0.120

9.0% (7.5)

6.82% (6.8)

0.209

Alive
Deceased
Yes
No

15 (100%)
0
0
15 (100.0%)

60 (90.9%)
6 (9.1%)
10 (16.7%)
50 (83.3%)

0.587 a

14 (87.5%)
2 (12.5%)
0
13 (100.0%)

61 (93.8%)
4 (6.2%)
6 (10.3%)
52 (89.7%)

0.338 a

34
3
1
31

41
3
5
34

1.000 a

Alive
Deceased
Yes
No

15 (100.0%)
0
n/a

56 (84.8%)
10 (15.2%)
n/a

0.195

13 (81.3%)
3 (18.8%)
4 (25.0%)
12 (75.0%)

58 (89.2%)
7 (10.8%)
11 (16.9%)
54 (83.1%)

0.405 a

32
5
13 (35.1%)
24 (64.9%)

39
5
2 (4.5%)
42 (95.5%)

1.000

Yes
No

4
11

12
54

0.481 a

n/a

n/a

n/a

9
28

7
37

0.407

Yes
No

13 (86.7%)
2 (13.3%)

24 (36.4%)
42 (63.6%)

0.000 a

9 (56.3%)
7 (43.8%)

28 (43.1%)
0

0.407 a

n/a

n/a

n/a

Yes
No

1 (6.7%)
14 (93.3%)

9 (15.0%)
51 (85.0%)

0.676 a

3 (21.4%)
11 (78.6%)

7 (11.5%)
54 (88.5%)

0.384 a

4
30

6
35

1.000 a

0.196

n/a

SD = standard deviation
a
Using Fisher’s exact test
b
Using lowest recorded weight
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0.584 a

0.481

0.213 a

0.000 a

Reactive nasogastric tube placements
Three patients (3.7%) received a reactive nasogastric tube during treatment. These occurred in the fifth and
seventh weeks of radiotherapy and in the first week post-radiotherapy. Patients who received a reactive
nasogastric tube were more likely to have a nutrition-related hospitalisation compared to those who did not
have a feeding tube (100% vs 10%, p=0.004) and compared to those who received a feeding tube
prophylactically (100% vs 18.8%, p=0.011). They were also more likely to require reactive intravenous
fluids compared to those who did not receive a feeding tube (100.0% vs 30.0%, p=0.040) (Table 12.)
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Table 12. Factors associated with reactive feeding tubes versus no feeding tubes and reactive feeding tubes and prophylactic feeding tubes from Study 1
(Chapter 4)

Patient characteristics

Age (years)
Gender
Tumour site

Stage
T

Treatment modality
delivered

Chemotherapy

Baseline malnutrition
using the PG-SGA©
global rating score
(n=74)
Pre-treatment critical
weight loss
Baseline BMI

Reactive nasogastric
tube (n=3)

No feeding tube
(n=30)

P value (reactive
nasogastric tube
vs no feeding tube)

Prophylactic feeding
tube (n=48)

P value (reactive
nasogastric tube vs
prophylactic feeding
tube)

63 (10.9)
7 (14.6%)
41 (85.4%)
31 (64.6%)
8 (16.7%)
5 (10.4%)
2 (4.2%)
0
2 (4.2%)

n/a
1.000 a

2 (4.2%)
46 (95.8%)
7 (14.6%)
9 (18.8%)
20 (41.7%)
12 (25.0%)
39 (81.3%)
3 (6.3%)
3 (6.3%)
3 (6.3%)

1.000 a

5 (10.4%)
25 (52.1%)
18 (37.5%)
19 (41.3%)
27 (58.7%)

0.218 a

15 (31.9%)
32 (68.1%)
8 (16.7%)

1.000 a

Mean (SD)
Female
Male
Oropharynx
Oral cavity
Larynx
Nasopharynx
Parotid
Hypopharynx

48 (25.8)
0
3 (100%)
1 (33.3%)
1 (33.3%)
1 (33.3%)
0
0
0

65 (13.96)
6 (20.0%)
24 (88.9%)
10 (33.3%)
13 (43.3%)
5 (16.7%)
0
2 (6.7%)
0

0.085
1.000 a

0-II
III-IV
1
2
3
4
Radiotherapy +
chemotherapy
Surgery + radiotherapy
Radiotherapy alone
Surgery + radiotherapy and
chemotherapy
None
Cisplatin
Cetuximab
Yes
No

0
3 (100%)
2 (66.7%)
0
1 (33.3%)
0
1 (33.3%)
1 (33.3%)
0
1 (33.3%)

11 (36.7%)
19 (63.3%)
9 (30.0%)
11 (36.7%)
5 (16.7%)
5 (16.7%)
6 (20.1%)
5 (16.7%)
1 (3.3%)
18 (60.0%)

0.534 a

1 (33.3%)
2 (66.7%)
0
1 (50.0%)
1 (50.0%)

23 (76.7%)
6 (20.0%)
1 (3.3%)
5 (19.2%)
21 (80.8%)

0.224 a

Yes
No
Underweight

1 (33.3%)
2 (66.7%)
0

9 (30.0%)
21 (70.0%)
3 (10%)

1.000 a
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0.817 a

0.534 a

0.415 a

0.389 a

0.570 a

0.405 a

0.221 a

0.114 a

1.000 a

0.707 a

Baseline oral-diet texture

Saw a dietitian every
week of radiotherapy
Weight loss during
radiotherapy b
Percentage weight loss
during radiotherapy b
Total weight loss from
baseline to three months
post-radiotherapy
Assessed as
malnourished during
radiotherapy
Nutrition- related
hospitalisation
Radiotherapy rescanning
due to weight loss
Reactive IV fluids

Normal
Overweight
Obese
Nil intake
Normal
Soft/ minced
Puree
Yes
No
Mean (SD)

1 (33.3%)
2 (66.7%)
0
0
1 (33.3%)
2 (66.7%)
0
1 (33.3%)
2 (66.7%)
7.83kg (1.19)

17 (56.7%)
8 (26.7%)
2 (6.7%)
0
16 (57.1%)
11 (39.3%)
1 (3.6%)
18 (60.0%)
12 (40.0%)
4.0kg (3.48kg)

0.070

21 (43.8%)
13 (27.1%)
6 (12.5%)
3 (6.4%)
16 (34.0%)
26 (55.3%)
2 (4.3%)
31 (64.6%)
17 (35.4%)
6.34kg (4.37kg)

Mean (SD)

9.8% (3.57)

5.11% (3.82)

0.052

7.7% (4.91)

0.484

5.30kg (3.52kg)

5.33kg (3.74kg)

0.990

7.48kg (7.31kg)

0.615

Yes
No

3 (100.0%)
0

16 (53.3%)
14 (46.7%)

0.244 a

32 (66.7%)
16 (33.3%)

0.543 a

Yes
No
Yes
No
Yes
No

3 (100.0%)
0
1 (33.3%)
2 (66.7%)
3 (100.0%)
0

3 (10.0%)
27 (90.0%)
3 (10.0%)
27 (90.0%)
9 (30.0%)
21 (70.0%)

0.004 a

9 (18.8%)
39 (81.3%)
12 (25.0%)
36 (75.0%)
25 (52.1%)
23 (47.9%)

0.011 a

Mean (SD)

SD = standard deviation
a
Using Fisher’s exact test
b
Using lowest recorded weight
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0.607 a

0.561 a

0.330 a
0.040 a

1.000 a

0.547 a
0.561

1.000 a
0.242 a

Prolonged feeding-tube use
At three months post-radiotherapy 15 patients were still using a feeding tube. By six months postradiotherapy eight patients were still using their feeding tube (9.9% of the whole sample and 15.7% of
those with a feeding tube). Two of these patients passed away before 12 months post-radiotherapy. The
other six were still using their feeding tube at 12 months (7.4% of the whole sample and 11.8% of those
who received a feeding tube). There were no statistically significant differences between patients who
were still using their feeding tube at six and 12 months post-treatment, compared to those who were not.
However, there was a higher proportion of patients who were using a feeding tube prior to commencing
radiotherapy among those who were still using their feeding tube at 12 months (16.7% vs 2.6%, p=0.083)
and fewer who were tolerating a normal oral diet without texture modifications at baseline (12.5% vs
42.1%, p=0.084). Additionally, there was a higher proportion of patients who were still using their
feeding tube at 12 months post-radiotherapy who by 18 months post radiotherapy had recurrent disease
(33.3% vs 15.8%, p=0.297) or were deceased (33.3% vs 5.3%, p=0.083) (Table 13).
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Table 13. Feeding tube use at six and 12 months post-radiotherapy and associated factors from Study 1 (Chapter 4)

Patient characteristics

Age
Gender
Tumour site

Stage
T

Treatment modality
delivered

Chemotherapy

Baseline malnutrition
using the PG-SGA© global
rating score (n=80)
Pre-radiotherapy weight
loss >5%
Baseline BMI

Baseline dysphagia

Feeding- tube
use at six
months (n=8)
(17.0%)

No feeding tube
use at six months
(n=39)

P value

Mean (SD)
Female
Male
Oropharynx
Oral cavity
Larynx
Nasopharynx
Parotid
Hypopharynx
0-II
III-IV
1
2
3
4
Radiotherapy +
chemotherapy
Surgery + radiotherapy
Radiotherapy alone
Surgery + radiotherapy
and chemotherapy
None
Cisplatin
Cetuximab
Yes
No

68 (9.66)
2 (25.0%)
6 (75.0%)
6 (75.0%)
2 (25.0%)
0
0
0
0
0
8 (100.0%)
1 (12.5%)
1 (12.5%)
4 (50.0%)
2 (25.0%)
5 (62.5%)
1 (12.5%)
1 (12.5%)
1 (12.5%)

61 (12.7)
5 (12.8%)
34 (87.2%)
23 (59.0%)
7 (17.9%)
5 (12.8%)
2 (5.1%)
0
0
2 (5.1%)
94.9%)
9 (23.1%)
7 (17.9%)
15 (38.5%)
8 (20.5%)
32 (82.1%)
2 (5.1%)
2 (5.1%)
3 (7.7%)

0.173
0.585 a

1 (12.5%)
4 (50.0%)
3 (37.5%)
4 (50.0%)
4 (50.0%)

4 (10.3%)
20 (51.3%)
15 (38.5%)
23 (63.9%)
13 (36.1%)

1.00 a

Yes
No
Underweight
Normal
Overweight
Obese
Yes
No

3 (42.9%)
4 (57.1%)
1 (12.5%)
5 (62.5%)
2 (25.0%)
0
4 (66.7%)
2 (33.3%)

11 (28.2%)
28 (71.8%)
6 (15.4%)
16 (41.0%)
12 (30.8%)
5 (12.8%)
13 (65.0%)
7 (35.0%)

0.658 a
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0.864 a

1.000 a
0.950 a

0.306 a

0.690 a

0.837 a

1.000 a

Feeding-tube
use at 12
months postradiotherapy
(n=6) (13.6%),
11.8%

No feeding
tube use at 12
months postradiotherapy
(n=38)

P value

67 (10.1)
1 (16.7%)
5 (83.3%)
5 (83.3%)
1 (16.7%)
0
0
0
0
0
6 (100.0%)
1 (16.7%)
0
2 (33.3%)
3 (50.0%)
5 (83.3%)
0
0
1 (16.7%)

61 (12.7)
6 (15.8%)
32 (84.2%)
22 (57.9%)
7 (18.4%)
5 (13.2%)
2 (5.3%)
0
2 (5.3%)
2 (5.3%)
36 (94.7%)
8 (21.1%)
8 (21.1%)
15 (39.5%)
7 (18.4%)
31 (86.1%)
2 (5.3%)
3 (7.9%)
2 (5.3%)

0.281
1.000 a

0
3 (50.0%)
3 (50.0%)
3 (50.0%)
3 (50.0%)

2 (5.3%)
21 (53.3%)
14 (36.8%)
12 (34.3%)
23 (56.7%)

0.795 a

1 (20.0%)
4 (80.0%)
2 (33.3%)
3 (50.0%)
1 (16.7%)
0
3 (60.0%)
2 (40.0%)

12 (31.6%)
26 (68.4%)
5 (13.2%)
16 (42.1%)
12 (31.6%)
5 (13.2%)
12 (63.2%)
7 (36.8%)

1.000 a

0.901 a

1.000 a
0.357 a

0.724 a

0.651 a

0.523 a

1.000 a

Baseline oral-diet texture

Baseline nutritional-intake
source
Saw a dietitian every week
of radiotherapy
Recurrence by 12 months
post-radiotherapy
Survival at 12 months
post-radiotherapy
Recurrence by 18 months
post-radiotherapy
Survival at 18 months
post-radiotherapy
Malnourished during
radiotherapy
Average weight loss during
radiotherapy b
Percentage weight loss
during radiotherapy b
Weight loss by three
months post-radiotherapy
Percentage weight loss by
three months postradiotherapy
Nutrition –related
hospitalisations
Radiotherapy rescanning
for weight loss
Reactive intravenous fluids

Nil intake
normal
Soft/ minced
Puree
Oral
Oral + enteral
Full enteral
Yes
No
Yes
No
Alive
Deceased
Yes
No
Alive
Deceased
Yes
No
Mean (SD)

1 (12.5%)
1 (12.5%)
5 (62.5%)
1 (12.5%)
6 (75.0%)
1 (12.5%)
1 (12.5%)
7 (87.5%)
1 (12.5%)
1 (12.5%)
6 (75.0%)
7 (87.5%)
1 (12.5%)
1 (14.3%)
6 (85.7%)
6 (75.0%)
2 (25.0%)
6 (75.0%)
2 (25.0%)
4.73kg (4.60kg)

0
16 (42.1%)
20 (52.6%)
2 (5.3%)
36 (94.7%)
1 (2.6%)
1 (2.6%)
23 (59%)
16 (41%)
8 (20.5%)
31 (79.5%)
39 (100%)
0
7 (17.9%)
32 (82.1%)
36 (92.3%)
3 (7.7%)
25 (64.1%)
14 (35.9%)
6.74kg (4.03)

0.084 a

1 (16.7%)
1 (16.7%)
4 (66.7%)
0
4 (66.7%)
1 (16.7%)
1 (16.7%)
5 (83.3%)
1 (16.7%)
2 (33.3%)
4 (66.7%)
n/a

0
16 (43.2%)
19 (51.4%)
2 (5.4%)
36 (94.7%)
1 (2.6%)
1 (2.6%)
22 (57.9%)
16 (42.1%)
7 (18.4%)
31 (81.6%)
n/a

0.160 a

6 (15.8%)
32 (84.2%)
36 (94.7%)
2 (5.3%)
24 (63.2%)
14 (36.8%)
6.79kg (4.07kg)

0.297 a

0.214

2 (33.3%)
4 (66.7%)
4 (66.7%)
2 (33.3%)
5 (83.3%)
1 (16.7%)
5.47kg (5.27kg)

Mean (SD)

5.94% (5.7)

8.11% (4.5)

0.241

7.1% (6.6)

8.2% (4.5)

0.607

Mean (SD)

7.49kg (4.97kg)

0.699

6.5kg (15.47kg)

7.49kg (5.06kg)

0.882

Mean (SD)

5.59kg
(13.18kg)
4.4% (14.9)

9.08% (5.8%

0.150

5.1% (17.8)

9.1% (5.9)

0.607

Yes
No
Yes
No
Yes
No

3 (37.5%)
5 (62.5%)
3 (37.5%)
5 (62.5%)
4 (50.0%)
4 (50.0%)

9 (23.1%)
30 (76.9%)
9 (23.1%)
30 (76.9%)
21 (53.8%)
18 (46.2%)

0.403 a

2 (33.3%)
4 (66.7%)
2 (33.3%)
4 (66.7%)
4 (66.7%)
2 (33.3%)

10 (26.3%)
28 (73.7%)
9 (23.7%)
29 (76.3%)
21 (55.3%)
17 (44.7%)

0.658 a

SD = standard deviation
a
Using Fisher’s exact test
b
Using lowest recorded weight
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0.134 a

0.228a
1.000 a
0.170 a
1.000 a
0.196 a
0.697 a

0.188 a
1.000 a

0.083 a

0.380a
0.586 a
n/a

0.083 a
0.647 a
0.482

0.630 a
0.684 a

4.6 Discussion
This retrospective review of the electronic medical records of patients treated with HNC in a regional
cancer-care network highlights the nutritional burden that is experienced prior to and during radiotherapy.
For example, in this study more than half of patients had lost weight within the six months prior to treatment
and 31% started radiotherapy with a PG-SGA© global rating score of B or C, thus were considered
moderately to severely malnourished. This is consistent with other studies with HNC patients that have
found that 30-50% of patients experience weight loss (43, 165, 166) and 30-70% of patients are malnourished
prior to commencing radiotherapy

(48, 49, 160, 167, 168).

Some studies have only included patients with HNC

who received concurrent chemo-radiation or who had more-advanced disease, which may explain why our
results showed a relatively lower rate of pre-treatment weight-loss and malnutrition (25). However, even at
the lower end of this range, patients with HNC remain a nutritionally vulnerable patient population
compared with most other cancer sub-groups

(169).

Routine formal malnutrition screening at the point of

diagnosis could be worthwhile to allow for more-timely nutritional intervention to help minimise the impact
of pre-treatment weight-loss and malnutrition on treatment tolerance, survival, and recovery (37). However,
as this period can be overwhelming for cancer patients

(170)

more research is needed to understand the

perceived value of, and capacity for dietetic involvement at the point of diagnosis. Qualitative research with
both patients and healthcare professionals that explores dietitians’ roles and nutritional care within the
context of a complex multidisciplinary cancer-care journey for patients with HNC could help to address
this.
In the present study patients lost on average 5.6% of their body weight from week 1 to the final week of
treatment. Weight loss tapered off to 7.1% one-month post-treatment and to 7.9% three months posttreatment. This was comparable to two other studies that were recently conducted in Australian
metropolitan cancer centres where 80% of patients with HNC saw a dietitian weekly
weekly dietitian-led nutrition care clinic was implemented

(47).

(129)

and where a

Rates of weight loss from those studies were

as follows: 4.4-6.7% by the final week of radiotherapy, 5.4-8.6% at one month post-treatment and 10.3%
three months post-treatment

(47, 129).

This supports that the recommendation for weekly dietetic reviews

during radiotherapy should be reviewed, as patients with high-risk features such as stage III-IV tumours
and who receive chemotherapy may benefit from more frequent contact

(97).

Patient non-attendance was

identified as a primary reason for why not all patients saw a dietitian weekly in a study by Hofto, Abbott
(97).

Thus, future research should explore how patients prioritise dietetic appointments within their cancer-

care journey. Moreover, an Australian survey involving 60 HNC teams found that there was wide variation
in dietetic resourcing, and that the reported dietetic resources would not have been able to meet the national
EBG recommendation for weekly dietetic review during radiotherapy (144). Thus, qualitative research with
healthcare professionals in different HNC teams would be worthwhile to provide insight into how staffing
and funding for dietetic positions may influence the capacity for dietitians to adhere to the EBGs (25).
In this study, there was a higher proportion of patients who were overweight at baseline who lost greater
than or equal for five percent of their weight during radiotherapy and required radiotherapy rescanning due
to weight loss. This supports other studies that have highlighted that baseline BMI may not be the best
indicator of nutritional risk

(31, 171, 172).

Physicians and nurses are often responsible for conducting
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malnutrition screening and to refer patients to dietitians. However, a qualitative study with healthcare
professionals in five European cancer centres found that referrals to dietitians were often based on physicalappearance interpretations of nutritional risk, which often meant that patients would not see a dietitian until
they were already malnourished

(70).

This highlights the importance of routine early nutritional screening

using a validated tool for all patients with HNC as recommended by EBGs

(25)

and the need to improve

nutrition-related knowledge among other healthcare professionals on HNC teams. Further qualitative
research that explores healthcare professionals’ perspectives of the dietitian’s role and the value of
nutritional care for patients with HNC would be informative to how this recommendation is implemented
in practice.
A patient’s ability to act on dietetic advice that aims to prevent weight-loss and other nutrition-related
adverse events is an important consideration, as this may influence patient outcomes, irrespective of
whether evidence-based care was made available (25, 173). Sub-group analysis of patients who had a feeding
tube demonstrated that there was difficulty reaching evidence-based energy targets of 30kcal/kg/day
throughout the entire course of radiotherapy

(25).

This is concerning, as recent evidence suggests that a

minimum of 34kcal/kg/day may be required for weight stability among patients with HNC

(174).

It is likely

that patients struggled to consume adequate energy due to severe treatment side effects such as nausea and
pain

(173).

However, findings from qualitative research also suggests that patients with HNC may

intentionally delay using their feeding tube because they view it as a sign of failure or because weight loss
is considered a positive outcome (118, 175). Further qualitative research with patients with HNC and healthcare
professionals that explores their perceptions of and experiences with feeding tubes would be worthwhile to
better understand patient acceptance of feeding tubes and their capacity to action evidence-based enteral
feeding recommendations made by dietitians.
The timing of feeding-tube placements is a controversial topic. The Australian nutritional EBGs
recommend that prophylactic feeding tubes should be considered for patients who have T4 or hypopharyngeal tumours and are undergoing concurrent chemo-radiotherapy

(25).

However, attempts at

randomising patients to receive either a prophylactic gastrostomy tube or a nasogastric tube reactively have
not been highly successful to date

(149, 150).

Subsequently, the lack of conclusive evidence supporting one

approach over another has been attributed to differences in practice (25). An argument against a prophylactic
gastrostomy tube approach is that the up-front costs are higher than the placement costs of nasogastric tubes
(approximately $750 and $80 AUD, respectively)

(150).

However, in the present study the three patients

(4%) who required a reactive nasogastric tube during treatment were also more likely to require reactive
intravenous fluids and were hospitalised (p<0.05). In Australia, the average cost of a hospitalisation per day
is $1,839 and the reactive provision of intravenous fluids also represents a burden for patients and the
healthcare service. Therefore, a prophylactic gastrostomy tube approach may reduce the requirement for
additional healthcare and the associated cost. Another argument against the prophylactic gastrostomy tube
approach is that it may lead to unnecessary procedures for patients and costs for the health service if patients
do not use it for nutrition (176). However, in this study, only two patients did not use their gastrostomy tube
throughout the treatment period, yet they both lost weight, which suggests that they may have benefited
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from supplemental enteral nutrition. More research on patient acceptance of and capacity to use a feeding
tube as recommended by healthcare professionals is required.
Finally, a concern that is frequently debated with regards to feeding tubes for patients with HNC, is the risk
of prolonged feeding tube use (or tube-dependence) and dysphagia as a result of a prophylactic gastrostomy
tube enabling patients to unnecessarily limit the use of their swallowing muscles during radiotherapy (69).
In the present study there was a high level of adherence to evidence-based recommendations regarding the
placement of prophylactic feeding tubes (25) and only 10% and 7% of patients were still using a feeding tube
at six and 12 months post-radiotherapy respectively. Additionally, this was more common among patients
or who had recurrent disease or were deceased at 18 months post treatment, or who started treatment with
swallow issues. The prevalence of prolonged feeding-tube use in our study was at the lower end of what
has been reported in other studies ranging from 3-53% at six months and 6-29% at 12 months post
radiotherapy

(177).

The large variation between different studies may be related to differences in patient

sampling and inconsistencies in how tube-dependence is defined

(69).

However, another consideration is

that few studies provide details on patient access to speech pathologists and dietitians and adherence to
swallow-rehabilitation exercises, yet this is known to promote better swallow outcomes and support patients
during the challenging transition back to full oral intake

(178, 179).

It is possible that the weekly clinic with

the specialist oncology nurse, dietitian and speech pathologist had a positive impact on post-radiotherapy
swallow function in the present study, where prophylactic gastrostomy tubes were frequently used. Future
research that explores perceptions and experiences among healthcare professionals in different HNC teams
would be useful to provide insight on the factors that determine whether a prophylactic gastrostomy tube
approach or reactive approach is recommended. Qualitative research on feeding tube perceptions and
experiences among patients with HNC is also important to ensure there are the voices of individuals who
have suffered from HNC and their carers within the evidence-base that directs practices related to the timing
of feeding-tube placement and the type of feeding tube recommended.
One of the study’s main limitations is the retrospective design, as we were unable to capture some data,
including reasons why not all patients saw a dietitian weekly (180). Similarly, we were unable to capture data
that quantified involvement from a speech pathologist and patient adherence to swallow exercises that
would have been useful to add to the discussion on prolonged feeding tube use. Body-composition data was
also not available. However, this would have been a useful measure of sarcopenia and an important data
point in consideration of the association between muscle loss and prognosis, particularly within this sample
of HNC patients whom had high rates of obesity at baseline

(171).

This should be accounted for in future

studies in the HNC context. Furthermore, multi-variate analysis was not feasible due to the small sample
size. Future prospective randomised trials are required and there is a need for qualitative research to explore
perceptions and experiences of patients with HNC and healthcare professionals on the role of the dietitian
and feeding tube use in HNC teams.
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4.7 Conclusion
This retrospective review of the electronic medical records of patients with HNC treated in a regional
cancer-care network displayed a high level of adherence to EBG recommendations related to dietitians
undertaking validated malnutrition assessment during radiotherapy and to prophylactic feeding-tube use
and cessation. However, other EBG recommendations were less evident, as only 62% of patients were seen
by a dietitian weekly during radiotherapy, and there was a struggle to meet evidence-based energy targets.
This may explain why adverse nutrition-related events, such as nutrition-related hospitalisations, still
occurred. The quantitative findings from the present study should be expanded upon by research that
explores the perceptions and experiences among HNC patients and healthcare professionals from different
HNC teams, for insight into how patient and workplace structures may influence the implementation of
nutritional EBGs. Further research in this field may enable clearer recommendations that articulate
opportunities for earlier dietetic involvement, collaborative nutritional care, and how to prioritise patient
preferences and consider their capacity to action recommendations from healthcare professionals, for better
outcomes.
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CHAPTER 5: The experience of nutritional care among
patients with head and neck cancer treated in a regional
Australian cancer care network: A longitudinal qualitative
study
5.1 Chapter overview
In Study 2 that is reported on in this chapter, I aimed to explore the patients’ experience of nutritional care,
including perspectives on a clinic that combined the services of a specialist oncology nurse, dietitian and
speech pathologist. This study was designed to help address Objective 3 of this thesis: Identify and explore
factors that influence the implementation of nutritional evidence-based guidelines (EBGs) for patients with
head and neck cancer (HNC), based on their own perspectives and experiences. This study was conducted
in the same setting as Study 1, and the data collection period also overlapped with that of Study 1 (Chapter
4). Using a qualitative longitudinal design this study builds on the quantitative findings from the previous
chapter by providing insight in the patients’ experience of nutritional care at key points throughout their
treatment journey.
The study reported on in this chapter was published in Supportive Care in Cancer in 2021.
Citation. Hazzard E, Haughton J, Fish J, Milosavljevic M, Dickson V, Boehm J, Walton K, Ashford B.
The experience of nutritional care according to patients with head and neck cancer involved with a
combined dietitian, specialist nurse and speech pathologist clinic in a regional Australia: a qualitative
longitudinal study. Support Care Cancer. 2021. doi: 10.1007/s00520-020-05917-9. Epub ahead of print.
PMID: 33415362.
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5.2 Abstract
Background: Malnutrition is a co-morbidity of head and neck cancer (HNC) that has negative
consequences for patients. Evidence-based guidelines (EBGs) provide recommendations to prevent and
manage malnutrition. A clinic that combines the services of a dietitian, specialist oncology nurse and speech
pathologist may promote the implementation of nutritional EBGs in regional Australia. This study aimed
to explore the nutritional care experience that patients with HNC had in this setting.
Methods: A qualitative longitudinal study collected data via semi-structured interviews with HNC patients
who were treated in one regional cancer-care network in Australia. Interviews were conducted at key points
in their HNC journey from diagnosis to four months post-radiotherapy. Data was analysed using a
grounded-theory approach.
Results: Ten participants completed a total of thirty-six interviews. The findings were grouped into four
categories: preparing for nutritional challenges, multidisciplinary care directed by patient needs, the battle
to eat, and incongruence between patient values and nutritional priorities.
Conclusion: These findings highlight the nutritional burden associated with HNC and barriers to patients
accepting nutritional support from healthcare professionals. Information provided by physicians and nurses
prior to treatment may help patients prepare for the nutritional challenges ahead and accept support from
dietitians. Furthermore, clinics that promote continuity through treatment and allow dietitians to lead
aspects of nutritional care, in collaboration with nurses, speech pathologists, and physicians may also
enhance the nutritional-care experience. More qualitative research with healthcare professionals would
provide further insight on enhancing the implementation of nutritional EBGs to improve outcomes for these
patients.
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5.3 Introduction
National evidence-based guidelines (EBGs) for the nutritional management of patients with HNC, provide
recommendations for practice that promote best outcomes this group

(21, 25, 73).

However, barriers to the

implementation of evidence-based nutritional care have been identified in other settings

(145, 181, 182).

For

example, the structure of and resources available within the healthcare service, healthcare providers’ ability
to deliver evidence-based care, and patient characteristics can affect adherence to nutritional EBGs

(145).

Research within the HNC context is required to explore how nutritional EBGs for HNC patients are
implemented, so that strategies can be developed to improve the delivery of nutritional care within these
services and patient outcomes (80).
Qualitative research with patients is recognised as an important method to explore the implementation of
(80).

EBGs

Researchers have used qualitative research methods to provide insight into the physical

symptoms, nutritional challenges, life impact, and information and communication needs of individuals
with HNC

(46, 52, 183-188).

(46, 52, 183-188)

HNC

Findings demonstrate the impact of HNC on physical function and quality of life

and the importance of support from healthcare professionals and family as well as peers with

(183, 184).

However, there is a gap in knowledge related to patient perceptions and experiences of

nutritional care as a component of the HNC treatment journey, particularly in regional Australia. There
have been a small number of studies with HNC patients that have used longitudinal designs to explore
experiences over time, with a focus on symptom burden, the experience of pain and how patients cope (113,
114, 189).

A qualitative longitudinal study designed to explore the perspectives and experiences of nutritional

care among patients with HNC would provide in-depth insight into how nutritional care is valued and
actioned by patients. This would build on quantitative research that has measured adherence to several
recommendations within the nutritional EBGs and associated outcomes within the HNC context (Chapter
4) (47, 97, 133).
With increasing demand on HNC services and the complex sequelae of side effects, more novel models of
multidisciplinary care that position dietitians to lead aspects of nutritional care have been developed (46, 47).
An example of this is a clinic that combines the services of a specialist oncology nurse, dietitian and speech
pathologist for patients treated for HNC in a regional area of Australia. Research demonstrates that similar
clinics may promote the implementation of nutritional EBGs as they are well received by patients and can
result in good clinical outcomes, such as fewer nutrition-related hospitalisations and unnecessary feedingtube placements while minimising costs to the health service

(46, 47, 190, 191).

However, more research is

required to understand how patients with HNC view this clinic structure within the context of their
multidisciplinary cancer-care journey.
The aim of this study was to explore patient experiences of nutritional care, including involvement with a
clinic that combined the services of specialist oncology nurse, dietitian and speech pathologist, while
undergoing treatment for HNC in regional Australia.
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5.4 Methods
This study was part of a larger research study that explored the HNC patient journey, including their
involvement with general practitioners. The focus of the present study was on the experience of nutritional
care. Other findings will be published elsewhere.

Qualitative approach and research paradigm
The study reported here was guided by a grounded-theory approach described by Charmaz (10). Grounded
theory enabled a systematic method for qualitative research (105). Additionally, the paper by O'Brien, Harris
(192)

was referred to and the checklist of consolidated criteria for reporting qualitative research (COREQ)

formulated by Tong, Sainsbury (128) was applied to ensure the standards of high-quality qualitative research
reporting were met. This study was approved by the Human Research Ethics Committee at the University
of Wollongong (HE14/470).
In this study we used a qualitative longitudinal design. This type of study, which involves interviewing
participants at different points, is useful for developing rapport between the researcher and participant to
explore personal topics and for understanding patients’ evolving experiences and changing needs (193). The
interview points in this study were chosen to align with transitions between medical departments and key
junctures in treatment.

Researcher characteristics and reflexivity
The research team comprised a group of researchers and clinicians with backgrounds in dietetics, nursing,
speech pathology, head and neck surgery, academia and management. The research team members were
chosen due to their expertise in the care of patients with HNC, as well as in qualitative research and
grounded theory. Four members of the research team were directly involved in the clinical care of patients
involved in this study. To minimise the risk of bias, non-clinical members of the research team collected,
de-identified and analysed the data prior to providing access to those members who potentially had an
established professional relationship with some participants.

Context
The study was conducted in a regional cancer-care network in New South Wales, Australia. This cancercare network had two treatment centres at the time of this study. Patients with HNC treated in this cancercare network had access to a joint clinic involving a dietitian, HNC-specific clinical nurse consultant and
speech pathologist. Patients were scheduled to attend this clinic weekly during radiotherapy and for two
weeks post treatment then on an ad-hoc basis thereafter depending on their ongoing needs.

Sampling strategy
Patients who were planned to receive surgery alone or surgery with adjuvant radiotherapy (Sx+RT) or
concurrent radiotherapy and chemotherapy (CRT) for cancers of the oropharynx were eligible to participate.
Patients with oropharynx tumours were purposively sampled, as data from Study 1 (Chapter 4) and other
nutritional HNC studies indicated that this HNC sub-group experiences high rates of adverse nutritionrelated events, including significant weight loss (162). Additionally, the incidence of oropharyngeal cancers
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has increased significantly in recent years due to the rise in human papilloma virus related HNC

(194).

Therefore, research that provides insight into the needs of these patients is timely so that HNC services can
best accommodate the changing HNC demographic (76). Patients were excluded who were palliative, nonEnglish-speaking, or under the age of 18.
A consecutive sample of eligible patients was recruited between May 2015 and November 2016. After a
diagnosis of HNC was confirmed eligible patients were identified and approached face-to-face by a surgeon
from their head and neck surgery clinic or by a nurse after their initial radiotherapy consult. Verbal or
written consent was obtained to contact them via telephone, to provide additional study details and arrange
for a recruitment package to be posted. After a signed consent form was returned, either via post, email or
fax, participants were then phoned to schedule the first interview. Recruitment for this study ceased when
saturation of categories was reached (10).

Data collection
Data was collected via individual semi-structured interviews to obtain rich insights into the patient
experience of undergoing treatment for HNC (10). Interviews were facilitated by one member of the research
team and an interview guide was used to ensure that key topic areas were covered that concerned the
patients’ emotional and physical state, processes associated with diagnosis, treatment and surveillance and
their experiences with healthcare professionals (Appendix 2). The interview guide remained flexible so that
participants could raise topics that were most important to them and so that these topics could be explored
in more detail in proceeding interviews to promote saturation

(10).

Interviews were digitally recorded and

transcribed verbatim.
Participants treated with Sx+RT were interviewed at five points: following their initial surgical consult;
one-week after hospital discharge following surgery; after their initial radiotherapy consult; six weeks postradiotherapy and four months post-radiotherapy. The CRT participants were interviewed at three points:
following their initial radiotherapy consult; six weeks post-radiotherapy; and four months postradiotherapy.

Data analysis
Data was analysed using a grounded-theory approach guided by Charmaz (10). Coding in grounded theory
is used to label pieces of data according to actions (10). The focus of analysis for this study was on participant
responses related to nutritional care. Initial line-by-line coding was completed, followed by focused coding,
which allowed larger segments of data to be coded based on consistent conceptual underpinnings

(10).

The

constant-comparison technique facilitated this process. This included reviewing interview statements and
comparing them to those within the same interview and other interviews, as well as to codes, to discover
similarities and differences that substantiated the categories (10). Memos were also recorded to keep an audit
trail (10).
After the first author had collected, transcribed and coded all interviews, the research team met for two
half-day group coding sessions. To enhance the trustworthiness and consistency of findings, authors coded
the interview transcripts of four randomly selected participants independently. Findings were then
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discussed until consensus was reached on the categories that best represented the data (195). NVIVO version
11 (QSR International Pty Ltd, Melbourne, Australia) was used to manage participant quotes. Supporting
quotes are provided below to authenticate findings

(196).

Participants were provided with an identifying

number. The number assigned to each participant and the time-point of the interview are provided with
each quote to help contextualise the data.
Section 2.4 (Chapter 2) provides further detail on the grounded-theory methodological approach used for
the qualitative studies included in this thesis.
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5.5 Results
Demographics
Twenty-five patients were identified as eligible for participation in the study. Three patients were unable to
be contacted to arrange delivery of the recruitment pack and one patient declined a recruitment pack
following initial telephone contact. The remaining 21 patients agreed to have the recruitment pack posted
to them. Eleven returned a signed consent form. One patient was subsequently withdrawn from the study
as they did not proceed with treatment. The remaining 10 participants were interviewed three to five times
each over the study period. Two participants who were treated with Sx+RT missed their first and third
interviews, respectively, as they were unavailable at that time. Questions from the missed interviews were
included in their next interview. The final data set comprised 36 interviews which ranged from eight to 71
minutes each with a median duration of 20 minutes.
Four participants were treated with surgery and adjuvant radiotherapy and six were treated with
radiotherapy and chemotherapy. The median age was 63 years which is comparable to national and
international trends (197, 198). There was a higher representation of females in this study (3 males to 2 females)
than shown in worldwide HNC male-to-female ratio trends, which range from 2:1 to 4:1 (199) (Table 14).

Table 14. Demographics of patients who participated in Study 2 (Chapter 5) (n=10)

Characteristics

Total sample (n=10)
63 (52-74)

Median age (range)
Gender
Male
Female
CRT
SX + RT
Received a percutaneous endoscopic gastrostomy
tube prior to radiotherapy (i.e. prophylactically)
Persistent disease at final interview

6 (60%)
4 (40%)
6 (60%)
4 (40%)
7 (70%)
1 (10%)

CRT= concurrent chemo-radiotherapy; Sx+RT = surgery with adjuvant radiotherapy

Summary of categories
Experiences with nutritional care, including involvement with the clinic that combined the services of a
dietitian, specialist oncology nurse and speech pathologist, were summarised by four categories: preparing
for nutritional challenges; multidisciplinary care directed by patient needs; the battle to eat and
incongruence between patient values and nutritional priorities. Appendix 3 provides a summary of the
coding tree.

Preparing for nutritional challenges
Nutrition first became a consideration for most participants when they were informed about the expected
nutritional challenges associated with treatment by a surgeon, radiation oncologist or a specialist oncology
nurse. For some patients this was also the first time that the recommendation to have a prophylactic
gastrostomy tube placed was presented. Some saw a dietitian or speech pathologist prior to radiotherapy
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who informed them of the nutritional support available and provided education about dietary changes and
how to use a feeding tube. This information helped participants feel more prepared for their treatment
journey ahead. They were reassured knowing they would have regular contact with a dietitian as a
component of the joint specialist oncology nurse and allied health clinic during and after radiotherapy.
P1 (pre-radiotherapy): “[They] organised for a PEG tube… because of the nature of my…cancer….
I will probably have compromised eating and drinking … So that’s why it’s in there so that’s good…that
box was ticked very quickly.”
P2 (pre-radiotherapy): “The PEG…I was a bit worried about that… so I was talking to [the oncology
nurse]... and then…the dietitian… the two of those put me at ease”
P7 (pre-radiotherapy): “The dietitian came up and had a chat to me…what to expect [with my] diet.”
P9 (pre-radiotherapy): “I was talking to the dietitian she was saying, ‘…this is the type of food you’re
going to be eating’ and [told me that] I’ll just progress, progress and progress, and everything that she
said has come to fruition.”
P8 (pre-radiotherapy): I had a phone call from the dietitian and I had a phone call from the speech
therapist… they’re all part of the team and they’ll be there to…see me through it all and answer
questions in relation to eating, and… swallowing…. It’s comforting to know that you’re not on your
own…. They do say the treatment is quite gruelling on your body and you can lose a lot of weight – you
lose your taste buds, you don’t feel like eating…. So, it’s good to know you’ve got [the team] there”

While some participants valued the large amount information provided by different healthcare
professionals, and being involved in the decision-making process for their care prior to radiotherapy, others
felt overwhelmed. This highlights the importance of individualised and well-coordinated multidisciplinary
teams prior to treatment commencement.
P6 (pre-radiotherapy): “I’ve probably got too much [information]. I would rather… be told…you’re
gonna have this feeding tube, that’s gonna go in there, you need to look after it by flushing out a couple
of times at least, see you when you start your radiation’.... I would’ve been quite happy with that level
of interaction.”

Multidisciplinary approach directed by patient needs
Participants felt reassured by the multidisciplinary nature of their healthcare team as they had access to
different professionals for expert advice or intervention for different health priorities. This included access
to a dietitian for nutritional information and to physicians for medical support.
P1 (pre-radiotherapy): “[The dietitian] …is a constant… She had a look at the PEG tube, sorted
things out. She’s been lovely and constant.… You’re not going to get your hands on a doctor very often”
P10 (six weeks post-radiotherapy): “It was a horrendous experience; I wouldn’t wish it on anybody…
It’s more like a team effort… everybody’s in charge. [The surgeon] has given me directions, [the
radiation oncologist] has given me directions. The [oncology] nurse gives me directions when I go to
her clinics…. The nutritionist gives me directions… keep my nutrition up…so it’s a shared load.”
P8 (six weeks post-radiotherapy): “The whole lot of the team’s been very helpful…in each of their
fields…. The speech lady, the dietitian…they’ve all been quite helpful in their own field.”
P4 (pre-radiotherapy): “[The oncology nurse] looks after me and then you got the… dietitians and
the speech therapist…. It’s a team effort… they all work together…. I’m comfortable with them.”

They felt there was good collaboration and continuity of care with the combined specialist nurse and allied
health clinic that liaised closely with their physicians. Hence, having limited face-to-face contact with a
physician during radiotherapy was not a significant concern for participants.
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P4 (six weeks post-radiotherapy): “[the oncology nurse, dietitian and speech pathologist] give me
the answers, if they don’t know they go away and find out.”
P1 (six weeks post-radiotherapy): “I go to a head and neck clinic…. I see the dietitian, the speech
pathologist and…a [nurse] that looks after my case … I ask a question [and] they say, ‘Well, that’s…a
medical issue, we’ll have to find out about that.’… And they do their best to find out about it.”
Interviewer: “Is there anything that really stands out to you as… helpful…?”
P5 (six weeks post-radiotherapy): “The [joint clinic] crew, the information that they’ve given me….
I had the [radiation oncologist’s] crew checking on me when I was in hospital…but not as much when
I was an outpatient.”
P6 (six weeks post-radiotherapy): “I saw [the oncology nurse] and the dietitian on a regular basis….
And it keeps that line of communication open all the time…. I didn’t see the radiotherapy consultant all
the way through the treatment…because I suppose…they work out in the background…. The [oncology
nurse] and the team… are there and that they’ve been excellent all the way through… no one would
want to go through this but if you had to, you couldn’t ask for a better place or a better team of people
to…go through it with”.

The battle to eat
The participants described the severe and accumulative nutritional burden associated with treatment. This
included oral pain, dysphagia, numbness, dysgeusia and xerostomia. Participants described challenges with
eating enough and having to modify their food, and most patients experienced weight loss. These
experiences helped some to recognise the value of nutritional care.
P1 (six weeks post-radiotherapy): “When you’ve got head and neck [cancer]…, it’s affecting everything
you eat, and drink and breathe…. Radiation’s been finished for about seven… weeks now… the dryness…
is with you all the time.”
P7 (four months post-treatment): “Having the PEG in, that’s a necessity, unfortunately… probably
about two to three weeks, I [was] just on liquids… the stuff they give you using the PEG… I lost eight
kilograms in one week… I needed it, you know, just to feed myself and survive.”
P5 (six weeks post-radiotherapy): “It’s taken me…close to two months to, to get food into me… It’s
taken me all those weeks just to get to the stage where I can actually swallow…a bit of sausage…it’s a
lot of work just to chew it up and swallow.”

Incongruence between patient values and nutritional priorities
While most participants valued nutritional care, few had priorities or beliefs that conflicted with nutritionrelated recommendations. For example, some participants viewed weight-loss as a positive side effect of
treatment or associated feeding-tube use with being unwell. Hence, they were less inclined to take on advice
from their healthcare professionals, such as to initiate enteral feeding. This highlights a significant challenge
that healthcare professionals within HNC teams may experience.
P6 (pre-radiotherapy): “I’m hoping that I’m not going to need to use the PEG tube, you know – if I can
continue eating, even if it’s sort of liquid diet…I don’t plan on being any sicker than I have to be
[laughs].”
P10 (six weeks post-radiotherapy): “That was one good thing… they don’t think it’s good, I’ve lost ten
kilos! ... It’s lovely, I now have a figure, [laughs] but they are not real happy with that…. Because I’m
not eating all the supplements they advised.”
P7 (six weeks post-treatment): “The feeding tube…. Couldn’t wait it to get rid of it…. I stopped using
it…it was just sitting there…. It’s been extremely helpful because when the radiation got to a…certain
level I couldn’t eat… but after that it just sort of was sitting there… [Laughs]”.
P7 (four months post-radiotherapy): “I’m a little bit lighter, which is better…. Not the best way to lose
weight, but... [Laughs].”
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P6 (four months post-radiotherapy): “The cancer has gone…and I’m… keeping the weight off, which
is good, actually, I was glad I lost some weight – I mean, you know, a pretty drastic way of doing it, but
pretty glad that I’m a bit lighter now, which is what I wanted anyway [laughs].”

One participant found it particularly difficult to stop using their feeding tube due to pain and persistent taste
changes post radiotherapy. There appeared to be incongruence between the patient’s personal experience
and the nutrition-related recommendations provided by their healthcare professionals that led them to
reflect negatively on their nutrition care experience.
P3 (six weeks post-radiotherapy): “It is still hurting…swallowing. I’m still on the feeding tube.”
P3 (six weeks post-radiotherapy): “They [are] too pushy…. I’m not 24 anymore…I need a bit more
time to, to complete this journey instead of pushing me to eat this and eat that…. I need just a bit more
time than normal.”
P3 (four months post-radiotherapy): “I’m only 55kg now…. I can’t eat anything with any spice and
everything tastes like cardboard, you just chew on it and swallow and that’s it…. I can’t, I can’t have a
sandwich, I can’t have a piece of cake, and I can’t have anything with flour in it, nothing…. So why
should I fight anymore? I have no fight left in me…. There’s nothing they can do about it, is there?... All
they want is to make sure that I do eat! ... They don’t know my taste; I know my taste. I’m the only one
who knows, nobody else.”
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5.6 Discussion
By completing thirty-six interviews with 10 patients with HNC at key points during their cancer-care
journey, this study provides in-depth insight into the experience of receiving nutritional care as a key
component of a complex and challenging period. Findings from this study expand on a quantitative study
conducted in this same cancer-care network which assessed adherence to several recommendations within
nutritional EBGs and measured adverse nutrition-related events among patients (Chapter 4). This study
found that nearly half of patients had lost weight prior to commencing radiotherapy (Chapter 4). However,
in the present study nutrition did not appear to be a salient consideration for patients until they had had
contact with a surgeon, oncologist, specialist oncology nurse, dietitian or speech pathologist, who discussed
the nutritional burden associated with radiotherapy. Once they gained this knowledge, participants appeared
to have greater acceptance for weekly dietitian reviews throughout radiotherapy and for a prophylactic
feeding tube. This highlights the need for a coordinated multidisciplinary team approach prior to treatment
to help prepare patients for the expected nutritional burden associated with HNC treatment and to enhance
their acceptance of nutritional support.
The quantitative data related to pre-radiotherapy weight loss and malnutrition in Chapter 4 highlighted the
potential value of earlier dietetic involvement. However, the present study indicates that patients often felt
overwhelmed by the amount of information provided in the pre-radiotherapy period. This supports the need
for formal nutritional screening in line with nutritional EBG recommendations to occur routinely so that
pre-treatment dietetic involvement can be targeted

(25).

Targeted involvement is particularly important

considering the international strain on dietetic resources within the HNC context (13, 144). Early nutritional
screening at the point of diagnosis and treatment planning would require support from physicians and
nurses. Therefore, it would be worthwhile to explore the scope for earlier dietetic involvement directly from
the perspectives of those healthcare professionals via qualitative methods.
In this study it was evident that patients value the continuity of care and collaborative support provided by
a weekly clinic that combines the services of a dietitian, specialist oncology nurse and speech pathologist
during and after radiotherapy. Our study also found that the participants appreciated having routine support
from dietitians, as nutritional issues such as weight loss were common and many required enteral nutrition.
Several participants described having had limited contact with their consulting radiation oncologists during
treatment. However, they were confident that any issues that required additional medical input would be
identified by the specialist oncology nurse, dietitian and speech pathologist and managed through liaison
with physicians. These findings support other research that demonstrates that clinics that involve specialist
oncology nurses and dietitians are well received by patients, enhance the implementation of nutritional
EBGs and can improve patient outcomes (46, 47, 200, 201). Qualitative research with healthcare professionals in
HNC teams may help to expand these findings by providing insight into how the efficacy of this joint clinic
structure is perceived by the providers of healthcare.
Patient acceptance of and adherence to nutritional recommendations from dietitians has been identified as
a potential barrier to the implementation of nutritional EBGs

(70).

This was reflected in the category

“incongruence between patient values and nutritional priorities”. While it was evident that several nutritionimpact symptoms may affect a patient’s ability to meet energy targets, psychosocial factors related to
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patient values and beliefs also influenced their adherence to nutritional advice. For example, several
participants viewed weight loss as a positive side effect, and some associated feeding-tube use with being
unwell and thus tried to avoid using it. This phenomenon has also been noted in another qualitative study
with patients affected by HNC (142). These findings highlight patient-related barriers to the implementation
of nutritional EBGs. Further qualitative research with both patients and healthcare professionals would be
worthwhile to understand how these perceptions are formed, so that strategies can be developed that address
this to minimise the risk of adverse outcomes associated with poor nutrition status (29, 36-43).
Reflexive strategies were employed to identify and manage biases within the research team. This included
use of the constant-comparison grounded-theory technique and group analysis sessions (10). The longitudinal
study design also helped to limit biases, as the core concepts, sub-concepts and categories were
substantiated over multiple interviews. Additionally, multiple interviews with the same participant were
beneficial for building rapport between interviewer and participant, allowing participants to feel more
comfortable discussing sensitive topics. The strength of qualitative research lies in its ability to help readers
consider the findings in their own context (5, 202). Hence, this study narrates the patient experience over time,
and identifies opportunities to enhance the continuity of care for patients. Conducting similar longitudinal
research in other regions of Australia and internationally is important to continually inform patient-centred
care across the entire treatment trajectory for people who have HNC.
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5.7 Conclusion
From this longitudinal qualitative study with patients with HNC, perceptions of and experiences with
dietitians and nutritional care were summarised four categories: preparing for nutritional challenges;
multidisciplinary care directed by patient needs; the battle to eat; and incongruence between patient values
and nutritional priorities. These categories provide insight into factors that may influence the
implementation of nutritional EBGs. For example, patients undergoing treatment for HNC can experience
significant physical and psychosocial barriers that may affect their ability to meet evidence-based energy
targets and to use a feeding tube as recommended. Given the issues highlighted within this study the
following recommendations may assist in improving the dietetic support for these patients: a wellcoordinated multidisciplinary approach to patient care, service structures that promote continuity with the
dietitian, and a shared leadership model of care. To achieve this, it is important that all members of the
multidisciplinary team support and reinforce the recommended nutritional interventions. We propose that
if both physicians and nurses reinforce the importance of adherence to a nutrition regime it may improve
the patients’ acceptance. Patient acceptance of nutritional advice may also be enhanced through having
structures that promote continuity and rapport, and position nutrition as a core component of care, such as
weekly clinics that combine the services of a dietitian, specialist oncology nurse and speech pathologist.
More-focused qualitative research with patients and healthcare professionals in HNC teams could help to
expand on findings by providing insight into their perceptions of and experiences with feeding tubes, the
role of dietitians and interprofessional nutritional care to enhance the implementation of EBGs.
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CHAPTER 6: The patient experience of having a feeding tube
during treatment for head and neck cancer: A systematic
literature review
6.1 Chapter overview
In Study 3 that is reported on in this chapter, I aimed to help address Objective 3: Identify and explore
factors that influence the implementation of nutritional evidence-based guidelines (EBGs) for patients with
head and neck cancer (HNC) based on their own perspectives and experiences.
In nutritional EBGs for patients with HNC there are certain circumstances in which enteral feeding is
recommended for individuals to promote best outcomes. However, Study 1 (Chapter 4) identified that it
can be difficult for patients to meet energy targets set out in EBGs, even if patients have a feeding tube and
receive consistent dietetic support throughout radiotherapy. Furthermore, Study 2 (Chapter 5) identified
factors that may make it difficult for patients to implement advice from healthcare professionals. This
included physical and psychosocial barriers such as incongruence between evidence-based nutritional care
and patients’ values and beliefs. From the study included in this chapter I help to expand on findings from
Chapters 4 and 5 by formally summarising the qualitative research to date on the experience of having and
using a feeding tube during treatment for HNC.
The systematic literature review included in this chapter was published in Clinical Nutrition ESPEN in
2019.
Citation: Hazzard E, Gulliver S, Walton K, McMahon AT, Milosavljevic M, Tapsell L. The patient
experience of having a feeding tube during treatment for head and neck cancer: A systematic literature
review. Clin Nutr ESPEN. 2019; 33:66-85.
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6.2 Abstract
Background: Evidence-based guidelines (EBGs) recommend that patients with head and neck cancer
(HNC) should be considered for enteral nutrition in certain circumstances to promote best outcomes. Patient
acceptance of and ability to use a feeding tube may influence the implementation of nutritional EBG
recommendations related to enteral nutrition for patients with HNC. This review aimed to describe the
patient experience of having a feeding tube during treatment for HNC.
Methods: A systematic literature review of qualitative studies was undertaken in the databases Web of
Science, CINAHL, Scopus and Science Direct using Prospero and the Joanna Briggs Institute guidelines.
Results: Nine studies were included providing the perspectives of 159 patients who had a feeding tube
during treatment for HNC. One hundred and fifty findings and 183 illustrations, which were primarily
participant quotes, were extracted. Analysis resulted in 42 categories from which nine synthesised findings
were produced: initial reluctance and fear; different understandings and expectations; individual
preferences; physical discomfort; restrictions to social life and daily living; new challenges and
responsibilities; gradual acceptance; a challenging but rewarding transition process; and overall a
worthwhile decision.
Conclusion: The findings highlight the nutrition-related burden patients with HNC experience and support
the need for multidisciplinary HNC teams that integrate dietitians and speech pathologists. This review
supports the assertion that individual approaches to feeding-tube placement decisions are required. Further
studies are needed to explore how healthcare professionals consider personal patient preferences when
making recommendations on the placement of a feeding tube.
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6.3 Introduction
Evidence-based guidelines (EBGs) recommend that patients with head and neck cancer (HNC) who have
T4 tumours undergoing concurrent chemo-radiotherapy or hypo-pharyngeal tumours are considered for a
prophylactic gastrostomy tube (i.e. a gastrostomy tube placed prior to radiotherapy and the onset of severe
nutrition-impact symptoms). Additionally, they recommend that “other patient groups should be considered
by the multidisciplinary team on an individual basis dependent on other clinical factors such as tumour site,
staging, effect of multi-modality treatments, radiotherapy treatment fields and dose, type of surgical
procedure, nutritional status and dysphagia”

(25).

There is strong evidence to support the benefit of enteral

nutrition over oral intake alone in increasing energy and protein intake and minimising weight loss (38, 52).
However, tube type and the timing of placement remain debated topics (157).
In 2014 the Canadian Agency for Drugs and Technologies in Health published a review of systematic
reviews and EBGs to determine the effectiveness of nasogastric tubes compared to percutaneous
endoscopic gastrostomy (PEG) tubes (56). They found that due to a lack of randomised controlled trials there
was limited evidence to support one type of feeding tube over another

(56).

Therefore, they concluded that

tube selection should be individualised to suit: the expected duration of enteral feeding, the patient’s
psychosocial characteristics and personal preferences and medical considerations that may restrict patients
to the use of one approach (56). The debate about the timing of feeding tube-placement centres on the use of
a prophylactic gastrostomy tube approach or a reactive feeding tube approach (i.e. placing a gastrostomy
or nasogastric tube at the time that a patient required nutritional supplementation from enteral nutrition).
Authors of a systematic review that included two randomised controlled trials found that a prophylactic
gastrostomy tube approach offered shorter-term benefits, but that there were minimal differences in the
longer term (38).
Due to the lack of conclusive evidence supporting the recommendation for prophylactic gastrostomy tubes,
feeding-tube use for patients with HNC is currently largely directed by the treating radiation oncologist and
may be influenced by their personal preferences and institutional traditions (157). This raises concerns about
the consistency and quality of nutritional care for patients with HNC. To provide some clarity regarding
the feeding-tube debate from a patient-centred perspective, several researchers have recognised the value
in qualitative research to explore the patient experience of having a feeding tube

(203).

This research

highlights that patients may be fearful of tube placement (118, 143). However, over the course of radiotherapy
a feeding tube can become a source of reassurance and is associated with survival

(143, 204).

Additionally,

while a prophylactic gastrostomy tube may initially be viewed less favourably due to the procedure
involved, patients who have a nasogastric tube can experience stigma associated with the visible feeding
tube and this can affect quality of life (142, 175).
Two systematic literature reviews have been undertaken that synthesise qualitative evidence with HNC
patients that has explored the patient experiences of eating post-treatment
managing nutrition-impact symptoms during treatment

(206).

(205)

and the experiences of

However, neither of these focused on the

patient experience of having a feeding tube while undergoing treatment for HNC. Addressing this gap in
the literature is an important step in exploring patient-related factors that may influence how well nutritional
EBGs related to feeding tubes for patients with HNC can be implemented in practice. Therefore, the aim
94

of this systematic literature review was to provide a summary of key findings related to the patient
experience of having a feeding tube during treatment for HNC.
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6.4 Methods
Design
This review was carried out in three stages following the Preferred Reporting Items for Systematic Review
and Meta-Analyses (PRISMA) format: (a) development of criteria for inclusion and literature search; (b)
extraction and coding of study characteristics and findings; and (c) data analysis and aggregation of
findings. Because this review aimed to summarise patient perspectives from qualitative studies, the Joanna
Briggs Institute Reviewer’s Manual (126) was used to guide the handling of qualitative data. A protocol for
the review has been made available through PROSPERO (registration number: CRD42017069016).

Inclusion criteria
As recommended by the Joanna Briggs Institute

(126),

the eligibility criteria were developed using the

‘PiCO’ format (Phenomenon of interest, Context and Outcome) (Table 15). However, they explain that in
qualitative reviews the phenomenon of interest is the outcome; therefore there is no requirement for an
outcome statement (126) (p 27).

Table 15. Eligibility criteria for a systematic literature review on the patient experience of having a
feeding tube during treatment for head and neck cancer (Chapter 6)

Category

Inclusion

Exclusion

Phenomenon of
interest

Experiences of adults who had a feeding
tube during treatment for head and neck
cancer.

Context

Feeding tubes placed pre-treatment in
anticipation of radiotherapy or during
treatment for head and neck cancer.

Design considerations

Qualitative studies.
Mixed-method studies.
Participant experiences collected via
interview, focus group or open-ended
survey questions.
Full-text studies.
English language.

Experiences of patients who were <18
years old, did not have a feeding tube or
did not receive treatment for head and
neck cancer.
Perspectives of others (i.e. carers or
healthcare professionals).
Pre-existing long-term feeding tubes prior
to head and neck cancer diagnosis.
Feeding tubes placed three months or
later post-treatment.
Quantitative studies.
Data collection via closed-question
surveys.
Non-original research papers.
Non-English language.
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Types of studies
This review included original research papers that focused on, or included qualitative data captured via
individual interviews, focus groups or open-ended survey questions, to provide patient perspectives that
were less prone to bias than closed-question survey methods

(207).

Study designs included, but were not

limited to, descriptive, grounded theory, phenomenology, and ethnography studies.

Participants
Eligible studies included the perspectives of non-palliative adult patients who had been treated for HNC
and had a feeding tube during that period. In this review, HNC is the umbrella term used to include
squamous cell cancers of the oral cavity, nasopharynx, oropharynx, hypopharynx, and larynx. The term
“feeding tube” includes gastrostomy, jejunostomy and nasogastric tubes. Total parenteral nutrition was
excluded as its management is significantly different, particularly in the outpatient setting and typically
patients with HNC can tolerate enteral nutrition, as the digestive tract (beyond the oral cavity) remains
unaffected by treatment. Method of feeding-tube insertion was not restricted, allowing bedside,
endoscopically, radiologically, and surgically inserted feeding tubes, that were placed in either the inpatient
or outpatient setting to be included. Time of feeding-tube placement was restricted to feeding tubes placed
pre-radiotherapy in anticipation of treatment side effects that might limit oral intake (prophylactically),
during treatment and up to three months post-treatment. It was decided that it was less likely that feeding
tubes placed outside of this time frame were placed because of the effects from HNC and its treatment. The
length of time the feeding tube was used for nutrition was not restricted, nor was the proportion of total
nutrition delivered via the feeding tube, allowing the perspectives of patients who received total enteral
nutrition and supplementary enteral nutrition to be included.

Phenomenon of interest
This review considered studies that investigated the experience of having a feeding tube throughout
treatment for HNC. Studies that included the perspectives of patients with other diagnoses and studies that
included non-patients such as caregivers and healthcare professionals, were only included if HNC patients
comprised greater than 50% of the total sample and if specific findings could be directly attributed to a
patient with HNC via direct quotes or descriptions of observations.

Literature search
A three-step search strategy was implemented as advised by the Joanna Briggs Institute (126) and was carried
out between October and December 2018. First, to identify all relevant key terms for inclusion in the search
strategy, an initial pilot search was undertaken in the Web of Science database using broad terms related to
patient perspectives, feeding tubes and HNC. The search strategy was then developed (Table 16) and
applied to the Web of Science, CINAHL, Scopus and Science Direct databases. Finally, the reference lists
of studies identified for appraisal were searched to capture additional relevant studies. The searches were
restricted to journal articles published in English. A time frame in relation to their publication date was not
applied to increase the opportunity for all relevant literature to be captured.
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Table 16. Search strategy used for the systematic literature review in Study 3 (Chapter 6)

MeSH terms and Boolean operators a
Head and neck OR oral OR oropharyngeal OR *pharynx OR upper gastro* OR upper *digest*
Patient OR adult OR person OR individual
Perspective OR experience OR view OR attitude
Enteral OR feeding tube OR gastrostomy OR nasogastric OR jejunostomy
Cancer OR oncology OR neoplasm OR malignancy OR tumour
a

Each row joined by “AND”

Study selection
A three-step screening and eligibility inclusion process was undertaken using the PRISMA flow diagram
(Figure 5). Articles were first scanned for duplicates, which were removed. Titles and abstracts of all
remaining articles were independently screened for eligibility using the eligibility criteria (Table 15).
Finally, all remaining articles were read in full for inclusion in the review. Fifteen articles were
subsequently excluded as: they had closed- question survey data only (n=6), the findings could not be
directly attributed to a patient with HNC (n=4), less than 50% of all participants were affected by HNC
(n=2), less than two findings related to the experience of having a feeding tube (n=2) and the study was
with palliative patients (n=1).

98

Figure 5. PRISMA flow diagram for the systematic literature review for Study 3 (Chapter 6)
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Quality appraisal
The qualitative studies identified for inclusion were assessed for methodological validity prior to inclusion
in the review using the standardised critical appraisal instruments from the Joanna Briggs Institute
Qualitative Assessment and Review Instrument (JBI-QARI)(126) (Appendix 1, Table 3). Any disagreements
that arose between reviewers were resolved through discussion and consensus.

Data extraction
The data extraction and synthesis of the qualitative studies was guided by the Joanna Briggs Institute
Reviewer’s Manual

(126).

Information extracted from the eligible studies included primary author,

publication year, geographical location, methodology, phenomena of interest, data collection and analysis
methods, relevant study-population information, and the papers summarised results and conclusions
(Appendix 1, Table 3). The author’s findings (i.e. verbatim extracts of the authors analytic interpretations,
related to an “illustration” (i.e. a participant quote) with regards to patient experiences of feeding tubes
were also extracted, along with supporting illustrations. The extraction of the author’s findings was the first
step of data synthesis (126).

Data synthesis
Data was synthesised using the Joanna Briggs (126) model of meta-synthesis which uses a met-aggregative
approach. This methodology is sensitive to the primary author’s findings and does not seek to reinterpret
those findings. This methodology seeks to allow the development of statements that can be used as practice
recommendations.
Data synthesis was carried out through repeated reading of the included papers, “author’s findings” (i.e.
relevant categorised main findings, sub-findings and verbatim descriptions of findings), were identified and
extracted, along with the related illustrations. Each finding was assessed for credibility using the Joanna
Briggs (126) credibility scale (p. 41) (i.e. U = Unequivocal: findings accompanied by an illustration that is
beyond reasonable doubt and therefore not open to challenge; C = Credible: findings accompanied by an
illustration lacking clear association with it and therefore open to challenge; and N = Unsupported: findings
not supported by data).
“Findings” were then grouped together based on similar concepts into “Categories”. “Synthesised findings”
were then developed to describe the overarching conceptual basis of a group of categorised findings.
Consensus for the ‘synthesised findings’ was reached by the reviewers through discussion. The final
synthesised findings were expressed as “indicatory” statements that could be developed into
recommendations for practice.
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6.5 Results
Searching
The initial search yielded 1,134 papers after duplicates were removed. Following eligibility screening of
titles and abstracts 1,110 papers were removed. The remaining 24 studies were read in full to assess their
eligibility. Fifteen studies were excluded due to: the use of closed-question survey data only (n=6), author
findings that could not be directly attributed to patients with HNC (n=4), patients with HNC representing
less than half of all participants and inability to differentiate their perspectives from those of other
participants (n=2), fewer than two author findings related to a feeding tube (n=2) and participants being
palliative (n=1). The nine remaining articles were then appraised for quality and were eligible for inclusion
in the review (Fig. 1).

Description of included studies
All nine studies included in the final review were of high quality according to the QARI critical appraisal
tool scoring 8/10 or above
United Kingdom

(126)

(Appendix 1, Table 3). Five of the included studies were conducted in the

(107, 119-121, 175),

three in Canada

(118, 122, 208)

and one in Sweden

(142).

No studies were

published prior to 2011. Seven studies used a descriptive qualitative study design. Six of these used patient
interviews (107, 118, 119, 142, 175, 208) and one used focus groups with the patient and their carer

(121).

One study

used a Q-methodology design that included patient interviews with a subsample of five patients with HNC
(120)

and one used a mixed-methods study design that included patients answering four open-ended survey

questions

(122).

included carers
feeding tubes

Seven of the studies solely included patients with HNC
(121)

(107).

(118-120, 122, 142, 175, 208),

one also

and one also included patients with other disease and clinical conditions who had

Five studies solely included patients who had a PEG

patients who had either a nasogastric tube or a PEG
NGT or radiologically-inserted-gastrostomy tube

(118, 142),

(175)

(119-122, 208).

Two studies included

one study included patients with either a PEG,

and one study more broadly included patients with

gastrostomy tubes (107) (Appendix 1, Table 3).

Synthesis
Collectively, the nine included studies provided the perspectives of 159 patients who had a feeding tube
while undergoing treatment for HNC. From the studies, 150 verbatim author findings that related to the
patients’ experiences of having a feeding tube were extracted, along with 183 illustrations, the majority of
which were direct patient quotes. These were analysed and grouped into 42 categories, from which nine
synthesised findings were produced (Table 17). See Appendix 4 for the synthesised findings with their
categories and author findings.
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Table 17. Synthesised findings regarding the patient experience of having a feeding tube during
treatment for head and neck cancer from Study 3 (Chapter 6)

Synthesised findings
1.

2.

3.

4.

5.

6.
7.

8.

9.

Patients may initially experience feelings of reluctance, fear and anxiety toward feeding tubes, including
regarding insertion and removal, nutritional decline through treatment, feeding-tube permanence, social
stigma and the potential risks.
Understandings and expectations of feeding tubes can vary among patients with HNC. Some patients may
view the feeding tube as a necessary part of cancer treatment, while others may have uncertain
expectations about the feeding tube. Being informed may positively influence patient understanding;
whereas conflicting views from healthcare professionals may negatively affect patient understanding.
The experience of choice with regards to feeding tubes can vary among patients with HNC. Some patients
may feel that the choice was presented as theirs to make, while other may feel that a feeding tube is a
necessary part of cancer treatment. Some may value having choice, while other patients may feel
overwhelmed by that responsibility.
Physical discomfort due to the feeding tube may be experienced by patients with HNC, such as discomfort
with the presence and insertion of the feeding tube, nose and throat irritation from a nasogastric tube, or
gastrostomy tube insertion-site pain.
For patients with HNC, a feeding tube may place restrictions on their social life and activities of daily
living. This can include strain on personal relationships, self-consciousness and missing the experience of
eating.
Having a feeding tube may present new challenges and responsibilities for patients with HNC, including
in relation to finances, feeding-regimen burden, tube use and maintenance.
Patients with HNC may become more accepting of the feeding tube over time by adapting their routine,
developing coping strategies, finding that the feeding tube is less burdensome than expected and receiving
social support when eating orally becomes a significant struggle.
For patients with HNC, transitioning from a feeding tube to an oral diet can be a challenging yet rewarding
process, as experiences can include slow progression, oral-intake discomfort, removal impatience and
feeding-tube dependence.
Patients with HNC may recommend a feeding tube to other patients as an overall worthwhile decision, as
having a feeding tube may help patients manage their disease and treatment side effects and prevent
nutritional decline
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6.6 Discussion
This review aimed to synthesise qualitative evidence on the patient experience of having a feeding tube
while undergoing treatment for HNC. The experience was summarised as: initial reluctance and fear;
different understandings and expectations; individual perceptions and preferences regarding choice;
physical discomfort; restrictions to social life and activities of daily living; new challenges and
responsibilities; gradual acceptance; a challenging yet rewarding transition process; and overall a
worthwhile decision.
Previously, most of the research on the use of feeding tubes with HNC patients has used quantitative data
(158, 159, 209).

However, from 2010 there has been a growing number of qualitative studies with this group.

Other authors have summarised qualitative studies on HNC patient experiences with eating post-treatment
(205)

and managing nutrition-impact symptoms during treatment (206). This review helps to address a gap in

evidence and provides a stronger patient voice within the literature that may direct feeding tube practices
and inform EBGs for this group. Furthermore, this review helps with exploring how nutritional EBG
recommendations related to feeding tubes are implemented in practice, as it identifies potential barriers and
enablers to patients using them as recommended by a healthcare professional. For example, the findings
expand on quantitative data from Chapter 4 by highlighting physical and psychosocial barriers that help to
explain why patients with feeding tubes may struggle to meet energy targets and why transitioning off a
feeding tube after treatment can be difficult.
Comparing the findings from this review, to those of Ganzer, Touger-Decker (186) and Bressan, Bagnasco
(187)

shows that undergoing treatment for HNC can present similar challenging experiences for patients with

or without a feeding tube. For example, a common theme is the sense of restriction to one’s social life and
activities of daily living, as eating can feel like a chore rather than a pleasant experience to share with others
(107, 121, 142, 175, 205, 206, 208).

Likewise, adaptation is a phenomenon that may be experienced by HNC patients

as they alter their daily routines and usual diet to manage side effects such as dysphagia, xerostomia and
pain (107, 119-121, 175, 208). These findings demonstrate that nutrition is one of the most challenging aspects of
undergoing treatment for HNC for patients, which reflects statistics that demonstrates the particularly high
incidence of adverse nutrition-related events among this group (36, 67, 165, 210, 211). This supports the need for
collaborative multidisciplinary HNC teams inclusive of dietitians to promote best outcomes.
Patients can experience reluctance, anxiety and fear when faced with the prospect of having a feeding tube
during treatment for HNC. These feelings may relate to the insertion and removal procedure, the risk of
permanence and pain and the social stigma associated with having a feeding tube

(107, 118-120, 175, 208).

Moreover, some patients may feel that using a feeding tube is a sign of personal failure

(118, 175).

Being

adequately informed via regular access to healthcare professionals and peer-support can help patients have
clearer understandings and expectations of the feeding tube

(107, 121, 175).

Having choices in relation to

feeding-tube type, the timing of placement and feeding mode (i.e. bolus or continuous) can also promote a
more positive feeding-tube experience (107, 175, 208). These findings are supported by a systematic review by
Jaafar, Mahadeva

(203),

who summarised the attitudes towards gastrostomy feeding among patients,
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healthcare professionals and carers and found that a major barrier to gastrostomy tube acceptance for
patients was a lack of choice and knowledge (203). To help address this they recommended that attention be
paid to staff competency and skill to help patients feel more confident in feeding-tube decisions (203, 212). As
individuals can have different preferences about their involvement in feeding-tube placement decisionmaking, which may be influenced by factors including age, gender and education level

(213),

an individual

patient-centred approach to feeding-tube placements should be emphasised within EBGs that provide
recommendations on feeding tube for patients with HNC to promote acceptance.
Several findings from this review relate to the experience of having a specific type of feeding tube. For
example, nose and throat irritation was a physical symptom that was only voiced by participants with a
nasogastric tube

(124, 142),

gastrostomy tube

(120, 124, 142).

whereas gastrostomy insertion site pain was only voiced by those with a
It was apparent that some patients may be reluctant to have a gastrostomy tube

placed pre-treatment due to concerns about the procedure

(120, 124, 208).

However, two studies highlighted

some of the participants who initially declined a gastrostomy tube but later required a reactive nasogastric
tube, experienced a sense of regret due to the social stigma attached to having a visible feeding tube
142).

(124,

Additionally, in another study, one of the factors identified that helped patients who had a gastrostomy

tube accept their feeding tube was the discretion that it offered (120). These experiences are supported by a
randomised trial which found that significantly more patients with a nasogastric tube experienced altered
body image and greater feeding-tube related interference with social activities than those with a gastrostomy
tube (150). This is an important finding that should be considered and discussed with patients with HNC who
could benefit from a feeding tube, to help them make an informed decision prior to treatment
commencement.
Feeding-tube dependence is a central argument in the debate about whether a reactive nasogastric tube
approach is better than placing a gastrostomy tube prophylactically, to minimise the risk of prolonged or
permanent swallow-function impairment (177, 214, 215). This review confirms that patients can feel emotionally
dependent on the tube, which can present a challenge to transitioning back to full oral intake (121, 208). The
evidence also suggests that patients can appreciate the risk of swallow-function decline from lack of use
(107, 118, 175).

This can be a reason why some are reluctant to have a gastrostomy tube prophylactically, while

for others it can be a source of motivation to adhere to swallow exercises throughout treatment

(118, 119, 175).

Dietetic support was identified as a factor that can help patients overcome feelings of dependence and wean
off the tube with more confidence

(119, 121).

This supports other research that suggests that if patients have

regular access to a dietitian and speech pathologist for swallow therapy, the risk of tube-dependence
associated with a prophylactic gastrostomy tube may be a manageable concern

(179, 216, 217).

This is an

important consideration for practice when a gastrostomy tube may be more appropriate due to the patient’s
individual preferences and circumstances and if the prophylactic placement of a feeding tube is indicated
according to EBGs (e.g. for patients who have T4 tumours undergoing concurrent chemo-radiotherapy or
hypo-pharyngeal tumours) (25, 142, 175).
Finally, the risk of unnecessary feeding-tube placement with the prophylactic gastrostomy tube approach
is a concern that has been discussed in the literature (176). However, the study by Osborne, Collin (122) found
that even if a patient did not use the feeding tube they still felt comforted by its presence. Furthermore, a
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common theme throughout several studies was that patients valued the feeding tube as a source of
reassurance throughout treatment

(107, 120, 124, 142, 208)

and many would advise future patients with HNC to

have a feeding tube placed if and when it was recommended by that patient’s healthcare professionals (122,
124, 208).

This suggests that for patients with HNC, a prophylactic feeding tube could help them cope through

treatment and provides a positive quality of life outcome. This adds to the quantitative research in the HNC
field that demonstrates that a prophylactic feeding tube for higher risk patients (i.e. those with T4 or
oropharyngeal tumours and treated with concurrent chemotherapy) can help to minimise weight loss,
malnutrition, nutrition-related hospitalisations and treatment interruptions and delays (13, 53, 218).
The potential for bias in each of the nine studies included in this review is recognised. However, the nine
studies reported strategies to minimise bias, such as adequately representing participant voices through the
inclusion of direct quotes, disclosing potential author biases, and including their theoretical and cultural
backgrounds. Furthermore, this review helps to confirm the individual findings from each study, as all the
synthesised findings were saturated with examples from most of the included studies. Despite the current
study’s use of a systematic search strategy guided by the Joanna Brigg’s Institute

(126),

it is possible that

some qualitative studies may have been missed. Qualitative studies can be more difficult to find, as it is
accepted that the level of indexing and archiving is poorer than for quantitative studies

(219).

Studies

conducted following this literature search were not included. Additionally, only articles available in English
were included, with the majority carried out in the UK. As HNC incidence rates are high among many other
countries around the world including India and those in Central Europe
culturally and socially influenced

(213),

(220)

and as experiences can be

this could restrict the transferability of results to other populations.

This review may need to be updated in the future as new studies emerge and those written in other languages
are considered.
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6.7 Conclusion
This review highlights that having a feeding tube while undergoing treatment for HNC can be an evolving
experience for patients. Initially patients may feel a sense of reluctance, fear, and uncertainty; and may
experience physical and social life challenges. However, a sense of acceptance through adaptation often
occurs, along with a challenging but rewarding transition back to oral intake. Overall, patients typically
perceive that having a feeding tube placed when it is recommended is a worthwhile decision to support
them through treatment. These findings highlight the nutritional burden faced by patients undergoing
treatment for HNC and thus the need for multidisciplinary healthcare teams inclusive of dietitians; and for
an individual patient-centred approach to feeding-tube placement decision-making. This is an important
consideration that should be emphasised in EBGs that provide recommendations on feeding tubes for
patients with HNC. Qualitative research with healthcare professionals involved in the care of patients with
HNC could expand on these findings by providing insight into how patient preferences influence feedingtube placement recommendations in practice.
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CHAPTER 7: Healthcare professionals’ perceptions of
feeding tube practices for patients with head and neck cancer:
A qualitative multi-site study (Study 4a)
7.1 Chapter overview
In Study 4a that is reported in this chapter, I aimed to explore healthcare professionals’ perspectives and
experiences with feeding tubes in four HNC teams in Australia and the United States. This study was
designed to help address Objective 4 of this thesis: Identify and explore factors that influence the
implementation of nutritional EBGs for patients with HNC, from the perspectives and experiences of
healthcare professionals.
From the retrospective medical record review that was conducted in one local NSW cancer centre a high
level of adherence to EBGs that recommend which patients should receive a prophylactic feeding tube was
found (Chapter 4). However, anecdotally in practice there is variability in feeding-tube use, with some
centres preferring a reactive feeding-tube approach. Therefore, the findings from this study provide a
broader perspective on feeding tube use and how this aligns with EBGs for patients with HNC
internationally. Findings from this study also help to expand on the patient experience of having a feeding
tube (Chapter 6). This is important for understanding how recommendations within nutritional EBGs
related to enteral nutrition are implemented. Opportunities for promoting consistent evidence-based and
patient-centred practices within HNC teams are identified and discussed.
Findings from the study reported on in this chapter have been published in the Journal of Parenteral and
Enteral Nutrition in 2019 and were presented at the national Dietitian’s Association of Australia conference
in August 2019 and at the ESPEN Congress on Clinical Nutrition and Metabolism in 2018.
Citations:
Hazzard E, Walton K, McMahon A-T, Milosavljevic M, Tapsell L. Healthcare Professionals’ Perceptions
of Feeding Tube Practices for Patients with Head and Neck Cancer Across 4 International Radiation
Oncology Departments. JPEN. 2019; early view doi.org/10.1002/jpen.1699
Hazzard, E. Walton, K. McMahon, A. Milosavljevic, M. Tapsell, L. (2019) Perceptions of feeding tube
related practices for patients with head and neck cancer, across four international radiation oncology
departments, Dietitian’s Association of Australia National Conference, 12-14 August 2018, Gold Coast,
Australia.
Hazzard, E. Walton, K. McMahon, A. Milosavljevic, M. Tapsell, L. (2018) Prophylactic gastrostomy tube
practice for head and neck patients: an international mixed methods study, ESPEN Congress on Clinical
Nutrition and Metabolism, 1-4 September 2017, Madrid Spain.
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7.2 Abstract
Background: Evidence-based guidelines (EBGs) recommend enteral feeding for patients with HNC in
certain circumstances. However, there is debate on feeding-tube use, including whether a reactive
nasogastric tube or prophylactic gastrostomy tube approach is best and this may be contributing to
variability in practices. This study aimed to explore healthcare professionals’ perspectives and experiences
with feeding tubes in four HNC teams from diverse settings.
Methods: Healthcare professionals involved in the clinical care of patients undergoing radiotherapy for
HNC were recruited from two HNC teams in Australia and two in the United States. Individual-interviews
were recorded and analysed using a grounded-theory approach.
Results: Seventeen radiation-oncologists, 12 nurses, 11 dietitians and six speech pathologists participated.
The first category: perspectives of feeding tubes, comprised four sub-categories: a valued support, more
individualised, no universal practice, and prophylactic gastrostomy tubes versus reactive nasogastric tubes.
The second category: placement considerations, comprised two sub-categories: patient factors and servicestructure factors. Patient factors were: planned treatment, tumour characteristics, nutrition and swallow
status, tube-dependence risk, psychosocial status and patient preferences), and service-structure factors
were: dietetic access, speech-pathology access, interprofessional collaboration, and nutrition support
resources.
Conclusion: While the targeted use of feeding tubes was valued by healthcare professionals, several patient
and service-structure factors may influence how EBG recommendations related to enteral nutrition are
implemented in practice. Nutritional EBGs should place greater emphasis on individual patient preferences
and department structures, such as access to nutritional resources and ways to support collaborative
multidisciplinary decisions. This may encourage consistent evidence-based and patient-centred feedingtube practices for enhanced outcomes. More research is required that compares outcomes between
prophylactic gastrostomy tubes and reactive nasogastric tubes so that more conclusive recommendations
on enteral nutrition can be developed for patients with HNC.
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7.3 Introduction
As outlined in Chapter 6, it is recommended that patients with HNC receive a prophylactic gastrostomy
tube (i.e. a gastrostomy tube placed prior to radiotherapy and the onset of severe nutrition-impact
symptoms) if they meet certain criteria related to the site of their tumour, stage of disease, treatment plan,
nutritional status and swallowing function (25). From the retrospective medical record review undertaken in
Chapter 4, the cancer centre included had a high level of adherence to that recommendation, as all patients
with hypo-pharyngeal tumours, 70% of patients with T4 tumours and proportionally more patients who
were treated with chemo-radiotherapy received a prophylactic feeding tube (81.3% vs 21.2%, p = 0.000).
However, in practice there is variability in feeding-tube use, with some institutions preferring a reactive
feeding-tube approach (i.e. placing a gastrostomy or nasogastric tube at the time that a patient requires
nutritional supplementation from enteral nutrition) (157). There is currently a lack of conclusive evidence to
support one approach over another (38), hence, physician clinical opinion directs practice (157, 221). Qualitative
research in different HNC services is required to better understand feeding tube use and how this aligns
with evidence-based guidelines (EBGs) for these patients.
Authors of a study that explored radiation oncologists’ attitudes found that their personal understanding of
gastrostomy tubes was associated with their willingness to place one

(221).

However, there was poor

knowledge and lack of skill with gastrostomy tubes overall (221). Furthermore, Martin, de van der Schueren
(70)

found that healthcare professionals from five different European cancer centres believed that a lack of

evidence demonstrating the benefit of enteral nutrition, was a barrier to patients with HNC receiving
evidence-based nutritional care (70). Likewise, Cahill, Suurdt (145) found that healthcare professionals in the
Canadian intensive-care setting believed that the strength of evidence on which recommendations were
based, affected how well EBGs were adhered to in practice

(145).

Therefore, the attitudes, knowledge and

skills of healthcare professionals, and the strength of evidence related to nutritional interventions may
influence how recommendations regarding enteral nutrition for patients with HNC are implemented in
practice. However, more focused research in this context is required. The inclusion of different healthcare
disciplines who have a role in feeding-tube management, such as radiation oncologists, dietitians, nurses,
and speech pathologists, and who are from different cancer services and nations, would allow for broader
exploration and relevance.
Finally, in Chapters 5 and 6 I explored the patient experience of nutritional care and enteral nutrition during
the treatment journey of those affected by HNC, respectively. This research highlighted the importance of
individualising feeding tube recommendations for patients. However, it is unclear how patients’ preferences
influence the decisions that healthcare professionals’ make with regards to feeding tubes. Qualitative
research with healthcare professionals is required to address this gap in knowledge.
To identify and address potential barriers to those affected by HNC accessing evidence-based nutritional
care for best outcomes, this study aimed to explore healthcare professionals’ perspectives on and
experiences of the use of feeding tubes in HNC teams in Australia and the United States.
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7.4 Methods
Study 4a reported on in this chapter is the first component of a larger research study that aimed to explore
the perspectives of and experiences with nutritional care among healthcare professionals in HNC teams in
Australia and the United States broadly. This larger study focused on three key areas that related to how
nutritional EBGs are implemented in practice: feeding-tube use; the role and perceptions of the dietitian in
multidisciplinary HNC teams and what facilitates collaborative nutritional care in HNC teams. The findings
are reported on in this thesis, as individual studies in Chapters 7, 8 and 9, respectively. The following
methods section provides an overview of the methods used in these three chapters.

Qualitative approach and research paradigm
Grounded theory provided a systematic methodology for exploring contextualised social processes such as
feeding-tube placement decision making, how the role of the dietitian is perceived and enacted and
collaboration in healthcare services, by capturing the experiences of healthcare professionals from diverse
HNC teams (5, 102, 105, 222). To promote rigour and transparency, the approach published by Harris, Gleason
(223)

guided the study design. In addition, the checklist outlining the consolidated criteria for reporting

qualitative research (COREQ) formulated by Tong, Sainsbury (128) was applied. This study was approved
by the Human Research Ethics Committee (reference number: 2017/013).

Researcher characteristics and reflexivity
The research team comprised researchers and dietitians with backgrounds in the hospital setting, academia
and management. The research-team members were chosen due to their expertise in nutritional care, and in
qualitative research, including grounded theory. To minimise the risk of bias, reflexive strategies were
employed to identify and manage biases within the research team. This included use of the constantcomparison grounded-theory technique and group analysis sessions (10, 202).

Context
The study sites were purposively approached for inclusion to provide perspectives from different national
healthcare systems and geographical locations

(224).

However, the trends in HNC prevalence and survival

are comparable between Australia and the United States, which helps to control for a variable that may
influence how dietitians practice internationally (12).

Sampling strategy
Healthcare professionals were recruited between February and November 2017 from four radiationoncology departments in Australia and the United States.
Participant eligibility criteria included healthcare professionals who were employed at each department
during the data-collection period, and who had a role in the clinical care of HNC patients. A snowballing
technique was used for recruitment. Consent was first obtained by the first author face-to-face. A followup email that included the participant information sheet and a consent form was then sent to consenting
participants.

Data collection
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To build rapport and to gain contextual knowledge to enhance the interpretation of findings, the PhD
candidate spent one month at each radiation oncology department shadowing multidisciplinary healthcare
professionals. During this time data was collected via semi-structured interviews, either face-to-face in a
private room or over the phone, depending on the participant’s preference. Interviews are useful to allow
participants to discuss what is most important and relevant to their personal experiences (10).
An interview guide ensured that key topic areas were covered (Appendix 5). Questions covered patients’
nutritional priorities, the dietitian’s role, interprofessional nutritional care and how nutritional issues were
managed by the team. The guide was flexible to allow participants to raise important topics, which could
then be explored in more detail in subsequent interviews

(10).

Interviews were recorded using a digital

recorder and transcribed verbatim by the first author. Personal identifiers were removed and participants
were assigned an identifying code to preserve anonymity.

Data analysis
The focus of analysis for Study 4a which is reported on in this chapter, was healthcare professionals’
perspectives and experiences of feeding tubes. Grounded theory recommended the concurrent collection
and analysis of data so that emergent ideas could be explored in more detail in future interviews, to promote
saturation

(10).

Hence, each interview was transcribed and coded in Microsoft Word (2010) no later than

one week after it was recorded (10).
Codes are used in grounded theory to label pieces of the data according to actions

(10).

Initial line-by-line

coding helped to immerse the researcher in the data. Focused coding followed to separate, sort and
synthesise larger segments of data (10). As the focused codes became more saturated, they were refined into
categories and themes

(10).

The constant-comparison technique was used during coding to refine and

substantiate the codes and themes until saturation was reached

(10).

This involved comparing interview

statements to other statements made by the same participant and to statements from other participants to
discover similarities and differences

(10).

Memos were documented during data collection and analysis to

ensure that the researcher remained reflexive by keeping an audit trail (225). Diagramming was also used to
understand the emerging patterns and relationships between the codes, themes and categories (10).
After the PhD candidate had collected, transcribed and coded the interviews, all authors carried out a group
coding session with a sample of de-identified transcripts that represented each participating HNC team and
each healthcare discipline. The authors coded the transcripts independently and through discussion, came
to agree upon the themes and categories that best represented the data

(195).

NVivo version 11 (QSR

International Pty Ltd, Melbourne, Australia) was used to manage participant quotes. Supporting quotes are
provided to authenticate findings

(196).

The first initial of the participants’ identifier codes refers to their

HNC team (A, B, C or D). The second initial refers to their profession (D=dietitian, N=nurse, R=radiation
oncologist or S=speech pathologist).
Section 2.4 (Chapter 2) gives further detail on the grounded-theory methodological approach used for the
qualitative studies in this thesis.
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7.5 Results
Participant details
Forty-seven healthcare professionals were identified as eligible to participate in the interview and all
provided verbal consent. However, one radiation oncologist from team D was unable to complete the
interview as they were unavailable during the data-collection period. The final sample comprised n=46
healthcare professionals.
Radiation oncologists had the largest representation, accounting for 37% of participants. More than half of
all participants reported that they had spent five years or more working with HNC patients in their current
occupation. Nearly two-thirds reported that more than 15 hours of their working week was dedicated to
patients with HNC (Table 18). Interviews ranged from 14 to 45 minutes, with a median length of 25
minutes.
Teams A and D were from Australia and teams B and C were from the United States. Teams B, C and D
were all from large metropolitan areas (Table 19). Team A operated within a regional health district that
also included both rural and metropolitan areas. In this setting, all patients with HNC were routinely
scheduled to be reviewed in a clinic that combined the services of a specialist oncology nurse, dietitian, and
speech pathologist. This clinic was designed to review patients each week of radiotherapy, and prior to and
post-radiotherapy as needed. The radiation oncology departments where teams B, C and D operated were
all located in a metropolitan area. Dietitian reviews in these three teams were primarily based on a referral
from a physician or nurse. Teams A, B and C reported that dietitians had been part of their HNC teams for
at least 10 years prior to the study, whereas Team B had only had a permanent dietitian position within their
team in the previous four years. Teams A, B and D favoured a prophylactic gastrostomy tube approach to
enteral feeding, whereas team C favoured a reactive nasogastric tube approach for patients with HNC.
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Table 18. Demographic data on the healthcare professionals who were interviewed to explore their experiences with nutritional care for patients with head and neck
cancer for Study 4 (Chapters 7-9) (n=46)

Demographic category

All participants (n=46)
n

%

Team A (n=15)

Team B (n=11)

Team C (n=10)

Team D (n=10)

n

n

n

n

%

%

%

%

Gender
Female

35

76

11

73.3

7

63.6

8

80

9

90

Male

11

24

4

26.7

4

36.4

2

20

1

10

Dietitian

11

24

5

33.3

1

9.1

3

30

2

20

Nurse

12

26

2

13.3

2

18.2

4

40

4

40

Radiation oncologist

17

37

6

40.1

7

63.6

2

20

2

20

Speech pathologist

6

13

2

13.3

1

9.1

1

10

2

20

Profession

Reported length of time involved in the care of head and neck cancer outpatients
<5 years

21

45.7

8

53.3

5

45.5

3

30

5

50

5-10 years

11

23.9

1

6.7

3

27.3

4

40

3

30

11-15 years

7

15.2

3

20

0

0

3

30

1

10

>15 years

7

15.2

3

20

3

27.3

0

0

1

10

Reported number of hours dedicated to head and neck cancer outpatients per week
<5 hours

4

8.7

4

26.7

0

0

0

0

0

0

5-10 hours

6

13

3

20

2

18.2

0

0

1

10

11-15 hours

6

13

5

33.3

0

0

1

10

0

0

>15 hours

30

65.2

3

20

9

81.8

9

90

9

90
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Table 19. Characteristics of the participating head and neck cancer teams involved with Study 4 (Chapter 7-9)

Characteristics

Team A

Team B

Team C

Team D

Country (state)

Australia (NSW)

United States (Washington)

United States (Pennsylvania)

Australia (NSW)

Location

Regional health district with
metropolitan and rural areas

Metropolitan city

Metropolitan city

Metropolitan city

Radiation department

Two radiotherapy departments
attached to the local public hospital

One radiotherapy department
located within a university hospital

One radiotherapy department
located within a private cancer
centre

One radiotherapy department
attached to the local public hospital

Treating radiation oncologist ontreatment- review frequency

Variable. Directed by the treating
physician

At least weekly

At least weekly

At least weekly

Dietitian availability per week

Five days

Four days

Five days

Five days

Structure of dietitian review
during radiotherapy

All HNC patients are scheduled to
attend joint clinic with a dietitian,
clinical-nurse-consultant and
speech-pathologist. Additional
reviews as needed.

Dietitian attempts to see all HNC
patients at least once. Review is
typically completed on the same
day as the treating radiation
oncologist’s on-treatment-review.
Additional reviews as needed.

Dietitian attempts to see all HNC
patients at least once. Review is
typically completed on the same
day as the treating radiation
oncologist’s on-treatment-review.
Additional reviews as needed.

Dietitian attempts to see all HNC
patients at least once. Review is
typically completed on the same
day as the treating radiation
oncologist’s on-treatment-review.
More than once weekly reviews as
needed. Ad-hoc joint reviews with
speech pathologist

Malnutrition screening/ referral

Blanket referral for dietitian to see
all HNC patients. Malnutrition
screening by a clinical-nurseconsultant or dietitian during the
fortnightly multidisciplinary
treatment planning meeting to
identify and schedule patients for
pre-treatment assessment.

Referral-based. Other healthcare
professionals identify patients at
risk. Informal screening undertaken
by the dietitian for patients who are
on-treatment.

Referral-based. Malnutrition
screening tool used by a nurse
during a patient’s weekly ontreatment-review with their treating
radiation oncologist to determine if
a dietetic review is required that
week.

Referral-based. Malnutrition
screening undertaken by a nurse
navigator pre-treatment. Patients at
risk of malnutrition have access to
a pre-treatment clinic involving a
dietitian.

HNC = head and neck cancer.
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Summary of key findings
Two categories and six sub-categories were identified, as outlined in Table 20. Appendix 6 provides an
outline of the coding tree of findings.

Table 20. Overview of categories and sub-categories from Study 4a (Chapter 7)
Perspectives of feeding tubes for patients with

Placement considerations

head and neck cancer
-

A valued support

-

Patient-related factors

-

More individualised

-

Service-structure-related factors

-

No universal practice

-

Prophylactic gastrostomy tubes versus
reactive nasogastric tubes

Perspectives of feeding tubes for patients with head and neck cancer
A valued support
Participants recognised the importance of nutritional care for patients with HNC. Feeding tubes were
connected to minimising the risk of adverse nutrition-related events, thus they were valued to support
patients through treatment. This was encapsulated by a dietitian from team D and a radiation oncologist
from team A.
D D1: “Nutrition… it’s definitely a priority for our head and neck patients…. That’s the main thing,
but it affects all the plans that the radiation oncologists have in place.”
A R3: “To ensure that during the course of their treatment…they do get their treatment…they have
supplemental feeding through a PEG or through a [nasogastric tube].”

More individualised
Participants described a shift in practice over approximately the last decade. It was reported that previously,
gastrostomy tubes were recommended for all patients with HNC. However, at the time of this study,
participants explained that a more individualised approach to feeding-tube placement was preferred. The
more discerning use of feeding tubes were attributed to technological developments in anti-cancer treatment
that have less severe side-effects, emerging evidence on patient outcomes related to nutritional support,
enhanced interprofessional care to support patients through treatment, and an awareness of potential risks
associated with feeding tubes.
B R1: “It’s more on an individual basis depending on the patient and the physician, I think that’s
evolved over time, maybe 10 years ago we’d give a [gastrostomy tube] pretty much routinely.”
C N4: “If their surgery or their anatomy is going to change a lot they’ll [place a feeding tube],
but…because we have such an awesome department with nutrition and getting the services that they
need and pain management… I just sort of feel like they want to try and manage it without going to the
tube first.”
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D R1: “We don’t have a definite protocol and the thinking around who should – who’s appropriate for
pre-treatment PEGs and who isn’t has changed quite a lot over time and has changed with our
technique. So, our radiotherapy technique has improved a lot and we can actually avoid… the
pharyngeal constrictor muscles in some settings…. There are cases where we might not put a PEG in
someone that we used to because…we can actually avoid those structures.”

No universal practice
None of the participating HNC teams had a feeding-tube placement protocol or guideline to direct feedingtube practices. Rather, the radiation oncologist consultants were identified as the primary decision-maker
when it came to determine whether a patient should receive a feeding tube, including whether this should
be placed prophylactically. Because of this, participants had experienced different practices between
different radiation oncologists and between different institutions. Some also believed this may have
prevented some nutritionally vulnerable patients from receiving a feeding tube due to physicians’
assumptions about a patient’s nutritional status based on their appearance.
A S2: “Ultimately the radiation oncologist is the one who makes that final call.”
B R5: “It can be a little bit provider-dependent.”
C D1: “It’s very much of a moving target and very much clinician-based here. We don’t have any sort
of algorithm other than sort of some experience, some clinical experience that tells you you should do
this probably now rather than wait, or we could probably hold off and see if this person’s going to do
okay.”
D R1: “There’s probably slight differences, because we don’t have a definite protocol.”
C D3: “The different radiation oncologists have different ideas about what that threshold of weight
loss is [for deciding] whether or not a tube should be met. The dietitian’s goal is no more than 5%
weight loss in three weeks, whereas the radiation oncologist I work with has a higher threshold of 10%
over that same time period.”
D D2: “I think it’s definitely clinician based…. People can be having the same treatment and one might
get a PEG and the other might not…. So, I think it just depends on…the consultant. But I do notice that
if the patient looks better-nourished, I think sometimes they don’t give them, but I haven’t asked
anyone…that’s just me noticing that that’s what they do…. A bit more guidelines around…reactive
enteral feeding…would be a little bit easier…. Maybe there wouldn’t be as much back and forth…. It’s
something that as a unit needs to be a bit more defined…. It’s always consultant-based; everyone needs
to be on the same page, which is hard.”

Prophylactic gastrostomy versus reactive nasogastric tubes
The two feeding-tube approaches that participants were most familiar with in practice were a prophylactic
gastrostomy tube and a reactive nasogastric tube. At the time of this study positive perceptions of the
prophylactic approach were more commonly voiced by participants from teams A, B and D, although these
teams still used nasogastric tubes if patients became nutritionally compromised and had not had a
gastrostomy placed prophylactically. In contrast, participants from team C preferred the reactive nasogastric
tube approach.
A R1: “We decide a – whether they are going to be at risk of poor oral intake…and often that will mean
the pre-emptive placement of a [gastrostomy tube] …and those patients perhaps not receiving extensive
radiation. We’ll make a decision whether to monitor them within that multidisciplinary team, assess their
intake, and if they are struggling, probably react by a reactive nasogastric tube at the time they need it.”
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B R3: “It probably inter-varies across institutions with how aggressively you do nutritional support with
PEG tubes…. I think we tend to be proactive about it and place it more than many institutions. There’s a
lot of debate.”
C R2: “I think our preference is to not put [a feeding tube] in if we can.”

Feeding-tube placement considerations
Despite differences in preferences and practices among the teams with regards to the types of feeding tubes
used and the timing of placement, there were several consistent patient and service-structure factors that
may be considered when determining whether a patient would benefit from a feeding tube (Table 21)

Table 21. Summary of feeding-tube placement considerations for patients with head and neck cancer
according to healthcare professionals interviewed in Study 4 (Chapter 7)

Patient factors

Service-structure factors

-

Planned treatment

-

Dietetic access

-

Tumour characteristics

-

Speech-pathology access

-

Nutrition and swallow status

-

Inter-professional collaboration

-

Risk of “tube dependence”

-

-

Resources to support timely feeding-tube
placements (i.e. staffing and equipment)

Psychosocial status

-

Patient preferences

Patient factors
Planned treatment: Participants described how the intent, modality, dose, and field of a patient’s planned
treatment were considered. Specifically, definitive treatments, chemo-radiation, bilateral neck radiotherapy
and a large mucosal dose were factors that were viewed in favour of a prophylactic gastrostomy tube
placement because of the expected nutritional burden. Participants were more willing to wait and place a
nasogastric tube reactively if the patient was planned to receive a less-intense treatment regimen.
Tumour characteristics: The tumour stage and its location were also considered. For example, patients with
midline oro-pharyngeal tumours were identified as a nutritionally at-risk sub-group. Hence, radiation
oncologists were more likely to consider a prophylactic gastrostomy tube placement for these patients. The
importance of considering both the patients’ planned treatment and their tumour characteristics is
highlighted by a radiation oncologist from team B and a nurse from team D.
B R2: “If they’re getting chemo-rad and if it is a midline tumour and then you are treating both sides
of the neck, then I’m thinking about a [gastrostomy tube]. So the tumour factors, the location of the
tumour, the size of the tumour, the treatment factors would be ‘Are you adding chemo or not?’ the
radiation factors would be ‘Are you treating both sides of the neck or not?’ One side of the neck is
much easier to tolerate. It puts much less burden on the patient.”
D N1: “The decision’s made by the [radiation oncologist] obviously and it’s based on the amount of
grey that they’re getting and the location – like, if it’s bilateral neck and they’re getting huge dose, the
[radiation oncologist] will prophylactically put a [gastrostomy tube] in.”
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Nutrition and swallow status: Several participants discussed the importance of considering a patient’s pretreatment nutrition and swallow status. This information was used to assess the risk of nutritional decline
during treatment and thus determine whether they might benefit from a prophylactic gastrostomy tube.
C R1: “We’ve moved toward not prophylactically placing PEGs in, I’d say, the majority of patients,
[and placing them] only in patients where there are real red flags – so, I’d say, only in patients who
have issues prior to starting radiotherapy, meaning a fair amount of weight loss.”
C R2: “if they’re already malnourished before treatment and not able to take enough calories in from
a functional standpoint then we would put one in … If their swallowing function is not really recovering
in patients who are malnourished and we don’t expect that to improve after surgery and we don’t expect
that to improve before radiation, we would put a feeding tube in”
B R3: “For the patients who are already having swallowing dysfunction up front and weight loss going
into it, it may just be if they’re decompensated or their performance status or age, and then the tumour
itself causing problems, it’s those patients that clearly would benefit from having [a feeding tube] up
front, so we’ll place it.”

Risk of tube-dependence: Some radiation oncologists explained they had become more discerning about
placing prophylactic gastrostomy tubes due to the risk of “feeding-tube dependence” due to swallowmuscle atrophy from patients relying too heavily on the feeding tube. However, other participants felt that
these concerns were not grounded in strong evidence and that confounding variables needed to be
considered. For example, it was suggested that increased radiation dosing and new chemotherapy drugs,
such as Cisplatin, could cause more-severe long-standing side effects, and thus longer use of feeding tubes
should be expected in patients treated with modern therapies.
B R1: “Because of the data that’s come out in terms of the long term effects on deleterious effects of
long term swallow function people are simply aren’t taking anything orally, we don’t do it often and
particularly if a patient is interested in trying to manage through treatment without a PEG”
C R1: “My understanding is that if they continue to swallow during the course of treatment, all of the
muscles that go into swallowing function are more likely to remain strong… so we’ve shied away from
placing PEG’s in all patients and really only in those that we feel really need it
A R1: “I now see more people with swallowing difficulties than I did before…. I don’t know if it’s a
case of [when you] put in a [gastrostomy tube] you never have to swallow, and therefore there’s very
little movement…and you get atrophy…. It may just be higher-dose, more chemo, and that’s all that
you need.”

The three speech pathologists from the United States teams (teams B and C) had more-negative perceptions
of the prophylactic gastrostomy approach due to concerns with tube-dependence compared to their three
colleagues from Australia (teams A and D).
B S1: “I don’t have enough data to know, but form my own ideas and, like theory behind it, I think it’s
better to not place it.”
C S1: “Some facilities they put a PEG tube in anyone who may have radiation prior… what we sort of
sell is that if patients have that then they’ll use it even if they can [eat orally] and their swallowing
suffers afterwards because they’re not using the muscles so they can become really fibrotic and tight
or have some atrophy. So, we prefer them to be swallowing and if they need to have it put in then they
do and I would say that I think that’s a small percentage of people”.
D S2: “I’ve seen patients who don’t get the prophylactic [gastrostomy tube] and then their toxicities
are so bad and their swallow function is so bad and then they’ve been [nasogastric] dependent…my
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impression is that the experience [of a nasogastric tube] is a lot more traumatic…as well, so it can
make it kind of harder to get back to oral intake.”
A S1: “Depending on where we’re actually treating…areas that we know exacerbate dysphagia to the
point where they can’t tolerate, we often do the prophylactic PEG, which is really good.”

Psychosocial status: Participants identified that a patient’s social support, personality, physical health, and
economic status could influence that individual’s ability and motivation to use the feeding tube as advised
by a healthcare professional. Hence, participants remarked on the need to consider the patient holistically,
to ensure that feeding-tube placement decisions were efficacious.
D D1: “The social economic barriers to them meeting their nutritional requirements… whether they’re
financially capable of… getting those supplies or whether they have social support or the environmental
capacity to be able…. That’s great, we can put a prophylactic PEG in patients because they’re expected
to have these symptoms…but are they able to take care of that, are they able to feed themselves through
it?”
A S2: “I think there's the patient factors as well I find that a lot of the time… if they have support from
other people, they tend to do a bit better as oppose to the ones who live alone”

One barrier to the use of prophylactic gastrostomy tubes that dietitians identified was a patient’s health
insurance. Specifically, challenges to getting prophylactic gastrostomy tube costs covered by Medicare in
the United States were discussed. In this situation patients would often start treatment without a feeding
tube; a nasogastric tube would be placed reactively when it was needed.
C D2: “For our Medicare patients we have so much difficulty getting coverage for them…. That…plays
a role because…for Medicare to cover the tube placement there needs to be documented issues with
swallowing…. It has to be documented that the tube will be needed for greater than 90 days or more
and meeting the majority of their nutritional needs…. So, because of that, if it’s prophylactic and, let’s
say they don’t have that dysphagia or aspiration, often times it’ll get kicked back and there’s not any
sort of cover then, so it’s all out of pocket. And for the patient, you know, it’s hard to sort of justify that
sometimes.”
C D3: “We have to have a number of different criteria in order for Medicare to cover the feeding
supplies… above 65 years or for those on disability… they must have some kind of tumour burden
documented and both the medical the M.D note preventing swallowing, usually they like to see the
speech and language pathology recommendation… you also have to have some documentation of the
time that the tube needs to be in place, it needs to be at least three months… dietitian recommendations
on minimum amount of calories… so it’s challenging”

Patient preferences: Some participants described experiences where patients had been very reluctant to
have a prophylactic gastrostomy tube placed. Thus, in those circumstances, they felt it was more appropriate
to attempt to support them through treatment without a feeding tube. In contrast, others felt it was more
patient-centred to encourage patients to have a gastrostomy tube placed prophylactically as it may help to
relieve some of the expected nutrition-related burden during treatment.
B N1: “Over the last couple of years…we’re more generous when a patient says, ‘I really don’t want
[a gastrostomy tube]’, We’ll say, ‘Okay, we’re going to give you a try,’ but be realistic and say, ‘Well,
if you’re unable to maintain your weight we’re going to have to have the feeding tube.’”
D D1: “It can make it easier sometimes just saying, ‘Okay, if you’re really struggling to drink orally
because of all the horrific side effects you’re getting put it through the PEG…”, so I think the patients
who have the PEG definitely have that advantage.”
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Service-structure factors
Dietetic access: Most participants spoke about the importance of dietetic access for feeding-tube
management. Occasionally, a pre-treatment assessment by a dietitian contributed to prophylactic
gastrostomy tube placement decision-making. However, dietitians were perceived to have a more
prominent role in initiating reactive nasogastric tube placements and in educating patients on feeding-tube
use and determining formula, volume and when to initiate enteral nutrition infusion.
B R7: “I think the role of the dietitian is to…deal with the PEG tube and the feedings and all of the
logistical things that it’s obviously very difficult for me as a physician to know how to do.”
B N2: “For those that the doctor has identified that they need a PEG tube placed proactively, it’s a
requirement in the process that the dietitian… before the tube is placed, have an appointment with the
patient and educate them about the tube”
A D5: “[The dietitians}… able to advocate for either IV fluids as an outpatient so they can prevent
them going into hospital or whether they need sort of a reactive nasogastric tube to be able to manage
their nutrition and hydration if it’s just sort of for a short period of time and they don’t have a
gastrostomy.”

Speech-pathology access: To minimise the risk of swallow-function decline and “feeding-tube
dependence”, participants discussed the need for patients to have access to a speech pathologist.
B S1: “We try to tell them that even if they have a PEG tube to try and keep swallowing throughout
treatment even if it’s just water.”

However, it was noted that speech-pathologists involved with the two United States-based teams consulted
patients following surgery and then following radiation, but rarely during radiation. Comparatively, those
from the Australian-based teams often reviewed patients at the same time as the dietitian whilst a patient
was undergoing radiotherapy. It was beyond the scope of this study to examine whether this affected the
level of swallow therapy that HNC patients had access to and perceptions of prolonged feeding-tube use,
as mentioned above under “Risk of tube-dependence”.
C D3: “I don’t know [the speech pathologist’s] schedule, to be honest…. The patient is supposed to
come back and see the speech and language pathologist within the first three weeks of their radiation
treatment, but I don’t think that’s always happening. I think it’s happening with the more motivated
patients…. I think that’s definitely something that we could probably do a little bit better.”
C S1: “Preferably we like them off the tube prior to starting [radiotherapy] so post-surgery. Some
patients are swallowing well enough to get the tube out at that point; sometimes we have to stay start
eating and then we’ll wean off the tube; and then if the patient does need a tube during radiation
treatment and chemo, when they’re all done with that then they come here and we do a swallow
evaluation and try to get them off it”
D S1: “We’re referred at the same time as the dietitian’s referred, and we’re looking more at the
function and safety of swallow… pre-, during and post-treatment…. We do a lot of joint sessions with
the dietitian…. I’ve worked across Queensland, New South Wales and Victoria and I think the… head
and neck clinics themselves are well established with the speechies and the dietitian doing the joint
session because it’s such a known need.”

Interprofessional collaboration: As the individual contributions of physicians, nurses, dietitians, and
speech-pathologists were valued, so too were service-structures that facilitated interprofessional
collaboration for feeding-tube placement decisions and management. For example, in team C a weekly
interprofessional case-conference-style meeting was recognised as an opportunity to identify patients who
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needed reactive nutrition support, given that prophylactic gastrostomy tubes were not favoured in this
setting.
C D3: “At that meeting, then, we go through all the active patients…. That’s when I’m able to bring
up any issues that I might have on patients that are losing greater than 5% weight loss: What are we
going to do, are we going to consider a tube?”
C N2: “We work so tightly together if any of us identify an issue with the patient’s nutritional status
we’ll just put it out on the table and discuss it and try to work through it and do what’s best for the
patient – you know, we don’t love feeding tubes.”

Nutrition-support resources: Participants from team B reported preferring the prophylactic gastrostomy
tube approach because they did not have the space or resources (i.e., the staffing and equipment) readily
available to provide intravenous fluids or reactive nasogastric tubes within their department.
B N2: “We just aren’t set up with personnel or the real estate to be able to devote a room to do that on
a regular basis.”

In contrast, participants from team C explained that they were comfortable not placing gastrostomy tubes
prophylactically because they had resources readily available should patients become nutritionally
compromised and require intermediate intravenous fluid support, followed by the placement of a
nasogastric tube.
C N3: “They don’t all automatically get feeding tubes put in anymore. So, by doing that you better have
a good plan in case they start to lose weight.”
C R1: “There’s still times, obviously, when a patient, especially the definitive patients if they’re having
a tonne of pain and if they stop eating, and if they don’t have a feeding tube they may be dehydrated…
then usually we’ll give them fluids in clinic”
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7.6 Discussion
This study provides important insights into how recommendations in nutritional EBGs related to enteral
nutrition are implemented in practice, by summarising the perspectives of healthcare professionals from
different HNC teams. Through providing perspectives from both Australia and the United States this study
highlights several consistent factors that influence enteral feeding tube practices, irrespective of the
different national healthcare systems (12). Therefore, these findings are more relevant to an international
audience and highlight opportunities that could improve patient care globally. Several of the patient factors
that were identified as important feeding-tube placement considerations align with EBGs such as tumour
stage, location, treatment modality, and the consideration of malnutrition, swallow, and psychosocial status
(25, 55).

The importance of considering patients’ social and economic context and their motivation and

personal preferences when deciding whether and what kind of feeding tube approach is most appropriate,
aligns with patients’ own perspectives and experiences on what is important (118, 143).
This study supports that there are often conflicting views about whether a prophylactic gastrostomy tube or
reactive nasogastric tube approach is better for patients with HNC. This reflects the inconclusive evidence
on this topic and helps to confirm why different practices exist

(209, 226).

Poor knowledge and lack of skill

have been identified as factors that can influence radiation oncologists’ willingness to place a gastrostomy
tube (221). This highlighted the need for future research and service developments focused on feeding-tube
education and training for healthcare professionals working within the HNC context. Dietitians are well
positioned to lead interprofessional education on enteral nutrition and to be an advocate for collaborative
feeding tube placement decisions that are in line with nutritional EBGs. Therefore, service managers and
developers should support opportunities for interprofessional education and collaboration in the workplace.
This, in conjunction with formal training to enhance feeding-tube placement skills, may ensure that
recommendations regarding feeding-tube placements are centred on the individual patient’s needs and are
not limited by the skills or knowledge of healthcare professionals.
Researchers of several studies that have previously been conducted to explore outcomes for patients with
prophylactic gastrostomy tubes or reactive nasogastric tubes, have not explained or investigated whether
service-structure factors are considered in the feeding-tube placement decision-making process. While most
authors note that a patients’ planned treatment, tumour characteristics, and their nutritional status are
considered, the exact decision parameters are often unclear

(68, 93, 94, 157).

This study highlights that other

factors, such as the availability of dietitians and speech pathologists and resources such as staffing and
equipment to support the reactive placement of feeding tubes, may also influence feeding-tube placement
decisions. Brown, Ross

(167)

and Kiss, Krishnasamy

(47),

who both evaluated the implementation of local

guidelines for enteral feeding for patients with HNC, support this and suggest that both prophylactic and
reactive approaches are feasible and can result in good outcomes if practice is consistent and individualised
to the local setting. More detail on the rationale for the feeding-tube approach used should be provided in
future observational studies. Additionally, future well-designed studies that compare prophylactic
gastrostomy tubes and reactive nasogastric tubes, should also report on and control for the availability of
nutritional resources (including available equipment and staffing, such as access to dietitians and speech
pathologists) to better understand the transferability of outcomes to different settings. This research may
122

allow nutritional EBGs to provide more specific recommendations about feeding-tube types and the timing
of placement. Until this evidence is available, the development of local guidelines that can account for
different service-structure variables would be worthwhile to promote consistent and quality nutritional-care
practices within HNC teams (227).
Prolonged feeding tube use and the resulting tube dependence were major sources of concern for some
participants in relation to the prophylactic gastrostomy approach. This confirms research by Fan, Li (221)who
found that the risk of potential side effects was a reason why radiation oncologists may not want to place a
gastrostomy tube. Despite these perceptions, the impact of prophylactic gastrostomy tube use on
swallowing remains inconclusive (69). Other factors have been associated with delayed return to oral intake,
such as high-dose radiotherapy to the larynx, pharyngeal constrictor muscles and parotid glands, advanced
tumours, pre-treatment weight loss and low social support (177, 228, 229). Feeding tube dependence is currently
not well defined and is at risk of misrepresentation, as the multifactorial influences of this phenomenon
have not been adequately researched

(157).

This needs to be addressed to ensure that unfounded concerns

about tube dependence are not affecting the implementation of EBG recommendations regarding the use of
prophylactic feeding tubes, and to ensure that appropriate management strategies to minimise the risk can
be implemented (25).
Speech pathologists from the United States who participated in this study had more negative perceptions
of the prophylactic gastrostomy tube approach because of concerns about tube dependence than did their
colleagues from Australia. Other researchers have demonstrated significant reductions in prolonged
feeding-tube use when patients with HNC see a speech pathologist pre-treatment and weekly throughout
radiotherapy

(179, 230).

Additionally, from the retrospective chart review in Chapter 4 there was relatively

low rates of prolonged feeding-tube use at six- and twelve-months post-treatment among patients who had
received a gastrostomy tube prophylactically. These promising findings may have been because the patients
involved in that study had routine access to a joint specialist nurse, dietitian, and speech pathologist clinic
prior to, during and following radiotherapy and this may have helped to support patients in transitioning
off a feeding tube. This is noteworthy, as in the present study it was apparent that patients treated by the
two United States teams may have had more difficulty accessing a speech pathologist whilst undergoing
radiotherapy. Thus, this may have resulted in more negative experiences with tube dependence among
healthcare professionals from those teams. More studies that control for speech pathologist’s involvement
with HNC patients, measure the effect that clinics that combine the services of speech pathologists,
dietitians, and specialist nurses, and assess patient adherence to swallow exercises should be prioritised, as
this may influence the implementation of nutritional EBGs and lead to improved outcomes for patients with
HNC.
Finally, the importance of considering a patient’s psychosocial background, including their socio-economic
status is highlighted. This aligns with recommendations provided in nutritional EBGs for patients with
HNC, and patients’ own preferences

(25).

For example, in this study we found that variations in patient

healthcare cover between nations such as Australia and the United States may contribute to variations in
feeding-tube practices, as this may place financial barriers to the efficacy of a prophylactic gastrostomy
tube. This supports findings by Martin, Blomberg (231) as well the studies in Chapters 5 and 6 of this thesis
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that highlights how a patient’s willingness and their ability to follow feeding-tube recommendations may
affect the efficacy of this intervention

(70).

Specifically, patients can have individual preferences for and

experiences with feeding tubes that may affect how they use the feeding tube in line with evidence-based
recommendations from healthcare professionals

(118, 142, 143, 175, 204).

Therefore, adopting an individualised

approach to feeding-tube placement decisions for patients with HNC should be prioritised.
In all studies there is risk of professional bias. Hence, reflexive strategies were employed to identify and
manage biases within the research team. This included use of the constant-comparison grounded-theory
technique

(10)

and the group analysis session and team-meetings to discuss and deliberate over findings.

Moreover, the population sampling was strategic to gain insight from a broad range of interdisciplinary
healthcare professionals. Similarly, the large sample size with participants from Australia and the United
States enhances the credibility of findings and their generalisability to wider populations. The strength of
qualitative research lies in the readers’ ability to consider the findings in their own context

(5, 202).

Hence,

from this study I have identified several tangible patient and service-structure considerations to offer novel
insight into feeding-tube practices in other HNC teams. It would be of benefit for similar work to be carried
out in radiation departments that do not have regular access to dietitians to explore how practice may vary,
and to provide quantitative data on malnutrition status, feeding-tube utilisation, and adherence to
swallowing exercises to help contextualise the qualitative findings.
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7.7 Conclusion
This study provides important insight into how nutritional EBG recommendations related to feeding tubes
for patients with HNC are implemented in practice. It was found that healthcare professionals involved in
the care of patients with HNC valued the targeted use of feeding tubes and that the decision to place a
feeding tube was largely directed by the treating physician. However, there were different perspectives on
whether the prophylactic gastrostomy tube approach or the reactive nasogastric tube approach was most
efficacious; this was attributed to variations in practice between individual physicians and between HNC
teams.
Several factors that are considered in the feeding-tube placement decision-making process such as tumour
stage and location, treatment modality and malnutrition, swallow, and psychosocial status, align with EBG
recommendations. Considerations that may influence the implementation of EBG recommendations related
to feeding tubes that require further exploration include how patients accept and have capacity to use the
feeding tube as recommended, access to dietitians and speech pathologists prior to, during and following
radiotherapy, the availability of staffing and equipment to support timely feeding-tube placements, and the
capacity for interprofessional collaboration within the HNC team. Until higher-level evidence is available
on whether a prophylactic gastrostomy or a reactive nasogastric tube approach is best for patients with
HNC, the development of local departmental guidelines may promote consistent and patient-centred
feeding-tube practices by accounting for specific service-structure variables, and by considering the goals
of individuals with HNC and their families.
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CHAPTER 8: Healthcare professionals’ perspectives on the
role of dietitians within multidisciplinary head and neck
cancer teams: A qualitative multi-site study (Study 4b).
8.1 Chapter overview
In Study 4b reported on in this chapter, I aimed to explore how the role of the dietitian was perceived and
enacted in different head and neck cancer (HNC) teams from the perspective of healthcare professionals.
This study was designed to help to address Objective 4 of this thesis: Identify and explore factors that
influence the implementation of nutritional evidence-based guidelines (EBGs) based on the perspectives
and experiences of healthcare professionals.
Several recommendations in nutritional EBGs relate to how dietitians should be involved with patients with
HNC. For example it is recommended that dietitians review patients weekly during radiotherapy

(25).

However, from the retrospective chart review in Chapter 4, this recommendation was only met for 62% of
patients. In chapters 5 and 6 I explored patient perceptions of nutritional care. This highlighted several
opportunities that may enhance patient acceptance of dietitians and the nutritional recommendations that
they provide. Exploring perceptions of the role of the dietitian on HNC teams, among healthcare
professionals, including radiation oncologists, nurses, speech pathologists and dietitians themselves, would
expand on the findings from the previous chapters. In doing so, the current chapter draws attention to
barriers and enablers to adhering to EBG recommendations that relate to how dietitians should be involved
with patients with HNC.
The study reported on in this chapter is currently under review for publication with a peer-reviewed journal
and findings related to the study reported on in this chapter were presented at the Dietitian’s Association of
Australia conference in 2018.
Citation: Hazzard, E. Walton, K. McMahon, A. Milosavljevic, M. Tapsell, L. (2018) Interdisciplinary
perceptions of the dietitian’s role in dehydration management for outpatients with head and neck cancer:
an international comparison, Dietitian’s Association of Australia National Conference, 17-19 May 2018,
Sydney Australia.
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8.2 Abstract
Background: Evidence-based guidelines (EBGs) provide recommendations on how dietitians should work
with patients with head and neck cancer (HNC) to promote best outcomes. Research with patients highlights
enablers and barriers to them accepting dietetic care. Research with healthcare professionals from HNC
teams would expand on this evidence. The aim of this study was to explore how the role of the dietitian is
perceived and enacted in different HNC teams from the perspective of healthcare professionals.
Methods: This qualitative study recruited radiation oncologists, nurses, dietitians and speech pathologists
from four different HNC teams in Australia and the United States. Data was collected via semi-structured
interviews and analysed using a grounded-theory approach.
Results: Seventeen radiation oncologists, 12 nurses, 11 dietitians and six speech pathologists participated.
The role of the dietitian was summarised by the category: the expert on nutritional care and this was
underpinned by three sub-categories: dietetic training and accreditation, patient priorities and gaps in
medical knowledge. The delineation of nutritional care was the second category that helped to explain how
the role of the dietitian was enacted in practice with five sub-categories: dietetic experience, nutrition-care
gatekeeping, clinic structure, culture, and national evidence-based guidelines.
Conclusion: Several factors influence how the role of the dietitian is enacted in HNC teams. Further
research on patient nutritional outcomes and on clinic structures that best use dietetic expertise is required
to support the implementation of EBG recommendations that relate to how dietitians should work with
HNC patients for best outcomes.
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8.3 Introduction
Internationally endorsed evidence-based guidelines (EBGs) for the nutritional management of patients with
head and neck cancer (HNC) recommend that all patients with HNC see a dietitian routinely during and
after radiotherapy (25). HNC is treated and managed within the context of a team of healthcare professionals
that also includes physicians, nurses, and speech pathologists. Thus, multidisciplinary support is required
to ensure that evidence-based nutritional care is effectively implemented

(19, 21).

For example these other

healthcare professionals have an important role in nutritional screening, referring to dietitians and in
ensuring that nutritional interventions can be actioned (25).
Exploring the perspectives and experiences of healthcare professionals is recommended by Peters, Tran (80)
in a report by the World Health Organisation, as a way to understand how EBGs are implemented in practice
(1).

Researchers who have conducted qualitative research with healthcare professionals in other settings

have identified several barriers to implementing EBG (75, 145). These have related to a lack of time, resources,
training, and professional experience

(75, 145).

Additionally, barriers to the integration of allied health

professionals in multidisciplinary healthcare teams have also been highlighted through qualitative research
(232, 233).

Specifically, introducing different scopes of practice and ways of working can be disruptive, and

traditional hierarchical cultures within healthcare can affect how well teams’ function (232, 233). This research
highlights factors that may also influence how recommendations from EBGs on how dietitians should work
with patients with HNC are implemented.
In their study with physicians, nurses, speech pathologists and nutrition professionals such as dietitians
from five different European nations, Martin, de van der Schueren (70) helps to expand on this knowledge,
through exploring enablers and barriers to nutrition care for patients with HNC

(70).

It was found that the

initiation of nutrition care for patients depended on support from a physician. However, there were often
higher priorities connected to an acceptance of nutrition decline during treatment, poor understanding of
the risks versus benefits of nutrition intervention, and prioritising funds for drugs and surgical equipment
(70).

Further international multi-site research with healthcare professionals from HNC teams in Australia

and the United States could expand on evidence related to the implementation of recommendations from
EBGs on how dietitians should work with patients with HNC for best outcomes. Therefore, the aim of this
study was to explore how the role of the dietitian is perceived and enacted in different HNC teams in
Australia and the United States, from the perspective of healthcare professionals.
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8.4 Methods
The focus of Study 4b in this chapter was healthcare professionals’ perspectives of the role of dietitians
within HNC teams. This study was the second component of a larger research project that aimed to explore
how nutritional EBGs are implemented in practice for patients with HNC from the perspectives and
experiences of healthcare professionals. The other two components (Studies 4a and 4c) focused on feedingtube practices, and what facilitates collaborative nutritional care in HNC teams. These two other studies are
included in this thesis in Chapters 7 and 9, respectively.
Section 7.4 (Chapter 7) gives details on the qualitative approach and research paradigm, researcher
characteristics and reflexivity, context, sampling strategy, data collection and data analysis used in this
study. The interview guide used for this study is included in Section 7.8. Section 2.4 (Chapter 2) gives
further detail on the grounded-theory methodological approach used for the four qualitative studies included
within this thesis, including for study 4b in this chapter.
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8.5 Results
Participant details
Section 7.5 (Chapter 7) and Tables 18 and 19 provides demographics of the individual participants and
overview of the structure of the four participating HNC teams and respectively.

Key findings
The role of the dietitian was summarised by the category the expert on nutritional care and this was
underpinned by three sub-categories: dietetic training and accreditation, patient priorities and gaps in
medical knowledge. Thus, participants viewed dietitians as having an important and core role within the
HNC teams.
The delineation of nutritional care was the second category and this was underpinned by five sub-categories
that related to how the role of the dietitian was enacted in practice: dietetic experience, nutrition-care
gatekeeping, clinic structure, culture, and national evidence-based guidelines.
The categories and sub-categories are summarised in Table 22 and are described in more detail below with
supporting quotes. The first initial of the quote identifier code refers to the HNC team that participant was
from (A, B, C or D). The second initial refers to their profession (D=dietitian, N=nurse, R=radiation
oncologist or S=speech pathologist).

Table 22. Summary of categories and sub-categories related to how the role of the dietitian is
perceived and enacted within head and neck cancer teams according to healthcare professionals
from Study 3b (Chapter 8)

Dietitians as the experts on nutritional care

The delineation of nutritional care within head
and neck cancer teams

-

Training and accreditation
Patient priorities
Gaps in medical knowledge

-
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Dietetic experience
Nutrition care gatekeeping
Clinic structure
Culture
National evidence-based guidelines

The experts in nutritional care
Dietetic training and accreditation
Dietitians were described as “nutrition-care experts”. Knowledge of training and accreditation was central
to how participants perceived the role of the dietitian. Training and accreditation was also perceived to
define the boundaries of the dietitians’ scope of practice within the HNC team.
D N2: “[Dietitians are] the expert on the diet.”
D S1: “I see the dietitian’s role as managing nutrition and hydration to minimise weight loss… before,
during and after treatment.”
A S1: “Identifying the amounts going in and the amounts of food and nutrition that are required and
working out whether or not they’re being met currently. If they’re not being met, figuring out
why…coming up with a plan on how to manage it”.
A N1: “What the dietitian can do and does very well…is… history and quantifying… they can tease that
information… I could, but not with the same ease or expertise that [the dietitian] does”

Patient priorities
Participants explained that a priority for all patients undergoing radiotherapy for HNC was to ensure that
they received their planned radiation dose without delays or interruptions to promote best outcomes.
Participants recognised that weight-loss and malnutrition could affect the accuracy of radiotherapy
treatment plans and result in treatment interruptions, delays, and poor recovery. Therefore, dietitians
working within HNC teams were identified as having a core role within the multidisciplinary team to help
address an overarching goal of treatment.
B R2: “I don’t want patients to lose weight because when they lose weight their anatomy changes and
the plan that we generate up front will no longer be valid.”
B N1: “[The dietitian] is in the clinic with us and sees almost every patient…that is critical because…
of the facial mask, weight loss is a really serious implication. We try not to let our patients lose any
weight based on the mapping from the mask-fitting.”
B R7: “The role of the dietitian is to not only help to set up that initial kind of risk assessment… but also
ongoing care… to really try to stabilise their weight to be able to get through a really difficult treatment”

Gaps in medical knowledge
Dietitians were seen to have an important role within the HNC team as they offered expertise on nutrition
care that could complement a gap in medical training.
A D3: “I don’t think many other professions would know how to get such a detailed response… I
think [dietitians] would be the best ones to get a really quantifiable amount of how much they’re
drinking.”
B R7: “The dietitian’s role in our service is really to kind of complement the team, the nursing staff,
the residents and the attending physician… [in] how to deal with the PEG tube… It’s very
appreciated… I have not been trained that way… so to have somebody that I trust…and knows a
whole other aspect of the patient…has been absolutely wonderful… if places can afford [a dietitian],
it’s so important.”

The delineation of nutritional care by the HNC teams
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Dietetic experience
In the absence of specialist training programs for dietitians, experience with patients with HNC was
identified as a way that dietitians could gain specific knowledge and skills in this area, beyond graduate
level skills. Radiation oncologists and nursing colleagues viewed dietetic experience favourably and this
appeared to influence how much they “trusted” the dietitian to direct nutritional care plans.
B R7: “We’re probably very lucky to have somebody that’s very experienced… this is a pretty special
sub-set of patients that go through a really tough time during treatment… somebody that has that
experience to pre-emptively know what to expect and to have… a cohesive way of…approaching
something is really important.”
A R1: “Once you’ve got that trust [the dietitian will] come along and say to the registrar, ‘Oh, look, this
guy is really dehydrated,’ and I’ll say, ‘Admit him. – ‘Why?’ ‘[The dietitian] says he’s dehydrated, admit
him…. She’s been spot on every other time.’ …Who is taking responsibility? Me. Who is ordering the
management? [The dietitian].”

Nutrition-care gatekeeping
Several examples were provided of physicians and nurses directing a patient’s nutritional care. For example,
in all four teams the decision to place a feeding tube prophylactically was often at the discretion of the
treating radiation oncologist, and this did not require dietetic consultation. Additionally, physicians needed
to agree to recommendations from dietitians related to the reactive placement of a feeding tube for patients,
and nursing engagement was required to action this plan.
D N1: “The decision is made by the [radiation oncologist] obviously… the [radiation oncologist] will
prophylactically put a [gastrostomy tube] in.”
B R1: “Once I get a dietitian involved, I basically will turn the diet management over to [the dietitian]
and our team nurse unless… I have to sign off on orders for… ordering of the liquid supplements
etcetera.”

A radiation oncologist from team B also believed that the dietitian’s role should adapt to how
knowledgeable, confident, and experienced the radiation oncologists and nurses were with respect
to nutritional issues, such as dehydration.
B R2: “We… see a lot of head and neck patients so they’re attuned to it, but if that’s not there…then
the dietitian’s role becomes stronger. In our set-up the dietitian’s role for dehydration is not –
specifically not as high up…. It might be different when you go to a smaller centre…. They might treat
only, like, 50 head and neck patients a year, or get one a month…. If they’re lucky enough to have an
in-house dietitian…there…the dietitian’s role to pick up dehydration becomes stronger.”

Furthermore, a referral from a physician or nurse typically initiated the first contact between a dietitian and
a patient in teams B, C and D.
C D3: “When the patient is on active treatment, they have a required weekly visit with the nurse and
the radiation oncologist. There’s a small screen that asks about weight loss… and any difficulty with
chewing or swallowing or both, and… if anybody has a feeding tube… nursing refer them… We don’t
review them until there is actually an active plan in place.”
C D2: “We don’t…have a mechanism for follow up…that next week will roll around [and] they’ll see
their radiation oncologist for treatment. And if they’ve lost weight have difficulty with chewing or
swallowing or have a feeding tube [then] that will be a consult again…”

Nutrition-care gatekeeping appeared to be connected to liability, as physicians were ultimately
responsible for the care of patients.
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A R1: “This is non-negotiable, this issue of who manages the patient.”

Clinic structure
Different clinic structures influenced how the dietitian’s role was enacted within the HNC teams. For
example, participants from teams B and C, which were based in the United States, explained that a
traditional physician-led clinic structure was a requirement for revenue within their healthcare system.
Thus, a referral to a dietitian was initiated if nutritional issues were identified by physicians or nursing staff.
Negatives of this model of care that were identified related to potential delays in nutritional care and an
overuse of medical staff.
B R2: “In Australia there’s no incentive to see the patient weekly…so unless they’re sick, they might not
get the doctor’s attention. [In the United States] billing is tied to the weekly visit…. The staff specialist
has to see them so those five fractions… can be billed”.
B N2: “Sometimes, for whatever reason…head and neck patients do not get referred and so… They might
be further down the path of their treatment and they start to struggle and then they get a referral placed,
and if the dietitian is not immediately available to see them… that’s a little bit problematic.”
B R1: “If the patient is not really having any problems, then there’s not really any need for [the
consultant] to see them… Let the resident manage things that are not complicated or not significant
and then spend [the consultant’s] time on people who have issues.”

In contrast, all patients with HNC in team A were scheduled to attend a weekly clinic that combined the
services of a specialist oncology nurse, dietitian, and speech pathologist. This clinic structure was valued,
as patients could be closely monitored throughout their treatment without the need for regular physician
involvement. Additionally, this clinic structure ensured that nutritional care was a core component of care
through raising the profile of the dietitian. This was considered beneficial for patients, staff, and the health
service.
A R2: “Patients on treatment here…for head and neck…are actually largely managed within the
context of a multidisciplinary… that team constitutes a [clinical nurse consultant] a dietitian and a
speech pathologist.”
A R6: “It’s run by…the three disciplines [clinical nurse consultant, dietitian and speech pathologist]
…and that is a way for… us as the treating department to keep an eye on those people…. Our dietitian
will be looking more deeply into their nutritional input…. The [clinical nurse consultant] is always very
quick to flag anybody that she thinks is running into trouble.”
A D4: “You were on top of things straight away and starting a process for them to improve…. I also
think that the doctors… actually like the clinic because we were keeping a very close eye on their
patients”.
A R3: “The multidisciplinary clinic… which emphasises not just the medical perspective, but it’s the
day-to-day nutrition, hydration, I think, that’s just as important…. What happens is that in place… of
multidisciplinary structure, you just have the ward filled up with people who are on drips.”

Culture
Many participants felt that the culture within HNC teams had evolved over time. This was attributed to
dietitians being more valued and having a greater emphasis on nutritional care. However, several radiation
oncologists explained that some physicians may be resistant to moving away from physician-led models of
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care and towards value-based clinic structures that give nursing and allied health professionals, such as
dietitians, more control of patient care.
D R1: “Hierarchies have changed… Dietitians and speech language therapists can now feel part of
the team without necessarily being worried about calling you ‘Doctor so and so… they’ve become more
familiar and more integral members of the clinic”
B N1: “Nutrition is actually part of the team now… I see [the dietitian] as a core member of the team…
to get a patient through their treatment – which is kind of a shift in our mentality.”
A R1: “You first have to accept that you don’t know everything…that somebody else has abilities
and…knowledge that you don’t possess. Which is a difficult thing for some doctors to come to.”
D R2: “[Team A] is the odd one out but I actually think…it’s the way that people should be going…. A
lot of my colleagues are just so stuck on this weekly review…. I don’t think it’s [a] good use of our
time… if we have the right support”.

National evidence-based nutritional care guidelines
Finally, the presence of nationally endorsed nutritional EBGs were valued to promote clarity and
consistency about dietitian involvement within HNC teams. This was encapsulated by a dietitian
from team C, who related the inconsistencies in dietitian involvement to the lack of national EBGs
that provide recommendations on the nutritional care of patients with HNC in the United States.
C D1: “The challenge is that in [the United States] there really are so many variabilities in what’s
offered… If we had standardised guidelines the way [Australia has] where every patient…had to be
seen by the dietitian and every patient…had to have a certain number of visits with the dietitians, it
would make sure that dietitians had that training…from a national standpoint…. There’s too much
data with head and neck cancer that shows…that minimising weight loss with patients… is associated
with better outcomes.”
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8.6 Discussion
This study explored how the role of the dietitian within HNC teams was perceived by radiation oncologists,
dietitians, nurses, and speech pathologists, and enacted in four different settings in Australia and the United
States. Through using an international, multi-site design this study helps to address a gap in knowledge
related to how evidence-based nutritional care for patients with HNC is implemented in practice. According
to participants, dietitians were viewed as the “experts” in nutritional care and this was underpinned by
dietetic training and accreditation, patient priorities and gaps in medical knowledge. However, it was also
found that the delineation of nutritional care and thus the dietitian’s role within the HNC teams was
influenced by dietetic experience, nutrition-care gatekeeping, clinic structures, culture, and the presence of
national evidence-based nutritional care guidelines. These findings support qualitative research with
healthcare professionals in other settings that have highlighted several barriers to implementing EBGs such
as resources, training and professional experience (75, 145), and that traditional cultures within healthcare can
influence how teams function and how allied-health professionals are integrated (232, 233).
The present study demonstrates that dietitians have become more valued and integrated within healthcare
teams over the last two decades, as research conducted nearly two decades prior found that at that time
most physicians included in those studies did not believe that dietitians had a role in the clinical care of
patients

(234-236).

The more positive view of dietitians over this time may be attributed to the growing

evidence base that shows the positive impact that dietitians have on the outcomes of patients with HNC (21,
25).

This is supported by Martin, de van der Schueren (70) whom found that having evidence that demonstrates

the positive impact of nutritional interventions on HNC patient outcomes encouraged other healthcare
professionals to prioritise nutrition. Additionally, it was highlighted that the presence of nationally endorsed
EBGs that provide recommendations on the nutritional care of patients with HNC promotes consistency in
how dietitians work in this setting

(70),

and this was supported by the present study. Further studies with

patients and dietitians should be prioritised to strengthen recommendations on how they should be involved
with HNC patients. This may allow EBGs that provide such recommendations, such as those by the Clinical
Oncology Society of Australia

(25),

to be endorsed by other countries to promote consistent, high quality

nutritional care for this patient group.
Although dietitians appear to have become more integrated within HNC teams, the present study found that
their involvement with patients and the implementation of nutritional care was often directed or controlled
by their physician and nursing colleagues. This reflects qualitative research with inpatient dietitians in
Sweden who described physicians and nurses as the “controlling members” of the healthcare team

(148).

Similarly, in Europe Martin, de van der Schueren (70) found that the initiation of nutritional care for patients
with HNC depended on support from a physician and nurses were described as the “lynch-pin” or
“gatekeepers” to nutrition care (70). This study also found that nutrition was not always prioritised due to an
acceptance of nutrition decline during treatment, limited knowledge of the risks versus the benefits of
nutrition intervention and as funding that could be put towards nutrition-care resources was often directed
towards drugs and surgical equipment

(70).

While EBGs recommend that HNC patients have early and

regular consultation with a dietitian throughout their treatment journey (237), further exploration into these
barriers is required so that the expertise that dietitians offer can be better utilised by HNC teams.
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Dietitian-led clinics and nurse-led clinics that include dietitians have gained interest over the past decade
as a value-based model of care that may lessen the financial burden associated with managing the complex
and prolonged needs of patients with HNC, whilst promoting the implementation of evidence-based
nutritional care (238, 239). Research has demonstrated that patients with HNC value the multidisciplinary care
that these clinics offer

(46)

and that implementation of these clinics can lead to fewer nutrition-related

hospital admissions and unplanned nasogastric-tube insertions, and can reduce the time taken for patients
to transition off a feeding tube after radiotherapy

(47).

The present study expands on this evidence by

highlighting that healthcare professionals, including radiation oncologists, valued this type of clinic
structure to provide value-based care. However, national revenue requirements and healthcare culture were
identified as barriers to their establishment. This supports other research that recommends that revenue
systems, patient liability, staff training costs and staff readiness must be considered to support the
implementation of value-based models of care, such as clinics that are led by nurses and dietitians (240-242).
More evaluative research into clinic structures that allow dietitians to have greater autonomy and leadership
in nutritional care for patients with HNC should be prioritised, as this may enhance the implementation of
evidence-based nutritional care for better patient outcomes.
To reduce the risk of professional bias in this qualitative study reflexive strategies were employed to
identify, consider, and control for biases. This included the use of a flexible interview guide that allowed
participants to discuss ideas that were most relevant to them, the rigorous constant-comparison technique
and the group coding session

(10).

Moreover, the population sampling was purposive to gain insights into

practice from several different disciplines with varying levels of experience. Additionally, the large sample
size with representation from four different HNC teams in Australia and the United States and from
metropolitan and regional locations enhanced the trustworthiness and meaningfulness of findings to a
diverse audience.
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8.7 Conclusion
This study found that radiation oncologists, dietitians, nurses, and speech pathologists from four different
HNC teams in the United States and Australia perceived dietitians as the experts in nutritional care.
However, the delineation of nutritional care and thus the dietitians’ role within the HNC team was
influenced by dietetic experience, nutrition-care gatekeeping, clinic structure, culture, and the presence of
national evidence-based nutritional care guidelines. These findings contribute to knowledge on how
nutritional EBGs that provide recommendations on how dietitians work with patients with HNC are
implemented in practice. Further research that supports EBG recommendations on how frequently patients
with HNC should see a dietitian should be prioritised to promote clarity and consistency in dietetic care
globally. Additionally, future research on dietitian-led clinics for patients with HNC may encourage the
development of clinic structures that best use dietetic expertise and thus enhance the provision of evidencebased nutritional care for best patient outcomes.
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CHAPTER 9. Healthcare professionals’ perspectives on what
facilitates collaborative nutritional care within head and neck
cancer teams: A multi-site qualitative study (Study 4c)
9.1 Chapter overview
In Study 4c that is reported in this chapter, I aimed to explore the elements that facilitate collaborative
interprofessional nutritional care on head and neck cancer (HNC) teams, from the perspectives of healthcare
professionals. This study was designed to help address Objective 4 of this thesis: Identify and explore
factors that influence the implementation of nutritional EBGs for patients with HNC from the perspectives
and experiences of healthcare professionals, by conducting interviews with healthcare professionals in
different HNC teams in Australia and the United States
Several recommendations from nutritional evidence-based guidelines (EBGs) for patients with HNC relate
to the need for collaborative nutritional care from a team of healthcare professionals to help ensure that
patients receive timely and effective nutritional interventions (25, 73). In Chapters 3, 4, 5 and 6 in this thesis,
I have discussed the importance of adopting a collaborative interprofessional approach to nutritional care
to ensure that patients are seen by dietitians in a timely manner, so that evidence-based nutritional care is
provided, and so patients have the best opportunity to action nutritional care recommendations. In the
current chapter I identify team systems and structures and professional characteristics that may help to
facilitate interprofessional collaboration within HNC teams, to enhance the implementation of evidencebased nutritional care for improved outcomes.
The study reported on in this chapter was published in The Journal of Interprofessional Care in 2021, and
related findings were presented at the Dietitians of Canada National Conference in 2017.
Citations: Hazzard E, Walton K, McMahon A-T, Milosavljevic M, Tapsell L. Collaborative,
interprofessional nutritional care within head and neck cancer teams: an international multi-site qualitative
study. J Interprofessional Care. 2021:1-8. early view DOI: 10.1080/13561820.2020.1865290.
Hazzard, E. Walton, K. McMahon, A. Milosavljevic, M, Tapsell, L (2017). Hydration in head and neck
cancer: Interdisciplinary perceptions of collaboration with dietitians for dehydration management in a
community-based cancer centre, Dietitians of Canada National Conference, 7-9th June 2017, St Johns,
Newfoundland
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9.2 Abstract
Background: Evidence-based guidelines (EBGs) for patients with head and neck cancer (HNC)
recommend that nutritional care is delivered by a multidisciplinary team inclusive of dietitians, physicians,
nurses, and speech pathologists. Barriers to interprofessional collaboration have been identified in other
healthcare contexts. However, research on this is currently lacking in the HNC setting, particularly with
regards to the provision of nutritional care. This study aimed to explore the elements that facilitate
collaborative nutritional care for patients with HNC from the perspectives of healthcare professionals.
Methods: This qualitative study used a grounded-theory approach. Healthcare professionals were recruited
from four HNC teams in Australia and the United States. Data was collected via semi-structured interviews
and analysed using a grounded-theory approach.
Results: Seventeen radiation-oncologists, 12 nurses, 11 dietitians and six speech pathologists participated.
Collaborative nutritional care for patients with HNC was underpinned by three categories and six subcategories: access, facilitated by, funding for dietitians and the strength of evidence; communication,
facilitated by team meetings, communication systems and multidisciplinary clinics, and role-clarity
facilitated by non-clinical activities and respect.
Conclusion: This study highlights opportunities that may enhance collaborative nutritional care within
HNC teams. Further research on the impact of the dietitian on patient outcomes, interprofessional education
involving dietitians, case-conference style team meetings and multidisciplinary clinics is required as this
may promote collaborative nutritional care for patients with HNC for improved outcomes.
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9.3 Introduction
Nutritional evidence-based guidelines (EBGs) for patients with head and neck cancer (HNC) recommend
a multidisciplinary team approach to nutritional care, which involves radiation oncologists, nurses,
dietitians, and speech pathologists (25, 73). This is to help ensure that patients who may benefit from enteral
feeding are identified, and to manage treatment side effects and psychosocial factors that may hinder patient
adherence to dietary advice (25).
The term “interprofessional collaboration” refers to several different healthcare professionals working
together to ensure that care provision is centered on the holistic needs of patients

(243-245).

Qualitative

research with healthcare professionals is a way to gain rich insight into interprofessional collaboration and
to explore the implementation of EBGs

(7, 238, 244, 246, 247).

Through qualitative research with healthcare

professionals, including those who work in cancer care, researchers have highlighted barriers to
interprofessional collaboration, such as time and resource limitations and power disparities between
different disciplines

(233, 248-252).

This provides some insight into factors that may influence the ability for

HNC teams to provide collaborative nutritional care in line with EBGs. However, focused research in this
area is required.
In their qualitative international study with healthcare professionals from five European nations, Martin,
de van der Schueren (70) expands on this knowledge as participants highlighted that having a dietitian within
the multidisciplinary team was important for ensuring that evidence-based nutrition care was prioritised.
However, the composition of HNC teams and the roles and responsibilities for nutrition care varied between
settings. Participants attributed this to different national credentialing for nutrition-care providers and a lack
of funding for dietitian positions (70). Researchers who conducted a multi-site survey in Australia with HNC
teams support this, as they found that the reported dietetic resources would not have been able to meet EBG
recommendations on the frequency of dietitian reviews for patients with HNC (144). Similarly, in a report by
the National Institute for Health and Clinical Excellence it is noted that there are shortages in specialist
HNC dietitians internationally

(13).

Further research into the facilitators of collaborative nutritional care

from the perspectives of healthcare professionals who work in HNC teams in different nations would
provide insight into how these findings translate elsewhere. Specifically, perspectives from Australia and
the United States could offer important insights as while trends in HNC prevalence and survival are
comparable and dietitians have similar clinical roles, the healthcare systems differ which may lead to
differences in multidisciplinary team structures and functions (12). This international research may help to
identify opportunities for enhancing collaborative evidence-based nutritional care for improved HNC
patient outcomes globally. Therefore, this study aimed to explore what facilitates collaborative
interprofessional nutritional care from the perspectives of healthcare professionals from HNC teams in
Australia and the United States.

140

9.4 Methods
The focus of Study 4c reported on in this chapter, was healthcare professionals’ perspectives of what may
facilitate collaborative interprofessional nutritional care within HNC teams. This study was the third
component of a larger research study that aimed to explore how nutritional EBGs are implemented in
practice for patients with HNC, from the perspectives of and experiences with nutritional care among
healthcare professionals. The other two components focused on feeding-tube practices, and the role and
perceptions of the dietitian in HNC teams. These are included in this thesis in Chapters 7 and 8, respectively.
Section 7.4 (Chapter 7) gives details on the qualitative approach and research paradigm, researcher
characteristics and reflexivity, context, sampling strategy, data collection and data analysis used in this
study. Section 2.4 (Chapter 2) gives further detail on the grounded-theory methodological approach used
for the four qualitative studies included within this thesis, including for Study 4b in this chapter. The
interview guide used for this study is included in Appendix 5.
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9.5 Results
Participant details
Section 7.5 and Tables 18 and 19 (Chapter 7) give the participant details and an overview of the
characteristics of the HNC teams from which participants were recruited.

Key findings
In this study, collaborative interprofessional nutritional care in HNC teams was underpinned by three
categories and six sub-categories: access to dietitians, facilitated by funding for dietitian positions and the
strength of evidence; communication, facilitated by team meetings, communication systems and
multidisciplinary clinics; and role-clarity, facilitated by non-clinical activities and respect. These categories
and sub-categories are summarised in Table 23 and are described in more detail below.

Table 23. Summary of categories and sub-categories that underpinned collaborative
multidisciplinary nutritional care within head and neck cancer teams according to healthcare
professionals from Study 4c (Chapter 9)

Communication

Access to dietitians
-

Funding for dietitian positions
Strength of evidence

-

Team meetings
Electronic communication
systems
Multidisciplinary clinics

Role-clarity
-

Non-clinical activities
Respect

Access to dietitians
Access to dietitians was identified as an important facilitator of collaborative nutritional care. This was
evident as participants reflected on experiences in other healthcare teams or in earlier years where there
was limited access to a dietitian.
B R5: “Where there’s not [a dietitian], there’s no collaboration because there is not somebody to
collaborate with.”
B R3: “Having a nutritionist on site is a big factor, and actually, in the department, I think it’s…key.”

Funding for dietitian positions and the strength of scientific evidence on the impact of dietitians were
identified as key facilitators of access. These two sub-categories were connected, as it was identified that
strong evidence was required to support funding for dietitian positions on HNC teams.
B R2: “We do need access to the dietitian…. I think the main barrier becomes access, and access in it
also carries funding implications.”
A N2: “Now that we’ve got a full-time dietitian… they’ll be able to do the review with us… prior the
dietitian was shared with many departments… that was a real hindrance”
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B R7: “If places can afford [a dietitian], it’s so important.”
D R1: “The scientific evidence that has shown positive relationship between dietetic involvement and
patient outcomes… that should be highlighted…if you were advocating for a specialist dietitian.”
C D1: “That’s all about trying to show the decrease in healthcare costs that you actually see when
patients are working directly with dietitians.”
B R5: “It kind of baffles me that there’s not a dietitian on…every head and neck radiation team… I
guess there’s not enough studies, or I’m not aware of them”

Communication
Communication related to the verbal and non-verbal exchange of information between members of the
team. This was central to collaborative nutritional care as it ensured that individual patient priorities could
be discussed and their nutritional goals could be developed and shared by the team.
B R3: “The communication for collaboration is important because we all… have our areas of expertise
and I learn a lot from [the dietitian] – maybe [they] learn a little bit from me”
C R2: “That constant communication and feedback to discuss patient care…I think those are the
important components.”
B R4: “I think it can be really wonderful to have that open communication from someone who’s
specifically looking at those factors to help you keep them on track.”
D D1: “I think communication – definitely one of the most important factors”

Team meetings, electronic communication systems and multidisciplinary clinics were identified as key
facilitators of communication. For example, participants identified having a meeting to discuss the care of
patients care as a team, could promote collaborative nutritional care. However, while the four HNC teams
participated in a weekly or fortnightly team meeting for treatment planning, these were described as
“medically focused” and it was highlighted that there was limited opportunity for patient nutritional care
discussions in this setting. Only team C had successfully implemented and maintained a separate team
meeting that provided an opportunity to discuss nutritional care. “A lack of time” was identified as a barrier
to having routine team meetings to discuss the care of patients undergoing treatment by participants from
the other teams.
B S1: “I think that having…case conferences would be great…run through patients… dietitian, speech
pathology, radiation, medical oncology, nursing… the key players…. It brings all the issues across to the
whole team”.
B R5: “We have a multidisciplinary conference with the other oncologists…. It’s not like… ‘What’s this
guy’s nutrition status...?’ It’s more like, ‘What is this plan, why are we treating, what is the max dose?’
kind of thing”.
D D2: “I do attend the [multidisciplinary team meeting] but it has been inconsistent over the years
because…it’s medically focused, let’s put it that way.”
B D1: “I think what is most difficult for me in our clinic is… open communication…. Since we don’t…
attend [the multidisciplinary team meeting], that’s just a little bit more difficult.”
D R1: “It’s always a matter of time, so we have our head and neck clinic and head and neck
[multidisciplinary team meeting] every second week and so we’re very tight for time.”
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C R2: “I think we work quite well together here. I think it’s all about having avenues of communication,
so we have that weekly [case conference team meeting] … having the chance to be able to discuss patients
in person with your collaborators is really important.”

Participants identified that electronic communication systems also promoted collaborative nutritional care
as this provided an avenue to communicate with and to send referrals to dietitians.
C R1: “Time just doesn’t necessarily allow for that sort of real-time collaboration, so many times that’s
where it’s helpful that the nurse puts the consult in to [the dietitian] so that [they] can see the patient
on [their] own time…. There’s a flag in place to say, ‘This patient has lost weight; you need to be
aware.’”
C D2: “The other thing that’s really helpful, too, in terms of sort of different integrated services is
through the electronic medical record. If you send messages through that, you know everybody can see
them… and you can see sort of where you are, I guess, in a timeline.”

Participants valued being able to review patients as a multidisciplinary team, as this could enhance
collaboration by promoting communication. Specifically, participants recognised that joint reviews helped
to ensure that nutrition care was appropriately prioritised and that a consistent evidence-based message for
patients could be reinforced by the team. An example of this was a weekly clinic that Team A had
implemented, which combined the services of a specialist oncology nurse, dietitian, and speech pathologist
for HNC patients.
B R7: “When we’re in the room together…I do learn so much about things… [a] specific example like
tube feeds…. It’s good for me to hear that, also because I can then reinforce with the patient [when]
the dietitian’s not there.”
D N1: “I think for the head and necks pre-treatment clinic is a good place for us as the team members
to hear what each other’s saying… to respect each other and to provide a united front to the patient.”
A S2: “Working quite closely with the dietitian in our clinic…sometimes it is a bit about compromise
so it's about saying, ‘Okay, yep, we’ve got this risk of aspiration or this going on, but…what do we
need to prioritise with their nutrition and hydration?’”

Role Clarity
Role-clarity related to team members understanding the professional responsibilities and skills of
their colleagues. Role clarity was also central to collaborative nutritional care in HNC teams as this
allowed team members to understand and utilise the expertise that dietitians could offer, to promote
collaborative nutritional care.
B D1: “Something what enhances [collaboration] is…the team knowing…the clinical skills or
experience of the dietitian.”
A S1: “It is really collaborative and I think it’s a lot to do with the staff…. I think it’s the fact that
everyone sort of knows everyone and has a good understanding of the roles.”
D D1: “Everyone in general is very supportive of each other….
understanding [of] the importance of each of the areas.”
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There’s definitely a good

Non-clinical activities and respect were identified as key facilitators of role clarity. For example, such as
journal clubs, interprofessional research projects and monthly service-development meetings were
identified as facilitators of role-clarity as this provided insight into the roles and skills of the different
healthcare professionals, including dietitians and allowed the team to set collaborative service goals.
However, staff consistency and time were identified as barriers to the longevity of these activities.
D S1: “Head and neck journal clubs…we used to have the surgeons, the [radiation oncologists], the
speechies, the dietitians…. I found that promoted a lot of discussion…. So, the dietitians would often
bring the PEG-related ones, speechies would be looking at swallow exercises and early referral…that
just helped”.
D R1: “I think research is quite a good way to get the team working together…. We used to have a
journal club; so that kind of fell to the wayside, but that wasn’t as well attended. But that could have
been another way as well.”
C N2: “I think the fact that we all work so well together, we all have collaborated together on many
projects.”
C D1: “We also have periodic meetings for…the [head and neck cancer] team, where we work on
improving patient care, patient information, patient education.”

Respect was viewed as a key facilitator of collaborative nutritional care as this encouraged healthcare
professionals to gain an understanding of and appreciate the professional responsibilities and skills of other
healthcare professionals, including dietitians.
C N3: “First and foremost, the thing that facilitates collaboration with the dietitian is just respect…. I
think that people do respect that [dietitians] have knowledge”.
A D1: “Everyone having an understanding and a respect for each discipline’s capacity to add a piece
to that puzzle.”
A D2: “Respect for each profession and an understanding that we each do know what we’re talking
about and each have a role.”
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9.6 Discussion
In this study I explored what facilitates collaborative nutritional care within HNC teams from the
perspectives of healthcare professionals from four different HNC teams in Australia and the United States.
Access, communication, and role-clarity were identified as key to collaboration, and these categories were
underpinned by funding for dietitians, the strength of evidence, team meetings, communication systems,
multidisciplinary clinics, non-clinical activities, and respect. The findings are supported by a report from
the World Health Organisation on the factors necessary for interprofessional collaboration within healthcare
teams (232, 253, 254). Additionally, communication and role-clarity are listed as competencies within healthcare
teams for several other patient groups (255, 256). The findings from this study that relate to the need for funding
for dietitians, team meetings, multidisciplinary clinics, electronic communication systems, non-clinical
activities, and the presence of respect, are also supported by other researchers who have explored
collaborative practice within different healthcare teams

(257-260).

Few studies have been conducted that

investigate what facilitates collaborative nutritional care within the HNC setting. Therefore, this study
addresses a gap in knowledge and highlights factors that influence the implementation of EBGs which
recommend an interprofessional team approach to nutritional care for patients with HNC (25).
To promote communication and role-clarity within healthcare teams, a report from the World Health
Organisation (232) indicates that interprofessional education be included in undergraduate training curricula,
and within postgraduate and continued professional-development programs

(232).

Within undergraduate

training, interprofessional education appears to be well received by student dietitians (261, 262). Furthermore,
interprofessional education sessions that are led by dietitians may promote collaboration by helping to
disseminate and enhance evidence-based nutritional knowledge within HNC teams

(263).

Further research

should explore interprofessional education in the dietetics profession as this may be an opportunity to
promote collaborative nutritional care for patients in practice, including those with HNC.
In this study having funding for a dietitian on the HNC teams was identified as central to being able to
provide collaborative nutritional care for patients. However, globally HNC services struggle to provide
adequate staffing resources for EBG recommendations to be met that relate to how frequently patients
should be reviewed by a dietitian (13, 144). Participants in this study also identified that demonstrating patientoutcomes and cost-savings from dietitian-led interventions may be key to advocating for funding for
dietitians. This reflects findings from a European study with healthcare professionals by Martin, de van
der Schueren (70) who found that the level of evidence on patient outcomes can influence the implementation
of nutritional care for patients with HN. Therefore, future studies that measure HNC patient outcomes
associated with dietitian-led interventions should be prioritised, as this evidence would help to advocate for
more dietetic resources for HNC teams.
This study supports research from other healthcare settings that similarly identifies team meetings as a way
of enhancing collaboration within healthcare teams

(248, 253).

Indeed, within the oncology context, regular

team meetings for treatment-planning are considered best practice (264). However, the present study indicates
that collaboration with allied health professionals, including dietitians, is rarely fostered in treatment
planning meetings for cancer patients and this has also been noted in other studies

(265, 266).

This may be a

missed opportunity for HNC teams, as early nutritional planning and intervention can promote better
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outcomes for patients with HNC. Due to the limited capacity for collaboration with dietitians in treatmentplanning team meetings, participants in the present study recognised that having a separate team meeting
to discuss the care of patients throughout their treatment may be necessary to promote collaborative
nutritional care. However, “a lack of time” hindered the establishment of these meetings which reflects
studies in other healthcare settings that have identified time as a barrier to collaboration (247, 248, 267, 268). The
perceptions behind why a lack of time is considered a barrier to establishing team-meetings that may foster
collaborative multidisciplinary nutritional care in the HNC setting needs be examined, so that potential
issues such as staff resources or respect for the importance of evidence-based nutritional care can be
addressed.
To our knowledge, few studies have directly explored collaborative nutritional care on HNC teams,
particularly from four different HNC teams in Australia and the United States. The healthcare professionals
who participated in this study had diverse international, metropolitan and regional experiences working
with patients with HNC that were captured through the flexible and open-ended interview guide, as
recommended by Charmaz (10). Therefore, the international multi-site design allowed findings to be relevant
to a more diverse audience. While it was beyond the scope of this study to capture metrics relating to patient
demographics, staff resources and funding allocations, future research on this would be worthwhile to
understand and address potential barriers to collaborative nutritional care on HNC teams. Future research
on what facilitates collaboration with dietitians from the perspectives of healthcare professionals should
also extend to other healthcare teams and include other allied health professions to see how the findings in
this study might also relate to other healthcare contexts.
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9.7 Conclusion
In this study collaborative nutritional care for patients with HNC was underpinned by access to dietitians,
communication, and clarity about professional roles within the multidisciplinary team. Six practice-based
facilitating elements that connected to these categories were also identified: funding for dietitians, team
meetings, electronic communication systems, multidisciplinary clinics, non-clinical activities, such as team
research projects and journal clubs, and respect. This study highlights opportunities for policymakers,
service developers and practising healthcare professionals to facilitate the implementation of EBGs that
recommend the provision of collaborative nutritional care to patients with HNC. Further studies that
measure HNC patient outcomes associated with dietetic intervention should be prioritised to support
funding for dietitian positions on HNC teams. Additionally, exploration into interprofessional education
involving dietitians and the establishment of team meetings that allow time for nutritional care planning
and goal setting, may also facilitate collaborative nutritional care within HNC teams for improved patient
outcomes.
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CHAPTER 10: Overarching discussion and conclusion
10.1 Chapter overview
Chapter 10 includes a discussion of findings from the research undertaken as part of this this thesis in
relation to the overarching thesis aim and objectives. The significance of the research and the contribution
to the field of dietetics are also discussed, as are the implications for clinical practice. The strengths and
limitations of the research are summarised and finally, opportunities for future research are identified.
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10.2 Discussion of results in relation to thesis aim and objectives
The overarching aim of this thesis was to explore the implementation of nutritional evidence-based
guidelines (EBGs) for patients with head and neck cancer (HNC). The translational-research theoretical
model “Practice-Based Research - ‘Blue Highways’ on the NIH Roadmap’”

(1)

in conjunction with

recommendations from the World Health Organisation on how to conduct implementation research in the
healthcare setting (80), were drawn upon to develop a sequential mixed-methods research design that would
address four objectives that connected to the overarching aim of this thesis.

Exploring the implementation of nutritional evidence-based guidelines for
patients with head and neck cancer: A narrative review (Chapter 3)
The narrative review in Chapter 3 was designed to address Objective 1 of this thesis: Synthesise current
knowledge related to the implementation of evidence-based nutritional care for patients with HNC.
Three quantitative studies (47, 129, 130), 18 qualitative studies with patients with HNC (106, 107, 118-121, 124, 125, 134143),

and one qualitative study with healthcare professionals

(70)

were identified for inclusion. The

quantitative studies indicated that a high level of adherence to nutritional EBGs for patients with HNC is
achievable and can result in positive patient outcomes. However, the qualitative research expanded on
quantitative findings by highlighting that several factors may influence how fully nutritional EBGs are
implemented in practice. Influencing factors included: support from executives and the availability of
dietetic resources, multidisciplinary clinic structures, perceptions and experiences of dietitians and
nutritional care among physicians and nurses, the level of evidence supporting recommendations, and
patient acceptance. Several gaps in knowledge that related to the implementation of nutritional EBGs for
patients with HNC were identified. This provided the rationale for the subsequent studies included in this
thesis.

Measuring adherence to nutritional evidence-based guidelines and outcomes
among patients treated for head and neck cancer in a regional Australian cancer
care setting: a retrospective review of patient medical records (Study 1, Chapter 4)
Study 1 was a retrospective chart review designed to address Objective 2 of this thesis: Measure the
implementation of nutritional EBGs for patients with HNC in a regional cancer-care network.
The electronic medical records of 81 patients treated for HNC in one cancer care network in regional NSW,
Australia, were retrospectively reviewed. All patients were seen by a dietitian and assessed for malnutrition
using a validated malnutrition assessment tool at least once during radiotherapy. However, the goal of
weekly dietetic reviews during radiotherapy was only met 62% of the time. Regarding the EBG
recommendations on the use of prophylactic feeding tubes, 60% of patients received a feeding tube
prophylactically. All patients with hypo-pharyngeal tumours, 70% with T4 tumours and proportionally
more patients who were treated with chemo-radiotherapy received a prophylactic feeding tube (81.3% vs
21.2%, p = 0.000). Among patients with a feeding tube, average energy intake from oral and enteral sources
combined was lowest in week 4 of radiotherapy (64% of energy requirements based on 30kcal/kg/day) and
highest in week 7 (79% of estimated requirements). Over this period the number of patients’ using their
feeding tube for nutrition also increased. In relation to prolonged feeding-tube use, only 7% of patients
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were still using a feeding tube at 12 months post-radiotherapy. This was more common among patients who
commenced treatment with swallowing issues (p=0.084).
This quantitative study provided information on patient characteristics and nutritional care practices
compared with key recommendations from nutritional EBGs in one regional Australian setting. It was
identified that explorative qualitative research on the nutritional care experience with both patients and
healthcare professionals was required to expand on and explain these findings.

The experience of nutritional care among patients treated for head and neck
cancer in a regional Australian cancer care network: A longitudinal qualitative
study (Study 2, Chapter 5)
Study 2, reported on in Chapter 5, was a longitudinal qualitative study with patients that was designed to
help address Objective 3 of this thesis: Identify and explore factors that influence the implementation of
nutritional EBGs for patients with HNC based on their own perspectives and experiences.
Thirty-six interviews were completed with 10 patients with HNC at key points throughout their treatment
journey. Perceptions of and experiences with dietitians and nutritional care were summarised by four
categories: preparing for nutritional challenges, multidisciplinary care directed by patient needs, the battle
to eat, and incongruence between patient values and nutritional priorities.
These categories provided insight into the factors that may influence the implementation of nutritional
EBGs. For example, patients undergoing treatment for HNC can experience significant physical and
psychosocial barriers that may affect their ability to meet evidence-based energy targets, and to use a
feeding tube as recommended by healthcare professionals. However, a well-coordinated multidisciplinary
approach to patient care, service structures that promote continuity with the dietitian, and a shared
leadership model of care may promote patient willingness and ability to implement evidence-based
nutritional recommendations from healthcare professionals. Examples included having both physicians and
nurses reinforce the importance of adherence to a nutrition regime and establishing clinics for patients that
combine the services of a dietitian, specialist oncology nurse, and speech pathologist.
It was also identified that more-focused qualitative research with patients and healthcare professionals in
HNC teams on perceptions of and experiences with feeding tubes, the role of dietitians and interprofessional
nutritional care would provide further insight into the implementation of key recommendations of
nutritional EBGs for patients with HNC.

The patient experience of having a feeding tube during treatment for head
and neck cancer: A systematic literature review (Study 3, Chapter 6)
Study 3 reported on in Chapter 6 was a systematic literature review of qualitative studies which was
designed to also help address Objective 3 of this thesis: Identify and explore factors that influence the
implementation of nutritional EBGs for patients with HNC based on their own perspectives and
experiences. Specifically, this study focused on the implementation of EBG recommendations on feeding
tubes.
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Nine studies were included which collectively provided the perspectives of 159 patients with HNC who
had a feeding tube. This chapter found that having a feeding tube while undergoing treatment for HNC can
be an evolving experience for patients. Initially they may feel a sense of reluctance, fear, and uncertainty
towards the feeding tube. However, having clear and consistent advice from healthcare professionals
assisted them to make informed choices and have clearer expectations regarding feeding tubes.
Moreover, during treatment many patients with HNC can experience physical, emotional, and social
challenges that relate to having a feeding tube. As an example, some patients may initially experience
physical discomfort around the gastrostomy site, although the thought of having a visible nasogastric tube
may be more disconcerting for some individuals because of the social stigma attached to illness. This
highlights the needs to adopt an individualised approach to feeding tube placement recommendations.
From this study I also found that patients often come to view a feeding tube as a source of reassurance and
thus transitioning off the feeding tube can be a physically and emotionally difficult process which may
explain why an emotional dependence towards the device can be experienced. Having support and a
consistent message from members of the multidisciplinary team and having access to a dietitian were
important to promote a more positive feeding-tube experience and to facilitate the transition back to oral
intake.
This study provided patient-centered insight into how EBG recommendations related to the use of feeding
tubes for patients with HNC are implemented in practice. This is an important perspective to contribute to
the inconclusive evidence on whether a prophylactic gastrostomy tube or a reactive nasogastric tube is best
for these patients.

Healthcare professionals’ experiences of providing nutritional care to
patients with head and neck cancer: A qualitative multi-site study (Study 4,
Chapters 7-9)
The studies reported on in Chapters 7, 8 and 9 were sub-studies of a larger research study with healthcare
professionals from four HNC teams in Australia and the United States. This larger research study was
designed to address Objective 4 of this thesis: Identify and explore factors that impact the implementation
of nutritional EBGs for patients with HNC from the perspectives and experiences of healthcare
professionals. Forty-six interviews were undertaken with 17 radiation oncologists, 12 nurses, 11 dietitians
and six speech pathologists from two HNC teams in Australia and two in the United States.
The three sub-studies included in Chapters 7, 8 and 9 focused on the implementation of EBG
recommendations on: feeding-tube use; the role of the dietitian and what facilitates collaborative nutritional
care in HNC teams, respectively.

Healthcare professionals’ experiences of feeding tube use for patients with head
and neck cancer (Study 4a, Chapter 7)
Study 4a, presented in Chapter 7 aimed to explore healthcare professionals’ perspectives and experiences
with feeding tubes in four HNC teams in Australia and the United States to provide insight into how
nutritional EBGs that provide recommendations on the use of feeding tubes are implemented in practice.
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Healthcare professionals valued the targeted use of feeding tubes, and identified that the decision to place
a feeding tube was largely directed by the treating physician. However, there were different perspectives
on whether a prophylactic gastrostomy tube or reactive nasogastric tube approach was most efficacious.
The participants highlighted several factors that were often considered in the feeding-tube placement
decision-making process which align with EBG recommendations, such as tumour stage and location,
treatment modality and malnutrition, swallow function and psychosocial status. Factors were also identified
that may influence how well feeding tube practices align with nutritional EBGs, such as patient acceptance
of and capacity to use the feeding tube as recommended, access to dietitians and speech pathologists within
the HNC team, the availability of resources and equipment to support timely feeding-tube placements, and
the capacity for collaboration within the HNC team.

Healthcare professionals’ perspectives on the role of the dietitian within
multidisciplinary head and neck cancer teams (Study 4b, Chapter 8)
Study 4b reported on in Chapter 8 aimed to explore how the role of the dietitian within HNC teams is
perceived by healthcare professionals from different disciplines in several HNC teams in Australia and the
United States.
In this study I found that healthcare professionals perceived dietitians as the experts in nutritional care.
However, the delineation of nutritional care and thus the dietitians’ role within the HNC teams were
influenced by dietetic experience, nutrition-care gatekeeping, clinic structure, culture, and the presence of
national evidence-based nutritional care guidelines.
This contributes to knowledge on how EBGs that provide recommendations on how dietitians should work
with patients with HNC are implemented and highlight opportunities for enhancing evidence-based
nutritional care through raising the profile of dietitians within this setting.

Healthcare professionals’ perspectives on what facilitates collaborative
nutritional care within head and neck cancer teams (Study 4c, Chapter 9)
Study 4c presented in Chapter 9 aimed to explore the elements that facilitate collaborative interprofessional
nutritional care from the perspectives of healthcare professionals from different HNC teams.
I found that collaborative nutritional care for patients with HNC was underpinned by access to dietitians,
which was facilitated by funding for dietitian positions and the strength of evidence; communication which
was facilitated by team meetings, communication systems and multidisciplinary clinics; and role-clarity
which was facilitated by non-clinical activities and respect. This adds an important final empirical piece to
this thesis through identifying opportunities for facilitating a collaborative multidisciplinary team approach
to the provision of evidence-based nutritional care, for best outcomes for individuals with HNC.
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10.3 Significance of the thesis
Contribution to the field of dietetics
The research in this thesis has made a significant contribution to the field of nutrition and dietetics and
cancer care with four manuscripts (Chapters 5, 6, 7 and 10) accepted for publication in high-impact journals
(Supportive Care in Cancer, Clinical Nutrition ESPEN, the Journal of Parental and Enteral Nutrition and
the Journal of Interprofessional Care, respectively). Chapter 8 is also currently submitted and under review.
Peer-reviewed abstracts directly related to this thesis have also been presented at four international and
national conferences, locally within the Illawarra Shoalhaven Local Health District, and to the Dietitian’s
Association of Australia NSW Chapter oncology interest group.
The thesis includes original research that contributes to the knowledge of how nutritional EBGs for patients
with HNC are implemented in practice. The publications arising from this thesis highlight opportunities to
enhance the implementation of nutritional EBGs for improved outcomes for patients with HNC globally.

Implications for clinical practice
Factors that may influence the implementation of nutritional evidence-based
guidelines for patients with head and neck cancer
A synthesis of the quantitative and qualitative research included within this thesis has identified 12 factors
that may influence how nutritional EBGs for patients with HNC are implemented in practice. These are
outlined in Figure 8 under four headings: policy and training, organisation, healthcare professionals, and
patients. In summary, this thesis highlights the need for a multi-level approach to enhance the
implementation of nutritional EBGs for patients with HNC. Specific considerations for key stakeholders
that may promote the implementation of these EBGs are discussed below.
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Evidence-based
guidelines

Practice

Policy and training a

Organisation a

Patients a

Healthcare professionals
a

-

-

Completion and
dissemination of studies
that support and expand
on nutritional EBGs
Interprofessional
education
Specialist training for
dietitians

-

-

-

-

Local nutrition care
guidelines (e.g. nutritional
screening/feeding tube
placements)
Multidisciplinary clinic
structures (e.g. combined
specialist nurse and allied
health clinics)
Non-clinical activities (e.g.
journal clubs)
Nutrition resources (e.g.
staffing/clinic
space/equipment)
Team meetings (e.g. case
conferences separate from
treatment planning meetings)

-

Dietetic experience
Interprofessional respect

-

Physical side-effects
Psychosocial status

Figure 6. Summary of factors identified from this thesis that may influence the implementation of nutritional evidence-based guidelines
for patients with head and neck cancer
a

Factors are listed alphabetically. EBGs = evidence-based guidelines, HNC= head and neck cancer.
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Considerations for policy and training
Further research that supports and expands on nutritional EBGs should be completed and disseminated
through peer-reviewed publication and presentation at national and international conferences to promote
awareness among governing bodies (such as government health departments, leading cancer-care
organisations, oncology-focused physician and surgical training programs and dietetic associations).
Increased awareness on the important role of dietitians and nutritional interventions for patients with HNC
among these stakeholders via research, may encourage the development of policies that ensure adequate
funding for dietetic staffing and nutritional equipment, to promote the implementation of evidence-based
nutritional care within HNC teams.
Several recommendations made throughout this thesis relate to the need to enhance collaborative
interprofessional nutritional care for patients with HNC. EBGs for patients with HNC could provide clearer
guidance or specific examples about different multidisciplinary team structures that may help translate this
to practice. Examples identified that require further support through research, include the establishment of
multidisciplinary clinics that combine the services of dietitians, specialist oncology nurses and speech
pathologists, case-conferences and interprofessional education sessions in the field of HNC nutritional care
to enhance nutritional knowledge within the multidisciplinary team.
From this thesis I have also highlighted a lack of specialist training opportunities for dietitians, including
in the field of HNC. Hence, experience was identified as the primary way for dietitians to develop expert
nutritional knowledge and skills for this patient group which highlights a challenge for those who are new
to HNC services. Therefore, professional dietetic associations and tertiary institutions could develop and
encourage continuing professional-development and interprofessional training opportunities focused on
HNC to ensure that dietitians are better equipped with the knowledge and confidence to advocate for the
implementation of nutritional EBGs within the HNC setting.

Considerations for organisations
Establishing routine case-conference-style team meetings for dietitians, physicians, nurses, and other
members of the HNC team who are involved in nutritional care, was recognised as way to enhance the
implementation of nutritional EBGs. However, from this thesis I have highlighted that the uptake of this
practice can be challenging within some HNC teams. Support from service managers and developers
through providing meeting spaces and ensuring that there is adequate staffing so that time can be dedicated
to interprofessional case-conferences, could enhance practice. Adequate staffing is also central to ensuring
that healthcare professionals have time to undertake interprofessional education opportunities focused on
nutritional care through mediums such as journal clubs. Finally, ensuring there is a dedicated clinic space
for dietetic consultations that allows for collaborative reviews with nurses, other allied health professionals
and physicians could further enhance the implementation of nutritional EBGs by facilitating collaboration
and improving access for patients.

Considerations for dietitians, and other healthcare professionals
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A common theme throughout this thesis was how patients’ willingness and ability to act on
recommendations could influence the implementation of nutritional EBGs. Physicians and nurses were
identified as having an important role in openly discussing the potential nutritional burden associated with
HNC treatment and the availability of dietitians and nutritional interventions, so that patients were informed
and were more accepting of nutritional care. This communication with patients could occur shortly
following diagnosis to promote best nutritional outcomes, and should be delivered in a well-coordinated
way as to not overwhelm patients and their carers. Specialist oncology nurses are well positioned to lead
early nutritional care conversations with patients. Conducting formal nutritional screening and referring
patients to dietitians should also be prioritized at this time.
Throughout this thesis I point to challenges that dietitians and other healthcare professionals can face when
evidence-based nutritional recommendations do not align with a patient’s personal goals, their values, or
abilities. Examples included when patients viewed weight loss as a positive outcome, or when consuming
adequate energy was difficult due to side effects. These examples demonstrate the need for adopting an
individualised patient-centred approach to nutritional care. Moreover, dietitians and other healthcare
professionals should seek opportunities to up-skill in patient and family centred counselling techniques and
to work closely with counsellors, psychologists, and social workers to ensure that psychosocial barriers can
be addressed in order help patients to action nutritional care recommendations.
I also identified continuity of care as another important consideration that could influence a patient’s
willingness and ability to act on dietetic recommendations. Dietitians and other members of the team could
support this through pre-emptively scheduling weekly dietetic appointments for patients with HNC and
providing reminders to promote attendance to promote adherence to EBG recommendations related to how
frequently patients should be reviewed by a dietitian.
As a final example, dietitians are positioned to advocate for nutritional EBGs within HNC teams, thus
should aim to share knowledge through collaboration and seek opportunities for interprofessional
education. This could be via initiating patient nutritional-care discussions with other members of the team,
interprofessional research projects and journal clubs and advocating for the development of local nutritioncare guidelines, pathways and clinics that are inclusive of nutritional care at the executive level.

10.4 Strengths and limitations
Within each study in this thesis, I have discussed the methodological strengths and limitations of the
research conducted. The following section describes those of the thesis more broadly.
In theses by compilation it is a requirement that there is a coherent link between chapters, so that the thesis
reads as one body of work (11). To ensure that this occurred I used an overarching theoretical framework to
position all of the chapters within this thesis to address one overarching research question and specific
thesis objectives (1, 80). I also included a chapter overview at the start of each chapter to identify which thesis
objective that chapter addressed. The Chapter Overview sections also provide a link to the other chapters
and a summary of key findings that relate to the overarching thesis aim to promote cohesion.
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Furthermore, the sequential mixed-methods research design was used to promote cohesion as the
methodology requires the quantitative and qualitative findings to be “mixed”. In this thesis I used
quantitative data to help identify areas warranting further exploration through qualitative research, and the
qualitative data was then used to expand on and to help explain the quantitative findings. I then summarised
the quantitative and qualitative findings in relation to the overarching thesis in Section 10.2 and in Figure
8.
A strength of using a mixed-methods research design is to help to address the limitations that occur when
either quantitative and qualitative data is used in isolation (82). In this thesis I used quantitative data from a
medical record review to provide insight into nutritional-care practices for patients with HNC in one local
cancer-care network in regional Australia (Chapter 4). This study on its own was limited in depth and its
generalisability to other settings. However, it provides important data on nutritional care practices and
patient outcomes from a relatively large sample of patients treated in a regional setting. This helped to
contextualise the following qualitative studies, which then allowed me to provide a deeper exploration into
how nutritional EBGs are implemented in practice. Specifically, the quantitative data is expanded on
through qualitative research with patients with HNC who were treated in the same setting and during the
same period as the medical record review sample (Chapter 5). I was then able to make the findings from
this thesis more transferable and generalisable to other settings from the systematic review from which I
summarised perspectives from 159 patients with HNC from the UK, Canada, and Sweden (Chapter 6), in
addition to the qualitative interviews with healthcare professionals that were conducted in four HNC teams
in regional and metropolitan Australia and in the United States (Chapters 7-9).
In the qualitative studies in Chapters 5 and 7-9 I draw upon a constructivist grounded-theory approach for
data collection and analysis (10). The choice of this methodology was deliberate and considered. In the first
semester of PhD enrolment, I focused on understanding my own ontological and epistemological
assumptions. Thus, I researched and sought expert opinion on different qualitative methodologies that
aligned with the constructivist philosophical paradigm and were suited to implementation research

(80, 90).

Grounded theory is also valued in healthcare for its rigorous analytical methods that promote reflexivity
(10).

The quality of a grounded-theory study is measured against several criteria: credibility, originality,
resonance and usefulness

(10).

Credibility relates to whether data is sufficient to support claims in

consideration of the range, number and depth of observations (10). Through the longitudinal interviews with
10 patients with HNC at specific points in their treatment journey I provided a richness and depth that
would be missed in single-interview studies (Chapter 5). The international, multi-site qualitative study with
46 healthcare professionals was then used to address a different aspect of credibility by providing a breadth
of perspectives through including physicians, nurses, speech pathologists and dietitians from four different
HNC teams (Chapters 7-9).
Originality in grounded-theory research relates to whether the findings offer new insights

(10).

The

comprehensive narrative review in Chapter 3 was undertaken to identify gaps in the current knowledge
base that should be addressed through new research. This guided the development of the studies included
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in Chapters 4 through 9. As an example, the decision to adopt a prophylactic or reactive approach to
feeding-tube placements for patients with HNC has been heavily debated over the last decade. However,
through Chapters 6 and 7 I was able to provide rich and novel insight into this practice problem by
qualitatively exploring patients’ and the healthcare professionals’ perspectives on and experiences with
feeding tubes in the HNC context, respectively.
Originality is also assessed on whether the findings challenge, extend or refine current ideas or practices
(10).

In each chapter I included a detailed discussion of the findings in relation to nutritional-care practices

for patients with HNC. In these sections I have identified opportunities for improving current practices in
line with nutritional EBGs, and recommendations for future work which may help with implementation are
provided. These are summarised in Section 10.3.
Resonance is reflected in categories that portray the fullness of the studied experience

(10).

This principle

was addressed within the analysis of the qualitative data, as rather than dismissing emergent ideas as
singular experiences, earlier transcripts and codes were revisited so that similarities and differences could
be identified. Through keeping memos, I promoted resonance in new interviews as this ensured that
comparisons could be made to earlier codes and categories.
The usefulness of a grounded-theory study is assessed on whether the interpretations are useful to everyday
practices, whether analysis prompts research in other substantive areas and whether it contributes to making
improvements in the world (10). The considerations for practice that I described throughout this thesis and
summarised in Section 10.2, were developed to be realistic and translatable to practice. I also identified
several areas for further research throughout this thesis; some I was able to address in proceeding chapters
and in Section 10.5 I have summarised opportunities for future research. Finally, the rationale that
underpinned this thesis was to improve outcomes for patients with HNC through enhancing the
implementation of nutritional EBGs, thus discussed several opportunities for doing so throughout this
thesis.

159

10.5 Recommendations for future research
From this thesis I identified that the strength of the evidence that supports recommendations within
nutritional EBGs can affect implementation in HNC teams. Therefore, future studies on HNC patient
outcomes associated with nutritional interventions, dietetic involvement and interprofessional collaboration
on HNC and that address patient-related barriers to implementing nutritional advice are required.

Evidence-based recommendations on feeding tube use
Based on the strength of current evidence, the optimal method of tube feeding for patients with HNC is
unclear

(52, 158).

Nevertheless, there do appear to be positive outcomes associated with the placement of

prophylactic gastrostomy tubes for patients with high-risk characteristics (i.e. T4 tumours, concurrent
chemo-radiotherapy, hypo-pharyngeal tumours, radiotherapy treatment fields and dose, type of surgical
procedure, nutritional status and dysphagia) (25). Well-designed randomised studies that compare outcomes
between patients who receive a prophylactic gastrostomy tube and those who are reactively managed (i.e.
via the placement of a gastrostomy or nasogastric tube when it is required) are necessary to support
recommendations in EBGs related to enteral nutrition for patients with HNC.
Previous attempts at undertaking randomised controlled trials to compare these two feeding-tube
approaches with HNC patients have been limited due to patients declining randomisation

(149, 150).

The

present thesis highlights opportunities for further research that may provide clarity on this from a different
perspective. For example, Study 4a in Chapter 7 found that different department structures may contribute
to why a certain approach is favoured in that setting. Specifically, a prophylactic gastrostomy tube approach
may promote better outcomes in departments where patients have routine access to a speech pathologist for
swallow therapy during and after treatment because the risk of prolonged swallow dysfunction that is often
attributed to prophylactic gastrostomy tubes, can be proactively managed. In comparison, a reactive
feeding-tube placement approach may be considered more efficacious in departments that have limited
access to speech pathologists but are well resourced with staffing and equipment to support patients
immediately should they become nutritionally compromised. Therefore, future research that measures
patient outcomes associated with feeding tubes should ensure that contextual characteristics, such as access
to speech pathologists, dietitians, and nutrition care resources (including staffing and equipment), are
described in detail. Practices and outcomes should also be measured against recommendations from
nutritional EBGs to provide greater depth to the data.
The risk of feeding-tube dependence associated with the use of prophylactic gastrostomy tubes remains an
area of controversy. This thesis has expanded on findings by highlighting that the risk of feeding-tube
dependence is a concern for radiation oncologists, and that this may influence their preferences about
whether a prophylactic gastrostomy tube approach or a reactive feeding-tube approach is best for patients.
This was despite finding relatively low rates of patients who were still using their feeding tube 12-18 months
following treatment in Study 1 (Chapter 4). Additionally, those who were, were more likely to have pretreatment swallow issues or persistent disease. Inconsistent definitions of feeding tube dependence and
unclear details about the availability of and adherence to proactive swallow therapy among patients with
HNC should be addressed in future studies to provide further clarity on this controversial topic (159).
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The local guidelines on feeding tube placements that have been evaluated by Brown, Spurgin (269) and Kiss,
Krishnasamy

(47)

favoured different approaches to enteral feeding for patients with HNC (a prophylactic

and reactive approach respectively). Nevertheless, both studies demonstrated positive outcomes when the
local guidelines were implemented. Therefore, more research should explore the development and
validation of local nutrition-care guidelines that provide direction on identifying high-risk patients that
would benefit from a feeding tube, such as those with T4 tumours of the oropharynx who are planned to
undergo chemoradiation (Chapter 4). This may promote consistency and quality in care until higher level
evidence is available that would allow for international recommendations on which feeding-tube approach
results in better outcomes.

Evidence-based recommendations on how dietitians should work with
patients
This thesis has highlighted that the period between diagnosis and just before treatment is one of uncertainty
for patients with HNC (Chapter 5). Additionally, patients may already be experiencing weight loss and
malnutrition (Chapter 4). Despite this, current EBGs do not provide clear recommendations on dietetic
involvement at this early stage of their treatment journey. This may be because patients with HNC are
typically managed in the outpatient general practice setting, and dietitians may not be as easily accessed as
they are within cancer centres. Furthermore, liability and billing considerations often mean that dietitians
employed by cancer services cannot formally provide care to patients until it is confirmed that they will
receive surgery and/or radiotherapy treatment with one of the specialist physicians or surgeons in that
institution (Chapter 8). More research that focuses on nutritional-care screening, assessment, and
information provision at the point of diagnosis for patients with HNC could help to improve outcomes.
Finally, this thesis also highlighted that the availability of dietetic resources may be a barrier to adhering
with EBGs that recommend that patients are reviewed by a dietitian weekly during treatment (Chapter 4
and 9). This supports other Australian and UK research that indicates that dietetic resources are currently
unable to provide for weekly reviews for all patients with HNC during radiotherapy (13, 144). Moreover, the
research that the recommendation for weekly reviews is based on was conducted with patients receiving
radiotherapy alone

(48, 49).

Hence, patients receiving more-intensive treatments (e.g. chemo-radiotherapy)

may in fact require more-frequent contact with a dietitian. Future research should not only focus on
advocacy strategies to address the adequacy of dietetic staffing at a funding level, but also aim to provide
clarity for practising dietitians about which patients, and at what time point in their treatment journey they
should be reviewed.

Evidence-based recommendations on interprofessional collaboration
From this thesis enhancing interprofessional collaboration within HNC teams was identified as a key
facilitator of nutritional EBG implementation. However, several opportunities for doing so were identified
that require further exploration through research. For example, more studies should explore patient
outcomes associated with joint clinics that involve specialist nurses, dietitians, and speech pathologists in
different settings. This should be in conjunction with qualitative research with patients and other healthcare
professionals to provide insight into the perceived efficacy of this model of care in practice. More
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opportunities for and outcomes associated with interprofessional education in the undergraduate and
clinical setting should also be explored as a way to promote interprofessional knowledge about nutritional
care

(45).

practice

Finally, this thesis supports that case-conference-style team meetings are often considered best
(253)

However, their establishment may be hindered by staffing and time pressures in the HNC

context. The perceptions behind barriers to case-conference-style team meetings in the HNC setting should
be examined so that potential issues such as funding for adequate staffing or awareness of the impact of
nutritional care can be addressed.

Addressing patient-related barriers to implementing nutritional advice
This thesis identified that patients’ willingness and ability to use a feeding tube can vary and this may
contribute to why it is difficult for patients to meet estimated energy intake targets while undergoing
treatment for HNC (Chapters 4-6). Future studies should explore these perceptions to ensure that patients
are adequately informed of the risk of not adhering to evidence-based nutritional recommendations and to
guarantee that there is consistent and evidence-based nutritional care communication with patients from all
healthcare professionals on HNC teams.
Additionally, further studies should measure patient outcomes associated with feeding-tube use and report
on estimated energy intake adequacy to build on the evidence base about how well patients can adhere to
nutritional recommendations. This is also important to help explain the occurrence of adverse nutritionrelated events, such as weight loss. This should be in conjunction with qualitative research with patients
and healthcare professionals to expand on the quantitative data and provide insight into potential barriers
to their use of enteral nutrition to meet estimated energy targets. Therefore, future research should consider
the use of a mixed-methods research design as a useful way to contextualise and provide a patient-centred
and practice-based perspective on quantitative outcome data.
A study that measures the effect of patient choice of feeding tubes on outcomes would be worthwhile to
promote shared decision-making. Furthermore, research into interprofessional approaches to feeding-tube
placement decision-making and management may also help to enhance patients’ willingness and capacity
to implement recommendations based on EBGs. This could include more research on behavioural
counselling via collaboration between psychologists and dietitians; and on dietitians working in joint clinics
with speech pathologists, specialist nurses and physicians to help manage the emotional and physical
barriers to nutritional intake.

162

10.6 Conclusion
The original research from this thesis has contributed to the body of knowledge on the implementation of
nutritional EBGs for patients with HNC. The thesis includes a retrospective review of patient medical
records that measured adherence to key EBG recommendations on nutritional care in one regional cancercare network. This provided information on nutritional-care practices and associated patient outcomes.
Longitudinal qualitative interviews with patients showed that support from physicians and nurses, clinic
structures which allowed dietitians to lead aspects of nutritional care, and physical and psychosocial barriers
may influence a patient’s ability and willingness to adhere to nutritional recommendations. A systematic
literature review provided focused insight into the patient experience of having a feeding-tube and
highlighted that interprofessional support and an individual patient-centred approach to feeding-tube
placement is necessary. International, multi-site qualitative research with healthcare professionals from four
HNC teams supported and expanded on the quantitative data and the qualitative research with patients by
highlighting several factors that may influence the implementation of recommendations from EBGs on
feeding-tube practices, how dietitians work with patients and interprofessional nutritional care for patients
with HNC.
The findings from this thesis were synthesised into 12 factors that influence the implementation of
nutritional EBGs for patients with HNC: the completion and dissemination of research that supports and
expands on EBGs, interprofessional education, specialist training for dietitians, clinic structures, local
nutritional guidelines, nonclinical activities, nutrition resources, team meetings, experience, respect, and
patients’ physical and psychosocial characteristics. This thesis highlights the multifaceted and challenging
nature of implementing nutritional EBGs in practice. A multi-level approach that engages with international
and national governing organisations, professional associations, service managers and developers,
healthcare professionals, researchers, and patients, is required to enhance the implementation of nutritional
EBGs and thus promote best outcomes for patients with HNC.
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Appendices
APPENDIX 1: Summary of papers included in the narrative review (Chapter 3) and the systematic literature
review (Chapter 6)
Table 1. Quantitative studies included in Chapter 3 that have measured adherence to national nutritional evidence-based guidelines for patients with head and
neck cancer
First
author,
year,
geographic
al location

Study design and
aim

Hofto,
2018,
Australia

Retrospective
cohort study to
determine local
adherence to local
and national
evidence-based
practice guidelines
for the nutritional
management of
adult patients with
HNC.

Study setting and
eligibility criteria

Description of
study

Data
collection

Sample

Summary of
relevant results

Author’s
conclusions

Quality
rating
(100)

18 years or older
and received ≥20
fractions of
definitive or highdose radiation
treatment to the
head and neck
between the 1st
April 2014 and the
31st of March
2016.

Local clinical
practice was
assessed against
four selected
recommendations
from the Clinical
Oncology Society
of Australia
guidelines.

Data was
retrieved
retrospectively
form patient
medical
records.

Number of HNC
participants

Total: n=209
Females: n=32
Males: n=177

Mean age, y

<50 years: n=26
50-65 years: n=86
>65 years: n=97

Tumour
locations

Oral cavity: n= 22
Oropharynx: n= 56
Nasopharynx: n=8
Hypopharynx: n=7
Larynx: n=21
Salivary: n=19
Skin primary: n=67
Unknown primary: n=6
Other: n=3

T stage

T0: n=24
T1: n=35
T2: n=51
T3: n=37
T4: n=48
TX: n=12
Other: n=2

Treatment

RT: n=50
RT + CT: n=96
S + RT: n=54
S + RT + CT: n=10

176

Use of a validated
malnutrition
screening tool pretreatment was met in
86% of cases
Use of a validated
nutrition assessment
tool during treatment
(PG-SGA©) was met
for 100% of patients.
Weekly review by a
dietitian during
treatment occurred
80% of the time
62% of patients were
reviewed bi-weekly
for six weeks posttreatment

This study
supports the use
of current
Australian
guidelines as a
method of
identifying
patients who may
need enteral
feeding. However,
dietetic
monitoring by
tumour site has
the potential to
improve patient
outcomes and
could be a better
use of healthcare
resources.

+

Kiss, 2012,
Australia

Pre-and post-test
design cohort study
to evaluate the
acceptability,
organisational
efficiency and
clinical outcomes
of a dietitian led
HNC clinic.

Primary diagnosis
of HNC, ≥18 years
of age,
chemoradiotherapy
naive and
receiving treatment
with at least 15
fractions of
radiotherapy.

Patients in the preintervention group
were scheduled for
an initial
assessment with a
dietitian in week 1
and then reviewed
as frequently as
deemed necessary.
Commencement of
enteral feeding was
at the instigation of
the radiation
oncologist or the
dietitian.

Medical
record data

Patients recruited in
the dietitian-led
clinic (postintervention) group
attended weekly
consults with a
dietitian during
radiotherapy, two to
four dietitian
consults in the eight
weeks postradiotherapy. A
local protocol was
followed for the
placement of
feeding tubes.
Radiation
oncologist reviews
at two weeks posttreatment were
replaced by
dietitian reviews.
McCarter,
2018,
Australia

Multisite, steppedwedge, randomised
controlled trial
(non-blinded) to
assess the impact
of practice change
strategies in
improving dietitian
implementation of
best-practice
guideline
recommendations
for the nutritional

Four radiotherapy
departments
located within
major metropolitan
Australian
hospitals.
Eligibility: Patients
scheduled to
undergo definitive
or postoperative
radiotherapy, 18
years or older,

Dietitians provided
treatment as usual.
Dietitians were then
trained in
behaviour-change
skills. During the
implementation
phase strategies
were implemented
to enhance
implementation of
practice guidelines
(prompts, executive

Number of HNC
participants

Pre-intervention: n=98
Post-intervention:
n=100

Mean age, y

Pre-intervention: 60.2 y
Post-intervention:
63.12

Tumour
locations (pre
intervention/post
-intervention)

Oropharynx: n=20/33
Oral cavity: n=18/11
Larynx/ hypopharynx:
n= 23/22
Nasopharynx/
paranasal sinuses:
n=8/9
Other: n=29/25

Tumour stage
(pre
intervention/post
-intervention)

I: n=15/18
II: n=19/18
III: n=20/25
IV: n=38/38
n/a/ X: n=6/1

Treatment

Chemo-RT: n=46/55
Infield boost RT: n=6/9
RT alone: n=45/36

Patients seen by a
dietitian in the first
five days of RT: 81%
vs 39.8%
(p=<0.0001).
Fortnightly review up
to six weeks posttreatment ~90% vs
86%.

This study has
shown a dietitianled clinic to be a
feasible model of
care and an
effective way of
integrating bestpractice
guidelines into
clinical care.

+

The clinical
practice change
strategies
significantly
improved the odds
of provision of
four of the six
guideline
recommendations.

+

Transition back to
oral diet 8 weeks post
treatment: 76.7% vs
68.3% (p=0.10)
Nutrition-related
hospitalisations: 4.5%
vs 12% (p=0.003)
Radiation oncologist
reviews within two
weeks post-treatment:
15% vs 32%
(p=0.009)
Unplanned NGT
placements: 15 vs 11
(0.02)
Dietitian adherence to
care pathway: 92.399.7%

Chart reviews
of patient
medical
records from
the dietitian’s
clinical
consultations
were
conducted

Number of HNC
participants

Control group (pre
intervention: n=151
Intervention group:
n=156

Mean age, y

58 years

Tumour
locations (preintervention/

Nasopharynx: n=12/11
Oropharynx: n=83/88
Oral cavity: n=30/36
Larynx: n=14/15

177

Dietitian contact
weekly during RT:
63.5% vs 71.5%
(p=0.0339)
Nutritional
assessment at week 1
of RT: 69.1% vs
89.7% (p=0.0002)
Monitor weight,
intake and nutritional
status during and

management of
HNC patients.

diagnosed with
HNC and were
receiving care
from an oncology
dietitian at a
participating
radiotherapy
department.

support and
endorsement, staff
training, academic
detailing,
performance audit
and feedback and
provision of tools
and resources).

postintervention)

Hypopharynx: n=9/2
Unknown: n=3/4

Tumour staging
(preintervention/
postintervention)

I: n=6/6
II: n=22/17
III: n=25/32
IV: n=98/101

Treatment

n/a

after RT: 56.7% vs
88.8% (p<0.001)

HNC= head and neck cancer
Table 2. Qualitative studies included in Chapter 3 that describe head and neck cancer patient experiences with eating
Reference,
year,
geographic
al location

Study
design /
methodolo
gy

Phenomen
on of
interest

Qualitative
datacollection
method (data
analysis)

Ganzer,
2015, The
Netherland
s

Mixedmethods
study

The eating
experience
in long
term
survivors of
HNC

Semistructured
interviews
(unclear)

Kristensen,
2019,
Denmark

Qualitative

HNC
survivors’
experiences
of everyday
life with
eating
problems
after cancer
treatment
and
experiences

Semistructured
focus groups
(Content
analysis)

Author’s summary of results

Participants

Author’s conclusions

COREQ
score
(128)

Number of
HNC
participants

Total n=10

Overarching theme: Adaption

Mean age,
(range) y

55.7 (40-67)

Four categories: Psychological; Functional
impacts; Social impacts; Current eating
experience

Tumour
locations

Tongue: n=5
Tonsil: n=3
Larynx: n=1
Larynx and base
of tongue: n=1

Tumour
staging

III: n=1
IV or IVa: n=9

Treatment

n/d

Number of
HNC
participants

Total: n=40
Females: n=20
Males: n=20

Median age,
(range) y

60 (39-80)

Tumour
locations

Oral cavity: n=5
Pharynx: n=23
Larynx, salivary
gland, thyroid,

Fifteen subthemes: Downplaying; Adjusting to
current situation; Support; Coping/ resilience;
Drinking water/ fluid; Mucosal sensitivity;
Limiting foods; Adapting how food is prepared;
Taste; Food choice related to symptoms; Dental
health; Dry mouth; Social impact; Food/ menu
selection; Eating in public.

HNC survivors’ experiences of everyday life with
eating problems after treatment:
To eat is to practice—when physical challenges
make eating an obligation or a training situation
The last third of the pie is missing—the
emotional loss.
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Various challenges related to the eating
experience were present, even 11 years
post-treatment, and there were a
diversity of coping mechanisms.
Participants had found ways to accept,
cope with, and adapt to their current
situation to facilitate eating and to
maintain social interaction, despite
challenges. Health care practitioners,
including nutrition professionals, should
explore potential late effects of HNC
treatment in follow-up visits. Providing
a holistic interdisciplinary approach that
supports patients in regard to the
physiological, psychological, and social
aspects can maximise nutritional wellbeing and the eating experience within
this population.

23

For many HNC survivors, eating
becomes an obligation or a training
situation, and the eating problems
challenge their relationships with their
relatives and may lead to social
withdrawal. Unmet needs for support to
cope with the eating problems are
frequent, and HNC survivors often feel
left by themselves after completion of
treatment. HNC survivors found the
multidisciplinary residential

24

of
participatin
g in a
multidiscipl
inary
residential
rehabilitatio
n program
with a
primary
focus on
physical,
psychologic
al, and
social
aspects of
eating
problems
after
treatment.
Larsson,
2003,
Sweden

Phenomeno
logy

HNC
patients'
lived
experiences
of eating
problems,
their
consequenc
es in daily
life and
patients'
strategies
of coping
with these
problems.

oesophagus:
n=40
Unknown other
primary tumour
with cervical
metastases: n=5

Interviews
(Colaizzi’s
1978 method)

“I’ll just come by for the coffee”—eating
problems affect social life and relationships with
close relatives
On your own, finding one’s feet in the vacuum
that occurs after a long and intensive treatment

Tumour
staging

n/d

Treatment

RT: n=39
Surgery: n=19
CT: n=22

Number of
HNC
participants

Total: n=8
Female: n=2
Male: n=6

Age range y

43-66

Tumour
locations

n/d

Themes: Experiences of change in saliva quantity
and consistency; experiences of narrowness and
pain; Experiences of taste changes and nausea

Tumour
staging

n/d

Consequences in daily life

Treatment

RT: n=8

Eating problems experienced
Main themes: Ability to chew and swallow; will
and desire to eat

Main theme: The way life is disturbed
Themes: Loss of the meal – loss of togetherness,
paralysing tiredness, life itself is threatened, the
image of self is changed – shame waits around
the corner
Ways to cope
Main theme: Trying to see the end – to survive
Themes: Moving between hope and despair; to
endure the situation
Sub-themes: Strength comes from inside;
strength comes from outside

179

rehabilitation program as beneficial to
meet their rehabilitation needs.
Furthermore, participants experienced
the residential rehabilitation program as
a safe environment to experiment and
practice eating skills, and they benefited
from meeting peers.

This study identifies the need to view
eating problems as a complex
phenomenon in a specific context
including the individual patient's life
situation. The findings create the
opportunity to develop nursing
interventions based on patients' own
needs. To facilitate this, a specialist
nurse should be responsible for
reviewing patients regularly throughout
radiation therapy. Intervention studies
are needed to provide optimal clinical
guidelines.

22

McCarter,
2018,
Australia

McQuestio
n, 2011,
Canada

McLaughli
n, 2014,
United
States

Grounded
theory

Qualitative

Qualitative

HNC
patient
experience
of a new
dietitiandelivered
health
behaviour
intervention
: ‘you know
you have to
eat to
survive’

The
changed
meaning of
food for
patients
with HNC

The
strategies
HNC
patient
survivors
employ to
cope with

Semistructured
interviews
(Grounded
theory)

Interviews
(qualitative
descriptive
analysis using
Giorgi’s
(1985)
analytical
technique)

Semi
structured
interviews
(content
analysis)

Number of
HNC
participants

Total n=9

Mean age, y

61.3

Tumour
locations

Nasopharynx:
n=1
Oropharynx:
n=7
Oral cavity: n=1

Tumour
staging

I: n=1
II: n=0
III: n=1
IV: n=7

Treatment

Radiotherapy:
n=9
Surgery prior to
radiotherapy:
n=2
Concurrent
chemotherapy:
n=7

Number of
HNC
participants

Total: n=17
Female: n=5
Male: n=12

Age ranges

30-49: n=4
50-69: n=11
>70: n=2

Tumour
locations

n/d

Tumour
staging

n/d

Treatment

Daily RT: n=15
twice daily RT:
n=2

Number of
HNC
participants

Total: n=11

Mean age
(range)

n/d

1.

Information

Dietitians can be trained to deliver a
health behaviour change intervention,
EAT, to help prevent malnutrition
during RT for HNC. This intervention
appears to assist patients to link eating
with survival and was perceived as
being empathically delivered in a
supportive context. Furthermore, this
approach facilitates a feeling of control
and motivation in the difficult HNC
treatment journey.
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2.

Challenges of treatment experience: side
effects; finding food to eat, additional
support pre-or post-treatment (dietitian)

3.

Key messages: importance of eating and
maintaining weight

4.

Dietitian’s approach: empathy; compassion;
survival; support

Changed meaning of food was evident in three
parts of their life: physical loss; emotional loss;
social loss

It is important for nurses and other
health care professionals to understand
and talk with patients about their
experience, the disruptions, meanings
and losses associated with treatment in
order to provide support, practical
strategies and interventions for coping
with the changes and losses.

13

1.

Patients should be instructed to
experiment with a variety of food
textures and food seasoning, and their
caregivers and family members should
be included in this discussion. The
families of survivors also should be
encouraged to help identify ways to

17
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Food preferences and aversions: smooth or
blended, nutritional supplements, more
pepper or hot sauce, more gravy or
condiments, ground meats

eating and
taste
impairment
s

Ottosson,
2013,
Sweden

Qualitative

The
experience
of food,
eating and
meals
following
radiotherap
y in
patients
with HNC.

Semistructured
interviews
(Content
analysis)

Tumour
locations

n/d

2.

Taste-related food changes: Sweet salty,
sour or bitter food

Tumour
staging

n/d

3.

Social isolation

4.

Eating and dry mouth

Treatment

n/d
5.

Oral sensory complaints: Dry mouths,
sensitivity to spicy food, sensitivity to
texture eating is painful, eating is work,
alcohol burns, sensitivity to temperature)

6.

Weight loss benefits

Number of
HNC
participants

Total: n=13
Female: n=2
Male: n=11

Median age
(range) y

60 (47-70)

Tumour
locations

Oral cavity: n=6
Pharynx: n=6

Six categories
1.

A long journey – taking small steps to an
uncertain future: struggling through the
acute phase; demanding and positive
physical changes; remaining treatment
toxicities; the journey; thoughts about the
future

2.

A new way of eating: nearly back to
normal; adaption of food choice; Nutrition
support: a help and defeat; The timeconsuming meal; The unclean mouth

3.

Eating without satisfaction: limitations in
food choice; the meaning of food; the
important taste

4.

Challenging meals outside the family:
eating together with others; eating outside
the family; adjustments and understanding
among others; ambivalence towards dinner
invitations; not being able to eat the same
as others; being different

5.

Support and information the key to a
successful journey: significant others; the
healthcare system; receiving the right
information; prefer to be unaware; knowing
what to come; the support from others; to
manage on your own

6.

The creation and acceptance of a new
normal: a changed platform; the food in
relation to the disease; to handle the
situation; facilitating with strategies;
practical issues

Larynx: n=1
Tumour
staging

n/d

Treatment

Conventional
fractionation
RT: n=5
Accelerated
fractionation
RT: n=1
Surgery +
Conventional
fractionation
RT: n=4
Surgery +
Accelerated
fractionation
RT: n=3
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provide emotional support when taste
and eating are impaired.

HNC cancer signifies a long journey
where physical, psychological and
social dimensions of food, eating and
meals are affected. Problems related to
food, eating and meals were still present
nine months after treatment. Through
the trajectory, the patients in this study
tried to find ways to cope with and
accept the new way of living using
different strategies to facilitate eating
and social interaction. Information and
support were shown to be important
instruments to help the patients during
the treatment and convalescence period.
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Pateman,
2015,
Australia

Sandmael,
2019,
Norway

Qualitative

Qualitative

How
people who
have been
treated for
HNC cope
with altered
oral health
and
function
and to
identify
their
supportive
care needs

How
patients
with HNC
experience
the
nutritional
situation
and
perceive
nutritional
support in
the period
from
diagnosis to
the acute
post‐
treatment
phase.

Semistructured
interview
(inductive
and directed
content
analysis by
applying key
concepts of
the Stress,
Appraisal and
Coping
model).

Semistructured
interviews
(content
analysis)

Participant’s experience of changed oral health
and function

Number of
HNC
participants

Total: n=6
Female: n=2
Male: n-4

Mean age
(range) y

61.3 (50-72)

Tumour
locations

Oropharynx:
n=1
Nasopharynx x:
n=1
Tonsil: n=1
Mandible: n=1
Parotid gland:
n=1
Tongue: n=1

Tumour
staging

n/d

Treatment

CT+RT: n=3
Surgery + RT:
n=2
Surgery: n=1

Number of
HNC
participants

N=10
Females: n=5
Males: n=5

Waiting to get started: preparing for RT (Limited
nutritional preparations, difficulty eating, weight
loss)’, receiving information

Age ranges

40-49: n=1
50-59: n=4
60-69: n=4
70-79: n=1

Tumour
locations

Oropharynx:
n=7
Salivary glands:
n=2
Unknown
origin: n=1

Undergoing daily radiotherapy turns life upside
down: increasing side effects and diminishing
food intake; coping with increasing nutritional
problems; using oral nutritional supplements as
nutritional first aid; deciding hospitalisation and
starting tube-feeding

Tumour
staging

I-II: n=2
III: n=2
IVA: n=5
not assessed:
n=1

1.

Dimensions of eating: changed masticatory
function; dysgeusia; dysphagia; sensitive
mouth; finding the motivation to eat and
recover

2.

Maintaining oral health after treatment:
adjusting to the chronic side effects of
treatment

Finally done but still troubling: persisting sideeffects and altered senses
Moving toward the usual life
Reflecting on the treatment trajectory:
highlighting tailored information and specialised
nutritional support
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These findings provide insight into
factors that may influence positive
coping among this population.

20

The comprehensive nutritional problems
that patients with HNC experience from
diagnosis to the recovery phase after
treatment indicate a need for dietitianled individually tailored nutritional care
to improve patient outcomes. This
implies early individual assessments of
needs for information and nutritional
support for all patients, including
continuous reassessments of changing
needs. In this way, individualised
nutritional care may become an
integrated part of the clinical HNC
pathway.

20

Treatment

Surgery + CT:
n=4
surgery + RT:
n=3
CT: n=2
RT: n=1

CT= chemotherapy; FT= feeding tube; HNC = head and neck cancer; NGT= nasogastric tube; PEG = percutaneous endoscopic gastrostomy tube; RIG = radiological
inserted gastrostomy tube; RT = radiotherapy
Table 3. Qualitative studies that describe head and neck cancer patients’ experiences of having a feeding tube included in the narrative review in Chapter 3
and the systematic literature review in Chapter 6
Author
, year,
geogra
phical
locatio
n
Alberd
a,
2017,
Canada

Study
Design/
methodolo
gy

Phenomen
on of
interest

Qualitative
descriptive
study

The
patients’
experiences
with
nutrition
care in the
context of
their
treatment
and
Recovery.

Datacollection
method
(and
analytical
approach)
Semistructured
interviews
(content
analysis)

Number of
HNC
participant
s
Mean age,
y
Tumour
locations
Tumour
staging
Treatment

FT Type

Duration
FT insitu
Ehrsso
n,
2015,
Swede
n

Qualitative
descriptive
study

Quality of
life with
HNC
patients,
with focus

Semistructured
interviews
(content
analysis)

Author’s summary of results

Participants

Number of
HNC
participant
s
Mean age,
y

Total: n=10
Female: n=2
Male: n=10

Three main themes
1.

62.6 (45-79)
2.
n/d
3.

n/d

Coping with the physical and
psychosocial aspects of illness
and nutrition
Understanding the nature of the
illness, treatment and nutrition
pathways
Being supported during the
trajectory of care

RT: n=1
RT + CT +
surgery: n= 3
RT + surgery:
n= 9
Surgery + RT:
n=6
NGT: n=10
(perioperatively, but
removed preRT)
PEG: n=2
n/d

Total: n=41
Total with FT:
n=23

Four main categories, thirteen subcategories:
1.

62.3

-

Nutrition
Nutritional comfort
Maintaining and Gaining Weight
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Author’s conclusion

CORE
Q
score

JBIQARI
score

(128)

(126)a

Patients with HNC need individualised
complex support that include ongoing
medical information and guidance, along
with nutrition and emotional support for
the patients and their families.
The resources should be available inside
and outside the walls of the hospital or
cancer-care centre. The results point to the
need for patient-focused evidence-based
guidelines as one of the primary enablers
of nutrition care so that all patients receive
the benefit of nutrition care, and health
services are modelled to provide
consistent care from all healthcare
providers. The conflicting messages
provided by different professionals were a
constant source of anxiety and uncertainty
and may have been interpreted as lack of
support.

24

8/10,
indicate
s low
risk of
bias

Eating aspects are fundamental for
patients with HNC, but the perception of
general or disease-related quality of life
did not differ between patients who
received enteral nutrition and patients who
did not. Patients receiving enteral nutrition

20

8/10,
indicate
s low
risk of
bias

on which
areas in life
are
important
to quality
of life, and
which are
influenced
by the
disease and
by having
oral or
enteral
nutrition:
and which
areas in life
are
influenced
by having a
NGT or a
PEG

Tumour
locations

Tumour
staging

Treatment

FT Type

Goven
der,
2017,
United
Kingdo
m

Qualitative
descriptive
study
drawing
upon the
theoretical
domains
framework
(TDF) and
the COM-B
(Capability,
opportunity
, motivation
behaviour)
model.

The
barriers and
facilitators
of
swallowing
exercise
adherence
from a
patient
perspective.

Semistructured
interviews
(content
analysis)

Oropharynx:
n=15
Oral cavity: n=8
Larynx: n=5
Unknown
primary: n= 4
Nasopharynx:
n=3
Salivary glands:
n=3
Hypopharynx:
n=2
Oral cavity and
oropharynx:
n=1
T1: n=6
T2: n=5
T3: n=4
T4: n=22
No stage: n=4
RT: n=16
RT + CT +/surgery: n= 13
RT + surgery:
n= 9
Surgery + RT:
n=3
Total: n=23
PEG: n=14
NGT: n=9

Duration
FT insitu

n/d

Number of
HNC
participant
s

Total: n=13
Total with FT:
n=11
Females: n=4
Male: n=9

Age

60 years and
over: n= 4
Less than 60:
n=9
n/d

Tumour
locations
Tumour
staging
Treatment

-

Long Feeding Time
Missing Oral Eating
Losing weight

2.

Function
Functioning Well
Difficult to Handle
Gastrointestinal Problems
Nose and Throat problems
Pain
3. Limitations
Feel Unhygienic
Confined to a Tube
Social Limitations
4. Miscellaneous
-

Barriers and facilitators to
exercise adherence
Barrier:
Inadequate knowledge of how
treatment will affect own
swallowing.
Facilitator:
To prevent negative consequences
such as long-term tube feeding
(reflective motivation)

Advanced
RT: n=3
RT + CT: n= 5
RT + CT +
surgery: n=4
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considered that type of treatment to be
something positive and necessary.
However, both NGT and PEG were
associated with restrictions with different
spectra. From the patients’ perspective
neither of the two feeding tubes was
clearly preferable.

Patient adherence is one aspect of the
complex intervention involved in
swallowing rehabilitation after HNC. This
study described the use of a theory-based
qualitative approach in examining what
drives adherent/non-adherent exercise
behaviours in patients with HNC.
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8/10,
indicate
s low
risk of
bias

FT Type

Kwong
, 2017,
Canada

Qualitative
descriptive
study

The
decisionmaking
process for
PEGs tube
from the
patient’s
perspective

Semi‐
structured
interview
(“qualitativ
e thematic
analysis”)

Duration
FT insitu
Number of
HNC
participant
s
Mean age
(range), y

n/d

Tumour
locations

Throat, tongue,
nasopharynx,
tonsil,
oropharynx,
lymph node
“Advanced”

Tumour
staging
Treatment

MayreChilton
, 2011
United
Kingdo
m

Qualitative
descriptive
study

The daily
impact of
gastrostom
y feeding
on head and
neck
patients and
their
caregivers.

Focus
group
interviews
(“qualitativ
e thematic
analysis”)

CT + surgery:
n=1
PEG: n=11

Total: n=15
Female: n=3
Male: n=12
60.2 (44-77)

RT: n=1
RT + CT: n=13
RT + CT +
surgery: n= 1

FT Type

PEG: n=15

Duration
FT insitu:
Mean
(range),
mo.
Number of
HNC
participant
s
Mean age
(range), y

7 (3-10)

Tumour
locations

Oropharynx:
n=2
Larynx: n=2
Sarcoma
mandible: n=1
Unknown
primary: n=1
T1: n=2
T2: n=1
T3: n=1
T4: N=1
Pre-tumorous
stage: n=1
n/d

Tumour
staging

Treatment

Total: n= 6
Female: n=2
Male: n=4

Thirteen major codes:
1. Choices Around PEG Tube Insertion*
2. Weight
3. Eating/Oral Intake
4. Experiences of Daily Living with the
PEG Tube*
5. PEG Feeding
6. Spillage
7. The Cap as a Problem
8. Support
9. Socialisation
10. PEG Tube Challenges
11. Transitioning from the PEG Tube Back
to an Oral Diet*
12. Thoughts and Feelings Associated with
the PEG Tube
13. Recognition of the Value of the PEG
Tube*

The experience of patients with [HNC]
living with a PEG tube can be described
overall as a dichotomy. While there were
issues with the PEG tube, all participants
found the tube to be beneficial.
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9/10,
indicate
s low
risk of
bias

(*Four codes that summarised the
overarching ideas and progressive
experience or patient journey with the PEG)

Eight key themes:
Three themes were experienced differently
between patients and caregivers:

64
1.
2.
3.

Knowledge and Understanding Why
the Tube Was Necessary
Personal Perceptions
Objectives of Nutritional Support

Five themes were experienced similarly
between patients and caregivers:
4.
5.
6.
7.
8.

Developing Positive Coping Strategies
Preventing Nutritional Decline
Gastrostomy Tube Dependency
Recognition of Survival
Support Network
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The findings identify factors that
contribute to the challenges of weaning
from enteral to oral nutrition. The present
study shows that a support process
involving multidisciplinary specialists is
required to guide head and neck cancer
patients and their caregivers through the
treatment process together: from diagnosis
and the pre-assessment clinic, before and
during treatment, and finally to the
rehabilitation and re-establishment of
daily living for long-term survivorship.

15

9/10,
indicate
s low
risk of
bias

Merric
k,
2012,
United
Kingdo
m

Qualitative
Qmethodolog
y

The
experience
of PEG
tube
feeding in
HNC
patients
undergoing
cancer
treatment

Semistructured
interviews
thematicall
y analysed
(thematic
analysis
and PQ
Method
software
package)

FT Type

PEG: n=6

Duration
FT insitu

n/d

Number of
HNC
participant
s

Total: n=5
Female: n=1
Male: n=4
(M=4, F=1) 4879 years
48-79

Age range,
y
Tumour
locations
Tumour
staging
Treatment
FT Type
Duration
FT insitu

Four global themes:
1.

n/d
n/d
Curative
treatment
Prophylactic
PEG: n=5
n/d

2.

3.

4.

Osborn
e,
2012,
Canada
b

Cross‐
sectional,
retrospectiv
e
descriptive
study

The
experience
of patients
living with
a PEG tube.

A mixed‐
method,
PEG‐
specific
questionnai
re (Four
open‐ended
questions)

Number of
HNC
participant
s
Age
ranges, y

Total: n=51
Female: n=14
Male: n=37

Q methodology analysis:
1. ‘Constructive cognitive appraisal’ –
Positive adaptation and acceptance
of PEG
2. ‘Cognitive-affective dissonance’
ambivalence between acceptance and
rejection of PEG
3. ‘Emotion-focused appraisal’ – tube
focused anxiety and fear
Main responses to the four open-ended
questions:
1.

18-40: n=11
41-50: n=8
51-60: n=18
61-75: n=14

Psycho‐Social Impact: Physical
(Complications, Practicalities,
Discomfort, Care), Psychosocial
impact on me (Emotional, Social,
Confidence, Intrusion, Sleep),
Psychosocial Impact on Others
(Emotional, Social, Burden), In
Context of Diagnosis (Treatment,
Temporary)
Physical Impact: Effects of the Feed
(Abdominal Effects, Sensation of
Feed, Volume), Treatment Effects
(Practical, Psychological), Process
(Practicalities, confidence, Time)
Affective Impact: Placement
(Support, Being Told Information),
Tube (Ability to Self-Care,
Capability), Feeding Method
(Sensation, Ease, Pump)
Clinical/Medical Impact: Provision of
Nutrition and Fluids (Life Saving,
Quality of Life); vs Cons (Social, vs
a Nasogastric tube)

Main advantage of having the PEG
tube: Provided nutrition when I
couldn’t eat orally; kept me alive/
survival; kept my weight up; provided
relief from metal burden
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The findings broadly confirm Levanthal et
al.'s Self‐Regulatory Model of coping
(driven by the need to re‐establish a state
of normality, the patient interprets the
problem posed by the illness within a
cognitive and emotional framework,
develops a coping strategy based on this
and then appraises the success of the
coping strategy). The findings highlight
the need for an impartial and genuinely
patient‐centred approach to nutritional
care, reflecting the heterogeneity in patient
attitude to, and experience of, gastrostomy
feeding by head and neck cancer patients
undergoing curative treatment.
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9/10,
indicate
s low
risk of
bias

Most patients with advanced HNCA who
went through the outpatient PEG tube
program at the OCC had a positive or
neutral experience and would recommend
the PEG tube to patients in similar
situations.

n/a b

9/10,
indicate
s low
risk of
bias

(Grounded
theory)

Tumour
locations

Tumour
staging
Treatment

FT Type

Duration
FT insitu
Thoma
s,
2019,
UK c

Qualitative
study

The impact
of living
with home
enteral
feeding:
perspective
s of people
who have
had a
diagnosis
of HNC

Semistructured
interviews
(Interpretiv
e
phenomeno
logy)

Oropharynx:
n=21
Oral cavity: n=8
Nasopharynx:
n=13
Hypopharynx:
n=4
Glottic: n=4
Other: n=1
Stage 3-4

Main disadvantage: No disadvantage;
leaking/ cap coming off; discomfort;
caring for the tub; awkward when
showering

3.

How could the experience with the
PEG be improved: No improvement;
Improve the cap to avoid leakage

4.

One thing about your experience with a
PEG that you would tell another
patient: Get it; it doesn’t hurt; it can be
essential to save your life; the benefits
outweigh the negatives; it’s not that big
of a deal; trust the advice of the
professionals.

RT: n=1
RT + CT +/surgery: 50
PEG: n=51
PEG placed preRT: 4
PEG placed
between days 121 or RT: 29
PEG placed
from day 22 of
RT: 18
n/d

Number of
HNC
participant
s
Mean age
(y)
Tumour
locations
Tumour
staging
Treatment

Total n=15

FT Type

Balloon
gastrostomy
m=13
Low profile
button n=2
PEG n=0
Jejunostomy or
NGT n=0
<1 - <6months:
n=10
>6 - <10
months: n=3

Duration
FT insitu,
mean
(range)
mo.

2.

Five cluster themes
1. Change: deviation from the norm:
Physical impact; Social impact;
Emotional impact

61.3
2.

Adaption: regaining control leading
to empowerment

n/d

3.

Creating a new normal

n/d

4.

External modifiers of the home
enteral feeding experience

5.

Internal modifiers of the home
enteral feeding experience

n/d
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Understanding the wider impact of HEF
on each patient's daily life and identifying
barriers to their achieving a sense of
normality, can assist people in making the
transition to establishing their new
normality. Tailored skill and knowledge
development empower patients, and this
supports them with adapting to HEF.
Educating patients on how they can adjust
the volume, rate or timing of the feeding
regime to fit around different activities
enables inclusion and participation, and
this encourages patients to regain a sense
of control and freedom into their daily
lives.
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n/a c

White,
2018,
United
Kingdo
m

Willia
ms,
2018,
United
Kingdo
m

Qualitative
descriptive
study

Qualitative
descriptive
study

Patient
views on
the role of
considering
their values
in the
decision to
have a
gastrostom
y

Patients'
experiences
of enteral
feeding and
the
surrounding
decisionmaking
process.

Semistructured
interviews
(groundedtheory
approach)

Semistructured
interviews
(thematic
analysis)

Number of
participant
s

Mean age
(range) y
Tumour
locations
Tumour
staging
Treatment

>12 - <18
months: n=1
>18 - < 24
months: n=0
>24 - <30
months: n=1
Total: n= 11
Total with
HNC: n=7
Females: n=3
Males: n=4
63 (53-76)

2.

n/d

Duration
FT insitu,
mean
(range)
mo.
Number of
HNC
participant
s
Median
age
(range), y
Tumour
locations

9.4 (3-12)

FT Type

Duration
FT insitu

3.

Weighing up the benefits and concerns:
Benefits of starting home enteral
feeding; Concerns about home enteral
feeding
Perceptions of choice: Felt had a
choice; Felt no choice given; Felt had
no choice due to no viable alternative
Expectations and decision regret:
Expectations; Decision regret

Patients may have a varied need for their
values to be clarified during decisionmaking to have an enteral feeding tube
placed. Therefore, the decision-making
approach may need to be modified based
on patient preferences for involvement and
the context in which the decision is being
made.

20

9/10
score
indicate
s low
risk of
bias

Patients highly valued inclusion and
personal choice in the pre-treatment
decision-making process. As part of this
process it is important that patients are
prepared for the likelihood of [enteral
feeding] so that it is not subsequently
perceived as a failure on their part.
Patients frequently offered suggestions
based around peer-support for decisionmaking and coping mechanisms during
[enteral feeding]; future developments
could increasingly look to integrate peersupport into [enteral feeding] practices. A
patient-centred approach including
informed decision-making, underpinned
by an understanding of health literacy,
peer support and strategies to improve
resilience, should be considered for all
those who require enteral tube feeding.
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8/10,
indicate
s low
risk of
bias

n/d
GT: n=7

Treatment

1.

n/d

FT Type

Tumour
staging

Three main themes and seven sub-themes:

Total: n=10
Female: n= 2
Male: n=8
54 (43-65)

Tonsil: n= 6
Base of tongue:
n= 2
Lateral tongue:
n= 1
Glottis: n=1
T2: n=1
T3: n=1
T4: n=8
RT: 1
RT + CT: n= 9
RIG: n=6
PEG: n=1
NGT: n=3
n/a

Seven key themes and 12
sub-themes:
1.
2.

The Battle to Eat
Fear: Insertion/Procedure; Tube
Displacement)
3. Restricted Life: Going Out/Body
Image; Missing Eating; Enteral
Feeding Regimen Restrictions;
Activities of Daily Living;
Relationships
4. Coping Mechanism: Reducing Burden;
Living a Normal Life; Downward
Social Comparison; Hope/ Loss of
Hope; Resilience
Control)
5. “It’s Our Body”- Having Choice
6. Support
7. Value of Tube

CT= chemotherapy; FT= feeding tube; HNC = head and neck cancer; NGT= nasogastric tube; PEG = percutaneous endoscopic gastrostomy tube; RIG = radiological
inserted gastrostomy tube; RT = radiotherapy
a
JBI-QARI score (126) used to assess quality of studies included in the qualitative systematic literature review in Chapter 6 as recommended by the Joanna Briggs
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Institute (126)
b
Study not included in narrative review in Chapter 3, as data was collected via a questionnaire tool rather than interview or focus group
c
Study included in the systematic literature review reported on in Chapter 6, as it was published following the literature search.

Table 3. Qualitative study on the perspectives of nutritional care for patients with head and neck cancer among healthcare professionals included in the
narrative review in Chapter 3.

Reference,
year,
geographical
location

Study design
/
methodology

Phenomenon
of interest

Datacollection
method

Martin,
Europe, 2014

Qualitative

Barriers and
enablers to
nutrition care
in patients
with head
and neck and
oesophageal
cancers in
several
international
settings

Semistructured
interview
and focus
group
(thematic
analysis).

Author’s summary of results

Author’s conclusions

COREQ
score (128)

Roles and responsibilities of nutrition care:

Interview and focusgroup participants
agreed the following
actions will result in
improvements in
nutrition care: (1)
enhance the evidence
base to test the benefit
of nutrition
interventions, with a
focus on resolving
specific controversies
regarding nutrition
therapy, and (2)
establish a minimum
data set with a goal to
create standardised
nutrition-care pathways
where roles and
responsibilities for care
are clearly defined.
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Participants

Total
healthcare
professionals

Country

Disciplines

n=29

The Netherlands: n=8
Sweden: n=3
Italy: n=6
Scotland: n=5
France: n=7
Surgeons: n= 8
Radiation oncologists:
n=3
Medical oncologists: n=3
Physician nutritionist:
n=2
Nutrition professionals:
n=6
Nurses: n=5
Speech language
pathologist: n=1
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-

At every site, the physician (oncologist or
surgeon) was identified as the team leader and
primary decision-maker for nutrition care

-

Other team members involved in nutrition care
(e.g., nurses, dietitians, speech and language
pathologists) were identified with varying
frequency, and the expected contribution to
nutrition care was variable

-

The dietitian's primary role is to assess, plan, and
provide nutrition interventions and to follow up
patients' nutrition status while under care.

Barriers and enablers to nutrition care: Evidence base
demonstrating benefit of nutrition interventions;
Implementation processes for nutrition care (inclusive
of assessment, intervention and follow-up); Provider
characteristics; Site factors; Patient characteristics.

APPENDIX 2: Interview guide used with patients in Study 2
(Chapter 5)
Rounding Questions 1 - After Initial Surgical or Radiotherapy Consultation











How are things going at the moment?
Tell me about how you came to be diagnosed?
Have you seen a general practitioner (GP) since your consult with the Surgeon/Radiation Oncologist? If so, how
many times?
Are you still seeing the same GP who referred you regarding your cancer diagnosis?
Do you talk to your GP about the plan for the cancer treatment?
What are the next steps before you have surgery/start the radiotherapy treatment? Who do you feel is “in charge”
of your treatment plan at the moment?
Have you had contact with any other health professionals other than a doctor at this time (e.g. speech pathologist,
dietitian, social work, specialist nurses etc.), and if so, is there a plan for follow follow-up with any/all of these
health professionals?
If you have questions or concerns about your treatment, who would you talk to? Do you feel this helps?
Do you feel you have enough information about your condition and treatment?
Do you feel that there is sufficient communication between the health professionals about your condition and
treatment?

Rounding Questions 2 - Post-Operative Interview











How are things going at the moment?
Tell me about your hospital stay and the surgery – was it what you had expected?
What is the next step now that you have been discharged from hospital?
Have you had an opportunity to see the surgeon again after your surgery?
Did you see any other health professionals while you were in hospital (e.g. speech pathologist, dietician, social
work, specialist nurses etc)? If so, is there any plan to follow up with these health professionals?
Have you seen a GP since your discharge from hospital? If so, how many times?
Are you still seeing the same GP who referred you regarding your cancer diagnosis?
Do you talk to your GP about the cancer treatment?
Do you feel you have enough information about your condition and treatment?
Do you feel that there is sufficient communication between the health professionals about your condition and
treatment?

Rounding Questions 3 – Post-surgery OR Six Weeks Post-Completion of Radiotherapy










How are things going at the moment?
What do you understand is the “next step” /where to from here?
Have you seen a GP since your surgery/since completing the radiotherapy? If so, how many times?
Are you still seeing the same GP who referred you regarding your cancer diagnosis?
Do you have any ongoing contact with health professionals other than doctors? If so, what is the plan for followup with these health professionals?
Is there anything that has been helpful or unhelpful to your understanding of your current progress?
When you have questions or concerns about your progress, who do you feel most comfortable discussing this
with? Do you feel that any concerns or questions that you have are being addressed?
Do you feel you have enough information about your condition and treatment?
Do you feel that there is sufficient communication between the health professionals about your condition and
treatment?

Rounding Questions 4 – Four Months Post-Surgery OR Post-Completion of Radiotherapy








How are things going at the moment?
Is there a plan for ongoing follow-up? How are you feeling about this? Does your GP play a part in the followup?
Do you have any ongoing contact with health professionals other than doctors?
Is there anything that has been helpful or unhelpful to your understanding of your current progress?
Is there anything that you feel is an issue for you or that you have concerns about, which aren’t being addressed?
Do you feel you have enough information about your condition and treatment?
Do you feel that there is sufficient communication between the health professionals about your condition and
treatment?
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APPENDIX 3: Outline of the coding-tree from Study 2 (Chapter 5)
Table 1. Coding tree of categories, sub-categories and focused codes related to patients’ perceptions of nutritional care
Categories
Preparing for nutritional
challenges

Sub-categories
Becoming informed by healthcare
professionals

Becoming familiar with clinic structure with nurse, dietitian and speech pathologist
Being prepared for dietetic involvement throughout treatment
Feeling reassured through being informed
Learning of the need for a PEG tube
Preparing for feeding tube insertion
Receiving information from physicians and nurses about potential nutritional side-effects
Receiving PEG education

Experiencing early nutrition-impact
symptoms

Experiencing oral pain
Having no appetite
Having to make dietary texture adjustments
Fearing mortality
Fearing potential side-effects
Feeling isolated
Having unanswered questions
Preparing for whole-of-life impact

Fear and uncertainty in diagnosis

Overwhelmed with information

Multidisciplinary approach
directed by patient needs

Focused codes

Having multiple health priorities

Importance of interprofessional
collaboration

Attending multiple appointments
Meeting several different specialists and healthcare professionals
Receiving information from multiple sources
Being hospitalised
Benefiting from tailored information and interventions
Coping with side effects
Experiencing nutritional issues
Experiencing swallow issues
Having issues with transport or accommodation
Requiring emotional support
Trying to manage medications
Experiencing well-coordinated care
Receiving well-coordinated collaborative care
Recognising scope-of-practice boundaries of different healthcare professionals
Sorting out issues in a timely fashion within the team
Valuing continuity of care
Valuing good communication
Valuing joint clinic structure with nurses and allied health
Viewing treatment as a whole-of-team approach
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The battle to eat

Incongruence between patient
values and nutritional
priorities

Requiring support from healthcare
professionals with different expertise

Dietitians lading nutritional care
Nursing support for symptoms and coordination of care
Physicians for medical priorities
Physicians directing treatment
Speech pathologists for swallow therapy

Physical barriers

Experiencing anorexia
Experiencing dysgeusia
Experiencing dysphagia
Experiencing fatigue
Experiencing mucositis
Experiencing nausea
Experiencing oral numbness
Experiencing oral pain
Experiencing radiotherapy burn
Experiencing weight loss
Experiencing xerostomia

Psychosocial barriers

Associating feeding tube use with illness
Having depressive episodes
Having family commitments
Viewing weight loss as a positive side-effect

Disagreeing with advice and
recommendations from healthcare
professionals

Conflicting beliefs with healthcare professionals
Negative eating experiences
Negative feeding-tube experiences
Perceiving a lack of empathy
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APPENDIX 4: Synthesised findings, categories and author findings from the systematic literature review
(Chapter 6)
Table 1. Synthesis of Finding One

Synthesised finding
Patients may initially experience
feelings of reluctance, fear and
anxiety toward feeding tubes,
including feeding tube insertion and
removal, nutritional decline,
feeding tube permanence, social
stigma and the risks of feeding
tubes.

Categories
Being tube-fed

Findings
Constant fear of being fed via feeding tube, if not compliant, added to patient stress and frustration (Alberda p. 669)
Most individuals talked about wanting to avoid a feeding tube, hoping to maintain the ability to eat and drink by mouth throughout the treatment
(Govender p. 563)
Participants described hope that [enteral feeding] would be short-term and that they would resume normal eating (Williams p. 4)
Participants who declined a G-tube before treatment reported… the hope that they would not require enteral feeding as rationale for their decision.
(Williams p. 3)
Participants with both prophylactic G-tube and reactive NGTs described starting treatment with hope that they would not require enteral feeding
(Williams p. 2)
Pre-treatment they hoped that they would be able to continue to maintain oral intake during treatment and would not require [enteral feeding]. When
this hope was lost and they realised that they did require [enteral feeding] they did not cope well. (Williams p. 4)
Prior to PEG tube insertion, participants… felt a reluctance about the idea of having one inserted (Kwong p. 528)
When a PEG tube was offered as a supportive measure for nutrition during treatment, participants often struggled with the decision to accept its
placement (Kwong (p. 528)

Insertion and removal

Nutritional decline

Permanence

Distinguishing statements included … marked anxiety around the procedure to insert the tube (Merrick p. 500)
Their concerns were focused on initial tube insertion, removal of G-tube (Williams p. 2)
Participants had initial fears, including the tube falling or being pulled out (Kwong p. 529)
Participants who declined a G-tube before treatment reported the risks and apprehension associated with the procedure (Williams p. 3)
Their concerns were focused on accidental tube displacement (Williams p. 2)
Their primary response of this group was fear and anxiety, which appeared to be focused on the PEG tube but specifically the procedure to insert the
tube (Merrick p. 500)
Their concerns were focused on… nutritional decline during treatment (Williams p. 2)
Their inability to eat meant they could not achieve their recommended calorie and protein goals, which they were told was needed for physical
healing and recovery (Alberda p. 668)
Participants discussed their motivation to set goals and to progress with eating, with a view to avoiding dependence on their tube (Williams p. 2)
Some healthcare providers informed patients of a risk of relying on the feeding tube too much and, as a result, a risk of permanently losing
swallowing capacity. Therefore, most patients in the head and neck cancer group were reluctant, fearing that the feeding tube would be a permanent
solution (Alberda p. 668)
The expected time that the tube would remain in-situ was a major source of anxiety for many participants (White p. 1048)
Their concerns were focused on… the risk of enteral feeding tube dependence (Williams p. 2)
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Social stigma

Tube feeding risks

Participants with NGTs experienced anxiety over public reaction which influenced their confidence in socialising (Williams p. 3)
Some participant responses indicated that they viewed starting enteral feeding as an admission of defeat, describing feelings of disappointment and
failure (Williams p. 2)
The patients with HN cancer viewed tube insertion as a personal failure and therefore chose not to have a feeding tube placed (Alberda p. 668)
Another participant reported being distressed when he was only told about the risks associated with having the gastrostomy placed on arrival in the
endoscopy suite. He suggests that improved knowledge prior to tube placement could have prevented the significant anxiety he experienced,
allowing time for any questions to be answered (White p. 1050)
Knowing the risks may have made him more anxious during the time leading up to the gastrostomy placement (White p. 1048)
Participants had initial fears, including anticipation of pain (Kwong p. 529)
Some felt that being asked to fully consider the impact of [home enteral feeding] may have caused additional anxiety and were content with dealing
with any adverse consequences as they occurred (White p. 1049)

Table 2. Synthesis of Finding Two

Synthesised finding
Understandings and expectations
of feeding tubes can vary among
patients with head and neck
cancer. Some patients understand
the feeding tube as a necessary
part of cancer treatment, while
others experience uncertainty
toward the feeding tube. Being
informed can positively influence
understanding of feeding tubes,
whereas conflicting view from
healthcare professionals can
negatively affect patient
understanding.

Categories

Findings

Being informed

As the expected time that the tube would remain in-situ was a major source of anxiety for many participants, this was felt an important issue to be
addressed, in terms of managing their expectations (White p. 1048)
All participants felt well-supported on both a practical and emotional level. Participants valued information as a form of support and received it
from sources within the healthcare setting, via internet research and through information sharing with fellow patients. (Williams p. 3)
Patients were more able to cope [than caregivers] because they were the main focus of the treatment and time had been dedicated to help them make
an informed decision (Mayre-Chilton p. 452)
Another participant reported being distressed when he was only told about the risks associated with having the gastrostomy placed on arrival in the
endoscopy suite. He suggested that improved knowledge prior to tube placement could have prevented the significant anxiety he experienced,
allowing time for any questions to be answered. (White p. 1048)
Those participants who were informed about the possibility of pain post-gastrostomy placement, felt that this knowledge prepared them better for it
(White p. 1048)
Communication with the healthcare team aided participants’ decision-making (Kwong p 529)

Conflicting views from
healthcare professionals

There was an element of conflicting advice and the omission of information, which resulted in a negative impact on the patients (Mayre-Chilton p.
452)
They received mixed messages from different professionals involved in their care (Alberda p. 668)

Necessary part of cancer
treatment

A positive health outcome was the driving force in most participants’ decision to have a gastrostomy (White p. 1047)
As most patients had the gastrostomy placed in preparation for radiotherapy to the head and neck, the tube placement was perceived to be part of a
treatment package that included radiotherapy and the removal of teeth rather than a decision in its own right (White p. 1049)
Most participants had undergone radiotherapy for ENT [ear nose and throat] cancer, and decided to have the gastrostomy placed thinking that it
would maximise their chances of a successful outcome (White p. 1047)
Others found it easier to accept enteral feeding and viewed the tube as a necessity (Williams p. 2)
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There was discussion about participants feeling there was no choice in the matter; the tube was viewed as a necessity (Kwong p. 529)

Uncertain expectations

They perceived that gastrostomy placement was not the priority for the treating health professionals; it was just something that had to be done as
part of the treatment However, one participant was dissatisfied with gastrostomy placement being considered part of a treatment package (White p.
1048)
Most participants ‘didn't know what to expect’ (P4) about what it would be like to live on [home enteral feeding] (White p. 1049)
Patients with [head and neck] cancer felt uncertain about the role of the feeding tube (Alberda p.668)
Prior to PEG tube insertion, participants were unfamiliar with the tube (Kwong p. 528)
Some participants felt that they would not have been able to imagine what it would be like to be on HEF; and if asked to consider the potential
impact, they may have reacted by thinking that this wouldn't be the case for them (White p. 1049)

Table 3. Synthesis of Finding Three

Synthesised finding
The experience of choice with
regards to feeding tubes can
vary among patients with head
and neck cancer. Some patients
may feel that the choice was
presented as theirs to make,
while other may feel that a
feeding tube is a necessary part
of cancer treatment. Some may
value having choice, while
other patients may feel
overwhelmed with that
responsibility.

Categories
Given a choice

Findings
A minority of patients felt they had a choice about gastrostomy placement. These patients described being presented with some information on
gastrostomy placement and the reasons why the medical team felt it was necessary, but were also made aware that it was their decision to make
(White p. 1049)
Choices around the PEG tube focused on decision –making processes concerning the tube insertion and the timing of the procedure. Tubes were
inserted prior to treatment when serious eating problems were present or anticipated. Other PEG tubes were inserted at various stages of treatment
after challenges with oral intake emerged (Kwong p. 528)
Participants commonly reported that they felt they had been included in the decision-making process at pre-treatment and that they had made the
final decision regarding the choice of tube (Williams p. 3)
The option of having a feeding tube during radiation and chemotherapy, when the ability to eat and swallow was affected most, was presented to
patients as their own choice (Alberda p. 668)

No choice- tube is a
necessity

Overwhelmed by choice

As most patients had the gastrostomy placed in preparation for radiotherapy to the head and neck, the tube placement was perceived to be part of a
treatment package that included radiotherapy and the removal of teeth rather than a decision in its own right (White p. 1049)
Others found it easier to accept enteral feeding and viewed the tube as a necessity (Williams p. 2)
There was discussion about participants feeling there was no choice in the matter; the tube was viewed as a necessity (Kwong p. 529)
From diagnosis with cancer, decisions regarding the treatment plan were being made very quickly and there was little time to think too far into the
future (White p. 1049)
Participants informed that they have ENT cancer described having to cope with the shock of the diagnosis; the treatment plan; the removal of teeth;
in addition to the need for a gastrostomy (White p. 1048)
Participants were faced with many difficult decisions regarding treatment options. When a PEG tube was offered as a supportive measure for
nutrition during treatment, participants often struggled with the decision to accept its placement (Kwong (p. 528)
Several participants thought that being asked to consider the potential consequences of being on [home enteral feeding] may have been too much
information and even discourage patients from having the tube placed (White p. 1048)
Some felt that being asked to fully consider the impact of [home enteral feeding] may have caused additional anxiety and were content with dealing
with any adverse consequences as they occurred (White p. 1048)
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Value having a choice

All of the participants described strong rationale for their selection of enteral feeding tube. Participants who chose prophylactic G-tubes believed
they would not tolerate the physical presence of the nasogastric tube nor would they be able to cope with the social stigma associated with it.
(Williams p. 3)
Most acknowledged that this was important and the involvement in this decision may contribute to the positivity participants reported regarding the
value of their tube (Williams p. 3)
Most participants had undergone radiotherapy for ENT (ear nose and throat) cancer, and decided to have the gastrostomy placed thinking that it
would maximise their chances of a successful outcome (White p. 1047)
Participants coped well if they had control over the choice of enteral tube; the timing of the commencement of enteral feeding; and their enteral
feeding regimen and tube care. Most did describe control over these aspects during their treatment and, as a result, appeared to cope well (Williams
p. 3)

Table 4. Synthesis of Finding Four

Synthesised finding
Physical discomfort related to
feeding tubes may be
experienced by patients with
head and neck cancer, such as
discomfort with the presence
and insertion of feeding tubes,
nasogastric tubes related nose
and throat irritation, or
gastrostomy-tube insertion site
pain.

Categories
Gastrostomy site

Nose, throat and
gastrointestinal

Findings
Despite the fact that the negatively loaded statements suggest that the respondents had no real feeding problems with the PEG tube, they nonetheless
reported a number of negative concerns, such as… having problems with the site. (Merrick p. 500)
Other negative problems described by the patients were… that the stomach area around the PEG tube hurt (Ehrsson p. 287)
Patients with PEG more frequently reported problems with… pain around the stoma compared to patients with NGT (Ehrsson p. 287)
Other negative problems described by the patients were about having the tube), how it was irritating to have the NGT in the nose and throat
(Ehrsson p. 287)
Patients with NGT talked more about irritation in the nose and throat, drooling, viscous phlegm, and feelings of nausea when eating than did
patients with PEG (Ehrsson p. 287)

Tube presence and
insertion

A typical experience for patients having PEG was that the tube was disturbing and uncomfortable (Ehrsson p. 287)
In comparison with patients with NGT, patients with PEG more often stated that the manner of insertion of the PEG tube was a negative experience
(Ehrsson p. 287)
Participants described the presence and insertion of a NGT as uncomfortable (Williams p. 2)
Participants described varying experienced of G-tube insertion ranging from those who found the procedure easy, to those who described significant
pain and discomfort. (Williams p. 2)
Two participants suggested that they regretted having the tube placed (P1 and P3). They believed that the placement of a gastrostomy had not met
their expectations. Notably, they were also the only participants who experienced significant distress relating to tube placement and the impact of
[home enteral feeding] (White p. 1050)

Table 5. Synthesis of Finding Five

Synthesised finding

Categories
Activities of daily living

Findings
Other participants recognised the PEG tube as not fitting into a normal lifestyle (Kwong p. 530)
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For patients with head and neck
cancer, feeding tubes may
place restrictions on their social
life and activities of daily
living. Negative social and
daily life experiences may be
related to missing eating,
relationships and selfconsciousness.

[Home enteral feeding] tubes placed restrictions on hobbies, holiday plans, physical activity and return to work (Williams p. 4)

The tube was disturbing when they tried to sleep (Ehrsson p. 287)
Missing eating

Missing eating and craving for food was a particular challenge for many participants. This was reinforced at family mealtimes, when preparing food
for other members of the family and when exposed to food on television and in magazines (Williams p. 4)
Some patients also described that they missed eating and drinking orally (Ehrsson p. 287)

Relationships

Self-consciousness

Social life impact

Although only one of the participants identified that [enteral feeding] tubes had affected relationships within her family, the significance of this data
warrants its inclusion. This participant talked about how her NGT had affected her relationship with her grandchild and how, later in her treatment,
her G-tube affected intimacy in her relationship with her husband (Williams p. 4)
One issue brought up was intimacy (Mayre-Chilton p. 453)
For others, there was stigma associated with the tube (Kwong p. 530)
In comparison with patients with NGT, patients with PEG stated less often that it was embarrassing. (Ehrsson p. 287)
Participants coped better if they were able to continue living a normal life. Those with G-tubes reported this was possible due to the privacy and
discreetness offered by the G-tube (Williams p. 4)
Participants with NGTs experienced anxiety over public reaction which influenced their confidence in socialising (Williams p. 3)
Patients with PEG more frequently reported problems with the unhygienic feeling of the PEG tube with regard to leakage and a bad odour (Ehrsson
p. 287)
The experiences of those participants with G-tube were in stark contrast to the experiences of participants with NGTs, reporting that discreet nature
of the G-tube actually enabled them to continue to go out (Williams p. 3)
They felt embarrassed being around other people (Ehrsson p. 287)
Typical for patients with NGT was that they felt embarrassed because part of the tube was visible, which in turn hindered social activities (Ehrsson
p. 287)
There was a negative impact of perception and feelings of both groups, specifically for the social aspects of their lives (Mayre-Chilton p. 453)
There were discussions around socialization and daily living. Some participants reported no problems (Kwong p. 529)
When making the decision P11 admitted being a ‘stick your head in the sand type of person’ but was surprised by the impact that [home enteral
feeding] had on her home life, describing the effect on her social life as “massive” (White p. 1050)

Table 6. Synthesis of Finding Six

Synthesised finding
Having a feeding tube may
result in new challenges and
responsibilities for patients

Categories
Finances
Feeding-regimen burden

Findings
Issues about waiting for funding for a low-profile gastrostomy tube by the Primary Care Trust were expressed as a negative impact (Mayre-Chilton
p. 455)
For some participants, the [enteral feeding] regimen was particularly restrictive and time-consuming. (Williams p. 4)
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with head and neck cancer,
including finances, feedingregimen burden and tube use
and maintenance.

Tube use and maintenance

The negative aspects described in the interviews by the patients concerned problems with the feeding procedure as it was time-consuming and for
some patients it was difficult to manage to take all the planned nutritional bags per day (Ehrsson p. 287)
Insertion, care, and use of a PEG tube added additional elements to manage, which greatly affected the participants’ daily lives. Activities described
included tube and equipment care, feeding, ensuring adequate nutrition and hydration, and administration of medication. There was much discussion
of the work associated with the maintenance of the tube (Kwong p. 529)

Some participants commented on spillage (Kwong p. 529)
They also described practical difficulties with handling the tube and in connection to the feeding procedure (Ehrsson p. 287)
Unlike the many disadvantages that participants considered to be associated with NGTs, those participants with G-tubes considered the restrictions
of the [enteral feeding] regimen the main disadvantage associated with the tube (Williams p. 4)

Table 7. Synthesis of Finding Seven
Synthesised finding
Patients with head and neck
cancer may become more
accepting of the feeding tube
over time by adapting their
routine, through developing
coping strategies, if the feeding
tube is less burdensome than
expected, by receiving social
support and when eating orally
becomes a significant struggle.

Categories
Adapting to daily life

Findings
Caring for the tube became easier with time suggesting that these participants adapted effectively to their situation (Merrick p. 498)
Despite changes to the way of life they were accustomed to, most participants described how they adapted to being on [home enteral feeding] by
adopting a new routine. (White p. 1050)

Developing coping
strategies

Participants were able to learn, manage and incorporate many tube-related activities into their lives. To some, there was a sense of normalisation;
the tube became part of their routine (Kwong p. 529)
The ability to adapt was reflected in the way participants described getting used to the presence of the tube and the change to their daily routine
(White p. 1050)
Attempts to reduce burden both on family members and on healthcare professionals were used as a coping mechanism by some participants.
Participants described a personal responsibility for managing [enteral feeding] and the care of their [enteral feeding] tube (Williams p. 4)
Both patients and caregivers demonstrated the development of strategies to help them cope with changes in their daily lives as a result of the
gastrostomy tube. In the case of patients most positive outlooks and strategies were observed in accepting decisions, as well as in the areas of daily,
lifestyle and social activities (Mayre-Chilton p. 452)
For patients who recognized that swallowing function might be impaired, a desire to prevent negative consequences such as reliance on a
gastrostomy tube was identified as an important facilitator for initiating swallowing exercises (Govender p. 566)
Participant attempts to reduce financial burden to the NHS by minimising the waste of feed and equipment (Williams p. 4
Participants gave consideration to bolus and overnight pump regimens to reduce the burden of the [enteral feeding] regimen. (Williams p. 4)
Participants learned how to adapt to the tube and discovered strategies that worked well for them (Kwong p. 530)
Participants liked the option of either bolus feeding via syringe or gravity drip depending on their lifestyle and preference (Kwong p. 530)
Participants mentioned various strategies for oral intake that included soaking foods, adding gravies and sauces, eating slowly, carrying water, and
trialling different foods (Kwong p. 531)
Personal control appeared to have been significant in how participants coped with having an [enteral feeding] tube and with [enteral feeding].
Participants coped well if they had control over the choice of enteral tube; the timing of the commencement of enteral feeding; and their enteral
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Less burdensome than
expected

Social acceptance and
support

The struggle to eat

feeding regimen and tube care. Most did describe control over these aspects during their treatment and, as a result, appeared to cope well (Williams
p. 3)
Some participants appeared to use downward comparison as a coping strategy e comparing themselves to others whose problems were worse than
their own, enabling them to view their own situation in a more positive light. (Williams p. 4)
The level of resilience varied between participants. Those participants who had NGTs showed significant resilience although it is not clear whether
their resilient characteristics were the reason they felt able to cope with an NGT or if they developed resilience after having the NGT. When
considering attitudes of others, male participants with NGTs appeared to show more resilience than female participants (Williams p. 3)
Being able to go out because no one could see the tube was also a distinguishing statement. (Merrick p. 498)
On reflection, most participants generally felt that being on [home enteral feeding] was less of a burden than they thought it would be. (White p.
1050)
The tube was easier to look after than expected as was the process of feeding. There was no mess associated with feeding; organising it around
hospital visits was not considered problematic and it did not preclude holidays (Merrick p. 500)
Participants thought being honest, comfortable, and inclusive of others made interactions easier (Kwong p. 530)
Some patients expressed a lack of active care after their treatment and discharge into the community, which had a negative impact on them (MayreChilton p. 455)
Some required support for feeding while others did not (Kwong p. 530)
The patients and care-givers expressed a positive impact on approaching the hospital multidisciplinary team, especially those patients receiving
radiotherapy who attended the weekly treatment multidisciplinary clinic, where they had access to the registrar, dietitian, nurse and other
professionals in one clinic (Mayre-Chilton p. 455)
There was divided opinion on the role of the family in support with [enteral feeding] tubes and with [enteral feeding]. Only one participant
described a reliance on her husband to support her with [enteral feeding]. Other participants involved family members as a way of supporting that
family member. (Williams p. 3)
Timely dietetic management helped them wean off tube reliance with more confidence (Mayre-Chilton p. 454)
Initially, participants did not realise how difficult oral intake would become as treatment progressed (Kwong p. 529)
Participants experienced many nutrition-related concerns during treatment that influenced their decision to accept a medical/ dietetic
recommendation for enteral feeding. They described a battle and worry over physical symptoms (weight loss, dysphagia, pain and taste
disturbances) as the key reason for accepting the recommendation to commence enteral feeding during treatment (Williams p. 2)
Participants experienced various nutrition-related concerns that affected the decision to have a PEG tube placed, including pain, swallowing issues,
and significant weight loss. These difficulties were related to side effects of treatment or symptoms of the cancer, including xerostomia, taste
alterations, and trismus (Kwong p. 529)
Participants’ described a steady decline in their oral intake as treatment progressed. (Kwong p. 529)
The ability to adapt was reflected in the way participants described … their inability to take oral diet (White p. 1050)

Table 8. Synthesis of Finding Eight
Synthesised finding
For patients with head and
neck cancer, transitioning
from a feeding tube to an oral
diet can be a challenging,

Categories
Gradual progression

Findings
Individuals described feeling rewarded by small improvements in their swallowing which motivated them to do their exercises in the hope that they
could achieve more. This included receiving positive feedback about the outcome of doing their exercises (for example increased mouth opening,
seeing with biofeedback that they could reduce aspiration) or experiencing an improvement in function such as the ability to drink something after a
long period of being unable to (Govender p. 566)
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learning and rewarding
process, as experiences may
include oral intake
discomfort, removal
impatience and tube
dependence.

Oral-intake discomfort

Removal impatience

Tube dependence

Participants mentioned various strategies for oral intake that included soaking foods, adding gravies and sauces, eating slowly, carrying water, and
trialling different foods (Kwong p. 531)
They felt their lives could go back to some sort of normalcy (Kwong p. 531)
Transitioning was described as a gradual progression and a learning experience (Kwong p. 530)
While challenging, participants saw a gradual improvement in their eating/ oral intake (Kwong p. 530)
Both groups expressed the difficulties in weaning off the tube onto oral foods. Overall, the data highlight the many influential factors, such as taste,
smell, lack of saliva, pain, length of time taken to eat (Mayre-Chilton p. 454)
When asked to describe the first experience of returning to an oral diet, participants used words like “weird”, “strange”, and “unexplainable”
(Kwong p. 531)
Despite the fact that the negatively loaded statements suggest that the respondents had no real feeding problems with the PEG tube, they nonetheless
reported a number of negative concerns, such as the desire to have the PEG removed. (Merrick p. 500)
Distinguishing statements included looking forward to having the tube removed (Merrick p. 500)
Most participants reported frustration at the time it had taken for their dysphagia to resolve, and the subsequent effect it had on the length of time the
gastrostomy had remained in-situ (White p. 1050)
Most participants were either awaiting gastrostomy removal or heralded some hope of future tube removal. (White p. 1048)
There was an awareness of eating and understanding foods needed to have value (Kwong p. 530)
Both groups expressed many possible reasons that prevented them from weaning off the gastrostomy tube onto normal foods. Overall, the data
highlight the many influential factors, such as … psychological concerns, that the tube feeding helps them to cope with (Mayre-Chilton p. 454)
For some, there was a dependence on the tube (Kwong p. 531)
Participants celebrated tube removal but, at the same time, were fearful of no longer being able to rely on the tube (Kwong p. 531)
Timely dietetic management helped them wean off tube reliance with more confidence (Mayre-Chilton p. 454)

Table 9. Synthesis of Finding Nine
Synthesised finding
Patients with head and neck
cancer may recommend a
feeding tube to other patients
as an overall worthwhile
experience, as a feeding tube
may help with managing
disease and treatment side
effects, prevent nutritional
decline, relieve the fear of
choking, be a source of
reassurance through
treatment and be associated
with survival.

Categories
Benefits outweigh the
negatives

Findings
Having a tube attached is an inconvenience but lifesaving (Osborne p. 664)
Most patients felt they did not regret having the tube placed and would make the same decision again. This is despite experiencing some of the
negative impacts of being on [home enteral feeding] (White p. 1050)
The benefits outweigh the negatives (Osborne p. 664)

Managing cancer and
treatment side effects
Prevented nutritional decline

While viewed as a slight inconvenience, all participants recognized the value that the PEG tube held (Kwong p. 531)
With the benefit of hindsight some patients accepted that they needed to have the tube placed (White p. 1049)
Participants referred to the PEG tube as something they had to have in order to endure their cancer and treatment experience (Kwong p. 531)
Participants valued their tubes … in supporting recovery. (Williams p. 3)
The tube was viewed as a functional benefit—equipment that helped participants manage side effects of cancer treatment (Kwong p. 531)
Both groups found the main benefit and positive impact of the tube placement to be weight management (Mayre-Chilton p. 453)
Initially, participants did not realise how difficult oral intake would become as treatment progressed (Kwong p. 529)
Participants also acknowledged that the PEG tube either stopped or reduced their weight loss as it provided them with an alternate means of
obtaining nutrition (Kwong p. 531)
Maintaining nutritional intake, weight control… were amongst the positive outcomes mentioned. (White p. 1047)
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Relieved fear of choking

Source of reassurance

Survival

Would recommend to others

Participants, who described their expectations being met, generally referred to how being on [home enteral feeding] had facilitated the achievement
of a positive outcome, including… maintaining nutritional intake (White p. 1050
Participants recognised the problem-solving value of the PEG tube (Kwong p. 531)
Participants valued their tubes in practical terms (nutrition, fluid and medication provision) (Williams p. 3)
Realised they would have lost weight without it (Ehrsson p. 287)
The PEG tube was also identified as some patients’ sole source of nutrition (Kwong p. 531)
Participants made comments about the emotional/psychological benefits that having a PEG tube provided as it helped relieve the fear of choking
and the pain of swallowing (Kwong p. 531)
Participants, who described their expectations being met, generally referred to how being on [home enteral feeding] had facilitated the achievement
of a positive outcome, including preventing choking (White p. 1050
Preventing aspiration… amongst the positive outcomes mentioned. (White p. 1047)
Issues around reassurance when unable to eat also featured strongly (Merrick p. 498)
The PEG tube gave a sense of hope to participants (Kwong p. 531)
They also acknowledged the emotional/psychological benefits of an [enteral feeding] tube including making life easier; providing a relief from
worry and the pain of eating; and providing reassurance (Williams p. 3)
They did not have to battle with each meal and to worry about not getting beverage and food, they received calories (Ehrsson p. 287)
They had underestimated how difficult maintaining oral intake would be during treatment (Williams p. 2)
Tolerating treatment… amongst the positive outcomes mentioned. (White p. 1047)
Overall, both groups expressed a positive impact of having the gastrostomy tube placed before any further cancer treatment because they recognised
that they would not have survived without it (Mayre-Chilton p. 455)
Participants often described the tube as having saved their lives (Kwong p. 531)
Participants perceived had they not had the gastrostomy placed, they would not have been able to take adequate oral diet, which may have had
serious consequences in terms of their prognosis (White p. 1049)
Participants, who described their expectations being met, generally referred to how being on [home enteral feeding] had facilitated the achievement
of a positive outcome… and in many cases survival (White p. 1050
Survival was amongst the positive outcomes mentioned. (White p. 1047)
All participants would recommend to future patients that they have a tube placed if recommended by their healthcare professional (Kwong p. 531)
Because the value of the [enteral feeding] tube was recognised, all participants recommended that future patients have [enteral feeding] tubes placed
if advised, with only one participant recommending the alternative tube (G tube) to the one he had decided on (NGT) (Williams p. 3)
Two individuals who did not find the PEG tube worthwhile themselves would still recommend it to someone else (Osborne p. 667)
When asked what they would tell another patient about their experience with having a PEG tube, 51% independently responded with the same
spontaneous message of “get it.” (Osborne p. 664)

G tube = gastrostomy tube; HNC = head and neck cancer; NGT= nasogastric tube; PEG = percutaneous endoscopic gastrostomy tube
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APPENDIX 5: Interview guide used with healthcare professionals
for Study 4 (Chapters 7-9)
Can you tell me a bit about the main nutritional issues that arise with the head and neck patients in your opinion?
(Which patients are most nutritionally at risk? Do you have a system or guideline for identifying patients at nutritional
risk, e.g. screening process?)
Are you able to talk through a scenario where a patient with head and neck cancer had a nutritional issue and
how that was managed within the team? (Do you have any nutrition care policies or local guidelines? Feeding tube
placement process? Dietetic referral?)
Can you tell me a bit about the dietitian’s role within this cancer service for the patients with head and neck
cancer? (Does you department have a nutrition referral pathway?)
Can you tell me a bit about how the role of the dietitian fits within the head and neck cancer team? (What are
their key responsibilities? Do they have a role in feeding tube placement recommendations? Do they have a role in
managing dehydration? Are they managed by the department or managed by the hospital dietetic department? Source
of funding for the position? Full-time or part-time position?)
What things do you think enhances or hinders an effective multidisciplinary approach to nutritional care for
patients with head and neck cancer? (Physical layout of the clinic? Culture? Personalities?)
Do you have any other comments that you would like to make about the role of the dietitian, multidisciplinary
nutritional care or nutritional interventions for patients with head and neck cancer
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APPENDIX 6: Outline of the coding-tree from Study 4a (Chapter 7)
Table 1. Coding tree of categories, sub-categories and focused codes related to healthcare professionals’ perspectives on feeding tubes for patients with head and
neck cancer
Categories
Perspectives
of feeding
tubes for
patients with
HNC

Sub-categories

Focused codes

A valued support

Describing how feeding tubes can minimise treatment delays and interruptions
Highlighting the relationship between poor nutritional outcomes and health service burden
Linking positive patient outcomes with nutritional care
Recognising nutritional burden associated with HNC

More individualised

Shifting practices from using a blanket approach to gastrostomy placements
Changing practices as previously all patients treated with chemo-radiation received a tube
Becoming more discerning about placing feeding tube
Improving treatment technologies for improved nutritional outcomes and less need for feeding tubes
Emerging evidence on what patients benefit most from feeding tubes
Improving care via multidisciplinary teams as way to avoid feeding tube placements
Increasing evidence on gastrostomy-associated risks
Becoming more individualised with feeding-tube recommendations
Using more conformal treatments lessening the need for feeding tubes for all patients
Changing patient demographics resulting in less nutritionally vulnerable patients related to poor socioeconomic status
Becoming more familiar with patient profile and who will struggle nutritionally
Learning more about risk of complications with gastrostomy tubes
Having greater access to supportive-care services to get patients through treatment without a feeding tube
Conflicting evidence on enteral feeding linked to variable practices
Institutional traditions directing feeding-tube decisions
Lacking clear guidelines
Personal experiences affecting feeding -tube decisions
Feeling it is more patient-centred to encourage patients to maintain oral intake

No universal practices

Prophylactic gastrostomy
versus reactive
nasogastric tubes

Viewing gastrostomy approach as most beneficial
Reserving reactive nasogastric tubes to those who require it that did not receive a gastrostomy prophylactically
Preferring not to place feeding tubes prophylactically
Being open to placing gastrostomy tubes prior to radiotherapy if nutritional issues already present
Needing a reactive feeding tube option to support patients who become unwell quickly during treatment
Aiming to manage patients without feeding tube and reacting with NGT as last resort
Being guided to use a reactive NGT approach due to health insurance barriers to prophylactic placements
Viewing reactive gastrostomy approach as more dangerous due to increased infection risk with chemotherapy
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Feeding tube
placement
considerations

Patient factors
Planned treatment
Tumour
characteristics
Nutrition and
swallow status
Risk of feeding-tube
dependence
Psychosocial status
Patient preferences

Service-structure factors
Dietetic access
Speech-pathology
access
Interprofessional
collaboration
Nutrition-support
resources

Trying to encourage and motivate patients to have prophylactic gastrostomy as considered better approach
Taking the pressure off the patient with prophylactic gastrostomy tube
Viewing reactive feeding-tube placement as potential risk of treatment delays
Assessing whether a patient will be able to manage a feeding tube at home
Being concerned about the risk of tube dependence
Believing that patient motivation to adhere to swallow exercises is a consideration for gastrostomy tube to fear of tube dependence
Considering a dietitian’s pre-treatment nutritional assessment and need for early feeding-tube support
Considering a patient’s planned treatment and potential nutritional impact
Considering a prophylactic tube for patients with pre-treatment swallow issues
Considering mucosal dose and nutritional impact as need for a prophylactic tube
Considering multi-modality treatments and nutritional impact as need for a prophylactic tube
Considering nodal dose and nutritional impact as need for prophylactic tube
Considering patient willingness and ability to implement feeding tube recommendations
Considering whether a patient can manage a feeding tube financially
Determining patient preferences regarding feeding-tube placement
Determining whether a patient has lost weight prior to treatment
Determining whether a patient has social support to help with tube feeding
Encouraging swallow therapy throughout treatment
Experiencing that patients can also become dependent on NGT
Feeling that gastrostomy concerns are out of proportion based on own experiences
Getting patients off NGT is easier than gastrostomy
Learning of and experiencing more swallow dysfunction
Limiting gastrostomy-tube placements for fear of tube dependence
Linking a patient’s tumour characteristics with nutritional risk and need for a prophylactic tube
Linking treatment location with nutritional impact symptoms and need for a feeding tube
Preferring reactive approach to prevent swallow dysfunction
Trying to predict side effects based on several factors to assess whether a prophylactic feeding tube should be recommended
Being able to closely monitor need for reactive feeding tube with routine dietetic support
Being able to closely monitor nutritional status and need for feeding tube via team meeting as
Determining whether clinic facilities are available to support patients with IV fluids in department should they become nutritionally
comprised during treatment necessary for reactive approach
Having access to a speech pathologist for swallow therapy to manage risk of gastrostomy-related swallow dysfunction
Having access to dietitian for feeding-tube management and support
Having opportunities for collaborative decision-making and support around enteral feeding
Having staff available to set up IV fluids and place feeding tubes should patients require it reactively
Needing ways to appropriately manage patients with feeding tubes
Wanting patients to continue swallowing through treatment

HNC= head and cancer; IV= intravenous, NGT = nasogastric tube
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APPENDIX 7: Outline of the coding-tree from Study 4b (Chapter 8)
Table 1. Coding tree of categories, sub-categories and focused codes related to healthcare professionals’ perspectives of the role of the dietitian within head and neck
cancer teams
Categories
The expert on
nutritional
care

Sub-categories

Focused codes

Dietetic training and
accreditation

Assessing intake as key role of dietitian
Assessing weight loss viewed as a dietetic skill
Contributing to holistic patient assessment
Contributing to patient plans
Developing strategies for patient to meet nutritional targets
Educating patients on nutrition
Establishing nutritional goals
Having an awareness of dietetic skills through assumptions about dietetic training
Identifying scope-of-practice boundaries of dietitians based on dietetic credential
Leading nutritional assessment and prescription
Making assumptions about dietetic skills based on understanding of dietetic training
Providing important information on patients’ hydration status
Providing nutritional prescriptions
Recognising dietitians as experts on diet

Patient priorities

Aligning nutritional goals with radiotherapy goals
Contributing to overarching treatment goals through supportive care
Contributing to recovery
Contributing to the prevention of treatment delays
Helping to keep patients as outpatients
Helping to manage the burden on the health service
Identifying a relationship between treatment tolerance, outcomes and nutrition
Promoting patient independence and self-management
Promoting quality of life with the inclusion of nutritional care
Supporting patients through treatment
Viewing dietitians because of nutritional burden associated with HNC and its treatment
Valuing dietetic input to support patients and their medical goals
Adapting the dietitian’s role around the nutritional skills of radiation oncologists
Appreciating being able to distribute patient care
Complementing the knowledge of the medical team

Gap in medical
knowledge
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Filling a gap in medical training and knowledge
Going to dietitians for advice on patient’s nutrition
Having complex patients that need interprofessional approach
Recognising nutritional knowledge limitations of medical professionals (physicians and nurses)
Sharing the workload
Valuing dietitians focus on nutrition
Viewing dietitians as the expert on nutrition
The
delineation of
nutritional
care
The role of

Dietetic experience

Acknowledging lack of specialist training programs for dietitians
Becoming familiar with other members of the team
Becoming more familiar with nutritional priorities of HNC patients through experience
Developing trust and professional relationships through experience
Being able to provide objectivity to side-effect burden through nutritional assessment
Gaining experience is a way to have specialist HNC knowledge
Increasing awareness of anti-cancer treatment
Learning how to best prioritise HNC patients
Linking level of experience to autonomy within the team
Providing more tailored interventions
Understanding the patient journey through experience

Nutrition-care
gatekeeping

Balancing the experience of allied health professionals with the authority of junior physcians
Being unable to review patients until confirmed to be receiving treatment from a particular oncologist or centre
Describing physicians as the directors and overseers of care
Having a blanket referral to dietitians for HNC patients
Limiting dietetic autonomy due to liability requirements regarding patient responsibility
Needing a referral to initiate dietetic review
Needing approval for enteral formula prescription
Needing medical support to approve and place feeding tubes
Nurses being the coordinators of care
Nurses being the link between physicians, patients and dietitians
Overlapping roles related to nutritional care between physicians, nurses and dietitians
Physicians advocacy for dietitian position
Providing nutritional-care recommendations for approval by a physician
Requiring a referral from a physician or nurse
Requiring physicians and nurses to initiate nutritional intervention
Screening patients during a physician’s weekly on-treatment-review to determine dietetic input
Waiting to receive a referral before reviewing a patient
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Clinic structure

Being limited to traditional models of care because of funding structure
Having dedicated space for dietitians to review patients
Having weekly dietetic review as standard
Providing dietitian with specific clinic space to promote autonomy
Providing opportunities for interprofessional collaboration through joint clinics
Requiring referral to initiate dietetic review
Scheduling weekly dietetic reviews pre-emptively

Culture

Becoming more accepting of nutrition
Being resistant to change
Being unfamiliar with non-physician led models of care
Becoming more interdisciplinary
Gaining more experience of benefits of nutritional care for patients
Improving attitudes toward nutrition care
Promoting outcomes such as quality of life
Resisting move away from traditional models of care
Seeing value in non-physician-led clinic structures
Shifting healthcare models to be more holistic

National evidence-based
guidelines

Gaining more support for dietitians with the presence of evidence-based guidelines
Growing evidence base on benefit of supportive care and multidisciplinary approach
Growing evidence base on positive outcomes associated with non-traditional nursing and or allied health-led clinic structures
Having national evidence-based guidelines as a way of promoting consistency in dietetic care
Identifying variability in dietetic involvement in different settings related to a lack of evidence-based guidelines
Needing colleagues and executives to recognise dietetics an evidence-based profession
Needing more evidence to support shift away from traditional physician led structures

HNC= head and neck cancer
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APPENDIX 8: Outline of the coding-tree from Study 4c (Chapter 9)
Table 1. Coding tree of categories, sub-categories and focused codes related to healthcare professionals’ perceptions of interprofessional collaborative nutritional
care for patients with head and neck cancer
Categories
Access to
dietitians

Communication

Sub-categories

Focused codes

Funding for dietitians

Advocating to obtain funding for a permanent full-time dietitian position
Being limited by funding for dietetic positions
Being limited by staffing, working hours and other patient load responsibilities
Following up patients’ nutrition post-treatment is limited by funding/ dietetic staffing
Funding limited by nutritional knowledge among executive staff
Funding linked with being able to have access to dietitian and thus collaborate with them
Having adequate staffing for dietitians to review patients more than once weekly when needed
Having dietitians advocate for more funding
Improvements in amount of funding for dietitians over recent years
Needing executive staff to have awareness of the skills of the dietitian and benefit for patients
Needing funding for dietetic positions to promote collaborative nutritional care
Seeing dietitians as a relatively new profession in the healthcare setting that may not be properly understood at the executive level

Strength of evidence

Growing evidence base on benefit of supportive care and multidisciplinary approach
Growing evidence base on positive outcomes associated with non-traditional nursing and or allied health-led clinic structures
Having national evidence-based guidelines as a way of promoting consistency in dietetic care
Identifying that more research is needed to support funding for dietitian positions
Linking the availability of funding with the strength of and awareness of nutritional evidence
Needing executives to be aware of nutritional needs of HNC patients as means to gain dietetic funding
Needing more research to support the role of the dietitian as a core member of the team
Recognising that executive support for dietitians is connected to the strength of evidence
Being limited by time to implement and maintain routine case conference style meeting
Being limited in treatment-planning meeting to discuss nutritional priorities
Being provided with a protected dedicated space to discuss nutritional priorities
Gaining clarity about the roles of other professionals through face to face meeting to discuss clinical care plans
Gaining role-clarity through understanding dietetic skills and priorities for patients through meeting
Identifying that a dedicated meeting should be implemented for nutritional discussions
Needing opportunities to be able to communicate specifically about nutritional issues
Promoting interprofessional role-clarity through team meetings that involve nutritional care discussions

Team meetings
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Treatment-planning meeting to promote face-to-face interaction
Valuing separate case-conference style meeting to discuss nutritional priorities

Role Clarity

Electronic
communication systems

Overcoming physical barrier through communication systems
Being able to monitor and follow up patients through records kept on medical record
Needing opportunities to communicate when not face-to-face
Paging colleagues when unable to locate them
Providing opportunities for the team to discuss priorities in a timely fashion
Recording and disseminating nutritional plans through electronic record
Referring to dietitian through electronic system
Telephoning to promote communication when face-to-face not possible

Multidisciplinary clinics

Developing joint clinics to promote collaboration
Gaining awareness around professional skills through collaborative care
Having dedicated space for dietitian reviews
Increasing the presence of the dietitian within the team
Prioritising nutritional care because of dietetic presence
Promoting physical proximity between team members
Providing opportunities for face-to-face communication
Reinforcing nutritional messages from the dietitian due to joint consultations
Being limited by staff consistency and time
Building professional relationship through group projects
Developing professional relationships through collaborative research projects
Gaining understanding of disciplinary skills and priorities through journal clubs
Improving the service collaboratively through nonclinical team meetings
Promoting a culture that values nutrition through multidisciplinary education sessions
Sharing disciplinary knowledge through education sessions and journal clubs
Stimulating changes in practice to improve nutritional care through journal clubs

Nonclinical activities

Respect

Being approachable
Communicating openly
Reinforcing nutritional messages and recommendations provided by the dietitian to patients
Developing professional relationships and familiarity over time to promote a culture for collaboration
Escalating care when beyond dietetic scope
Gaining an awareness of other disciplinary skills and responsibilities to facilitate collaboration
Having clarity about the skills and priorities of dietitians
Helping to ensure that patient appointments with dietitians are attended by reminding and encouraging patients
Involving dietitians in nutrition-care discussions
Recognising scope-of-practice boundaries
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Referring patients to dietitians for nutritional advice
Seeking dietetic input with nutritional matters
Understanding the evidence for dietetic support for patients with HNC
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